000005|N05AX0801|Risperdal|töflur|0,5|mg|20|stk|1|þpakki||N05AX08|01.04.2000||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|1645|3073|lyfalmen|V1070|1792|00|20|0|2|Vistor hf|Janssen-Cilag AB|Risperídón||1645||1645|3073 000018|G01AF0501|Pevaryl|krem/sti|0| |15|g|1|sett|krem+3 stílar|G01AF05|01.05.1978||L|A|2|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||00|15|0|4|Vistor hf|Janssen-Cilag AB|Ekónazól||||| 000020|J07AL0201|Prevenar|stl|0| |0,5|ml|1|hgl||J07AL02|01.10.2002||R|K|2|0|0|0|0|WLV|0|0|0|100|USD|6568|9753|lyfalmen|||02|0|0|0|Icepharma hf|Wyeth Lederle Vaccines SA|Hreinsuð pneumococca poly­sakkaríð mótefnavakar (cojugated)||6568||6568|9753 000054|B03XA0103|NeoRecormon|stl|4000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|46610|59897|lyfsjukr|||00|2|0|24|Icepharma hf|Roche|Epóetín||46610||46610|59897 000145|B03XA0103|NeoRecormon|stl|6000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|69805|88775|lyfsjukr|||00|2|0|36|Icepharma hf|Roche|Epóetín||69805||69805|88775 000149|A02BC0102 |Losec|sh-tfl|10|mg|7|stk|1|þpakki||A02BC01|01.09.2009||L|A||0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||00|7|0|4|Vistor hf|AstraZeneca A/S DK|Ómeprazól||||| 000153|A02BC0102 |Losec|sh-tfl|20|mg|7|stk|1|þpakki||A02BC01|01.09.2009||L|A||0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||00|7|0|7|Vistor hf|AstraZeneca A/S DK|Ómeprazól||||| 000159|N05AH0302|Zyprexa Velotab|munndr.t|5|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|11777|16822|lyfalmen|||00|28|0|14|Icepharma hf|Eli Lilly Nederland -|Olanzapín||11777||11777|16822 000166|A07FA0201|Precosa|hylki|250|mg|20|stk|1|glas||A07FA02|01.12.1998||R|A|3|0|0|0|0|LAO|0|0|0|100|SEK|1859|3363|lyfalmen|||00|20|0|5|Vistor hf|Laboratories Biocodex|Saccharomyces boulardii||1859||1859|3363 000182|A07FA0201|Precosa|hylki|250|mg|50|stk|1|glas||A07FA02|01.12.1998||R|A|3|0|0|0|0|LAO|0|0|0|100|SEK|4289|6661|lyfalmen|||00|50|0|12|Vistor hf|Laboratories Biocodex|Saccharomyces boulardii||4289||4289|6661 000184|N05AH0302|Zyprexa Velotab|munndr.t|15|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|35041|45811|lyfalmen|||00|28|0|42|Icepharma hf|Eli Lilly Nederland -|Olanzapín||35041||35041|45811 000193|N05AH0302|Zyprexa Velotab|munnltfl|20|mg|28|stk|1|þpakki||N05AH03|01.12.2003||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|45572|58922|lyfalmen|||00|28|0|56|Icepharma hf|Eli Lilly Nederland -|Olanzapín||45572||45572|58922 000198|N05AH0302|Zyprexa Velotab|munndr.t|10|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|22927|30729|lyfalmen|V0813|30159|00|28|0|28|Icepharma hf|Eli Lilly Nederland -|Olanzapín||22927||22927|30729 000211|J07AL0201|Prevenar|stl|0| |0,5|ml|1|spr|áfyllt sprauta|J07AL02|01.04.2006||R|K|2|0|0|0|0|WLV|0|0|0|100|USD|9553|13804|lyfalmen|||02|0|0|0|Icepharma hf|Wyeth Lederle Vaccines SA|Hreinsuð pneumococca poly­sakkaríð mótefnavakar (cojugated)||9553||9553|13804 000223|G02CX0101|Tractocile|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.12.2006||R|K|2|0|1|0|1|FER|0|0|0|100|DKK|6714|9613|lyfsjukr|||00|1|0|0|Vistor hf|Ferring|Atosíban||6714||6714|9613 000225|QM01AC0601|Metacam|mixtúra|1,5|mg/ml|100|ml|1|fl||QM01AC06|01.05.2004||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|8627|16604|vetalmen|||00|100|0|0|Vistor hf|Boehringer Ingelheim|||8627||8627|16604 000237|G02CX0101|Tractocile|irþ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.12.2006||R|K|2|0|1|0|1|FER|0|0|0|100|DKK|18462|24853|lyfsjukr|||00|5|0|0|Vistor hf|Ferring|Atosíban||18462||18462|24853 000290|G03GA0601|Puregon|stl|300|ae/rörly|0,36|ml|1|pakki||G03GA06|01.02.2002||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|22975|30789|lyfalmen|||00|0|0|1|Vistor hf|N.V. Organon|Follitrópín beta||22975||22975|30789 000315|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|30|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|6102|8737|lyfsjukr|||00|3000|0|3|Icepharma hf|Fresenius Kabi|Elektrólýtar||6102||6102|8737 000316|G03GA0601|Puregon|stl|600|ae/rörly|0,72|ml|1|pakki||G03GA06|01.02.2002||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|45574|58925|lyfalmen|||00|1|0|6|Vistor hf|N.V. Organon|Follitrópín beta||45574||45574|58925 000373|N02CC0402|Maxalt Smelt|munnltfl|10|mg|6|stk|1|þpakki||N02CC04|01.03.1999||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|6052|9053|lyfalmen|||00|6|0|6|Icepharma hf|M.S.D.|Rizatriptan||6052||6052|9053 000390|J01CR0202|Augmentin|sts|600|mg/hgl|10|hgl|1|pakki|500+100 mg|J01CR02|01.01.2000||R|A|2|0|0|0|1|GSK|0|0|0|100|IKR|2534|3628|lyfsjukr|||00|10|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||2534||2534|3628 000402|J01CR0202|Augmentin|sts|1200|mg/hgl|5|hgl|1|pakki|1000+200 mg|J01CR02|01.01.2000||R|A|2|0|0|0|1|GSK|0|0|0|100|IKR|2175|3114|lyfsjukr|||00|5|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||2175||2175|3114 000448|D07AC1301|Elocon|húðlausn|0,1|%|100|ml|1|glas||D07AC13|01.03.2009||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|3616|5747|lyfalmen|||0|100|0|100|Vistor hf|Schering-Plough|Mómetasón||||3616|5747 000530|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|20|spr|án nála|J07BF03|01.06.2005||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|31749|41712|lyfalmen|||02|10|0|0|Icepharma hf|Sanofi Pasteur MSD|Mænusótt, dauð veira||31749||31749|41712 000548|S01GX0801|Zaditen|augndr|0,25|mg/ml|5|ml|1|glas||S01GX08|01.07.2001||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|2223|3857|lyfalmen|||06|5|0|0|Vistor hf|Novartis Healthcare A/S-|Ketotifen||2223||2223|3857 000552|G04BE0105|Caverject Dual|sts|20|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|5899|8846|lyfalmen|||23|2|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprostadíl||5899||5899|8846 000555|N03AX1101|Topimax|hylki|15|mg|60|stk|1|plglas||N03AX11|01.05.2001||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|4886|7471|lyfalmen|||00|60|0|3|Vistor hf|Janssen-Cilag AB|Tópíramat||4886||4886|7471 000565|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|20|sk-hyl||S01GX08|01.07.2001||L|A|2|0|0|0|0|NOH|0|0|0|100|IKR|||lyflausa|||00|8|0|0|Vistor hf|Novartis Healthcare A/S-|Ketotifen||||| 000573|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|60|sk-hyl||S01GX08|01.07.2001||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|6092|9108|lyfalmen|||00|24|0|0|Vistor hf|Novartis Healthcare A/S-|Ketotifen||6092||6092|9108 000641|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|100|ml|10|fl||B05BA02|01.04.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|16980|23008|lyfsjukr|||00|1000|0|1|Icepharma hf|Fresenius Kabi|Fitusambönd||16980||16980|23008 000646|C08CA0101|Norvasc|töflur|10|mg|30|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|5200|7897|lyfalmen|||00|30|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Amlódipín||||5200|7897 000770|V08BA0104|E-Z paste|pasta|60|%|1|lbs|1|pakki|til inntöku|V08BA01|01.01.1998||R|A||0|0|0|1|LDR|0|0|0|100|USD|11598|16307|lyfsjukr|||00|1|1|0|Parlogis hf|Parlogis - óskráð lyf|Baríumsúlfat||11598||11598|16307 000784|G04BE0105|Caverject Dual|sts|10|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|4302|6678|lyfalmen|||23|2|0|1|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprostadíl||4302||4302|6678 000801|R06AA0201|Benylan|mixtúra|2,8|mg/ml|125|ml|1|glas||R06AA02|01.05.1999||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|125|0|2|Vistor hf|McNeil Denmark ApS|Dífenhýdramín||||| 000815|R06AA0201|Benylan|mixtúra|1,4|mg/ml|125|ml|1|glas||R06AA02|01.06.2001||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|125|0|1|Vistor hf|McNeil Denmark ApS|Dífenhýdramín||||| 000879|L03AB0702|Rebif|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.01.2001||R|K|2|0|1|0|1|SEN|0|0|0|100|SEK|195864|245718|lyfsjukr|||00|6|0|123|Gróco ehf|Serono Nordic|Interferón beta-1a||195864||195864|245718 000957|H01AC0101|Genotropin|sts|5|mg|1|hgl|1|pakki|+ leysir 1 ml|H01AC01|01.05.2001||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|32954|42895|lyfsjukr|||02|5|0|7|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sómatrópín||32954||32954|42895 001167|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|1|spr||H01CC01|01.05.2001||R|A|2|0|1|0|1|ORG|0|0|0|100|DKK|7177|10276|lyfsjukr|||02|0|0|1|Vistor hf|N.V. Organon|Ganirelix||7177||7177|10276 001194|M01AH0101|Celebra|hylki|200|mg|10|stk|1|þpakki||M01AH01|01.03.2003||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|1947|3483|lyfalmen|||00|10|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Celekoxíb||1947||1947|3483 001225|C10AA0501|Zarator|töflur|80|mg|30|stk|1|þpakki||C10AA05|01.06.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|13437|18914|lyfalmen|||00|30|0|120|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||13437||13437|18914 001239|C10AA0501|Zarator|töflur|80|mg|100|stk|1|þpakki||C10AA05|01.06.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|25713|34198|lyfalmen|||00|100|0|400|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||25713||25713|34198 001291|C07AB0206|Seloken ZOC|forðatfl|23,75|mg|100|stk|1|plglas||C07AB02|01.05.2006||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2701|4506|lyfalmen|||43|100|0|16|Vistor hf|AstraZeneca A/S DK|Metóprólól||2701||2701|4506 001324|C09CA0201|Teveten|töflur|600|mg|98|stk|1|þpakki||C09CA02|01.08.2001||R|A|3|0|0|0|0|SOP|0|0|0|100|XEU|13348|18803|lyfalmen|||00|98|0|98|Icepharma hf|Solvay Pharmaceuticals|Eprosartan||13348||13348|18803 001337|V08CA0901|Gadovist|stl|1|mmol/ml|30|ml|10|hgl||V08CA09|01.12.2003||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|479155|598415|lyfsjukr|||02|300|0|0|Icepharma hf|Bayer Schering Pharma AG|Gadóbútról||479155||479155|598415 001346|C09CA0201|Teveten|töflur|400|mg|56|stk|1|þpakki||C09CA02|01.10.2001||R|A|3|0|0|0|0|SOP|0|0|0|100|XEU|5286|8014|lyfalmen|||00|56|0|37|Icepharma hf|Solvay Pharmaceuticals|Eprosartan||5286||5286|8014 001386|C10AA0102|Sivacor|töflur|10|mg|28|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|1400|1177|lyfalmen|||00|28|0|9|Actavis Group hf|Actavis hf|Simvastatín||248||248|1177 001399|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|5|spr||H01CC01|01.05.2001||R|A|2|0|1|0|1|ORG|0|0|0|100|DKK|36858|47756|lyfsjukr|||02|2|0|5|Vistor hf|N.V. Organon|Ganirelix||36858||36858|47756 001400|C10AA0102|Sivacor|töflur|10|mg|98|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|868|2018|lyfalmen|V0361|2018|00|98|0|33|Actavis Group hf|Actavis hf|Simvastatín||868||868|2018 001409|C10AA0102|Sivacor|töflur|20|mg|28|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|928|2100|lyfalmen|||00|28|0|19|Actavis Group hf|Actavis hf|Simvastatín||928||928|2100 001422|C10AA0102|Sivacor|töflur|20|mg|98|stk|1|glas||C10AA01|01.03.2000|30.09.2009|R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1050|2265|lyfalmen|||00|98|0|65|Actavis Group hf|Actavis hf|Simvastatín||1050||1050|2265 001431|C10AA0102|Sivacor|töflur|40|mg|28|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|2700|4504|lyfalmen|||00|28|0|37|Actavis Group hf|Actavis hf|Simvastatín||2700||2700|4504 001442|C10AA0102|Sivacor|töflur|40|mg|98|stk|1|plglas||C10AA01|01.03.2000||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1630|3052|lyfalmen|V0367|3052|00|98|0|131|Actavis Group hf|Actavis hf|Simvastatín||1630||1630|3052 001490|A10AD0502|NovoMix 30 Penfill|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.08.2002||R|K|2|0|0|*|0|NON|0|0|0|100|DKK|7566|11108|lyfalmen|||02|15|0|38|Vistor hf|Novo-Nordisk|Insulín aspart||7566||7566|11108 001512|C04AD0301|Trental|forðatfl|400|mg|100|stk|1|þpakki||C04AD03|01.05.2002||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|5255|7972|lyfalmen|||10|100|0|40|Vistor hf|Sanofi-aventis Norge AS|Pentoxífýllín||5255||5255|7972 001517|N06AB0308|Fluoxetin Actavis|hylki|20|mg|30|stk|1|þpakki||N06AB03|01.03.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|883|2039|lyfalmen|||10|30|0|30|Actavis Group hf|Actavis hf|Flúoxetín||883||883|2039 001528|N06AB0308|Fluoxetin Actavis|hylki|20|mg|100|stk|1|þpakki||N06AB03|01.03.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2456|4173|lyfalmen|||10|100|0|100|Actavis Group hf|Actavis hf|Flúoxetín||2456||2456|4173 001574|C09AA0209|Enalapril Mylan|töflur|2,5|mg|50|stk|1|þpakki||C09AA02|01.10.2009||R|A||0|0|B|0|PCO|0|0|0|100|SEK|555|1594|lyfalmen|||00|50|1|12|Distica|Distica - óskráð lyf|Enalapríl||555||555|1594 001588|B05BA1014|Kabiven|irl|900|kcal|1026|ml|4|pokar||B05BA10|01.08.2003||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|30399|39714|lyfsjukr|||00|4104|0|0|Icepharma hf|Fresenius Kabi|Blöndur||30399||30399|39714 001599|B03AC0201|Venofer|stl|20|mg/ml|5|ml|5|hgl||B03AC02|01.07.2005||R|A|3|0|0|E|0|VIF|0|0|1|100|CHF|14921|20762|lyfalmen|V0011|20759|00|25|0|5|Vistor hf|Vifor France SA|Járnoxíð (sykurflétta)||14921||14921|20762 001605|B05BA1014|Kabiven|irl|1400|kcal|1540|ml|4|pokar||B05BA10|01.08.2003||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|41198|53159|lyfsjukr|||00|6160|0|6|Icepharma hf|Fresenius Kabi|Blöndur||41198||41198|53159 001622|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|2|pokar||B05BA10|01.08.2003||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|27955|36671|lyfsjukr|||00|5132|0|5|Icepharma hf|Fresenius Kabi|Blöndur||27955||27955|36671 001685|B05AA0108|Albuminativ 200 g/l|irl|200|mg/ml|50|ml|1|hgl||B05AA01|01.03.1981||R|A|5|0|0|0|1|OCT|0|0|0|100|DKK|7851|11241|lyfsjukr|||02|50|0|0|Vistor hf|Octapharma AB|Albúmín||7851||7851|11241 001693|B05AA0108|Albuminativ 200 g/l|irl|200|mg/ml|100|ml|1|hgl||B05AA01|01.03.1981||R|A|5|0|0|0|1|OCT|0|0|0|100|DKK|12538|17477|lyfsjukr|||02|100|0|0|Vistor hf|Octapharma AB|Albúmín||12538||12538|17477 001792|N02BA0109|Alka-Seltzer|freyðit|324|mg|20|stk|1|pakki||N02BA01|01.08.2004||L|A|3|0|0|0|0|BAS|0|0|1|100|IKR|||lyflausa|||00|20|0|2|Vistor hf|Bayer A/S|Acetýlsalicýlsýra||||| 001874|G02AB0101|Methergin|stl|0,2|mg/ml|1|ml|10|lykjur||G02AB01|01.11.2001||R|K|3|0|0|0|1|NOH|0|0|0|100|DKK|1471|2106|lyfsjukr|||02|10|0|10|Vistor hf|Novartis Healthcare A/S-|Metýlergómetrín||1471||1471|2106 001878|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|3|glös||S01EC04|01.11.2001||R|A|2|0|0|*|0|ALC|0|0|0|100|USD|4187|6522|lyfalmen|||06|15|0|75|K.Pétursson hf|Alcon|Brinzólamíð||4187||4187|6522 001889|A02BC0501|Nexium|sh-tfl|20|mg|7|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|1221|2497|lyfalmen|||00|7|0|5|Vistor hf|AstraZeneca A/S DK|Esómeprazól||1221||1221|2497 001894|J05AR0401|Trizivir|filmhtfl|750|mg|60|stk|1|glas|300+150+300 mg|J05AR04|01.08.2003||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|84960|107643|lyfsjukr|||00|60|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|Zídóvúdín, lamívúdín og abacavír||84960||84960|107643 001954|N05AX0802|Rison|töflur|1|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|2358|4040|lyfalmen|V0791|4040|00|60|0|12|Actavis Group hf|Actavis hf|Risperídón||2358||2358|4040 001957|N05AX0802|Rison|töflur|4|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|12969|18331|lyfalmen|V0795|18331|00|60|0|48|Actavis Group hf|Actavis hf|Risperídón||12969||12969|18331 001962|N01BX0401|Capsina|krem|0,75|mg/g|45|g|1|túpa||N01BX04|01.06.1998||R|A|3|0|0|0|0|BIG|0|0|0|100|SEK|5214|7916|lyfalmen|||00|45|0|45|Icepharma hf|Bioglan AB|Capsaicin||5214||5214|7916 001965|N05AX0802|Rison|töflur|2|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|4691|7206|lyfalmen|V0793|7206|00|60|0|24|Actavis Group hf|Actavis hf|Risperídón||4691||4691|7206 001974|J01CA0801|Selexid|töflur|200|mg|100|stk|1|glas||J01CA08|01.10.1990||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|10217|14705|lyfalmen|V0456|14574|43|100|0|33|Vistor hf|LEO Pharma A/S|Pívmecillínam||10217||10217|14705 001980|A02BC0501|Nexium|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|4408|6822|lyfalmen|V0084|6821|00|28|0|19|Vistor hf|AstraZeneca A/S DK|Esómeprazól||4408||4408|6822 001986|N05AX0802|Rison|töflur|3|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|8009|11709|lyfalmen|V0794|11709|00|60|0|36|Actavis Group hf|Actavis hf|Risperídón||8009||8009|11709 001991|A02BC0501|Nexium|sh-tfl|20|mg|56|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|8615|12531|lyfalmen|V0086|12299|0|56|0|37|Vistor hf|AstraZeneca A/S DK|Esómeprazól||8615||8615|12531 002011|A02BC0501|Nexium|sh-tfl|40|mg|7|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|1610|3025|lyfalmen|||00|7|0|9|Vistor hf|AstraZeneca A/S DK|Esómeprazól||1610||1610|3025 002033|A02BC0501|Nexium|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|6031|9025|lyfalmen|||00|28|0|37|Vistor hf|AstraZeneca A/S DK|Esómeprazól||6031||6031|9025 002071|A07EC0204|Asacol|sh-tfl|400|mg|100|stk|1|þpakki||A07EC02|01.01.2000||R|A|2|0|0|B|0|TIL|0|0|0|100|SEK|5523|8335|lyfalmen|||00|100|0|27|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||5523||5523|8335 002169|B05BA1010|Kabiven Peripheral|irþ|0| |2400|ml|2|pokar|3ja hólfa poki |B05BA10|01.02.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|24275|32090|lyfsjukr|||00|4800|0|5|Icepharma hf|Fresenius Kabi|Blöndur||24275||24275|32090 002180|A02BC0501|Nexium|sh-tfl|20|mg|50|stk|1|þpakki|stakskammtar|A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|7372|10845|lyfalmen|||00|50|0|33|Vistor hf|AstraZeneca A/S DK|Esómeprazól||7372||7372|10845 002186|B05BA1010|Kabiven Peripheral|irþ|0| |1920|ml|2|pokar|3ja hólfa poki|B05BA10|01.02.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|21711|28898|lyfsjukr|||00|3840|0|4|Icepharma hf|Fresenius Kabi|Blöndur||21711||21711|28898 002194|B05BA1010|Kabiven Peripheral|irþ|0| |1440|ml|4|pokar|3ja hólfa poki|B05BA10|01.02.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|35527|46099|lyfsjukr|||00|5760|0|6|Icepharma hf|Fresenius Kabi|Blöndur||35527||35527|46099 002197|A02BC0501|Nexium|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|15165|21065|lyfalmen|V0087|21064|00|100|0|67|Vistor hf|AstraZeneca A/S DK|Esómeprazól||15165||15165|21065 002205|A02BC0501|Nexium|sh-tfl|40|mg|50|stk|1|veski|stakskammtar|A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|9619|13894|lyfalmen|||00|50|0|67|Vistor hf|AstraZeneca A/S DK|Esómeprazól||9619||9619|13894 002208|A10AB0504|NovoRapid|stl|100|ae/ml|10|ml|1|hgl||A10AB05|01.04.2006||R|A|2|0|0|*|0|NON|0|0|0|100|DKK|3566|5680|lyfalmen|||02|10|0|25|Vistor hf|Novo-Nordisk|Insúlín aspart||3566||3566|5680 002219|A02BC0501|Nexium|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|21496|28947|lyfalmen|V0089|28523|00|100|0|133|Vistor hf|AstraZeneca A/S DK|Esómeprazól||21496||21496|28947 002265|D05AX0201|Daivonex|krem|50|mcg/g|120|g|1|túpa||D05AX02|01.06.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|8079|11804|lyfalmen|||00|120|0|120|Vistor hf|LEO Pharma A/S|Kalcípótríól||8079||8079|11804 002276|D05AX0201|Daivonex|krem|50|mcg/g|60|g|1|túpa||D05AX02|01.06.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|4703|7223|lyfalmen|||00|60|0|60|Vistor hf|LEO Pharma A/S|Kalcípótríól||4703||4703|7223 002312|D01AE1501|Lamisil|hlaup|10|mg/g|15|g|1|túpa||D01AE15|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|15|0|15|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín||||| 002328|R03DC0301|Singulair|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.08.2002||R|A|2|0|0|B|0|MSD|0|0|0|100|XEU|19527|26496|lyfalmen|||00|98|0|39|Icepharma hf|M.S.D.|Montelúkast||19527||19527|26496 002342|B02BD0204|Helixate NexGen|sts|1000|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAH|0|0|0|100|SEK|117819|148552|lyfsjukr|||00|1|0|2|ZLB Behring AB|Bayer HealthCare AG-|Storkuþáttur VIII||117819||117819|148552 002356|B02BD0204|Helixate NexGen|sts|500|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAH|0|0|0|100|SEK|59182|75549|lyfsjukr|||00|1|0|1|ZLB Behring AB|Bayer HealthCare AG-|Storkuþáttur VIII||59182||59182|75549 002367|B02BD0204|Helixate NexGen|sts|250|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAH|0|0|0|100|SEK|33924|44103|lyfsjukr|||00|1|0|0|ZLB Behring AB|Bayer HealthCare AG-|Storkuþáttur VIII||33924||33924|44103 002391|G03AA1201|Yasmin|töflur|0||63|stk|1|þpakki|3+0,03 mg|G03AA12|01.02.2001||R|A|3|0|0|0|0|BAP|0|0|0|100|SEK|3164|5134|lyfalmen|||00|63|0|84|Icepharma hf|Bayer Schering Pharma AG|Dróspírenón og östrógen||||3164|5134 002405|C09AA0206|Enalapril Merck NM|töflur|2,5|mg|50|stk|1|þpakki||C09AA02|01.10.2007|30.09.2009|R|A||0|0|B|0|PCO|0|0|0|100|SEK|536|1568|lyfalmen|||00|50|1|12|Distica|Distica - óskráð lyf|Enalapríl||536||536|1568 002413|G03AA1204|Yasmin 28|töflur|0| |84|stk|1|þpakki|3+0,03 mg|G03AA12|01.10.2007||R|A|3|0|0|0|0|BAP|0|0|0|100|SEK|3164|5134|lyfalmen|||00|84|0|0|Icepharma hf|Bayer Schering Pharma AG|Dróspírenón og östrógen||3164||3164|5134 002487|R06AX1304|Loritin|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.10.2000||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|10|0|10|Actavis Group hf|Actavis hf|Lóratadín||||| 002499|R06AX1304|Loritin|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.10.2000||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|30|Actavis Group hf|Actavis hf|Lóratadín||||| 002510|R06AX1304|Loritin|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.10.2000||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|1679|3119|lyfalmen|V0984|3119|00|100|0|100|Actavis Group hf|Actavis hf|Lóratadín||1679||1679|3119 002616|S01LA0101|Visudyne|irs|15|mg/hgl|1|hgl|1|pakki||S01LA01|01.12.2000||R|A|4|0|1|0|1|NOO|0|0|0|100|DKK|224808|281753|lyfsjukr|||00|1|0|0|Vistor hf|Novartis Ophthalmics Europe Ltd.|Verteporfin||224808||224808|281753 002659|QP52AA0101|Droncit vet.|sts|57|mg/ml|10|ml|1|hgl|lausn|QP52AA01|01.03.2009||R|A|4|0|0|0|0|BAN|0|0|0|100|DKK|3263|5647|vetorma|||0|10|0|0|Vistor hf|Bayer Animal Health GmbH|||||3263|5647 002754|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|pakki||N07BA01|01.06.2002||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|204|0|7|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 002830|S01ED0106|Timosan Depot|augngel|1|mg/g|5|g|1|glas||S01ED01|01.08.2000||R|A|1,5|0|0|*|0|SAO|0|0|0|100|XEU|1437|2790|lyfalmen|||07|5|0|25|Icepharma hf|Santen Oy|Tímólól||1437||1437|2790 002853|M03AX0101|Botox|sts|100|ae/hgl|1|hgl|1|pakki||M03AX01|01.07.1994||R|K|3|0|1|0|1|ALL|0|0|0|100|SEK|34666|45027|lyfsjukr|||02|1|0|0|Vistor hf|Allergan|Clostridium botulinum toxín-A||34666||34666|45027 002966|G03GA0502|Gonal-f|sts|1050|ae|1|hgl|1|pakki|á 1,75 ml + leysir |G03GA05|01.02.2002||R|A|1|0|1|E|0|SEN|0|0|0|100|SEK|75762|96509|lyfalmen|||00|1|0|14|Gróco ehf|Serono Nordic|Follitrópín alfa||75762||75762|96509 003023|C09DA0104|Cozaar Comp Forte|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.06.2007||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|16138|17109|lyfalmen|||00|98|0|196|Icepharma hf|M.S.D.|Lósartan og þvagræsilyf||11988||11988|17109 003078|N03AX1401|Keppra|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|11951|17058|lyfalmen|||00|100|0|12|Vistor hf|U.C.B|Levetíracetam||11951||11951|17058 003099|L01DB0104|Myocet|irl|50|mg|2|sett|1|pakki||L01DB01|01.07.2006||R|K|1,5|0|1|0|1|ZEP|0|0|0|100|DKK|316157|395483|lyfsjukr|||02|2|0|0|Icepharma hf|Zeneus Pharma Limited-|Doxórúbicín||316157||316157|395483 003112|N03AX1401|Keppra|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|20634|27874|lyfalmen|V1710|27872|00|100|0|25|Vistor hf|U.C.B|Levetíracetam||20634||20634|27874 003158|N03AX1401|Keppra|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|40092|52100|lyfalmen|||00|100|0|50|Vistor hf|U.C.B|Levetíracetam||40092||40092|52100 003164|L01CA0401|Navelbine|hylki|20|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|K|3|0|1|*|0|PFP|0|0|0|100|SEK|10182|14658|lyfalmen|||00|1|0|0|Vistor hf|Pierre Fabre Pharma|Vínorelbín||10182||10182|14658 003175|L01CA0401|Navelbine|hylki|30|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|K|3|0|1|*|0|PFP|0|0|0|100|SEK|15190|21097|lyfalmen|||00|1|0|0|Vistor hf|Pierre Fabre Pharma|Vínorelbín||15190||15190|21097 003195|B03XA0201|Aranesp|stl|10|mcg/spr|0,4|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|21295|28380|lyfsjukr|||00|2|0|9|Vistor hf|Amgen|Darbepóetín alfa||21295||21295|28380 003208|B03XA0201|Aranesp|stl|15|mcg/spr|0,375|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|31724|41364|lyfsjukr|||00|2|0|13|Vistor hf|Amgen|Darbepóetín alfa||31724||31724|41364 003230|B03XA0201|Aranesp|stl|20|mcg/spr|0,5|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|33037|42999|lyfsjukr|||00|2|0|18|Vistor hf|Amgen|Darbepóetín alfa||33037||33037|42999 003238|J07AM0101|Tetavax|stl|40|ae|0,5|ml|1|lykja||J07AM01|01.03.2006||R|K||0|0|0|0|LDR|0|0|1|100|IKR|557|1596|lyfalmen|||00|0|1|0|Parlogis hf|Parlogis - óskráð lyf|||557||557|1596 003252|B03XA0201|Aranesp|stl|30|mcg/spr|0,3|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|48841|62675|lyfsjukr|||00|1|0|27|Vistor hf|Amgen|Darbepóetín alfa||48841||48841|62675 003274|B03XA0201|Aranesp|stl|40|mcg/spr|0,4|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|63988|81533|lyfsjukr|||00|2|0|36|Vistor hf|Amgen|Darbepóetín alfa||63988||63988|81533 003296|B03XA0201|Aranesp|stl|50|mcg/spr|0,5|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|78918|100120|lyfsjukr|||00|2|0|44|Vistor hf|Amgen|Darbepóetín alfa||78918||78918|100120 003298|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.04.2007||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|237924|298083|lyfsjukr|||02|150|0|0|Icepharma hf|Bayer Schering Pharma AG|Gadóbútról||237924||237924|298083 003310|R03AK0701|Symbicort Turbuhaler|innúðadu|164,5|mcg/sk|120|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|9336|13510|lyfalmen|||0|120|0|30|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9336||9336|13510 003318|B03XA0201|Aranesp|stl|60|mcg/spr|0,3|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|94777|119865|lyfsjukr|||00|1|0|53|Vistor hf|Amgen|Darbepóetín alfa||94777||94777|119865 003325|R03AK0702|Symbicort mite Turbuhaler|innúðadu|84,5|mcg/sk|120|sk|1|pakki|80+4,5 mcg/sk|R03AK07|01.08.2002||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|8532|12419|lyfalmen|||00|120|0|15|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||8532||8532|12419 003340|B03XA0201|Aranesp|stl|80|mcg/spr|0,4|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|124967|157451|lyfsjukr|||00|2|0|71|Vistor hf|Amgen|Darbepóetín alfa||124967||124967|157451 003353|L04AA1001|Rapamune|töflur|1|mg|100|stk|1|þpakki||L04AA10|01.04.2004||R|A|1,5|0|1|*|0|WTE|0|0|0|100|USD|67923|86749|lyfalmen|||00|100|0|33|Icepharma hf|Wyeth Europe|Sirolimus||67923||67923|86749 003355|D01AE1501|Lamisil|úðalausn|10|mg/g|15|ml|1|fl|úðalausn á húð|D01AE15|01.04.2002||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|15|0|15|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín||||| 003362|B03XA0201|Aranesp|stl|100|mcg/spr|0,5|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|154198|193844|lyfsjukr|||00|2|0|89|Vistor hf|Amgen|Darbepóetín alfa||154198||154198|193844 003386|B03XA0201|Aranesp|stl|150|mcg/spr|0,3|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|230514|288857|lyfsjukr|||00|1|0|133|Vistor hf|Amgen|Darbepóetín alfa||230514||230514|288857 003395|B03XA0201|Aranesp|stl|300|mcg/spr|0,6|ml|1|spr|áfyllt sprauta|B03XA02|01.12.2003||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|115308|145426|lyfsjukr|||00|1|0|67|Vistor hf|Amgen|Darbepóetín alfa||115308||115308|145426 003423|A10BG0301|Actos|töflur|15|mg|28|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|XEU|4719|7244|lyfalmen|||00|28|0|14|Eli Lilly Danmark A/S|Takeda Europe -|Píóglítazón||4719||4719|7244 003455|A02BB0101|Cytotec|töflur|0,2|mg|60|stk|1|þpakki||A02BB01|01.08.2002||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|4055|6343|lyfalmen|||00|60|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Mísóprostól||4055||4055|6343 003468|C09AA0208|Enalapril|töflur|2,5|mg|100|stk|1|þpakki||C09AA02|01.08.2009||R|A||0|0|B|0|PCO|0|0|0|100|SEK|1178|2439|lyfalmen|||00|100|1|25|Distica|Distica - óskráð lyf|Enalapríl||||1178|2439 003800|A10BG0301|Actos|töflur|15|mg|98|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|XEU|15838|21903|lyfalmen|||00|98|0|49|Eli Lilly Danmark A/S|Takeda Europe -|Píóglítazón||15838||15838|21903 003809|A10BG0301|Actos|töflur|30|mg|28|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|XEU|7256|10687|lyfalmen|||00|28|0|28|Eli Lilly Danmark A/S|Takeda Europe -|Píóglítazón||7256||7256|10687 003831|A10BG0301|Actos|töflur|30|mg|98|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|XEU|23258|31141|lyfalmen|||00|98|0|98|Eli Lilly Danmark A/S|Takeda Europe -|Píóglítazón||23258||23258|31141 003869|R01BA5202|Clarinase|forðatfl|10|mg|10|stk|1|pakki|þp 10+240 mg|R01BA52|01.09.1998||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|1002|2200|lyfalmen|||00|10|0|10|Vistor hf|Schering-Plough|Pseudóefedrín í blöndum||1002||1002|2200 003927|N06AB0602|Sertral|töflur|50|mg|28|stk|1|glas||N06AB06|01.11.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1017|2220|lyfalmen|V0931|2220|00|28|0|28|Actavis Group hf|Actavis hf|Sertralín||1017||1017|2220 003939|M01AB0505|Voltaren|sh-tfl|50|mg|20|stk|1|þpakki||M01AB05|01.03.1984||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|731|1832|lyfalmen|||67|20|0|10|Vistor hf|Novartis Healthcare A/S-|Díklófenak||731||731|1832 003950|N06AB0602|Sertral|töflur|50|mg|98|stk|1|glas||N06AB06|01.11.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|3016|4933|lyfalmen|V0933|4933|00|98|0|98|Actavis Group hf|Actavis hf|Sertralín||3016||3016|4933 003974|J05AE0601|Kaletra|mixtúra|100|mg/ml|60|ml|1|glas|80 + 20 mg/ml|J05AE06|01.08.2003||R|A|2|0|1|0|1|ABL|0|0|0|100|DKK|107952|136268|lyfsjukr|||00|60|0|8|Vistor hf|Abbott Laboratories A/S|Lopinavír||107952||107952|136268 003988|M01AB0505|Voltaren|sh-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.1984||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|2444|4157|lyfalmen|V0608|2237|67|100|0|50|Vistor hf|Novartis Healthcare A/S-|Díklófenak||2444||2444|4157 004002|L04AD0101|Sandimmun|irþ|50|mg/ml|5|ml|10|lykjur||L04AD01|01.10.1985||R|A|4|0|0|0|1|NOH|0|0|0|100|DKK|38071|49266|lyfsjukr|||00|50|0|10|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||38071||38071|49266 004014|N03AF0201|Trileptal|mixtúra|60|mg/ml|250|ml|1|fl||N03AF02|01.01.2002||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|9093|13180|lyfalmen|||00|250|0|15|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||9093||9093|13180 004028|A07DA0301|Imodium|mixtúra|0,2|mg/ml|100|ml|1|fl||A07DA03|01.01.1990||L|A|5|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||00|100|0|2|Vistor hf|Janssen-Cilag AB|Lóperamíð||||| 004050|R03AK0601|Seretide|innúðal|75|mcg/sk|120|skammtar|1|pakki|25+50 mcg/sk|R03AK06|01.10.2002||R|A|1|0|0|B|0|GSK|0|0|0|100|GBP|4395|6805|lyfalmen|||23|120|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||4395||4395|6805 004086|N06AB0601|Zoloft|töflur|25|mg|7|stk|1|þpakki||N06AB06|01.05.2003||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|680|1763|lyfalmen|||00|7|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sertralín||680||680|1763 004111|N05CD0102|Dalmadorm medium|hylki|15|mg|30|stk|1|þpakki||N05CD01|01.12.2000||R|A|5|0|0|0|0|MAB|0|0|1|100|DKK|1217|2492|lyfalmen|||10|30|0|15|Vistor hf|Meda AB|Flúrazepam||1217||1217|2492 004259|N05AE0401|Zeldox|hylki|40|mg|14|stk|1|þpakki|hart hylki|N05AE04|01.03.2003||R|A|4|0|0|0|0|PFI|0|1|0|100|DKK|7105|10482|lyfalmen|||00|14|0|7|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ziprasidon||7105||7105|10482 004282|R03AK0601|Seretide|innúðal|150|mcg/sk|120|skammtar|1|pakki|25+125 mcg/sk|R03AK06|01.10.2002||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|6413|9543|lyfalmen|||23|120|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||6413||6413|9543 004293|R03AK0601|Seretide|innúðal|275|mcg/sk|120|skammtar|1|pakki|25+250 mcg/sk|R03AK06|01.10.2002||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|8926|12953|lyfalmen|||23|120|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||8926||8926|12953 004298|R06AX2701|Aerius|töflur|5|mg|10|stk|1|þpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|861|2009|lyfalmen|||00|10|0|10|Vistor hf|Schering-Plough|Deslóratadín||861||861|2009 004301|N06AX1101|Remeron|mixtúra|15|mg/ml|66|ml|1|fl|lausn|N06AX11|01.01.2003||R|A|2|0|0|B|0|ORG|0|1|0|100|DKK|6810|10082|lyfalmen|||00|66|0|33|Vistor hf|N.V. Organon|Mirtazapín||6810||6810|10082 004352|J02AC0301|Vfend|irs|200|mg|1|hgl|1|pakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|25561|33691|lyfsjukr|||00|1|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Voricónazól||25561||25561|33691 004370|R06AX2701|Aerius|töflur|5|mg|30|stk|1|þpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|1903|3423|lyfalmen|V1901|3420|00|30|0|30|Vistor hf|Schering-Plough|Deslóratadín||1903||1903|3423 004374|A04AA0101|Zofran|töflur|4|mg|10|stk|1|glas||A04AA01|01.01.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|8933|12963|lyfalmen|||0|10|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||8933||8933|12963 004378|R06AX2701|Aerius|töflur|5|mg|100|stk|1|þpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|5321|8061|lyfalmen|||00|100|0|100|Vistor hf|Schering-Plough|Deslóratadín||5321||5321|8061 004388|QJ51RC2501|Benestermycin, vet.|spenalyf|0| |5|ml|20|spr||QJ51RC25|01.12.1978||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|5247|10166|vetalmen|||16|100|0|0|Vistor hf|Boehringer Ingelheim|||5247||5247|10166 004455|N02AX0208|Zytram|forðatfl|75|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|3731|5904|lyfalmen|||00|56|0|14|Icepharma hf|Norpharma |Tramadól||3731||3731|5904 004465|C01DA0801|Sorbangil|töflur|5|mg|100|stk|1|þpakki||C01DA08|01.06.1980||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|744|1850|lyfalmen|||00|100|0|8|Vistor hf|Recip AB|Ísósorbíð dínítrat||744||744|1850 004468|J07BC0203|Vaqta|bóluefni|25|ein|0,5|ml|1|spr|áfyllt spr. án nálar|J07BC02|01.03.2001||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|3664|5813|lyfalmen|||51|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3664||3664|5813 004478|N02AX0208|Zytram|forðatfl|100|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|4976|7593|lyfalmen|||00|56|0|19|Icepharma hf|Norpharma |Tramadól||4976||4976|7593 004487|L01BC0301|Uft|hylki|324|mg|21|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKG|0|0|0|100|DKK|37735|48848|lyfsjukr|||00|21|0|0|Merck AB|Merck KgaA (M)|Tegafur||37735||37735|48848 004489|N02AX0208|Zytram|forðatfl|150|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|7027|10376|lyfalmen|||00|56|0|28|Icepharma hf|Norpharma |Tramadól||7027||7027|10376 004500|N02AX0208|Zytram|forðatfl|200|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|9354|13534|lyfalmen|||00|56|0|37|Icepharma hf|Norpharma |Tramadól||9354||9354|13534 004502|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|0,5|ml|1|dæla|einnota dæla|J07BC01|01.01.1990||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|2124|3723|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsaðir mótefna­vakar||2124||2124|3723 004532|L01BC0301|Uft|hylki|324|mg|35|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKG|0|0|0|100|DKK|62892|80168|lyfsjukr|||00|35|0|0|Merck AB|Merck KgaA (M)|Tegafur||62892||62892|80168 004543|L01BC0301|Uft|hylki|324|mg|42|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKG|0|0|0|100|DKK|75471|95829|lyfsjukr|||00|42|0|0|Merck AB|Merck KgaA (M)|Tegafur||75471||75471|95829 004565|L01BC0301|Uft|hylki|324|mg|28|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKG|0|0|0|100|DKK|50314|64508|lyfsjukr|||00|28|0|0|Merck AB|Merck KgaA (M)|Tegafur||50314||50314|64508 004586|A10BB1201|Amaryl|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.06.2005||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|4899|7489|lyfalmen|||00|90|0|180|Vistor hf|Aventis Pharma |Glímepíríð||4899||4899|7489 004589|N06AB0402|Oropram|töflur|20|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2556|4309|lyfalmen|V0926|4309|00|100|0|100|Actavis Group hf|Actavis hf|Cítalópram||2556||2556|4309 004611|H01AC0104|Saizen|sts|8|mg/hgl|1|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|A|3|0|1|0|1|EME|0|0|0|100|SEK|44420|57170|lyfsjukr|||00|1|0|4|MedFarm ehf|E. Merck AB|Sómatrópín||44420||44420|57170 004612|D06BX0105|Metronidazol Actavis|krem|10|mg/g|25|g|1|túpa||D06BX01|01.07.1987||R|A|2|0|0|0|0|AGT|0|0|1|100|DKK|2207|3835|lyfalmen|||20|25|0|25|Actavis Group hf|Actavis Group hf|Metrónídazól||2207||2207|3835 004613|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|1|ml|1|dæla|einnotadæl|J07BC01|01.01.1990||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|2753|4576|lyfalmen|||00|1|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsaðir mótefna­vakar||2753||2753|4576 004623|J07BC0203|Vaqta|bóluefni|50|ein|1|ml|1|spr|áfyllt spr. án nálar|J07BC02|01.03.2001||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|5473|8268|lyfalmen|||51|1|0|0|Icepharma hf|Sanofi Pasteur MSD|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||5473||5473|8268 004625|N06AB0402|Oropram|töflur|40|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1836|3332|lyfalmen|V0927|3332|00|28|0|56|Actavis Group hf|Actavis hf|Cítalópram||1836||1836|3332 004636|N06AB0402|Oropram|töflur|40|mg|56|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|5188|7881|lyfalmen|V0929|7881|00|56|0|112|Actavis Group hf|Actavis hf|Cítalópram||5188||5188|7881 004645|N06AB0402|Oropram|töflur|40|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|5614|8459|lyfalmen|V0930|8459|00|100|0|200|Actavis Group hf|Actavis hf|Cítalópram||5614||5614|8459 004656|N06AB0402|Oropram|töflur|10|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|776|1893|lyfalmen|V0921|1893|00|28|0|14|Actavis Group hf|Actavis hf|Cítalópram||776||776|1893 004667|N06AB0402|Oropram|töflur|10|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2703|4508|lyfalmen|V0922|4508|00|100|0|50|Actavis Group hf|Actavis hf|Cítalópram||2703||2703|4508 004678|N06AB0402|Oropram|töflur|20|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|926|2097|lyfalmen|V0923|2097|00|28|0|28|Actavis Group hf|Actavis hf|Cítalópram||926||926|2097 004687|A02AA0403|Magnesia "medic"|filmhtfl|500|mg|100|stk|1|glas||A02AA04|01.02.2006||L|A|3|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||00|100|0|0|Vistor hf|Medic Team|Magnesíum hýdroxíð|||||1733 004688|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|7|spr||L04AC03|01.07.2002||R|K|2|0|1|0|1|BIA|0|0|0|100|DKK|49100|62997|lyfsjukr|||00|5|0|7|Vistor hf|Biovitrum AB (publ)|Anakinra||49100||49100|62997 004691|N06AB0402|Oropram|töflur|20|mg|56|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1778|3253|lyfalmen|V0925|3253|00|56|0|56|Actavis Group hf|Actavis hf|Cítalópram||1778||1778|3253 004696|R05DA0901|Dexomet|mixtúra|3|mg/ml|150|ml|1|glas||R05DA09|01.06.2001||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|150|0|5|Actavis Group hf|Actavis hf|Dextrómetorfan||||| 004699|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|28|spr||L04AC03|01.04.2007||R|K|2|0|1|0|1|BIA|0|0|0|100|DKK|189031|237211|lyfsjukr|||00|19|0|28|Vistor hf|Biovitrum AB (publ)|Anakinra||189031||189031|237211 004733|H01AC0104|Saizen|sts|8|mg/hgl|5|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|A|3|0|1|0|1|EME|0|0|0|100|SEK|222103|278386|lyfsjukr|||00|5|0|20|MedFarm ehf|E. Merck AB|Sómatrópín||222103||222103|278386 004746|A10AE0401|Lantus [OptiPen]|stl|100|ein/ml|3|ml|5|rörlyk|fyrir OptiPen|A10AE04|01.06.2004||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|11442|16368|lyfalmen|||00|15|0|38|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||11442||11442|16368 004834|N03AX1201|Neurontin|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|10114|8212|lyfalmen|V0714|8162|0|100|0|17|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gabapentín||5432||5432|8212 004845|N03AX1201|Neurontin|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|13248|10926|lyfalmen|V0715|10855|10|100|0|22|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gabapentín||7432||7432|10926 004855|P01AB0105|Metronidazol Actavis|töflur|250|mg|24|stk|1|þpakki||P01AB01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|746|1853|lyfalmen|||41|24|0|3|Actavis Group hf|Actavis Group hf|Metrónídazól||746||746|1853 004863|R03DX0501|Xolair|sts|150|mg|2|ml|1|hgl|+ leysir, lausn|R03DX05|01.01.2006||R|A|4|0|1|0|1|NOE|0|0|0|100|XEU|79169|100433|lyfsjukr|||00|2|0|9|Vistor hf|Novartis Europharm Ltd|Omalizúmab||79169||79169|100433 004880|J01FA1001|Zitromax|irs|500|mg/hgl|1|hgl|1|pakki||J01FA10|01.05.2003||R|A|3|0|0|0|1|PFI|0|0|0|100|DKK|6222|8908|lyfsjukr|||00|1|0|1|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Azitrómýcín||6222||6222|8908 004888|P01AB0105|Metronidazol Actavis|töflur|500|mg|8|stk|1|glas||P01AB01|01.03.1981||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|442|1440|lyfalmen|||41|8|0|2|Actavis Group hf|Actavis Group hf|Metrónídazól||442||442|1440 004921|P01AB0105|Metronidazol Actavis|töflur|500|mg|14|stk|1|glas||P01AB01|01.01.1988||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|754|1864|lyfalmen|||41|14|0|4|Actavis Group hf|Actavis Group hf|Metrónídazól||754||754|1864 004976|P01AB0105|Metronidazol Actavis|töflur|500|mg|30|stk|1|glas||P01AB01|01.01.1988||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|1426|2776|lyfalmen|||41|30|0|8|Actavis Group hf|Actavis Group hf|Metrónídazól||1426||1426|2776 005048|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|36|0|2|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 005059|N07BA0107|Nicotinell Mint|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|96|0|6|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 005070|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|204|0|14|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 005085|J07AJ5205|Boostrix|stl|0| |0,5|ml|1|spr|áfyllt, dreifa|J07AJ52|01.01.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|1853|3355|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Kíghósti, í blöndum með öðrum toxóíðum||1853||1853|3355 005089|J07AL0103|Pneumovax|stl|0||0,5|ml|1|hgl|lausn|J07AL01|01.11.2008||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|2660|4450|lyfalmen|||00|1|0|0|Icepharma hf|Sanofi Pasteur MSD|Hreinsuð pneumococca poly­sakkaríð mótefnavakar||||2660|4450 005108|G04CA0201|Omnic|forðahlk|0,4|mg|90|stk|1|þpakki||G04CA02|01.08.1998||R|A|4|0|0|E|0|YAM|0|0|0|100|XEU|10071|7795|lyfalmen|V0437|6694|00|90|0|90|Vistor hf|Yamanouchi Europe|Tamsúlósín||5125||5125|7795 005178|J01CF0102|Staklox|hylki|250|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|754|1864|lyfalmen|||10|30|0|4|Actavis Group hf|Actavis hf|Díkloxacillín||754||754|1864 005189|J01CF0102|Staklox|hylki|500|mg|20|stk|1|þpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|763|1876|lyfalmen|||10|20|0|5|Actavis Group hf|Actavis hf|Díkloxacillín||763||763|1876 005200|J01CF0102|Staklox|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1076|2301|lyfalmen|||10|30|0|8|Actavis Group hf|Actavis hf|Díkloxacillín||1076||1076|2301 005241|R03AK0701|Symbicort Turbuhaler|innúðadu|164,5|mcg/sk|360|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|28007|37054|lyfalmen|||00|360|0|90|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||28007||28007|37054 005296|N05AH0401|Seroquel|filmhtfl|300|mg|100|stk|1|þpakki||N05AH04|01.12.2002||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|50731|65345|lyfalmen|||00|100|0|75|Vistor hf|AstraZeneca UK Ltd|Quetíapín||50731||50731|65345 005303|N02CC0303|Zomig Nasal|nefúði|5|mg/sk|5|mg|2|stauk||N02CC03|01.02.2003||R|A|2,5|0|0|E|0|ASZ|0|0|0|100|SEK|3346|5381|lyfalmen|||00|10|0|4|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||3346||3346|5381 005330|D08AG0201|Betadine|áburður|100|mg/ml|500|ml|1|fl|sprittl.|D08AG02|01.09.1982||L|A|3|0|0|0|0|NAP|0|0|0|100|IKR|||lyflausa|||00|500|0|500|Icepharma hf|Napp|Joð/pólývídón||||| 005336|R01AA0704|Otrivin ukonserveret|nefúði|0,5|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.07.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|6|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín||||| 005355|S01AA1301|Fucithalmic|augndr|10|mg/g|0,2|g|12|sk-hyl|2 mg/sk|S01AA13|01.04.1992||R|A|2|0|0|E|0|LEP|0|0|1|100|DKK|1293|2595|lyfalmen|||00|2|0|0|Vistor hf|LEO Pharma A/S|Fúsidínsýra||1293||1293|2595 005363|L02AE0301|Zoladex|vefjalyf|10,8|mg|1|stk|1|glas|+ dæla|L02AE03|01.04.1996||R|A|3|0|1|*|0|ASZ|0|0|0|100|SEK|69949|89271|lyfalmen|||00|1|0|84|Vistor hf|AstraZeneca UK Ltd|Góserelín||69949||69949|89271 005380|L01XD0301|Metvix|krem|160|mg/g|2|g|1|túpa||L01XD03|01.04.2004||R|K|1|0|1|*|0|PHO|0|0|0|100|NOK|45828|59241|lyfalmen|||00|2|0|0|Icepharma hf|PhotoCure ASA|Metýlamínólevúlínat||45828||45828|59241 005390|R03BB0101|Atrovent|innúðal|20|mcg/sk|200|skammtar|1|stauk||R03BB01|01.08.2004||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|1707|3157|lyfalmen|||24|200|0|33|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||1707||1707|3157 005503|N05AH0301|Zyprexa|húðuðtfl|15|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|2|0|0|*|0|ELD|0|1|0|100|XEU|33949|20274|lyfalmen|V0815|17259|00|28|0|42|Icepharma hf|Eli Lilly Nederland -|Olanzapín||14529||14529|20274 005507|M05BA0403|Fosamax vikutafla 70 mg|töflur|70|mg|4|stk|1|þpakki||M05BA04|01.08.2001||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|6090|9105|lyfalmen|||00|4|0|28|Icepharma hf|M.S.D.|Alendrónsýra||6090||6090|9105 005526|N05AH0301|Zyprexa|húðuðtfl|20|mg|28|stk|1|þpakki||N05AH03|01.12.2003||R|A|2|0|0|*|0|ELD|0|1|0|100|XEU|43177|55940|lyfalmen|||00|28|0|56|Icepharma hf|Eli Lilly Nederland -|Olanzapín||43177||43177|55940 005538|G03AA0702|Microgyn|töflur|0| |63|stk|1|þpakki||G03AA07|01.06.1977||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|1228|2507|lyfalmen|V2200|2474|23|63|0|84|Icepharma hf|Bayer Schering Pharma AG|Levónorgestrel og östrógen||1228||1228|2507 005565|M05BA0403|Fosamax vikutafla 70 mg|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.08.2001||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|15111|20998|lyfalmen|||00|12|0|84|Icepharma hf|M.S.D.|Alendrónsýra||15111||15111|20998 005576|R05CA1002|Tussol|mixtúra|0| |150|ml|1|glas||R05CA10|01.10.2001||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||01|150|0|0|Actavis Group hf|Actavis hf|Blöndur||||| 005588|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.01.2003||R|A|2|0|0|B|0|BII|0|0|0|100|DKK|7189|10596|lyfalmen|||00|30|0|30|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||7189||7189|10596 005600|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.01.2003||R|A|2|0|0|B|0|BII|0|0|0|100|DKK|7576|11121|lyfalmen|||0|30|0|30|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||||7576|11121 005606|J07AH0703|NeisVac-C|bóluefni|0| |0,5|ml|1|spr|áfyllt sprauta|J07AH07|01.09.2001||R|K|3,5|0|0|0|0|BAX|0|0|0|100|USD|4209|6552|lyfalmen|||00|0|0|0|Icepharma hf|Baxter|Hreinsuð meningókokka C, poly­sakkaríð mótefnavakar||4209||4209|6552 005624|A10BB0902|Diamicron Uno|töflur|30|mg|30|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|1835|3331|lyfalmen|||00|30|0|6|Icepharma hf|Servier|Glíklazíð||1835||1835|3331 005641|A10BB0902|Diamicron Uno|töflur|30|mg|60|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|3199|5182|lyfalmen|||00|60|0|11|Icepharma hf|Servier|Glíklazíð||3199||3199|5182 005672|A10BB0902|Diamicron Uno|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|8493|12366|lyfalmen|||00|180|0|34|Icepharma hf|Servier|Glíklazíð||8493||8493|12366 005674|A10BB0902|Diamicron Uno|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|4667|7174|lyfalmen|||00|90|0|17|Icepharma hf|Servier|Glíklazíð||4667||4667|7174 005689|B01AC0601|Hjartamagnyl|töflur|75|mg|100|stk|1|plglas||B01AC06|01.06.2007||L|A|2|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||00|100|0|100|Actavis Group hf|Actavis hf|Asetýlsalicýlsýra||||| 005747|G03CA0317|Aerodiol|nefúði|150|mcg/sk|180|skammtar|1|pakki|60 skammtar x 3|G03CA03|01.01.2003||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|7065|10428|lyfalmen|||00|180|0|90|Icepharma hf|Servier|Estradíól||7065||7065|10428 005757|N06AB1001|Cipralex|töflur|5|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|2053|3626|lyfalmen|||00|28|0|14|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||2053||2053|3626 005766|H01CC0201|Cetrotide|sts|0,25|mg/hgl|1|hgl|1|pakki|+ leysir 3 ml|H01CC02|01.09.2001||R|A|2|0|1|0|1|SEN|0|0|0|100|SEK|5299|7587|lyfsjukr|||00|1|0|0|Gróco ehf|Serono Nordic|Cetrorelix||5299||5299|7587 005782|L01BB0501|Fludara|filmhtfl|10|mg|15|stk|1|þpakki||L01BB05|01.11.2002||R|A|3|0|1|0|1|BAP|0|0|0|100|SEK|80935|102632|lyfsjukr|||00|15|0|0|Icepharma hf|Bayer Schering Pharma AG|Flúdarabín||80935||80935|102632 005787|H01CC0201|Cetrotide|sts|0,25|mg/hgl|7|hgl|1|pakki|+ leysir 3 ml|H01CC02|01.09.2001||R|A|2|0|1|0|1|SEN|0|0|0|100|SEK|41549|53596|lyfsjukr|||00|7|0|0|Gróco ehf|Serono Nordic|Cetrorelix||41549||41549|53596 005789|H01CC0201|Cetrotide|sts|3|mg/hgl|1|hgl|1|pakki|+ leysir 3 ml|H01CC02|01.09.2001||R|A|2|0|1|0|1|SEN|0|0|0|100|SEK|41549|53596|lyfsjukr|||00|1|0|0|Gróco ehf|Serono Nordic|Cetrorelix||41549||41549|53596 005790|N06AB1001|Cipralex|töflur|5|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|7632|11197|lyfalmen|||00|100|0|50|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||7632||7632|11197 005812|N06AB1001|Cipralex|töflur|10|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|3619|5752|lyfalmen|V0939|5750|00|28|0|28|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||3619||3619|5752 005822|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|5|l|1|fl||QP54AA01|01.08.2001||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|18979|32844|vetorma|||16|5|0|0|Vistor hf|Merial (MSD)|||18979||18979|32844 005823|N06AB1001|Cipralex|töflur|10|mg|56|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|7372|10845|lyfalmen|||00|56|0|56|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||7372||7372|10845 005836|L01BB0501|Fludara|filmhtfl|10|mg|20|stk|1|þpakki||L01BB05|01.11.2002||R|A|3|0|1|0|1|BAP|0|0|0|100|SEK|90236|114211|lyfsjukr|||00|20|0|0|Icepharma hf|Bayer Schering Pharma AG|Flúdarabín||90236||90236|114211 005845|N06AB1001|Cipralex|töflur|10|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|12137|17296|lyfalmen|V0938|17296|00|100|0|100|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||12137||12137|17296 005867|N06AB1001|Cipralex|töflur|15|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|5813|8729|lyfalmen|||00|28|0|42|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||5813||5813|8729 005872|C09DA0701|MicardisPlus|töflur|52,5|mg|28|stk|1|þpakki|40 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|0|0|BII|0|0|0|100|DKK|3609|5738|lyfalmen|||00|28|0|28|Vistor hf|Boehringer Ingelheim International |Telmisartan og þvagræsilyf||3609||3609|5738 005884|P01BC0201|Lariam|töflur|250|mg|8|stk|1|þpakki||P01BC02|01.01.1993||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|3426|5490|lyfalmen|||59|8|0|2|Icepharma hf|Roche|Meflókvín||3426||3426|5490 005885|N05AH0301|Zyprexa|sts|10|mg|1|hgl|1|pakki||N05AH03|01.02.2004||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|1013|2215|lyfalmen|||00|1|0|1|Icepharma hf|Eli Lilly Nederland -|Olanzapín||1013||1013|2215 005894|C09DA0701|MicardisPlus|töflur|52,5|mg|98|stk|1|þpakki|40 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|0|0|BII|0|0|0|100|DKK|11810|16867|lyfalmen|||00|98|0|98|Vistor hf|Boehringer Ingelheim International |Telmisartan og þvagræsilyf||11810||11810|16867 005902|N06AB1001|Cipralex|töflur|15|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|18790|25579|lyfalmen|||00|100|0|150|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||18790||18790|25579 005910|C09CA0301|Diovan|töflur|80|mg|28|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|4225|6574|lyfalmen|||00|28|0|28|Vistor hf|Novartis Healthcare A/S-|Valsartan||4225||4225|6574 005922|N06AB1001|Cipralex|töflur|20|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|7425|10916|lyfalmen|||00|28|0|56|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||7425||7425|10916 005932|C09CA0301|Diovan|töflur|80|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|10845|13963|lyfalmen|||00|98|0|98|Vistor hf|Novartis Healthcare A/S-|Valsartan||9670||9670|13963 005933|N06AB1001|Cipralex|töflur|20|mg|56|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|14548|20297|lyfalmen|||00|56|0|112|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||14548||14548|20297 005954|C09CA0301|Diovan|töflur|160|mg|28|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|5388|8152|lyfalmen|||00|28|0|56|Vistor hf|Novartis Healthcare A/S-|Valsartan||5388||5388|8152 005976|C09CA0301|Diovan|töflur|160|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|14739|19608|lyfalmen|V1111|6874|00|98|0|196|Vistor hf|Novartis Healthcare A/S-|Valsartan||13994||13994|19608 006000|R07AA0201|Curosurf|innö.guf|80|mg/ml|1,5|ml|1|hgl||R07AA02|01.01.1995||R|K|1,5|0|1|0|1|NYG|0|0|0|100|DKK|97836|123673|lyfsjukr|||00|2|0|1|Gróco ehf|Nycomed Danmark A/S|Náttúrulegir fosfólípíðar||97836||97836|123673 006024|A10AD0501|NovoMix 30 FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.07.2002||R|K|2|0|0|*|0|NON|0|0|0|100|DKK|6640|9851|lyfalmen|||02|15|0|38|Vistor hf|Novo-Nordisk|Insulín aspart||6640||6640|9851 006026|L01XA0208|Carboplatin Mayne|irþ|10|mg/ml|60|ml|1|hgl||L01XA02|01.04.2007||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|38420|49700|lyfsjukr|||00|60|0|0|Icepharma hf|Mayne Pharma Plc|Karbóplatín||38420||38420|49700 006079|J02AX0403|Cancidas|irþ|70|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|K|2|0|1|0|1|MSD|0|0|0|100|XEU|142093|178773|lyfsjukr|||00|1|0|1|Icepharma hf|M.S.D.|Caspofungin||142093||142093|178773 006102|A10AB0501|NovoRapid FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|einnota pennar|A10AB05|01.12.2001||R|A|2,5|0|0|*|0|NON|0|0|0|100|DKK|6441|9581|lyfalmen|||02|15|0|38|Vistor hf|Novo-Nordisk|Insúlín aspart||6441||6441|9581 006111|R07AA0201|Curosurf|innö.guf|80|mg/ml|3|ml|1|hgl||R07AA02|01.01.1995||R|K|1,5|0|1|0|1|NYG|0|0|0|100|DKK|174629|219281|lyfsjukr|||00|3|0|2|Gróco ehf|Nycomed Danmark A/S|Náttúrulegir fosfólípíðar||174629||174629|219281 006115|J02AX0403|Cancidas|irþ|50|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|K|2|0|1|0|1|MSD|0|0|0|100|XEU|91380|115636|lyfsjukr|||00|1|0|1|Icepharma hf|M.S.D.|Caspofungin||91380||91380|115636 006172|S01XA2007|Simplex|augnsm|0| |4|g|1|túpa|paraf+vasel án ullarf.|S01XA20|01.07.2003||R|A||0|0|E|0|LDR|0|0|0|100|IKR|1434|2786|lyfalmen|||00|4|1|0|Parlogis hf|Parlogis - óskráð lyf|Gervitár og aðrar óvirkar sam­setningar||1434||1434|2786 006178|A10AE0402|Lantus [Optiset]|stl|100|ein/ml|3|ml|5|pennar||A10AE04|01.11.2005||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|10143|14605|lyfalmen|||00|15|0|38|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||10143||10143|14605 006212|J01MA0202|Ciproxin|irl|2|mg/ml|100|ml|12|pokar||J01MA02|01.12.2001||R|A|3|0|0|0|1|BAV|0|0|0|100|SEK|44342|57073|lyfsjukr|||00|1200|0|0|Vistor hf|Bayer Schering Pharma AG (V)|Cíprófloxacín||44342||44342|57073 006226|J01MA0202|Ciproxin|irl|2|mg/ml|200|ml|12|pokar||J01MA02|01.12.2001||R|A|3|0|0|0|1|BAV|0|0|0|100|SEK|76237|96783|lyfsjukr|||00|2400|0|0|Vistor hf|Bayer Schering Pharma AG (V)|Cíprófloxacín||76237||76237|96783 006239|J01CF0501|Heracillin|töflur|500|mg|30|stk|1|glas||J01CF05|01.10.1985|31.10.2009|R|A|2|0|0|0|0|REP|0|0|1|100|SEK|2841|4696|lyfalmen|||00|30|0|8|Vistor hf|Recip AB|Flúkloxacillín||||2841|4696 006346|N03AG0101|Depakine|sh-tfl|500|mg|40|stk|1|glas||N03AG01|01.04.1986||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|2867|4731|lyfalmen|||43|40|0|13|Vistor hf|Sanofi-aventis Norge AS|Valpróínsýra||2867||2867|4731 006443|QM01AC0601|Metacam|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.05.2004||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|10125|19458|vetalmen|||00|50|0|0|Vistor hf|Boehringer Ingelheim|||10125||10125|19458 006579|D05AX5201|Daivobet|smyrsli|0| |60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2002||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|8380|12212|lyfalmen|||00|60|0|0|Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||8380||8380|12212 006637|D05AX5201|Daivobet|smyrsli|0| |120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2002||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|14209|19875|lyfalmen|V2001|19874|00|120|0|0|Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||14209||14209|19875 006650|A04AA0301|Navoban|stl|1|mg/ml|5|ml|10|lykjur||A04AA03|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|DKK|40255|52302|lyfalmen|||02|50|0|10|Vistor hf|Novartis Healthcare A/S-|Trópísetrón||40255||40255|52302 006681|N02BE0109|Panodil Hot|skammtar|500|mg|10|skammtar|1|pakki||N02BE01|01.05.2003||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|10|0|2|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||||| 006785|G03AC0303|NorLevo|töflur|750|mcg|2|stk|1|þpakki||G03AC03|01.01.2005||L|A|3|0|0|0|0|LHP|0|0|0|100|IKR|||lyflausa|||23|2|0|0|Gróco ehf|Laboratoire HRA Pharma|Levonorgestrel||||| 006825|A04AA0301|Navoban|hylki|5|mg|5|stk|1|þpakki||A04AA03|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|DKK|17834|24388|lyfalmen|||10|5|0|5|Vistor hf|Novartis Healthcare A/S-|Trópísetrón||17834||17834|24388 006928|C09CA0101|Cozaar|töflur|100|mg|98|stk|1|þpakki||C09CA01|01.05.2002||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|16787|23085|lyfalmen|||00|98|0|196|Icepharma hf|M.S.D.|Lósartan||16787||16787|23085 007099|C10AA0701|Crestor|filmhtfl|10|mg|28|stk|1|þpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|4532|6991|lyfalmen|||00|28|0|28|Vistor hf|AstraZeneca A/S DK|||4532||4532|6991 007104|N05AA0201|Nozinan|töflur|5|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|832|1969|lyfalmen|||00|100|0|2|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||832||832|1969 007123|V03AE0201|Renagel|filmhtfl|800|mg|180|stk|1|glas||V03AE02|01.01.2004||R|A|2|0|0|0|0|GZE|0|0|0|100|XEU|32224|42304|lyfalmen|||00|180|0|22|Vistor hf|Genzyme Europe B.V.|Sevelamer||32224||32224|42304 007126|QJ01CE9002|Mamyzin vet.|sts|10|millj ae|20|hgl|1|pakki|+ leysir|QJ01CE90|01.12.2002||R|A|3|0|0|0|0|BID|0|0|0|100|DKK|27793|53113|vetalmen|||27|20|0|0|Vistor hf|Boehringer Ingelheim Danmark|||27793||27793|53113 007133|C10AA0701|Crestor|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|14417|20134|lyfalmen|||00|98|0|98|Vistor hf|AstraZeneca A/S DK|||14417||14417|20134 007138|N05AA0201|Nozinan|töflur|25|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|2168|3782|lyfalmen|||00|100|0|8|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||2168||2168|3782 007144|C10AA0701|Crestor|filmhtfl|20|mg|28|stk|1|þpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|6790|10055|lyfalmen|||00|28|0|56|Vistor hf|AstraZeneca A/S DK|||6790||6790|10055 007155|C10AA0701|Crestor|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|21605|29083|lyfalmen|V0341|29053|00|98|0|196|Vistor hf|AstraZeneca A/S DK|||21605||21605|29083 007161|N05AA0201|Nozinan|töflur|100|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|7014|10359|lyfalmen|||00|100|0|33|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||7014||7014|10359 007166|C10AA0701|Crestor|filmhtfl|40|mg|28|stk|1|þpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|9014|13073|lyfalmen|||00|28|0|112|Vistor hf|AstraZeneca A/S DK|||9014||9014|13073 007186|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|27869|36882|lyfalmen|||00|98|0|392|Vistor hf|AstraZeneca A/S DK|||27869||27869|36882 007223|B01AD1201|Ceprotin|sts|500|ae/hgl|1|hgl|1|pakki|+ 5 ml leysir|B01AD12|01.02.2002||R|K|2|0|1|0|1|BAX|0|0|0|100|SEK|179775|225687|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter|Prótein C||179775||179775|225687 007268|B01AD1201|Ceprotin|sts|1000|ae/hgl|1|hgl|1|pakki|+ 10 ml leysir|B01AD12|01.02.2002||R|K|2|0|1|0|1|BAX|0|0|0|100|SEK|317566|397237|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter|Prótein C||317566||317566|397237 007278|C08CA0302|Lomir Retard|forðahlk|2,5|mg|30|stk|1|þpakki||C08CA03|01.04.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|2422|4127|lyfalmen|||10|30|0|15|Vistor hf|Novartis Healthcare A/S-|Ísradipín||2422||2422|4127 007292|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|1|glös||S01EE03|01.04.2005||R|A|2|0|0|*|0|ALL|0|0|0|100|SEK|3174|5148|lyfalmen|||00|3|0|30|Vistor hf|Allergan|Bimatóprost||3174||3174|5148 007297|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.04.2002||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|14|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 007337|H01CB0302|Ipstyl Autogel|stl|60|mg/spr|1|spr|1|pakki|einnota sprauta|H01CB03|01.03.2002||R|K|2|0|1|0|1|INP|0|0|0|100|DKK|171624|215539|lyfsjukr|||00|1|0|20|Icepharma hf|Institut Produits Synthése (IPSEN) AB|Lanreótíð||171624||171624|215539 007360|H01CB0302|Ipstyl Autogel|stl|120|mg/spr|1|spr|1|pakki|einnota sprauta|H01CB03|01.03.2002||R|K|2|0|1|0|1|INP|0|0|0|100|DKK|264131|330711|lyfsjukr|||00|1|0|40|Icepharma hf|Institut Produits Synthése (IPSEN) AB|Lanreótíð||264131||264131|330711 007363|H01CB0302|Ipstyl Autogel|stl|90|mg/spr|1|spr|1|pakki|einnota sprauta|H01CB03|01.03.2002||R|K|2|0|1|0|1|INP|0|0|0|100|DKK|229635|287763|lyfsjukr|||00|1|0|30|Icepharma hf|Institut Produits Synthése (IPSEN) AB|Lanreótíð||229635||229635|287763 007375|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.04.2002||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 007378|J01XX0801|Zyvoxid|irl|2|mg/ml|300|ml|10|pokar||J01XX08|01.12.2001||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|149843|188422|lyfsjukr|||00|3000|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Linezolíd||149843||149843|188422 007385|A02BA0205|Zantac|töflur|150|mg|20|stk|1|þpakki||A02BA02|01.09.1983||L|A|5|0|0|0|0|GSK|0|0|0|100|IKR|||lyflausa|||00|20|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín||||| 007424|J01XX0801|Zyvoxid|töflur|600|mg|30|stk|1|þpakki||J01XX08|01.12.2001||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|363370|454263|lyfsjukr|||00|30|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Linezolíd||363370||363370|454263 007434|S01ED5106|Xalcom|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.12.2001||R|K|2|0|0|*|0|PFI|0|0|0|100|DKK|3709|5874|lyfalmen|V0988|5874|06|2|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Tímólól í blöndum||3709||3709|5874 007448|B05XC04|Cernevit|sts|0| |5|ml|10|hgl||B05XC|01.05.2002||R|A|3|0|0|0|1|CPS|0|0|0|100|SEK|8549|12240|lyfsjukr|||02|50|0|0|Icepharma hf|Clintec parenteral SA|||8549||8549|12240 007449|V03AB3401|Fomepizole OPi|irþ|5|mg/ml|20|ml|5|hgl||V03AB34|01.09.2003||R|A|2|0|0|0|1|OPO|0|0|0|100|XEU|138558|174372|lyfsjukr|||00|100|0|0|Swedish Orphan International AB|OPi Orphan Pharma international (S)|||138558||138558|174372 007462|N01AB0801|Sevorane|innönd.l|0| |250|ml|1|plastf||N01AB08|01.03.2002||R|A|3|0|0|0|1|ABS|0|0|0|100|DKK|27964|36683|lyfsjukr|||00|250|0|0|Vistor hf|Abbott Scandinavia AB|Sevóflúran||27964||27964|36683 007494|QP52AA0101|Droncit vet.|hlaup|9|%|6,67|g|1|dæla|til inntöku|QP52AA01|01.04.2002||L|A|2|0|0|0|0|BAN|0|0|0|0|DKK|||vetorma|||16|7|0|0|Vistor hf|Bayer Animal Health GmbH||||||3913 007505|G04BD0702|Detrusitol Retard|forðahlk|1,4|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|7173|10574|lyfalmen|||00|30|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Tólteródín||7173||7173|10574 007516|R03BA0701|Asmanex Twisthaler|innúðadu|200|mcg|60|skammtar|1|pakki||R03BA07|01.04.2003||R|A|2|0|0|B|0|SPL|0|0|0|100|DKK|5693|8566|lyfalmen|||00|60|0|30|Vistor hf|Schering-Plough Europe|Mometasón||5693||5693|8566 007534|C09CA0601|Atacand|töflur|16|mg|28|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|3617|5749|lyfalmen|||00|28|0|56|Vistor hf|AstraZeneca A/S DK|Candesartan||3617||3617|5749 007538|R03BA0701|Asmanex Twisthaler|innúðadu|400|mcg|30|skammtar|1|pakki||R03BA07|01.04.2003||R|A|2|0|0|B|0|SPL|0|0|0|100|DKK|5693|8566|lyfalmen|||00|30|0|30|Vistor hf|Schering-Plough Europe|Mometasón||5693||5693|8566 007540|N02BE0111|Perfalgan|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.08.2003||R|A|2|0|0|0|1|BRS|0|0|0|100|DKK|10449|14877|lyfsjukr|||00|1200|0|4|Vistor hf|Bristol-Myers Squibb|Paracetamól||10449||10449|14877 007541|J07BL0101|Stamaril|bóluefni|0| |0,5|ml|10|lykjur|+leysir|J07BL01|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|24679|32910|lyfalmen|||02|5|0|0|Icepharma hf|Sanofi Pasteur MSD|Gulusótt, veikluð veira||24679||24679|32910 007549|R03BA0701|Asmanex Twisthaler|innúðadu|400|mcg|60|skammtar|1|pakki||R03BA07|01.03.2003||R|A|2|0|0|B|0|SPL|0|0|0|100|DKK|11097|15900|lyfalmen|||00|60|0|60|Vistor hf|Schering-Plough Europe|Mometasón||11097||11097|15900 007559|C09CA0601|Atacand|töflur|16|mg|98|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|11511|16461|lyfalmen|||00|98|0|196|Vistor hf|AstraZeneca A/S DK|Candesartan||11511||11511|16461 007575|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|0| |1000|ml|9|plpok|Exel umbúðir|B05BB02|01.04.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|2905|4159|lyfsjukr|||02|9000|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||2905||2905|4159 007609|C09CA0601|Atacand|töflur|4|mg|28|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|2756|4580|lyfalmen|||00|28|0|14|Vistor hf|AstraZeneca A/S DK|Candesartan||2756||2756|4580 007760|G04BD0702|Detrusitol Retard|forðahlk|2,8|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|8249|12035|lyfalmen|||00|30|0|21|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Tólteródín||8249||8249|12035 007769|G04BD0702|Detrusitol Retard|forðahlk|2,8|mg|100|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|25001|33311|lyfalmen|||00|100|0|70|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Tólteródín||25001||25001|33311 007778|N05AX0802|Rison|töflur|0,5|mg|60|stk|1|glas||N05AX08|01.10.2001||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|1728|3185|lyfalmen|V1075|3185|00|60|0|6|Actavis Group hf|Actavis hf|Risperídón||1728||1728|3185 007852|G02BB0101|NuvaRing|sk-hring|0| |3|stk|1|pakki|með forðaverkun|G02BB01|01.11.2002||R|A|3,3|0|0|0|0|ORG|0|0|0|100|DKK|4596|7077|lyfalmen|||00|3|0|84|Vistor hf|N.V. Organon|Skeiðarinnleg með progestógeni og östrógeni||4596||4596|7077 007878|V07AB0001|Sterilt vatten Baxter Viaflo|leysir|0| |50|ml|50|pokar|leysir f.stungulyf|V07AB00|01.08.2005||L|A|1,5|0|0|0|0|BAM|0|0|0|100|IKR|||lyflausa|||00|2500|0|0|Icepharma hf|Baxter Medical AB|||||| 007889|V07AB0002|Sterilt Vand "Baxter" Viaflo|leysir|0| |100|ml|50|pokar|leysir f.stungulyf|V07AB00|01.02.2006||L|A|1,5|0|0|0|0|BAX|0|0|0|100|IKR|||lyflausa|||00|5000|0|0|Icepharma hf|Baxter|||||| 007920|S01EE0401|Travatan|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.02.2004||R|A|3|0|0|*|0|ALC|0|0|0|100|USD|2369|4055|lyfalmen|||00|2|0|0|K.Pétursson hf|Alcon|||2369||2369|4055 007921|S01GX0901|Opatanol|augndr|1|mg/ml|5|ml|1|glas||S01GX09|01.05.2004||R|A|3|0|0|0|0|ALC|0|0|0|100|USD|1337|2655|lyfalmen|||00|5|0|0|K.Pétursson hf|Alcon|Ólópatadín||1337||1337|2655 007978|B01AD1001|Xigris|irs|20|mg|1|hgl|1|pakki|lausn|B01AD10|01.11.2002||R|K|3|0|1|0|1|ELD|0|0|0|100|XEU|182850|229516|lyfsjukr|||00|1|0|0|Icepharma hf|Eli Lilly Nederland -|Drotrecogin alfa (virkjað)||182850||182850|229516 007986|D07AA0208|Mildison Lipid|krem|10|mg/g|15|g|1|túpa|feitt|D07AA02|01.01.1990||L|A|3|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||20|15|0|15|Vistor hf|Astellas Pharma A/S|Hýdrókortisón||||| 007995|R07AX0101|INOmax|innö.gas|400|ppm|10|l|1|gashyl||R07AX01|01.01.2004||R|A|2|0|1|0|1|AGA|0|0|0|100|XEU|25538|33662|lyfsjukr|||00|10|0|0|Ísaga ehf|AGA AB|Nituroxíð||25538||25538|33662 007997|H02AB0104|Betapred|lausnart|0,5|mg|30|stk|1|glas||H02AB01|01.09.1998||R|A||0|0|E|0|LVE|0|0|1|100|IKR|729|1830|lyfalmen|||00|30|1|10|Lyfjaver ehf|Lyfjaver - óskráð lyf|Betametasón||729||729|1830 008010|B01AD1001|Xigris|irs|5|mg|1|hgl|1|pakki|lausn|B01AD10|01.11.2002||R|K|3|0|1|0|1|ELD|0|0|0|100|XEU|46073|59228|lyfsjukr|||00|1|0|0|Icepharma hf|Eli Lilly Nederland -|Drotrecogin alfa (virkjað)||46073||46073|59228 008023|A10BA0201|Glucophage|töflur|1000|mg|30|stk|1|þpakki||A10BA02|01.01.2002||R|A|3|0|0|*|0|MCK|0|0|0|100|XEU|641|1710|lyfalmen|||00|30|0|15|Icepharma hf|Merck Santé s.a.s.|Metformín||641||641|1710 008028|J05AH0201|Tamiflu|mixtduft|12|mg/ml|1|stk|1|fl|750 mg í flösku|J05AH02|01.11.2002||R|A|2|0|0|0|0|RRL|0|0|0|100|DKK|4069|6362|lyfalmen|||00|1|0|5|Icepharma hf|Roche Registration Limited|Oseltamivír||4069||4069|6362 008058|B05BA1011|Oliclinomel N4 550E|irl|0| |1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|29090|38085|lyfsjukr|||00|6000|0|0|Icepharma hf|Baxter Medical AB|Blöndur||29090||29090|38085 008069|B05BA1011|Oliclinomel N4 550E|irl|0| |2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|36363|47139|lyfsjukr|||00|8000|0|0|Icepharma hf|Baxter Medical AB|Blöndur||36363||36363|47139 008097|N02CC0402|Maxalt Smelt|munnltfl|5|mg|6|stk|1|þpakki||N02CC04|01.03.2003||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|6312|9406|lyfalmen|||00|6|0|3|Icepharma hf|M.S.D.|Rizatriptan||6312||6312|9406 008101|L03AB1001|PegIntron|sts|50|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|106211|134100|lyfsjukr|||00|4|0|27|Vistor hf|Schering-Plough|Peginterferón alfa 2b||106211||106211|134100 008108|L03AB1001|PegIntron|sts|100|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|213528|267710|lyfsjukr|||00|4|0|53|Vistor hf|Schering-Plough|Peginterferón alfa 2b||213528||213528|267710 008131|L03AB1001|PegIntron|sts|80|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|154842|194646|lyfsjukr|||00|4|0|43|Vistor hf|Schering-Plough|Peginterferón alfa 2b||154842||154842|194646 008134|L03AB1001|PegIntron|sts|120|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|176387|221469|lyfsjukr|||00|4|0|64|Vistor hf|Schering-Plough|Peginterferón alfa 2b||176387||176387|221469 008145|L03AB1001|PegIntron|sts|150|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|266072|333127|lyfsjukr|||00|4|0|80|Vistor hf|Schering-Plough|Peginterferón alfa 2b||266072||266072|333127 008194|D07AA0208|Mildison Lipid|krem|10|mg/g|30|g|1|túpa|feitt|D07AA02|01.01.1990||L|A|3|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||20|30|0|30|Vistor hf|Astellas Pharma A/S|Hýdrókortisón||||| 008196|D07AA0208|Mildison Lipid|krem|10|mg/g|100|g|1|túpa|feitt|D07AA02|01.01.1990||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|2332|4005|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|Hýdrókortisón||2332||2332|4005 008197|R06AX2701|Aerius|saft|0,5|mg/ml|120|ml|1|fl||R06AX27|01.10.2002||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|1334|2651|lyfalmen|||00|120|0|12|Vistor hf|Schering-Plough|Deslóratadín||1334||1334|2651 008219|D07AC0101|Betnovat|áburður|1|mg/ml|20|ml|1|glas||D07AC01|01.12.1980||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|300|1247|lyfalmen|||20|20|0|20|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||300||300|1247 008223|B05BA1013|Oliclinomel N6 900E|irl|0| |1000|ml|6|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|38309|49562|lyfsjukr|||00|6000|0|0|Icepharma hf|Baxter Medical AB|Blöndur||38309||38309|49562 008234|B05BA1013|Oliclinomel N6 900E|irl|0| |1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|29913|39109|lyfsjukr|||00|6000|0|0|Icepharma hf|Baxter Medical AB|Blöndur||29913||29913|39109 008243|D07AC0101|Betnovat|áburður|1|mg/g|30|ml|1|glas|í hársvörð|D07AC01|01.01.1985||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|493|1509|lyfalmen|||33|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||493||493|1509 008245|B05BA1013|Oliclinomel N6 900E|irl|0| |2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|37487|48539|lyfsjukr|||00|8000|0|0|Icepharma hf|Baxter Medical AB|Blöndur||37487||37487|48539 008300|C09CA0601|Atacand|töflur|4|mg|98|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|8495|12369|lyfalmen|||00|98|0|49|Vistor hf|AstraZeneca A/S DK|Candesartan||8495||8495|12369 008301|N02AX0209|Tramol-L|forðatfl|100|mg|20|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|1351|2674|lyfalmen|V0733|2674|00|20|0|7|Actavis Group hf|Actavis hf|Tramadól||1351||1351|2674 008318|C09CA0601|Atacand|töflur|8|mg|28|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|2960|4857|lyfalmen|||00|28|0|28|Vistor hf|AstraZeneca A/S DK|Candesartan||2960||2960|4857 008326|D07AC0101|Betnovat|áburður|1|mg/g|100|ml|1|glas|í hársvörð|D07AC01|01.07.1988||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|1299|2603|lyfalmen|||33|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||1299||1299|2603 008334|C09CA0601|Atacand|töflur|8|mg|98|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|9420|13624|lyfalmen|||00|98|0|98|Vistor hf|AstraZeneca A/S DK|Candesartan||9420||9420|13624 008338|N02AX0209|Tramol-L|forðatfl|100|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|4230|6581|lyfalmen|V0734|6581|00|100|0|33|Actavis Group hf|Actavis hf|Tramadól||4230||4230|6581 008360|N02AX0209|Tramol-L|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|6492|9650|lyfalmen|V0736|9650|00|100|0|50|Actavis Group hf|Actavis hf|Tramadól||6492||6492|9650 008368|N02AX0209|Tramol-L|forðatfl|200|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|9829|14179|lyfalmen|V0738|14179|00|100|0|67|Actavis Group hf|Actavis hf|Tramadól||9829||9829|14179 008370|V04CJ0101|Thyrogen|sts|0,9|mg/hgl|2|hgl|1|pakki|lausn|V04CJ01|01.01.2006||R|K|3|0|1|0|1|GEZ|0|0|0|100|XEU|237482|297533|lyfsjukr|||02|2|0|0|Vistor hf|Genzyme BV|Thýrótrópín||237482||237482|297533 008396|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|þpakki||H03AA01|01.05.2002||R|A|3|0|0|B|0|MAC|0|0|0|100|XEU|869|2020|lyfalmen|V0431|2020|00|100|0|33|Actavis Group PTC ehf|Merck KgaA (A) |Levótýroxínnatríum||869||869|2020 008435|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|þpakki||H03AA01|01.05.2002||R|A|3|0|0|B|0|MAC|0|0|0|100|XEU|755|1865|lyfalmen|V0430|1865|00|100|0|67|Actavis Group PTC ehf|Merck KgaA (A) |Levótýroxínnatríum||755||755|1865 008484|QP52AC1303|Zerofen, vet.|mixtúra|10|%|1000|ml|1|plbrús||QP52AC13|01.11.2001||R|A|3|0|0|0|0|CHP|1|0|0|100|USD|5157|8924|vetorma|||00|1000|0|0|Icepharma hf|Chanelle Pharmaceuticals |||5157||5157|8924 008497|QN05CM9203|Chanazine, vet.|stl|10|%|50|ml|1|hgl||QN05CM92|01.11.2001||R|A|5|0|0|0|0|CHP|1|0|0|100|XEU|12520|24020|vetalmen|||00|50|0|0|Icepharma hf|Chanelle Pharmaceuticals |||12520||12520|24020 008498|R06AX2201|Kestine|töflur|10|mg|10|stk|1|þpakki||R06AX22|01.04.1998||L|A|3|0|0|0|0|ALF|0|0|1|100|IKR|||lyflausa|||00|10|0|10|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||||| 008523|R06AX2201|Kestine|töflur|10|mg|100|stk|1|þpakki||R06AX22|01.04.1998||R|A|3|0|0|E|0|ALF|0|0|1|100|NOK|4532|6991|lyfalmen|||00|100|0|100|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||4532||4532|6991 008534|R06AX2201|Kestine|töflur|10|mg|30|stk|1|þpakki||R06AX22|01.04.1998||L|A|3|0|0|0|0|ALF|0|0|1|100|IKR|||lyflausa|||00|30|0|30|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||||| 008545|G03FB0506|NovoFem|filmhtfl|0| |84|stk|1|skífup|1+1mg|G03FB05|01.06.2002||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|3319|5344|lyfalmen|||23|84|0|84|Vistor hf|Novo-Nordisk|Noretísterón og östrógen||3319||3319|5344 008745|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|2|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 008767|L03AB1101|Pegasys|stl|135|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|150924|189768|lyfsjukr|||00|2|0|0|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||150924||150924|189768 008768|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 008782|L03AB1101|Pegasys|stl|180|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|148843|187177|lyfsjukr|||00|2|0|28|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||148843||148843|187177 008785|QP52AC1303|Zerofen, vet.|mixtúra|10|%|500|ml|1|plbrús||QP52AC13|01.11.2001||R|A|3|0|0|0|0|CHP|1|0|0|100|USD|2642|4572|vetorma|||00|500|0|0|Icepharma hf|Chanelle Pharmaceuticals |||2642||2642|4572 008831|D11AX1501|Elidel|krem|1|%|15|g|1|túpa||D11AX15|01.11.2002||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|3534|5636|lyfalmen|||00|15|0|15|Vistor hf|Novartis Healthcare A/S-|Pímekrólímus||3534||3534|5636 008888|C09DA0601|Atacand Plus|töflur|28,5|mg|28|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.01.2001||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|3617|5749|lyfalmen|||00|28|0|56|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||3617||3617|5749 008904|D10AF0101|Dalacin|lausn|10|mg/ml|60|ml|1|glas|Áburður, lausn|D10AF01|01.01.1994||R|A|2,5|0|0|0|0|PFI|0|0|0|100|DKK|2628|4407|lyfalmen|||20|60|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||2628||2628|4407 008927|G04BE0801|Cialis|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|6939|10257|lyfalmen|V1350|10070|00|4|0|8|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||6939|10257 008938|H02AB0104|Betapred|stl|4|mg/ml|1|ml|5|lykjur||H02AB01|01.07.2004||R|A||0|0|0|0|LVE|0|0|1|100|DKK|1302|2425|lyfalmen|||02|5|1|13|Lyfjaver ehf|Lyfjaver - óskráð lyf|Betametasón||1168||1168|2425 008950|G04BE0801|Cialis|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|13670|19204|lyfalmen|V1351|18863|00|8|0|16|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||13670|19204 009065|D11AX1501|Elidel|krem|1|%|30|g|1|túpa||D11AX15|01.11.2002||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|5962|8931|lyfalmen|||00|30|0|30|Vistor hf|Novartis Healthcare A/S-|Pímekrólímus||5962||5962|8931 009079|D11AX1501|Elidel|krem|1|%|100|g|1|túpa||D11AX15|01.11.2002||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|18508|25227|lyfalmen|||00|100|0|100|Vistor hf|Novartis Healthcare A/S-|Pímekrólímus||18508||18508|25227 009192|M01AH0401|Dynastat|sts|40|mg/hgl|5|hgl|1|pakki|+leysir 2ml/lykju |M01AH04|01.06.2002||R|A|3|0|0|0|0|PFL|0|0|1|100|DKK|8436|12288|lyfalmen|||03|5|0|5|Vistor hf|Pfizer Limited|Parekoxíb||8436||8436|12288 009214|M01AH0401|Dynastat|sts|40|mg/hgl|10|hgl|1|pakki||M01AH04|01.06.2002||R|A|3|0|0|0|0|PFL|0|0|1|100|DKK|16015|22124|lyfalmen|||03|10|0|10|Vistor hf|Pfizer Limited|Parekoxíb||16015||16015|22124 009278|J02AC0301|Vfend|töflur|50|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|69978|88990|lyfsjukr|||00|30|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Voricónazól||69978||69978|88990 009282|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|A|3|0|0|0|0|FRP|0|0|0|100|DKK|||lyfalmen|||02|400|0|0|Icepharma hf|Fresenius Kabi||||||1789 009285|D11AX1401|Protopic|smyrsli|0,03|%|30|g|1|túpa||D11AX14|01.07.2003||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|6371|9486|lyfalmen|||00|30|0|0|Vistor hf|Astellas Pharma A/S|Takrólímus||6371||6371|9486 009340|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|0| |20|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|400|0|0|Icepharma hf|Fresenius Kabi|||||| 009409|G03CA0316|Vivelle Dot|forðapl|37,5|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1563|2961|lyfalmen|||23|8|0|21|Vistor hf|Novartis Healthcare A/S-|Estradíól||1563||1563|2961 009443|G03CA0316|Vivelle Dot|forðapl|50|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1680|3120|lyfalmen|||23|8|0|28|Vistor hf|Novartis Healthcare A/S-|Estradíól||1680||1680|3120 009465|G03CA0316|Vivelle Dot|forðapl|75|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1980|3527|lyfalmen|||23|8|0|42|Vistor hf|Novartis Healthcare A/S-|Estradíól||1980||1980|3527 009489|G03CA0316|Vivelle Dot|forðapl|100|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|2278|3932|lyfalmen|||23|8|0|56|Vistor hf|Novartis Healthcare A/S-|Estradíól||2278||2278|3932 009522|N02BE0101|Panodil|eþ-stil|500|mg|10|stk|1|pakki||N02BE01|01.11.1981||L|A|5|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||04|10|0|2|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||||| 009525|B05BD0001|Balance|kvið.sk|1,5|%|2000|ml|4|pokar|lausn|B05BD|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|8623|12346|lyfsjukr|||00|8000|0|8|Icepharma hf|Fresenius Medical Care Deutschland GmbH|||8623||8623|12346 009560|B05BD0001|Balance|kvið.sk|4,25|%|2000|ml|4|pokar|lausn|B05BD|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|7014|10042|lyfsjukr|||00|8000|0|8|Icepharma hf|Fresenius Medical Care Deutschland GmbH|||7014||7014|10042 009591|B05BD0001|Balance|kvið.sk|2,3|%|2000|ml|4|pokar|lausn|B05BD|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|8623|12346|lyfsjukr|||00|8000|0|8|Icepharma hf|Fresenius Medical Care Deutschland GmbH|||8623||8623|12346 009609|J02AC0301|Vfend|töflur|200|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|271782|340236|lyfsjukr|||00|30|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Voricónazól||271782||271782|340236 009649|D11AX1401|Protopic|smyrsli|0,1|%|30|g|1|túpa||D11AX14|01.07.2003||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|6535|9709|lyfalmen|||00|30|0|0|Vistor hf|Astellas Pharma A/S|Takrólímus||6535||6535|9709 009679|J05AF0701|Viread|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.04.2003||R|A|3|0|1|0|1|GIS|0|0|0|100|DKK|80746|102396|lyfsjukr|||00|30|0|30|Gilead Sience Sweden AB|Gilead Science International ltd.|Tenófóvír dísóproxíl||80746||80746|102396 009688|C09DA0601|Atacand Plus|töflur|28,5|mg|98|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.01.2001||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|11509|16459|lyfalmen|||00|98|0|196|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||11509||11509|16459 009830|B03XA0103|NeoRecormon|stl|20000|ae/spr|0,6|ml|1|spr||B03XA01|01.05.2006||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|47440|60930|lyfsjukr|||00|1|0|20|Icepharma hf|Roche|Epóetín||47440||47440|60930 009881|A10BD0201|Glucovance|filmhtfl|502,5|mg|30|stk|1|þpakki|500+2,5 mg|A10BD02|01.03.2003||R|A|3|0|0|*|0|MCK|0|0|0|100|XEU|965|2150|lyfalmen|||00|30|0|15|Icepharma hf|Merck Santé s.a.s.|Metformin og súlfónamíð||965||965|2150 009900|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk|sjálfs|N01BB03|01.03.1984||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|7548|11083|lyfalmen|||02|180|0|0|Vistor hf|Dentsply Limited|Mepívakaín||7548||7548|11083 009905|N01BB5402|Citanest Dental Octapressin|stl|0| |1,8|ml|100|rörlyk||N01BB54|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|7410|10896|lyfalmen|||00|180|0|0|Vistor hf|Dentsply Limited|||7410||7410|10896 009911|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml|N01BB52|01.12.1983||R|S|2|0|0|0|0|DPL|0|0|1|100|XEU|8643|12569|lyfalmen|||17|180|0|0|Vistor hf|Dentsply Limited|||8643||8643|12569 009913|N06AX1102|Remeron Smelt|munndr.t|15|mg|6|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|630|1695|lyfalmen|||00|6|0|3|Vistor hf|N.V. Organon|Mirtazapín||630||630|1695 009942|N01BB5402|Citanest Dental Octapressin|stl|0| |1,8|ml|100|rörlyk|sjálfsog|N01BB54|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|7995|11690|lyfalmen|||00|180|0|0|Vistor hf|Dentsply Limited|||7995||7995|11690 009945|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml-sjálfsog|N01BB52|01.12.1983||R|S|2|0|0|0|0|DPL|0|0|1|100|XEU|8814|12801|lyfalmen|||17|180|0|0|Vistor hf|Dentsply Limited|||8814||8814|12801 009947|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk||N01BB03|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|6781|10043|lyfalmen|||02|180|0|0|Vistor hf|Dentsply Limited|Mepívakaín||6781||6781|10043 010002|N06AX1102|Remeron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|2677|4473|lyfalmen|V1151|2565|00|30|0|15|Vistor hf|N.V. Organon|Mirtazapín||2677||2677|4473 010035|N06AX1102|Remeron Smelt|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|4749|7285|lyfalmen|V1152|4628|00|30|0|30|Vistor hf|N.V. Organon|Mirtazapín||4749||4749|7285 010057|N06AX1102|Remeron Smelt|munndr.t|45|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|10143|14605|lyfalmen|||00|30|0|45|Vistor hf|N.V. Organon|Mirtazapín||10143||10143|14605 010070|L03AA1301|Neulasta|stl|6|mg/spr|0,6|ml|1|spr|áfyllt sprauta, lausn|L03AA13|01.12.2003||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|195464|245220|lyfsjukr|||00|1|0|20|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||195464||195464|245220 010102|G03GA0502|Gonal-f|sts|75|ae|1|hgl|1|pakki|(5,5 mcg) + leysir|G03GA05|01.04.2003||R|A|1|0|1|E|0|SEE|0|0|0|100|SEK|5426|8204|lyfalmen|||00|1|0|1|Gróco ehf|Serono Europe|Follitrópín alfa||5426||5426|8204 010135|A10BD0201|Glucovance|filmhtfl|505|mg|30|stk|1|þpakki|500+5 mg|A10BD02|01.03.2003||R|A|3|0|0|*|0|MCK|0|0|0|100|XEU|1383|2717|lyfalmen|||00|30|0|15|Icepharma hf|Merck Santé s.a.s.|Metformin og súlfónamíð||1383||1383|2717 010159|G03GA0502|Gonal-f|sts|75|ae|10|hgl|1|pakki|(5,5 mcg) + leysir |G03GA05|01.04.2003||R|A|1|0|1|E|0|SEE|0|0|0|100|SEK|55748|71591|lyfalmen|||00|10|0|10|Gróco ehf|Serono Europe|Follitrópín alfa||55748||55748|71591 010164|G03GA0502|Gonal-f|sts|450|ae|1|hgl|1|pakki|á 0,75ml + leysir|G03GA05|01.04.2003||R|A|1|0|1|E|0|SEE|0|0|0|100|SEK|33451|43831|lyfalmen|||00|1|0|6|Gróco ehf|Serono Europe|Follitrópín alfa||33451||33451|43831 010182|J05AB1401|Valcyte|filmhtfl|450|mg|60|stk|1|plglas||J05AB14|01.11.2002||R|A|3|0|0|0|1|RRL|0|0|0|100|DKK|278723|348878|lyfsjukr|||00|60|0|30|Icepharma hf|Roche Registration Limited|Valgancíklóvír||278723||278723|348878 010187|H01AX0101|Somavert|sts|10|mg|30|hgl|1|pakki|+ leysir|H01AX01|01.02.2004||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|481795|601702|lyfsjukr|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Pegvisómant||481795||481795|601702 010203|B03XA0201|Aranesp|stl|500|mcg/spr|1|ml|1|spr|áfyllt sprauta|B03XA02|01.04.2005||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|186201|233688|lyfsjukr|||00|1|0|111|Vistor hf|Amgen|Darbepóetín alfa||186201||186201|233688 010234|J01DH0301|Invanz|irs|1|g/hgl|1|hgl|1|pakki||J01DH03|01.08.2002||R|A|2|0|1|0|1|MSD|0|0|0|100|XEU|8326|11921|lyfsjukr|||00|1|0|0|Icepharma hf|M.S.D.|Ertapenem||8326||8326|11921 010240|N06AX1102|Remeron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|14743|20540|lyfalmen|V1153|7478|00|96|0|96|Vistor hf|N.V. Organon|Mirtazapín||14743||14743|20540 010254|N06AX1102|Remeron Smelt|munndr.t|45|mg|96|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|20787|28065|lyfalmen|||00|96|0|144|Vistor hf|N.V. Organon|Mirtazapín||20787||20787|28065 010334|N06DX0101|Ebixa|töflur|10|mg|100|stk|1|þpakki||N06DX01|01.10.2002||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|26637|35348|lyfalmen|||00|100|0|50|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||26637||26637|35348 010339|C09DA0701|MicardisPlus|töflur|92,5|mg|28|stk|1|þpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|0|0|BII|0|0|0|100|DKK|4461|6894|lyfalmen|||00|28|0|56|Vistor hf|Boehringer Ingelheim International |Telmisartan og þvagræsilyf||4461||4461|6894 010348|J07BB0203|Vaxigrip|bóluefni|0| |0,5|ml|10|spr|einnotaspr|J07BB02|01.10.1995||R|K|1|0|0|0|0|SPM|0|0|0|100|XEU|10262|14766|lyfalmen|||51|5|0|0|Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsaðir mótefnavakar||10262||10262|14766 010361|C09DA0701|MicardisPlus|töflur|92,5|mg|98|stk|1|þpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|0|0|BII|0|0|0|100|DKK|14411|20127|lyfalmen|||00|98|0|196|Vistor hf|Boehringer Ingelheim International |Telmisartan og þvagræsilyf||14411||14411|20127 010437|QI09AB1301|Stellamune One|stl|0| |100|ml|10|glös|fleyti|QI09AB13|01.09.2008||R|K|3|0|0|0|0|PZR|0|0|0|100|DKK|85035|162150|vetalmen|||00|1000|0|0|Icepharma hf|Pfizer A/S (Í)|||85035||85035|162150 010446|A07EC0204|Asacol|sh-tfl|800|mg|60|stk|1|þpakki||A07EC02|01.01.2003||R|A|2|0|0|B|0|TIL|0|0|0|100|SEK|7589|11139|lyfalmen|||00|60|0|32|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||7589||7589|11139 010464|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|50|pokar|lausn|B05BB01|01.11.2002||R|A|1,5|0|0|0|1|BAM|0|0|0|100|SEK|14610|20057|lyfsjukr|||00|2500|0|0|Icepharma hf|Baxter Medical AB|Elektrólýtar||14610||14610|20057 010534|B05BA0108|Vaminolac|irl|0| |100|ml|10|fl||B05BA01|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|9597|13741|lyfsjukr|||00|1000|0|1|Icepharma hf|Fresenius Kabi|Amínósýrur||9597||9597|13741 010573|S01AX1901|Oftaquix|augndr|5|mg/ml|5|ml|1|glas||S01AX19|01.08.2002||R|A|3|0|0|0|0|SAO|0|0|1|100|XEU|1364|2691|lyfalmen|||00|5|0|0|Icepharma hf|Santen Oy|Levófloxacín||1364||1364|2691 010591|M05BA0702|Optinate Septimum|filmhtfl|35|mg|4|stk|1|þpakki||M05BA07|01.12.2002||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|5837|8761|lyfalmen|||00|4|0|28|Vistor hf|Sanofi-aventis Norge AS|||5837||5837|8761 010669|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|250|ml|30|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|7740|11082|lyfsjukr|||00|7500|0|8|Icepharma hf|Baxter Medical AB|Kolvetni||7740||7740|11082 010672|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|50|pokar|lausn|B05BA03|01.11.2002||R|A|2,5|0|0|0|1|BAM|0|0|0|100|SEK|14193|19538|lyfsjukr|||00|5000|0|5|Icepharma hf|Baxter Medical AB|Kolvetni||14193||14193|19538 010683|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|5402|7734|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|Kolvetni||5402||5402|7734 010691|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|3095|4431|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|Kolvetni||3095||3095|4431 010706|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|3|glös||S01EE03|01.04.2005||R|A|2|0|0|*|0|ALL|0|0|0|100|SEK|8827|12819|lyfalmen|||00|9|0|90|Vistor hf|Allergan|Bimatóprost||8827||8827|12819 010707|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|50|pokar|lausn|B05BB01|01.11.2002||R|A|2,5|0|0|0|1|BAM|0|0|0|100|SEK|14193|19538|lyfsjukr|||00|5000|0|5|Icepharma hf|Baxter Medical AB|Elektrólýtar||14193||14193|19538 010729|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|250|ml|30|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|7791|11155|lyfsjukr|||00|7500|0|8|Icepharma hf|Baxter Medical AB|Elektrólýtar||7791||7791|11155 010740|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|500|ml|20|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|5194|7437|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|Elektrólýtar||5194||5194|7437 010746|M05BA0702|Optinate Septimum|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.12.2002||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|15137|21031|lyfalmen|||00|12|0|84|Vistor hf|Sanofi-aventis Norge AS|||15137||15137|21031 010760|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|1000|ml|10|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|2883|4128|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|Elektrólýtar||2883||2883|4128 010804|C02KX0101|Tracleer|filmhtfl|62,5|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|A|4|0|1|0|1|ACR|0|0|0|100|DKK|480260|599791|lyfsjukr|||00|56|0|14|Swedish Orphan International AB|Actelion Registration Ltd. (S)|Bósentan||480260||480260|599791 010826|C02KX0101|Tracleer|filmhtfl|125|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|A|4|0|1|0|1|ACR|0|0|0|100|DKK|449629|561656|lyfsjukr|||00|56|0|28|Swedish Orphan International AB|Actelion Registration Ltd. (S)|Bósentan||449629||449629|561656 010837|H01AX0101|Somavert|sts|15|mg|30|hgl|1|pakki|+ leysir|H01AX01|01.02.2004||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|720068|898352|lyfsjukr|||00|30|0|45|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Pegvisómant||720068||720068|898352 010848|H01AX0101|Somavert|sts|20|mg|30|hgl|1|pakki|+ leysir|H01AX01|01.02.2004||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|958333|1194992|lyfsjukr|||00|30|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Pegvisómant||958333||958333|1194992 010890|A02BC0107|Lomex-T|sh-tfl|20|mg|28|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|1358|2672|lyfalmen|||10|28|0|28|Actavis Group hf|Actavis hf|Ómeprazól||1350||1350|2672 010900|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.07.1986||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|300|0|20|Icepharma hf|GlaxoSmithKline CH A/S|Klórhexidín||||| 010912|A02BC0107|Lomex-T|sh-tfl|20|mg|100|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|E|0|ACA|0|0|0|100|IKR|4936|7539|lyfalmen|V2171|7539|10|100|0|100|Actavis Group hf|Actavis hf|Ómeprazól||4936||4936|7539 010923|A02BC0107|Lomex-T|sh-tfl|20|mg|56|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|E|0|ACA|0|0|0|100|IKR|3182|4259|lyfalmen|V2170|4259|10|56|0|56|Actavis Group hf|Actavis hf|Ómeprazól||2519||2519|4259 010924|L01DC0103|Bleomycin Baxter|sts|15000|ae|10|hgl|1|pakki||L01DC01|01.04.1998||R|K|3,5|0|1|0|1|BAM|0|0|0|100|SEK|69101|87898|lyfsjukr|||03|10|0|0|Icepharma hf|Baxter Medical AB|Bleómýcín||69101||69101|87898 010935|J01CF0201|Ekvacillin|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.10.2003||R|A|3|0|0|0|1|REP|0|0|0|100|SEK|3240|4639|lyfsjukr|||03|10|0|5|Vistor hf|Recip AB|Kloxacillín||3240||3240|4639 010938|A02BC0304|Lanzo Melt|munndr.t|15|mg|28|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|WAB|0|0|0|100|SEK|3411|5469|lyfalmen|||00|28|0|14|Icepharma hf|Wyeth AB|Lansóprazól||3411||3411|5469 010951|N05AX1201|Abilify|töflur|10|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|23261|31145|lyfalmen|||00|28|0|19|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||23261||23261|31145 010953|N05AX1201|Abilify|töflur|15|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|22990|30808|lyfalmen|||00|28|0|28|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||22990||22990|30808 010959|A01AB0301|Corsodyl|munnh.hl|10|mg/g|50|g|1|túpa||A01AB03|01.09.1982||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|50|0|17|Icepharma hf|GlaxoSmithKline CH A/S|Klórhexidín||||| 011008|N05AX1201|Abilify|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|39605|51493|lyfalmen|V1702|51492|00|56|0|37|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||39605||39605|51493 011019|N05AX1201|Abilify|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|39335|51157|lyfalmen|V1703|51156|00|56|0|56|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||39335||39335|51157 011163|A07EA0601|Entocort|forðahlk|3|mg|100|stk|1|glas||A07EA06|01.10.1996||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|20755|28025|lyfalmen|||00|100|0|33|Vistor hf|AstraZeneca A/S DK|Búdesóníð||20755||20755|28025 011207|M01AH0501|Arcoxia|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|A|3|0|0|E|0|MSD|0|0|1|100|XEU|5186|7878|lyfalmen|||00|28|0|28|Icepharma hf|M.S.D.|Etoríkoxíb||5186||5186|7878 011271|M01AH0501|Arcoxia|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|A|3|0|0|E|0|MSD|0|0|1|100|XEU|5388|8152|lyfalmen|||00|28|0|42|Icepharma hf|M.S.D.|Etoríkoxíb||5388||5388|8152 011314|N06AB1001|Cipralex|töflur|20|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|23374|31286|lyfalmen|V2172|31286|00|100|0|200|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||23374||23374|31286 011335|C09CA0102|Lopress|töflur|12,5|mg|28|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|992|2187|lyfalmen|V0195|2187|00|28|0|7|Actavis Group hf|Actavis hf|Lósartan||992||992|2187 011353|N05AF0502|Cisordinol Depot|stl|500|mg/ml|1|ml|5|lykjur||N05AF05|01.10.1988||R|A|4|0|0|*|0|LBK|0|1|0|100|DKK|14158|19812|lyfalmen|||02|5|0|167|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||14158||14158|19812 011369|C09CA0102|Lopress|töflur|50|mg|28|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|1427|2777|lyfalmen|||00|28|0|28|Actavis Group hf|Actavis hf|Lósartan||1427||1427|2777 011380|C09CA0102|Lopress|töflur|50|mg|98|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|4069|3811|lyfalmen|V0197|3811|00|98|0|98|Actavis Group hf|Actavis hf|Lósartan||2189||2189|3811 011409|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|60|sk|1|pakki|320+9 mcg/sk|R03AK07|01.05.2003||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|9310|13475|lyfalmen|||00|60|0|30|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9310||9310|13475 011453|G04BE0901|Levitra|filmhtfl|5|mg|12|stk|1|þpakki||G04BE09|01.05.2003|31.10.2009|R|A|3|0|0|0|0|BAP|0|0|0|100|XEU|13269|18705|lyfalmen|||00|12|0|6|Vistor hf|Bayer Schering Pharma AG|Vardenafíl||13269||13269|18705 011489|N06BA0402|Concerta|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.01.2003||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|7696|11284|lyfalmen|||00|30|0|18|Vistor hf|Janssen-Cilag AB|Metýlfenídat||7696||7696|11284 011532|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.11.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|9041|12944|lyfsjukr|||02|10000|0|0|Icepharma hf|Baxter Medical AB|Mannitól||9041||9041|12944 011540|N01AX1401|S-Ketamin "Pfizer"|stl|5|mg/ml|5|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|A|3|1|0|0|1|PFI|0|0|0|100|DKK|2779|3979|lyfsjukr|||00|50|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Esketamín||2779||2779|3979 011547|M01AH0501|Arcoxia|filmhtfl|120|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|A|3|0|0|E|0|MSD|0|0|1|100|XEU|6776|10036|lyfalmen|||00|28|0|56|Icepharma hf|M.S.D.|Etoríkoxíb||6776||6776|10036 011555|N06BA0402|Concerta|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.01.2003||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|10054|14484|lyfalmen|||00|30|0|36|Vistor hf|Janssen-Cilag AB|Metýlfenídat||10054||10054|14484 011561|QN05CM9203|Chanazine, vet.|stl|2|%|25|ml|1|hgl||QN05CM92|01.09.2002||R|A|5|0|0|0|0|CHP|1|0|0|100|USD|1662|3280|vetalmen|||00|25|0|0|Icepharma hf|Chanelle Pharmaceuticals |||1662||1662|3280 011609|N01AX1401|S-Ketamin "Pfizer"|stl|25|mg/ml|2|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|A|3|1|0|0|1|PFI|0|0|0|100|DKK|5559|7959|lyfsjukr|||00|20|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Esketamín||5559||5559|7959 011620|G03CA0311|Estrogel|hlaup|0,6|mg/g|64|sk|1|fl|með skammtadælu|G03CA03|01.03.2000||R|A|2|0|0|E|0|OLF|0|0|0|100|SEK|1591|2999|lyfalmen|||00|64|0|29|Gróco ehf|Oy Leiras Finland Ab|Estradíól||1591||1591|2999 011690|J05AB0402|Copegus|töflur|200|mg|168|stk|1|plglas||J05AB04|01.03.2003||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|114883|144897|lyfsjukr|||00|168|0|34|Icepharma hf|Roche Registration Limited|Ribavirin||114883||114883|144897 011810|D11AX1501|Elidel|krem|1|%|60|g|1|túpa||D11AX15|01.11.2002||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|11863|16939|lyfalmen|||00|60|0|60|Vistor hf|Novartis Healthcare A/S-|Pímekrólímus||11863||11863|16939 011863|N06AB0602|Sertral|töflur|100|mg|28|stk|1|glas||N06AB06|01.10.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1773|3246|lyfalmen|V0935|3246|00|28|0|56|Actavis Group hf|Actavis hf|Sertralín||1773||1773|3246 011880|N06AB0602|Sertral|töflur|100|mg|98|stk|1|glas||N06AB06|01.10.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|5098|7759|lyfalmen|V0937|7759|00|98|0|196|Actavis Group hf|Actavis hf|Sertralín||5098||5098|7759 011953|N01BB0103|Marcain spinal|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|4751|6802|lyfsjukr|||02|20|0|0|Vistor hf|AstraZeneca A/S DK|Búpívakaín||4751||4751|6802 011969|N01BB0105|Marcain spinal tung|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|4315|6178|lyfsjukr|||02|20|0|0|Vistor hf|AstraZeneca A/S DK|Búpívakaín||4315||4315|6178 011985|N06DX0101|Ebixa|filmhtfl|10|mg|28|stk|1|þpakki||N06DX01|01.06.2009||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|9202|13328|lyfalmen|||00|28|0|14|Lundbeck Export A/S - útibú Íslandi|H. Lundbeck A/S|Memantín||||9202|13328 011986|C10AA0403|Lescol depot|forðatfl|80|mg|28|stk|1|þpakki||C10AA04|01.06.2004||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|5144|7821|lyfalmen|||00|28|0|37|Vistor hf|Novartis Healthcare A/S-|Flúvastatín||5144||5144|7821 011997|C10AA0403|Lescol depot|forðatfl|80|mg|98|stk|1|þpakki||C10AA04|01.06.2004||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|17708|24231|lyfalmen|||00|98|0|131|Vistor hf|Novartis Healthcare A/S-|Flúvastatín||17708||17708|24231 012030|J05AG0301|Stocrin|töflur|600|mg|30|stk|1|glas||J05AG03|01.01.2003||R|A|2|0|1|0|1|MSD|0|0|0|100|XEU|49304|63251|lyfsjukr|||00|30|0|30|Icepharma hf|M.S.D.|Efavirenz||49304||49304|63251 012209|G04CB0201|Avodart|hylki|0,5|mg|90|stk|1|pakki|mjúk hylki|G04CB02|01.05.2003||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|11994|17117|lyfalmen|||00|90|0|90|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríð||11994||11994|17117 012260|R01AC0301|Lastin|nefúði|1|mg/ml|20|ml|1|glas||R01AC03|01.06.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|1503|2880|lyfalmen|||00|20|0|36|Vistor hf|Meda AB|Azelastínum||1503||1503|2880 012273|G04BE0801|Cialis|filmhtfl|10|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|6916|10226|lyfalmen|||00|4|0|4|Icepharma hf|Lilly ICOS Limited|Tadalafíl||6916||6916|10226 012278|N07BA0106|Nicotinell|forðapl|7|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|7|0|4|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 012309|QP52AA5104|Zantel|töflur|550|mg|20|stk|1|þpakki|50+500 mg|QP52AA51|01.12.2003||R|A|3|0|0|0|0|ICE|0|0|0|100|USD|5835|10098|vetorma|||00|20|0|0|Icepharma hf|Icepharma hf|||5835||5835|10098 012310|A10BB1201|Amaryl|töflur|1|mg|30|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|973|2161|lyfalmen|||00|30|0|15|Vistor hf|Aventis Pharma |Glímepíríð||973||973|2161 012326|N06BA0402|Concerta|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.08.2005||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|11915|17010|lyfalmen|||00|30|0|54|Vistor hf|Janssen-Cilag AB|Metýlfenídat||11915||11915|17010 012461|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 012504|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|2|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 012508|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 012577|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|2|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 012640|QP52AA5104|Zantel|töflur|550|mg|100|stk|1|þpakki|50+500 mg|QP52AA51|01.12.2003||R|A|3|0|0|0|0|ICE|0|0|0|100|USD|27420|47452|vetorma|||00|100|0|0|Icepharma hf|Icepharma hf|||27420||27420|47452 012716|N07BA0106|Nicotinell|forðapl|14|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|7|0|7|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 012738|M05BC0101|InductOs|ígr.sett|12|mg|1|stk|1|pakki||M05BC01|01.09.2003||R|A|3|0|1|0|1|WTE|0|0|0|100|USD|515086|643150|lyfsjukr|||00|1|0|0|Icepharma hf|Wyeth Europe|Díbótermín alfa||515086||515086|643150 012770|G04BE0901|Levitra|filmhtfl|5|mg|4|stk|1|þpakki||G04BE09|01.05.2003|31.10.2009|R|A|3|0|0|0|0|BAP|0|0|0|100|XEU|4731|7261|lyfalmen|||00|4|0|2|Vistor hf|Bayer Schering Pharma AG|Vardenafíl||4731||4731|7261 012792|G04BE0901|Levitra|filmhtfl|10|mg|4|stk|1|þpakki||G04BE09|01.05.2003|31.10.2009|R|A|3|0|0|0|0|BAP|0|0|0|100|XEU|5235|7945|lyfalmen|||00|4|0|4|Vistor hf|Bayer Schering Pharma AG|Vardenafíl||5235||5235|7945 012799|N07BA0106|Nicotinell|forðapl|21|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|7|0|10|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 012816|G04BE0901|Levitra|filmhtfl|10|mg|12|stk|1|þpakki||G04BE09|01.05.2003|31.10.2009|R|A|3|0|0|0|0|BAP|0|0|0|100|XEU|15421|21384|lyfalmen|||00|12|0|12|Vistor hf|Bayer Schering Pharma AG|Vardenafíl||15421||15421|21384 012838|G04BE0901|Levitra|filmhtfl|20|mg|4|stk|1|þpakki||G04BE09|01.05.2003|31.10.2009|R|A|3|0|0|0|0|BAP|0|0|0|100|XEU|6490|9648|lyfalmen|||00|4|0|8|Vistor hf|Bayer Schering Pharma AG|Vardenafíl||6490||6490|9648 012860|G04BE0901|Levitra|filmhtfl|20|mg|12|stk|1|þpakki||G04BE09|01.05.2003|31.10.2009|R|A|3|0|0|0|0|BAP|0|0|0|100|XEU|18765|25547|lyfalmen|||00|12|0|24|Vistor hf|Bayer Schering Pharma AG|Vardenafíl||18765||18765|25547 012880|J01CR0202|Augmentin|mixtduft|62,5|mg/ml|80|ml|1|glas|50+12.5 mg|J01CR02|01.10.1989||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|718|1815|lyfalmen|||08|80|0|4|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||718||718|1815 012921|G03AA1301|Evra|forðapl|0| |9|stk|1|pakki|6 mg+600 mcg|G03AA13|01.11.2003||R|A|2|0|0|0|0|JCI|0|0|0|100|SEK|4770|7314|lyfalmen|||00|9|0|0|Vistor hf|Janssen-Cilag International N.V.|Norelgestromín og östrógen||4770||4770|7314 012953|G03BA0306|Testogel|hlaup|50|mg|30|sk-pokar|1|pakki||G03BA03|01.12.2003||R|A|3|0|0|E|0|LBI|0|0|0|100|SEK|7375|10849|lyfalmen|||00|30|0|30|Icepharma hf|Laboratoires Besins International|Testósterón||7375||7375|10849 013068|N06BA0403|Ritalin Uno|hylki|20|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|7106|10484|lyfalmen|||00|30|0|20|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||7106||7106|10484 013070|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|7792|15014|vetalmen|||00|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||7792||7792|15014 013079|N06BA0403|Ritalin Uno|hylki|40|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|10728|15399|lyfalmen|||00|30|0|40|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||10728||10728|15399 013082|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|2021|3988|vetalmen|||00|20|0|0|Icepharma hf|Pfizer Oy Animal Health|||2021||2021|3988 013097|A02BC0301|Lanzo|munndr.t|15|mg|14|stk|1|þpakki||A02BC03|01.02.2007||R|A|3|0|0|0|0|WAB|0|0|0|100|USD|1303|2609|lyfalmen|||00|14|0|7|Icepharma hf|Wyeth AB|Lansóprazól||1303||1303|2609 013100|R07AX0101|INOmax|innö.gas|400|ppm|2|l|1|gashyl||R07AX01|01.01.2004||R|A|2|0|1|0|1|AGA|0|0|0|100|XEU|25538|33662|lyfsjukr|||00|2|0|0|Ísaga ehf|AGA AB|Nituroxíð||25538||25538|33662 013172|J06BB0101|Rhophylac|stl|1500|ae|2|ml|1|spr||J06BB01|01.02.2004||R|K|3|0|0|0|1|ZLB|0|0|0|100|SEK|10565|15021|lyfsjukr|||17|2|0|0|Icepharma hf|ZLB GmbH|And-D(rh) immúnóglóbúlín||10565||10565|15021 013259|B02BD0901|BeneFIX|sts|0| |250|ae|1|hgl|+leysir|B02BD09|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|USD|34050|44260|lyfsjukr|||00|250|0|1|Icepharma hf|Wyeth Europe|Storkuþáttur IX||34050||34050|44260 013270|B02BD0901|BeneFIX|sts|0| |500|ae|1|hgl|+leysir|B02BD09|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|USD|68104|86657|lyfsjukr|||00|500|0|1|Icepharma hf|Wyeth Europe|Storkuþáttur IX||68104||68104|86657 013302|C02CA0405|Cardosin Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.09.2009||R|A||0|0|E|0|ANO|0|0|0|100|XEU|3881|5500|lyfalmen|V2120|5500|00|100|0|100|Actavis Group PTC hf|Actavis Nordic A/S|doxazósín||3434||3434|5500 013308|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|5118|9920|vetalmen|||00|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||5118||5118|9920 013317|QM01AE9101|Rimadyl vet.|tuggutfl|100|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|12300|23601|vetalmen|||00|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||12300||12300|23601 013328|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|1290|2546|vetalmen|||00|20|0|0|Icepharma hf|Pfizer Oy Animal Health|||1290||1290|2546 013341|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BAL|0|0|0|100|SEK|216736|271704|lyfsjukr|||00|1|0|3|Lyfjaver ehf|Baxter Medical AB (L)|Storkuþáttur VIII||216736||216736|271704 013362|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|36122|46839|lyfsjukr|||00|1|0|0|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||36122||36122|46839 013365|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|144491|181759|lyfsjukr|||00|1|0|2|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||144491||144491|181759 013373|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|70364|89471|lyfsjukr|||00|1|0|2|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||70364||70364|89471 013485|C10AX0901|Ezetrol|töflur|10|mg|98|stk|1|þpakki||C10AX09|01.05.2003||R|A|2|0|0|0|0|MSD|0|0|0|100|XEU|21645|29133|lyfalmen|||00|98|0|98|Icepharma hf|M.S.D.|Ezetimíb||21645||21645|29133 013544|L04AB0401|Humira|stl|40|mg/spr|0,8|ml|2|spr||L04AB04|01.12.2003||R|K|1,5|0|1|0|1|ABB|0|0|0|100|DKK|195346|245073|lyfsjukr|||00|2|0|28|Vistor hf|Abbott|Adalimumab||195346||195346|245073 013551|N02AA0503|Oxynorm|stl|10|mg/ml|1|ml|5|lykjur||N02AA05|01.08.2009||R|A||1|0|0|0|NOP|0|0|0|100|DKK|1404|2746|lyfalmen|||00|5|0|2|Icepharma hf|Norpharma|Oxýcódon||||1404|2746 013593|A01AA3001|Xerodent|munnstfl|0| |90|stk|1|plglas|28,6 mg /0,25 mg|A01AA30|01.01.2008||L|A|2|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||00|90|0|0|Actavis Group hf|Actavis Group hf|Blöndur|||||1367 013628|N02AA0503|Oxynorm|stl|10|mg/ml|2|ml|5|lykjur||N02AA05|01.08.2009||R|A||1|0|0|0|NOP|0|0|0|100|DKK|2697|4500|lyfalmen|||00|5|0|3|Icepharma hf|Norpharma|Oxýcódon||||2697|4500 013672|N03AG0101|Depakine|mixtúra|200|mg/ml|40|ml|1|glas||N03AG01|01.12.1978||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1501|2877|lyfalmen|||00|40|0|5|Vistor hf|Sanofi-aventis Norge AS|Valpróínsýra||1501||1501|2877 013707|N01BB0203|Xylocain|hlaup|20|mg/ml|30|g|1|túpa||N01BB02|01.10.2003||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|406|1391|lyfalmen|||00|30|0|0|Vistor hf|AstraZeneca A/S DK|Lídókaín||406||406|1391 013718|M05BA0801|Zometa|irþ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.05.2004||R|A|3|0|1|0|1|NOE|0|0|0|100|DKK|48921|62774|lyfsjukr|||00|5|0|1|Vistor hf|Novartis Europharm Ltd|||48921||48921|62774 013756|C09DA0307|Diovan Comp 160/25 mg|filmhtfl|185|mg|28|stk|1|þpakki||C09DA03|01.04.2005||R|A|2|0|0|0|0|NOH|0|0|0|100|DKK|5409|8181|lyfalmen|||00|28|0|56|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||5409||5409|8181 013767|C09DA0307|Diovan Comp 160/25 mg|filmhtfl|185|mg|98|stk|1|þpakki||C09DA03|01.04.2005||R|A|2|0|0|0|0|NOH|0|0|0|100|DKK|16341|22530|lyfalmen|||00|98|0|196|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||16341||16341|22530 013802|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|1|lykja||H02AB01|01.08.2009||R|A||0|0|B|0|SPL|0|0|1|100|DKK|1112|2349|lyfalmen|||00|1|0|5|Vistor hf|Schering-Plough Europe|Betametasón||||1112|2349 013861|J01CR0202|Augmentin|töflur|625|mg|20|stk|1|þpakki|500+125 mg|J01CR02|01.01.2003||R|A|3|0|0|0|0|GSK|0|0|1|100|IKR|1215|2489|lyfalmen|V0465|2489|00|20|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1215||1215|2489 013901|A10AC0108|Insulatard InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar spr.|A10AC01|01.02.2002||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|8010|11710|lyfalmen|||00|15|0|38|Vistor hf|Novo-Nordisk|Insúlín (manna)||8010||8010|11710 013909|A10AB0107|Actrapid NovoLet|stl|100|ae/ml|3|ml|5|rörlyk|einnotapen|A10AB01|01.08.2003||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|6223|9285|lyfalmen|||51|15|0|38|Vistor hf|Novo-Nordisk|Insúlín (manna)||6223||6223|9285 013950|A10AB0101|Actrapid|stl|100|ae/ml|10|ml|1|hgl||A10AB01|01.03.2004||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|3049|4978|lyfalmen|||51|10|0|25|Vistor hf|Novo-Nordisk|Insúlín (manna)||3049||3049|4978 013957|A10AC0109|Insulatard FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AC01|01.02.2004||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|5339|8086|lyfalmen|||00|15|0|38|Vistor hf|Novo-Nordisk|Insúlín (manna)||5339||5339|8086 013971|L01XE0101|Glivec|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.05.2004||R|A|2|0|1|0|1|NOE|0|0|0|100|DKK|239015|299441|lyfsjukr|||00|60|0|0|Vistor hf|Novartis Europharm Ltd|Imatiníb||239015||239015|299441 013982|L01XE0101|Glivec|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.05.2004||R|A|2|0|1|0|1|NOE|0|0|0|100|DKK|415510|519177|lyfsjukr|||00|30|0|0|Vistor hf|Novartis Europharm Ltd|Imatiníb||415510||415510|519177 014010|A10AC0103|Insulatard|stl|100|ae/ml|10|ml|1|hgl||A10AC01|01.04.1986||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|3022|4941|lyfalmen|||71|10|0|25|Vistor hf|Novo-Nordisk|Insúlín (manna)||3022||3022|4941 014031|A02BC0501|Nexium|sts|40|mg|5|ml|10|hgl|lausn|A02BC05|01.04.2004||R|A|2|0|0|0|1|AZD|0|0|0|100|SEK|17275|23375|lyfsjukr|||00|50|0|13|Vistor hf|AstraZeneca A/S DK|Esómeprazól||17275||17275|23375 014081|N03AX1401|Keppra|mixtúra|100|mg|300|ml|1|glas||N03AX14|01.12.2006||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|27021|35826|lyfalmen|||00|300|0|20|Vistor hf|U.C.B|Levetíracetam||27021||27021|35826 014094|H05AA0202|Forsteo|stl|250|mcg/ml|3|ml|1|penni|20 mcg/80 mcl|H05AA02|01.11.2003||R|K|2|0|0|0|0|ELD|0|0|0|100|XEU|65891|84219|lyfalmen|||AC|3|0|38|Icepharma hf|Eli Lilly Nederland -|Teriparatíð||65891||65891|84219 014138|B05BA1020|StructoKabiven elektrolyfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|41405|53417|lyfsjukr|||00|5908|0|0|Icepharma hf|Fresenius Kabi|Blöndur||41405||41405|53417 014185|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|180|sk|1|pakki|320+9 mcg/sk|R03AK07|01.08.2009||R|A||0|0|B|0|AZD|0|0|0|100|SEK|27929|36957|lyfalmen|||00|180|0|90|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||||27929|36957 014261|D10AX0302|Finacea|hlaup|15|%|30|g|1|túpa||D10AX03|01.04.2005||R|A|3|0|0|0|0|IGB|0|0|0|100|SEK|1525|2910|lyfalmen|||00|30|0|30|Icepharma hf|Intendis GmbH Berlin|Azelainsýra||1525||1525|2910 014285|B05BA1020|StructoKabiven elektrolyfri|irl|2100|kcal|1970|ml|2|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|25506|33622|lyfsjukr|||00|3940|0|0|Icepharma hf|Fresenius Kabi|Blöndur||25506||25506|33622 014290|S01GX0201|Livostin|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.10.1991||L|A|2|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||29|4|0|0|Vistor hf|Janssen-Cilag AB|Levókabastín||||| 014352|B05BA1015|StructoKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|28018|36750|lyfsjukr|||00|3944|0|0|Icepharma hf|Fresenius Kabi|Blöndur||28018||28018|36750 014361|B05BA1015|StructoKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|36537|47356|lyfsjukr|||00|5908|0|0|Icepharma hf|Fresenius Kabi|Blöndur||36537||36537|47356 014372|B05BA1015|StructoKabiven|irl|2100|kcal|1970|ml|2|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|25506|33622|lyfsjukr|||00|3940|0|0|Icepharma hf|Fresenius Kabi|Blöndur||25506||25506|33622 014415|P01AB0106|Flagyl|mixtúra|40|mg/ml|100|ml|1|flaska||P01AB01|01.08.2009||R|A||0|0|0|0|PCO|0|0|1|100|IKR|2314|3981|lyfalmen|||00|100|1||Distica|Distica - óskráð lyf|Metrónídazól||||2314|3981 014435|QM01AE03  |Dolovet vet.|duft|2,4|g|15|g|3|pokar||QM01AE03|01.06.2009||R|A|3|0|0|0|0|VET|0|0|0|100|XEU|2639|5198|vetalmen|||00|45|0|0|Dýraheilsa ehf|Vetcare Ltd.|||||2639|5198 014453|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.04.1994||R|A|3|0|0|0|0|SCH|0|0|0|100|SEK|18346|25026|lyfalmen|||23|1|0|1825|Icepharma hf|Schering Oy|Plast lyfjalykkja (IUD) með prógestógen||18346||18346|25026 014510|J05AF0801|Hepsera|töflur|10|mg|30|stk|1|glas||J05AF08|01.03.2009||R|A|2|0|1|0|1|GIS|0|0|0|100|DKK|95317|120537|lyfsjukr|||0|30|0|30|Gilead Sience Sweden AB|Gilead Science International ltd.|||||95317|120537 014541|QA02BX1201|Orbeseal|spenalyf|2,6|g/dælu|24|dælur|1|pakki||QA02BX12|01.04.2005||R|A|5|0|0|0|0|PFI|0|0|0|100|XEU|6560|12667|vetalmen|||16|24|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||6560||6560|12667 014583|J05AX0701|Fuzeon|sts|90|mg/ml|60|hgl|1|pakki|+ leysir|J05AX07|01.12.2003||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|325954|407680|lyfsjukr|||00|60|0|0|Icepharma hf|Roche Registration Limited|Enfúvirtíð||325954||325954|407680 014679|N02AA0501|Oxycontin|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.12.2005||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|2777|4609|lyfalmen|||10|28|0|2|Icepharma hf|Norpharma |Oxýcódon||2777||2777|4609 014702|C09CA0601|Atacand|töflur|32|mg|28|stk|1|þpakki||C09CA06|01.06.2005||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|5149|7828|lyfalmen|||00|28|0|112|Vistor hf|AstraZeneca A/S DK|Candesartan||5149||5149|7828 014713|C09CA0601|Atacand|töflur|32|mg|98|stk|1|þpakki||C09CA06|01.06.2005||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|16170|22317|lyfalmen|||00|98|0|392|Vistor hf|AstraZeneca A/S DK|Candesartan||16170||16170|22317 014728|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|78073|99068|lyfsjukr|||00|2|0|4|Vistor hf|Amgen Europe B.V.|Fílgrastím||78073||78073|99068 014739|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|122160|153957|lyfsjukr|||00|2|0|7|Vistor hf|Amgen Europe B.V.|Fílgrastím||122160||122160|153957 014795|C03EA0112|Miloride mite|töflur|27,5|mg|100|stk|1|glas|2,5+25 mg|C03EA01|01.11.2009||R|A||0|0|E|0|MYL|0|0|0|100|SEK|875|2028|lyfalmen|V2175|1055|00|100|0|100|Actavis Group PTC ehf|Mylan AB|Hýdróklórtíazíð og kalíumsparandi lyf||||875|2028 014847|L04AA1801|Certican|töflur|0,25|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|A|3|0|1|*|0|NOV|0|0|0|100|DKK|22243|29878|lyfalmen|||00|60|0|10|Icepharma hf|Novartis Healthcare A/S|Everolímus||22243||22243|29878 014853|L04AA1801|Certican|töflur|0,75|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|A|3|0|1|*|0|NOV|0|0|0|100|DKK|67121|85751|lyfalmen|||00|60|0|30|Icepharma hf|Novartis Healthcare A/S|Everolímus||67121||67121|85751 014859|L04AA1801|Certican|töflur|0,5|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|A|3|0|1|*|0|NOV|0|0|0|100|DKK|44678|57809|lyfalmen|||00|60|0|20|Icepharma hf|Novartis Healthcare A/S|Everolímus||44678||44678|57809 015037|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|90|stk|1|glas||M01AX05|01.10.2006||L|A|2|0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa|||00|90|0|24|Icepharma hf|Pharma Nord ApS|Glúkósamín||||| 015230|R01AC0301|Lastin|nefúði|1|mg/ml|10|ml|1|glas||R01AC03|01.06.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|765|1879|lyfalmen|||00|10|0|18|Vistor hf|Meda AB|Azelastínum||765||765|1879 015301|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|270|stk|1|glas||M01AX05|01.10.2006||L|A|2|0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa|||00|270|0|72|Icepharma hf|Pharma Nord ApS|Glúkósamín||||| 015316|N06AX1103|Miron|filmhtfl|30|mg|100|stk|1|plglas||N06AX11|01.07.2003||R|A|2|0|0|B|0|ACA|0|1|0|100|IKR|4886|7471|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|Mirtazapín||4886||4886|7471 015343|A10AE0501|Levemir FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AE05|01.12.2005||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|9911|14290|lyfalmen|||00|15|0|38|Vistor hf|Novo-Nordisk|Insúlín detemír||9911||9911|14290 015344|N06AX1103|Miron|filmhtfl|30|mg|30|stk|1|plglas||N06AX11|01.07.2003||R|A|2|0|0|B|0|ACA|0|1|0|100|IKR|1920|3446|lyfalmen|||00|30|0|30|Actavis Group hf|Actavis hf|Mirtazapín||1920||1920|3446 015381|H02AB0104|Betapred|lausnart|0,5|mg|100|stk|1|glas||H02AB01|01.01.1998||R|A||0|0|E|0|LVE|0|0|1|100|IKR|2760|4586|lyfalmen|||00|100|1|33|Lyfjaver ehf|Lyfjaver - óskráð lyf|Betametasón||2760||2760|4586 015419|G03CA0316|Vivelle Dot|forðapl|25|mcg/sólh|8|stk|1|pakki||G03CA03|01.02.2006||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1256|2545|lyfalmen|||23|8|0|14|Vistor hf|Novartis Healthcare A/S-|Estradíól||1256||1256|2545 015442|N02CC0103|Imigran Radis|filmhtfl|100|mg|6|stk|1|þpakki||N02CC01|01.10.2005||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|2084|3442|lyfalmen|V0832|3442|00|6|0|12|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||1917||1917|3442 015443|N02CC0103|Imigran Radis|filmhtfl|50|mg|12|stk|1|þpakki||N02CC01|01.10.2005||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|3042|4556|lyfalmen|V0831|4556|00|12|0|12|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||2738||2738|4556 015448|A10AE0502|Levemir Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AE05|01.03.2007||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|12203|17378|lyfalmen|||00|15|0|38|Vistor hf|Novo-Nordisk|Insúlín detemír||12203||12203|17378 015532|L01CX0101|Yondelis|irþ|1|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|K|3|0|1|0|1|PAM|0|0|0|100|DKK|398307|497760|lyfsjukr|||00|1|0|0|Lyfjaver ehf|Pharma Mar S.A.|Trabecetedín||398307||398307|497760 015598|L01CX0101|Yondelis|irþ|0,25|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|K|3|0|1|0|1|PAM|0|0|0|100|DKK|105868|133673|lyfsjukr|||00|1|0|0|Lyfjaver ehf|Pharma Mar S.A.|Trabecetedín||105868||105868|133673 015605|N04BA0301|Stalevo|filmhtfl|262,5|mg|30|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|7063|10425|lyfalmen|||00|30|0|3|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||7063||7063|10425 015652|N04BA0301|Stalevo|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|15566|21565|lyfalmen|V1732|21563|00|100|0|11|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||15566||15566|21565 015655|N04BA0301|Stalevo|filmhtfl|387,5|mg|30|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|7063|10425|lyfalmen|||00|30|0|10|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||7063||7063|10425 015663|N04BA0301|Stalevo|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|16827|23135|lyfalmen|V1731|23133|00|100|0|33|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||16827||16827|23135 015677|N05CF0201|Stilnoct|töflur|10|mg|1000|stk|1|þpakki||N05CF02|01.10.1992||R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|40013|52001|lyfalmen|||00|1000|0|1000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||40013||40013|52001 015679|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|þpakki||J05AE08|01.04.2005||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|92144|116587|lyfsjukr|||43|60|0|0|Vistor hf|Bristol-Myers Squibb|Atazanavír||92144||92144|116587 015695|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|þpakki||J05AE08|01.04.2005||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|92144|116587|lyfsjukr|||43|60|0|0|Vistor hf|Bristol-Myers Squibb|Atazanavír||92144||92144|116587 015699|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|85868|108773|lyfsjukr|||43|60|0|0|Vistor hf|Bristol-Myers Squibb|Atazanavír||85868||85868|108773 015707|N04BA0301|Stalevo|filmhtfl|325|mg|30|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|7063|10425|lyfalmen|||00|30|0|7|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||7063||7063|10425 015718|N04BA0301|Stalevo|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|15402|21360|lyfalmen|V1730|21359|00|100|0|22|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||15402||15402|21360 015723|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|92144|116587|lyfsjukr|||43|60|0|0|Vistor hf|Bristol-Myers Squibb|Atazanavír||92144||92144|116587 015733|L04AA0602|Myfortic|sh-tfl|180|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|A|2,5|0|1|*|0|NOH|0|0|0|100|DKK|26041|34606|lyfalmen|||00|120|0|10|Vistor hf|Novartis Healthcare A/S-|Mýcófenólsýra||26041||26041|34606 015755|L04AA0602|Myfortic|sh-tfl|360|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|A|2,5|0|1|*|0|NOH|0|0|0|100|DKK|55646|71464|lyfalmen|||00|120|0|22|Vistor hf|Novartis Healthcare A/S-|Mýcófenólsýra||55646||55646|71464 015800|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA04|01.01.1977||R|A|2|0|0|E|0|ALC|0|0|0|100|USD|998|2195|lyfalmen|||06|15|0|0|K.Pétursson hf|Alcon|Cýklópentólat||998||998|2195 015823|QP54AB5205|Advocate stórir kettir|bl.lausn|110|mg|0,8|ml|3|túpa|100+10 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|3673|6356|vetorma|||16|2|0|0|Vistor hf|Bayer HealthCare AG|||3673||3673|6356 015833|J01DC0204 |Cefuroxim Villerton|sts|750|mg/hgl|10|hgl|1|pakki||J01DC02|01.05.2009||R|A|3|0|0|0|1|VIL|0|0|0|100|NOK|4500|6443|lyfsjukr|||00|750|0|0|Lyfjaver ehf|Villerton Invest AS|Cefúroxím||||4500|6443 015844|J01DC0204 |Cefuroxim Villerton|sts|1500|mg/hgl|10|hgl|1|pakki||J01DC02|01.05.2009||R|A|3|0|0|0|1|VIL|0|0|0|100|NOK|8608|12325|lyfsjukr|||00|1500|0|0|Lyfjaver ehf|Villerton Invest AS|Cefúroxím||||8608|12325 015855|QP54AB5206|Advocate yfirstærðar hundar|bl.lausn|125|mg|4|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|5161|8931|vetorma|||16|12|0|0|Vistor hf|Bayer HealthCare AG|||5161||5161|8931 015873|QP54AB5202|Advocate litlir kettir|bl.lausn|110|mg|0,4|ml|3|túpa|100+10 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|3277|5671|vetorma|||16|1|0|0|Vistor hf|Bayer HealthCare AG|||3277||3277|5671 015882|QP54AB5203|Advocate millistórir hundar|bl.lausn|125|mg|1|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|4108|7109|vetorma|||16|3|0|0|Vistor hf|Bayer HealthCare AG|||4108||4108|7109 015883|M01CC0101|Atamir|hylki|250|mg|50|stk|1|þpakki||M01CC01|01.05.1978||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|5235|7945|lyfalmen|||10|50|0|25|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||5235||5235|7945 015904|QP54AB5204|Advocate stórir hundar|bl.lausn|125|mg|2,5|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|4603|7966|vetorma|||16|8|0|0|Vistor hf|Bayer HealthCare AG|||4603||4603|7966 015912|D11AX1401|Protopic|smyrsli|0,03|%|10|g|1|túpa||D11AX14|01.03.2009||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|2313|3979|lyfalmen|||0|10|0|0|Vistor hf|Astellas Pharma A/S|Takrólímus||||2313|3979 015923|D11AX1401|Protopic|smyrsli|0,1|%|10|g|1|túpa||D11AX14|01.10.2007||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|2598|4366|lyfalmen|||00|10|0|0|Vistor hf|Astellas Pharma A/S|Takrólímus||2598||2598|4366 015929|N02AA0110|Morphine Sulphate BP|stl|10|mg/ml|1|ml|10|lykjur||N02AA01|01.07.2003||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1635|3059|lyfalmen|||02|10|0|3|Icepharma hf|Martindale Pharmaceuticals|Morfín||1635||1635|3059 015944|QP54AB5201|Advocate litlir hundar|bl.lausn|125|mg|0,4|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|3673|6356|vetorma|||16|1|0|0|Vistor hf|Bayer HealthCare AG|||3673||3673|6356 015964|N06AB0501|Seroxat|töflur|10|mg|28|stk|1|þpakki||N06AB05|01.12.2006||R|A|3|0|0|B|0|GSK|0|1|0|100|GBP|1573|2975|lyfalmen|||00|28|0|14|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1573||1573|2975 015985|C09AA0401|Coversyl|töflur|8|mg|90|stk|1|þpakki||C09AA04|01.06.2005||R|A|2|0|0|0|0|SEV|0|0|0|100|DKK|17854|24413|lyfalmen|||00|90|0|180|Icepharma hf|Servier|Perindópríl||17854||17854|24413 016000|N02CC0501|Almogran|töflur|12,5|mg|6|stk|1|þpakki|filmuhúðaðar töflur|N02CC05|01.05.2001||R|A|5|0|0|E|0|LAA|0|0|0|100|SEK|5870|8806|lyfalmen|||00|6|0|6|Vistor hf|Laboratorios Almirall S.A.|Almótriptan||5870||5870|8806 016003|C09AA0401|Coversyl|töflur|8|mg|30|stk|1|þpakki||C09AA04|01.06.2005||R|A|2|0|0|0|0|SEV|0|0|0|100|DKK|6006|8991|lyfalmen|||00|30|0|60|Icepharma hf|Servier|Perindópríl||6006||6006|8991 016011|N02CC0501|Almogran|töflur|12,5|mg|9|stk|1|þpakki|filmuhúðaðar töflur|N02CC05|01.05.2001||R|A|5|0|0|E|0|LAA|0|0|0|100|SEK|8311|12119|lyfalmen|||00|9|0|9|Vistor hf|Laboratorios Almirall S.A.|Almótriptan||8311||8311|12119 016017|C10AA0701|Crestor|filmhtfl|10|mg|100|stk|1|þpakki||C10AA07|01.03.2004||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|14723|20515|lyfalmen|||00|100|0|100|Vistor hf|AstraZeneca A/S DK|||14723||14723|20515 016021|N02AB0203|Pethidine BP|stl|50|mg/ml|1|ml|10|lykjur||N02AB02|01.07.2003||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1215|2489|lyfalmen|||02|10|0|1|Icepharma hf|Martindale Pharmaceuticals|Petidín||1215||1215|2489 016028|C10AA0701|Crestor|filmhtfl|20|mg|100|stk|1|þpakki||C10AA07|01.03.2004||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|22057|29646|lyfalmen|V0341|29646|00|100|0|200|Vistor hf|AstraZeneca A/S DK|||22057||22057|29646 016032|N02AB0203|Pethidine BP|stl|50|mg/ml|2|ml|10|lykjur||N02AB02|01.01.2004||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1288|2588|lyfalmen|||02|20|0|2|Icepharma hf|Martindale Pharmaceuticals|Petidín||1288||1288|2588 016038|N02CC0501|Almogran|töflur|12,5|mg|3|stk|1|þpakki|filmuhúðaðar töflur|N02CC05|01.05.2001||R|A|5|0|0|E|0|LAA|0|0|0|100|SEK|3031|4954|lyfalmen|||00|3|0|3|Vistor hf|Laboratorios Almirall S.A.|Almótriptan||3031||3031|4954 016066|R02AA0303|Strepsils Sukkerfri med Citron og Örter|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.10.2005||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||| 016125|M02AA1001|Orudis|hlaup|25|mg/g|60|g|1|túpa||M02AA10|01.03.2000||L|A|2|0|0|0|0|SNO|0|0|1|100|IKR|||lyflausa|||00|60|0|0|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen||||| 016178|A10BD0301|Avandamet|filmhtfl|502|mg|112|stk|1|þpakki|500+2mg|A10BD03|01.03.2004||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|8469|12333|lyfalmen|||00|112|0|56|GlaxoSmithKline ehf|SmithKline Beecham PLC|Metformín og rosiglítazón||8469||8469|12333 016209|N05AX0801|Risperdal|töflur|2|mg|28|stk|1|þpakki|frostþ. töflur|N05AX08|01.09.2004||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|8806|12791|lyfalmen|||00|28|0|11|Vistor hf|Janssen-Cilag AB|Risperídón||8806||8806|12791 016239|A10BD0301|Avandamet|filmhtfl|501|mg|112|stk|1|þpakki|500+1mg|A10BD03|01.03.2004||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|4737|7269|lyfalmen|||00|112|0|56|GlaxoSmithKline ehf|SmithKline Beecham PLC|Metformín og rosiglítazón||4737||4737|7269 016285|N03AX1601|Lyrica|hylki|150|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|3788|5981|lyfalmen|||00|14|0|7|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3788||3788|5981 016294|N03AX1601|Lyrica|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|7713|11307|lyfalmen|||00|56|0|14|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||7713||7713|11307 016296|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|spr|lausn|G03GA08|01.03.2004||R|K|2|0|1|E|0|SEE|0|0|0|100|SEK|5476|8272|lyfalmen|||00|0|0|1|Gróco ehf|Serono Europe|Chóríógónadótrópín alfa||5476||5476|8272 016315|N03AX1601|Lyrica|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|11697|16714|lyfalmen|||00|56|0|28|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||11697||11697|16714 016318|N03AX1601|Lyrica|hylki|75|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|2545|4294|lyfalmen|||00|14|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2545||2545|4294 016323|N03AX1601|Lyrica|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|16993|23341|lyfalmen|||00|56|0|56|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||16993||16993|23341 016337|C08CA0302|Lomir Retard|forðahlk|5|mg|100|stk|1|þpakki||C08CA03|01.04.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|12866|18203|lyfalmen|||10|100|0|100|Vistor hf|Novartis Healthcare A/S-|Ísradipín||12866||12866|18203 016353|N05AX0801|Risperdal|töflur|1|mg|28|stk|1|þpakki|frostþ. töflur|N05AX08|01.08.2004||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|4960|7571|lyfalmen|||00|28|0|6|Vistor hf|Janssen-Cilag AB|Risperídón||4960||4960|7571 016363|L01BC0108|Cytarabine Pfizer|stl/irl|20|mg/ml|5|ml|5|hgl||L01BC01|01.11.2000||R|A|1.5|0|1|0|1|PFI|0|0|0|100|DKK|5345|7653|lyfsjukr|||00|25|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Cýtarabín||5345||5345|7653 016364|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|2|ml|5|hgl||L01BA01|01.10.1995||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|6767|9689|lyfsjukr|||00|10|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metótrexat||6767||6767|9689 016374|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|20|ml|1|hgl||L01BC01|01.10.1995||R|A|1.5|0|1|0|1|PFI|0|0|0|100|DKK|19653|26335|lyfsjukr|||00|20|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Cýtarabín||19653||19653|26335 016382|J02AC0301|Vfend|mixtúra|40|mg/ml|70|ml|1|fl||J02AC03|01.03.2005||R|A|1,5|0|0|0|1|PFI|0|0|0|100|DKK|162046|203615|lyfsjukr|||00|70|0|7|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Voricónazól||162046||162046|203615 016385|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1995||R|A|1.5|0|1|0|1|PFI|0|0|0|100|DKK|9828|14071|lyfsjukr|||00|10|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Cýtarabín||9828||9828|14071 016395|N03AX1601|Lyrica|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.01.2007||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|3015|4932|lyfalmen|||00|56|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3015||3015|4932 016396|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|20|ml|1|hgl||L01BA01|01.10.1995||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|9087|13010|lyfsjukr|||00|20|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metótrexat||9087||9087|13010 016474|L01XA0209|Carboplatin Pfizer|irþ|10|mg/ml|5|ml|5|hgl||L01XA02|01.08.1998||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|30806|40221|lyfsjukr|||00|25|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Karbóplatín||30806||30806|40221 016502|N07BA0111|Nicorette Classic|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.03.2004||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016506|N07BA0111|Nicorette Classic|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.03.2004||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|4|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016516|L01XA0209|Carboplatin Pfizer|irþ|10|mg/ml|45|ml|5|hgl||L01XA02|01.08.1998||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|258706|323956|lyfsjukr|||00|225|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Karbóplatín||258706||258706|323956 016524|N07BA0111|Nicorette Classic|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|210|0|14|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016528|N07BA0111|Nicorette Classic|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|210|0|28|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016534|L01XA0209|Carboplatin Pfizer|irþ|10|mg/ml|15|ml|5|hgl||L01XA02|01.08.1998||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|90732|114829|lyfsjukr|||00|75|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Karbóplatín||90732||90732|114829 016561|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|7|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016572|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016589|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|4|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016590|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016596|N05AX1201|Abilify|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.02.2006||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|20274|27426|lyfalmen|V1701|27425|00|28|0|6|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||20274||20274|27426 016605|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|14|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016611|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016622|A06AG1101|Microlax|innhl|0| |5|ml|50|túpa||A06AG11|01.09.2005||L|A|5|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||56|250|0|50|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||7907 016635|N05AX1201|Abilify|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.02.2006||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|39604|51492|lyfalmen|||00|56|0|12|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||39604||39604|51492 016637|J01CR0201|Amoksiklav|töflur|1000|mg|12|stk|1|pakki|875+125 mg|J01CR02|01.08.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1026|2233|lyfalmen|V0466|2218|00|12|0|12|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1026||1026|2233 016640|B03XA0103|NeoRecormon|stl|30000|ae/spr|0,6|ml|4|spr||B03XA01|01.05.2007||R|K|2|0|1|0|1|ROC|0|0|0|100|DKK|276946|346665|lyfsjukr|||00|2|0|180|Icepharma hf|Roche|Epóetín||276946||276946|346665 016686|H01AC0110|NutropinAq|stl|5|mg/ml|2|ml|3|rörlyk||H01AC01|01.03.2005||R|A|1,5|0|1|0|1|IPL|0|0|0|100|DKK|242114|303299|lyfsjukr|||00|6|0|0|Icepharma hf|Ipsen Ltd.|Sómatrópín||242114||242114|303299 016699|A10BA0202|Glucophage (Lyfjaver)|töflur|500|mg|400|stk|1|plglas||A10BA02|01.09.2003|31.10.2009|R|A|5|0|0|*|0|LVR|0|0|0|100|NOK|3180|5156|lyfalmen|||00|400|0|100|Lyfjaver ehf|Lyfjaver ehf|Metformín||3180||3180|5156 016727|N06BA0403|Ritalin Uno|hylki|30|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|9038|13105|lyfalmen|||00|30|0|30|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||9038||9038|13105 016728|H01AC0110|NutropinAq|stl|5|mg/ml|2|ml|1|rörlyk||H01AC01|01.03.2005||R|A|1,5|0|1|0|1|IPL|0|0|0|100|DKK|80705|102345|lyfsjukr|||00|2|0|0|Icepharma hf|Ipsen Ltd.|Sómatrópín||80705||80705|102345 016736|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|200|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|3538|5642|lyfalmen|V0789|5642|10|200|0|40|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||3538||3538|5642 016772|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|400|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|6531|9703|lyfalmen|V0713|9703|10|200|0|80|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||6531||6531|9703 016791|H05BX0101|Mimpara|filmhtfl|60|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|74375|94782|lyfalmen|||00|28|0|28|Vistor hf|Amgen Europe B.V.|Cinacalcet||74375||74375|94782 016802|H05BX0101|Mimpara|filmhtfl|90|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|109937|139057|lyfalmen|||00|28|0|42|Vistor hf|Amgen Europe B.V.|Cinacalcet||109937||109937|139057 016868|H05BX0101|Mimpara|filmhtfl|30|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|35776|46726|lyfalmen|||00|28|0|0|Vistor hf|Amgen Europe B.V.|Cinacalcet||35776||35776|46726 016892|G03GA0502|Gonal-f|stl|900|ae/penna|1,5|ml|1|penni|áfylltur penni (66 mcg) |G03GA05|01.07.2004||R|K|1|0|1|E|0|SEE|0|0|0|100|SEK|62555|80066|lyfalmen|||00|2|0|12|Gróco ehf|Serono Europe|Follitrópín alfa||62555||62555|80066 016927|G03GA0502|Gonal-f|stl|300|ae/penna|0,5|ml|1|penni|(22 mcg) áfylltur penni|G03GA05|01.07.2004||R|K|1|0|1|E|0|SEE|0|0|0|100|SEK|23927|31974|lyfalmen|||00|0|0|4|Gróco ehf|Serono Europe|Follitrópín alfa||23927||23927|31974 016938|G03GA0502|Gonal-f|stl|450|ae/penna|0,75|ml|1|penni|áfylltur penni (33 mcg) |G03GA05|01.07.2004||R|K|1|0|1|E|0|SEE|0|0|0|100|SEK|35888|46866|lyfalmen|||00|1|0|6|Gróco ehf|Serono Europe|Follitrópín alfa||35888||35888|46866 016943|A02BC0301|Lanzo|munndr.t|30|mg|14|stk|1|þpakki||A02BC03|01.02.2007||R|A|3|0|0|0|0|WAB|0|0|0|100|USD|2415|4118|lyfalmen|||00|14|0|14|Icepharma hf|Wyeth AB|Lansóprazól||2415||2415|4118 016946|A02BC0301|Lanzo|munndr.t|15|mg|56|stk|1|þpakki||A02BC03|01.11.2009||R|A||0|0|0|0|WAB|0|0|0|100|USD|4106|6412|lyfalmen|||00|56|0|28|Icepharma hf|Wyeth AB|Lansóprazól||||4106|6412 016954|A02BC0301|Lanzo|munndr.t|30|mg|28|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|WAB|0|0|0|100|USD|4687|7201|lyfalmen|||00|28|0|28|Icepharma hf|Wyeth AB|Lansóprazól||4687||4687|7201 016957|A02BC0301|Lanzo|munndr.t|15|mg|98|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|WAB|0|0|0|100|USD|9127|13226|lyfalmen|||00|98|0|49|Icepharma hf|Wyeth AB|Lansóprazól||9127||9127|13226 016965|A02BC0301|Lanzo|munndr.t|30|mg|56|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|WAB|0|0|0|100|USD|7364|10834|lyfalmen|||00|56|0|56|Icepharma hf|Wyeth AB|Lansóprazól||7364||7364|10834 016973|J05AF0901|Emtriva|hylki|200|mg|30|stk|1|glas||J05AF09|01.04.2004||R|A|3|0|1|0|1|GIS|0|0|0|100|XEU|46468|59720|lyfsjukr|||00|30|0|30|Gilead Sience Sweden AB|Gilead Science International ltd.|Emtrícítabín||46468||46468|59720 016976|A02BC0301|Lanzo|munndr.t|30|mg|98|stk|1|þpakki||A02BC03|01.02.2007||R|A|3|0|0|0|0|WAB|0|0|0|100|USD|16110|22242|lyfalmen|||00|98|0|98|Icepharma hf|Wyeth AB|Lansóprazól||16110||16110|22242 016979|N02AE0103|Norspan|forðapl|5|mg|4|stk|1|þpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|3994|6260|lyfalmen|||00|4|0|17|Icepharma hf|Norpharma |Búprenorfín||3994||3994|6260 016981|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dælu|60|dælur|1|pakki||QA02BX12|01.12.2006||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|21728|41560|vetalmen|||16|60|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||21728||21728|41560 017006|B05BA1019|StructoKabiven Perifer|irl|830|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.06.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|37595|48673|lyfsjukr|||00|4824|0|0|Icepharma hf|Fresenius Kabi|Blöndur||37595||37595|48673 017020|G03DA0201|Depo-Provera|stl|50|mg/ml|3|ml|1|hgl||G03DA02|01.12.1972||R|A|5|0|0|E|0|PFI|0|0|0|100|DKK|1769|3241|lyfalmen|||03|3|0|21|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Medroxýprógesterón||1769||1769|3241 017111|A09AA0201|Combizym|töflur|0| |100|stk|1|þpakki||A09AA02|01.07.1988||R|A|2|0|0|E|0|DSG|0|0|0|100|XEU|1789|3268|lyfalmen|||10|100|0|25|Icepharma hf|Daiichi Sankyo Europe GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||1789||1789|3268 017130|L01BC0109|DepoCyte|stl|50|mg/hgl|5|ml|1|hgl||L01BC01|01.07.2005||R|K|2|0|1|0|1|SKY|0|0|0|100|DKK|333011|416466|lyfsjukr|||00|5|0|0|Icepharma hf|SkyPharma PLC|Cýtarabín||333011||333011|416466 017145|C08DB0102|Cardizem Retard|forðatfl|180|mg|60|stk|1|glas||C08DB01|01.04.1990||R|A|2|0|0|B|0|FRO|0|0|0|100|DKK|8017|11720|lyfalmen|||10|60|0|45|Vistor hf|Ferrosan A/S|Diltíazem||8017||8017|11720 017195|L01XX3201|Velcade|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.09.2004||R|A|3|0|1|0|1|JCI|0|0|0|100|SEK|192524|241560|lyfsjukr|||00|1|0|0|Vistor hf|Janssen-Cilag International N.V.|Bortezomíb||192524||192524|241560 017203|M05BA0601|Bondronat|irþ|1|mg/ml|6|ml|1|hgl||M05BA06|01.09.2004||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|52502|67232|lyfsjukr|||00|6|0|1|Icepharma hf|Roche|||52502||52502|67232 017204|B05BA1019|StructoKabiven Perifer|irl|1300|kcal|1904|ml|3|pokar|fleyti|B05BA10|01.06.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|38857|50244|lyfsjukr|||00|5712|0|0|Icepharma hf|Fresenius Kabi|Blöndur||38857||38857|50244 017210|C03DA0102|Spirix|töflur|25|mg|100|stk|1|glas||C03DA01|01.02.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|1578|2982|lyfalmen|V0221|2982|00|100|0|33|Gróco ehf|Nycomed Danmark A/S|Spírónólaktón||1578||1578|2982 017234|L03AB0701|Avonex|stl|30|mcg/spr|0,5|ml|4|spr|lausn, áfylltar sprautur|L03AB07|01.12.2003||R|K|2|0|1|0|1|BIN|0|0|0|100|XEU|158203|198830|lyfsjukr|||00|2|0|28|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||158203||158203|198830 017238|M05BA0601|Bondronat|filmhtfl|50|mg|28|stk|1|þpakki||M05BA06|01.08.2004||R|A|1|0|0|0|0|ROC|0|0|0|100|DKK|58592|75132|lyfalmen|||00|28|0|28|Icepharma hf|Roche|||58592||58592|75132 017247|M05BA0601|Bondronat|filmhtfl|50|mg|84|stk|1|þpakki||M05BA06|01.08.2004||R|A|1|0|0|0|0|ROC|0|0|0|100|DKK|174885|219917|lyfalmen|||00|84|0|84|Icepharma hf|Roche|||174885||174885|219917 017266|N02AE0103|Norspan|forðapl|10|mg|4|stk|1|þpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|6314|9409|lyfalmen|||00|4|0|33|Icepharma hf|Norpharma |Búprenorfín||6314||6314|9409 017294|N03AX1202|Gabapentin NM Pharma|hylki|300|mg|100|stk|1|glas||N03AX12|01.10.2007|30.09.2009|R|A|2|0|0|E|0|MNA|0|0|0|100|SEK|4746|7281|lyfalmen|||00|100|0|17|Actavis Group PTC ehf|Merck NM AB|Gabapentín||4746||4746|7281 017326|N02AE0103|Norspan|forðapl|20|mg|4|stk|1|þpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|13203|18623|lyfalmen|||00|4|0|67|Icepharma hf|Norpharma |Búprenorfín||13203||13203|18623 017327|C03DA0102|Spirix|töflur|50|mg|100|stk|1|glas||C03DA01|01.02.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|3121|5076|lyfalmen|||00|100|0|67|Gróco ehf|Nycomed Danmark A/S|Spírónólaktón||3121||3121|5076 017331|A04AD1201|Emend|hylki|0| |3|stk|1|þpakki|samsett pakkning|A04AD12|01.04.2004||R|A|2,5|0|0|0|1|MSD|0|0|0|100|XEU|13193|18293|lyfsjukr|||00|3|0|0|Icepharma hf|M.S.D.|Aprepitant||13193||13193|18293 017365|J01CR0201|Amoksiklav|töflur|375|mg|20|stk|1|glas|250+125 mg|J01CR02|01.12.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|792|1915|lyfalmen|||00|20|0|5|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||792||792|1915 017384|H02AB0701|Deltison|töflur|50|mg|30|stk|1|glas||H02AB07|01.08.2005||R|A|2|0|0|E|0|REP|0|0|1|100|SEK|3411|5469|lyfalmen|||00|30|0|150|Vistor hf|Recip AB|Prednisón||3411||3411|5469 017541|N07CA0101|Betaserc|töflur|16|mg|100|stk|1|þpakki||N07CA01|01.06.1999||R|A|5|0|0|E|0|SOL|0|0|0|100|DKK|8368|12196|lyfalmen|||00|100|0|67|Medico ehf|Solvay Duphar |Betahistín||8368||8368|12196 017556|J01CR0201|Amoksiklav|töflur|625|mg|20|stk|1|glas|500+125 mg|J01CR02|01.12.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1215|2489|lyfalmen|V0465|2489|00|20|0|12|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1215||1215|2489 017564|QM01AC0601|Metacam|mixtúra|15|mg/ml|100|ml|1|fl||QM01AC06|01.09.2004||R|A|2|0|0|0|0|BOI|0|0|0|100|DKK|7755|14943|vetalmen|||00|100|0|0|Vistor hf|Boehringer Ingelheim|||7755||7755|14943 017763|N06DA0401|Reminyl|forðahlk|16|mg|84|stk|1|þpakki||N06DA04|01.08.2005||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|41936|54395|lyfalmen|V1371|54394|00|84|0|84|Vistor hf|Janssen-Cilag AB|Galantamín||41936||41936|54395 017773|N06DA0401|Reminyl|forðahlk|8|mg|28|stk|1|þpakki||N06DA04|01.08.2005||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|13123|18523|lyfalmen|V1370|18522|00|28|0|14|Vistor hf|Janssen-Cilag AB|Galantamín||13123||13123|18523 017792|C03DA0401|Inspra|filmhtfl|50|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|12977|18341|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Eplerenón||12977||12977|18341 017809|N06DA0401|Reminyl|forðahlk|24|mg|84|stk|1|þpakki||N06DA04|01.08.2005||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|46697|60323|lyfalmen|||00|84|0|126|Vistor hf|Janssen-Cilag AB|Galantamín||46697||46697|60323 017963|C03DA0401|Inspra|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|11023|15799|lyfalmen|||00|30|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Eplerenón||11023||11023|15799 018044|D06BX0103|Rozex|hlaup|7,5|mg/g|30|g|1|túpa||D06BX01|01.01.1998||R|A||0|0|0|0|LDR|0|0|1|100|IKR|1373|2704|lyfalmen|||00|30|1|30|Parlogis hf|Parlogis - óskráð lyf|Metrónídazól||1373||1373|2704 018268|G03FA1701|Angemin|töflur|0| |84|stk|1|þpakki|2+1 mg|G03FA17|01.06.2005||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|7125|10509|lyfalmen|||00|84|0|84|Icepharma hf|Bayer Schering Pharma AG|Dróspírenón og östrogen||7125||7125|10509 018311|C09CA0801|Olmetec|filmhtfl|10|mg|28|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|3128|5085|lyfalmen|||00|28|0|14|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||3128||3128|5085 018446|C09CA0801|Olmetec|filmhtfl|40|mg|28|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|4620|7110|lyfalmen|||00|28|0|56|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||4620||4620|7110 018453|L02BA0301|Faslodex|stl|250|mg/spr|5|ml|1|spr||L02BA03|01.06.2004||R|K|3|0|1|0|1|ASZ|0|0|0|100|SEK|72244|91811|lyfsjukr|||00|5|0|0|Vistor hf|AstraZeneca UK Ltd|Fulvestrant||72244||72244|91811 018502|C09CA0801|Olmetec|filmhtfl|40|mg|98|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|14468|20198|lyfalmen|||00|98|0|196|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||14468||14468|20198 018512|C09CA0801|Olmetec|filmhtfl|10|mg|98|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|10162|14631|lyfalmen|||00|98|0|49|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||10162||10162|14631 018514|J07BA0101|FSME-Immun Junior|stl|1,2|mcg/sk|0,25|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|K|2,5|0|0|0|0|BAA|0|0|0|100|SEK|3854|6070|lyfalmen|||02|0|0|0|Icepharma hf|Baxter AG|Heilabólguveira óvirk, borin með blóðmaur||3854||3854|6070 018527|J07BA0102|FSME-Immun Vuxen|stl|2,4|mcg/sk|0,5|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|K|2,5|0|0|0|0|BAA|0|0|0|100|SEK|4209|6552|lyfalmen|||02|0|0|0|Icepharma hf|Baxter AG|Heilabólguveira óvirk, borin með blóðmaur||4209||4209|6552 018534|C09CA0801|Olmetec|filmhtfl|20|mg|98|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|11935|17037|lyfalmen|||00|98|0|98|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||11935||11935|17037 018535|N03AX0901|Lamictal|dreifit.|25|mg|42|stk|1|þpakki||N03AX09|01.11.2004||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|1499|2875|lyfalmen|||00|42|0|4|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||1499||1499|2875 018558|L01CD0102|Paclitaxel Mayne|irþ|6|mg/ml|5|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|19378|25993|lyfsjukr|||00|5|0|0|Icepharma hf|Mayne Pharma Plc|Paklítaxel||19378||19378|25993 018569|L01CD0102|Paclitaxel Mayne|irþ|6|mg/ml|25|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|95821|121165|lyfsjukr|||00|25|0|0|Icepharma hf|Mayne Pharma Plc|Paklítaxel||95821||95821|121165 018586|C09CA0801|Olmetec|filmhtfl|20|mg|28|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|3885|6113|lyfalmen|||00|28|0|28|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||3885||3885|6113 018591|L01CD0102|Paclitaxel Mayne|irþ|6|mg/ml|16,7|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|39032|50462|lyfsjukr|||00|17|0|0|Icepharma hf|Mayne Pharma Plc|Paklítaxel||39032||39032|50462 018594|G04BD0801|Vesicare|filmhtfl|10|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|9566|13822|lyfalmen|||00|30|0|60|Vistor hf|Astellas Pharma A/S|Sólífenacín||9566||9566|13822 018663|J01DD0401|Rocephalin|stþ|1|g|1|stk|5|hgl|+ leysir, lausn|J01DD04|01.10.1985||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|15837|21585|lyfsjukr|||03|5|0|2|Icepharma hf|Roche|Ceftríaxón||15837||15837|21585 018670|C09CA0301|Diovan|filmhtfl|40|mg|14|stk|1|þpakki||C09CA03|01.07.2005||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|1690|3134|lyfalmen|||00|14|0|7|Vistor hf|Novartis Healthcare A/S-|Valsartan||1690||1690|3134 018677|G04BD0801|Vesicare|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|23442|31370|lyfalmen|||00|90|0|180|Vistor hf|Astellas Pharma A/S|Sólífenacín||23442||23442|31370 018681|C09CA0301|Diovan|filmhtfl|40|mg|28|stk|1|þpakki||C09CA03|01.07.2005||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|3381|5429|lyfalmen|||00|28|0|14|Vistor hf|Novartis Healthcare A/S-|Valsartan||3381||3381|5429 018682|H02AB0604|Decortin H|töflur|5|mg|100|stk|1|þpakki||H02AB06|11.06.2004||R|A|3|0|0|B|0|MAC|0|0|1|100|XEU|1027|2234|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck KgaA (A) |Prednisólón||1027||1027|2234 018685|G04BD0801|Vesicare|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|7547|11082|lyfalmen|||00|30|0|30|Vistor hf|Astellas Pharma A/S|Sólífenacín||7547||7547|11082 018694|G04BD0801|Vesicare|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|19086|25947|lyfalmen|||00|90|0|90|Vistor hf|Astellas Pharma A/S|Sólífenacín||19086||19086|25947 018714|C03DA0401|Inspra|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|43263|56047|lyfalmen|||00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Eplerenón||43263||43263|56047 018779|L03AX1301|Copaxone|stl|20|mg/spr|28|spr|1|pakki|+ leysir|L03AX13|01.08.2004||R|K|2|0|1|0|1|TEP|0|0|0|100|NOK|161151|202500|lyfsjukr|||00|28|0|28|Vistor hf|Teva Pharmaceuticals Limited|Glatíramer acetat||||161151|202500 018894|N06DA0202|Aricept (Lyfjaver)|töflur|5|mg|98|stk|1|þpakki||N06DA02|01.01.2005|31.10.2009|R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|49973|64401|lyfalmen|||00|98|0|65|Lyfjaver ehf|Lyfjaver ehf|Dónepezíl||49973||49973|64401 018908|N06DA0202|Aricept (Lyfjaver)|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.01.2005|31.10.2009|R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|55059|70733|lyfalmen|||00|98|0|131|Lyfjaver ehf|Lyfjaver ehf|Dónepezíl||55059||55059|70733 018927|M05BA0402|Fosamax (Lyfjaver)|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.03.2004|31.10.2009|R|A|2|0|0|0|0|LVR|0|0|0|100|XEU|14980|20835|lyfalmen|||00|12|0|84|Lyfjaver ehf|Lyfjaver ehf|Alendrónsýra||14980||14980|20835 018956|R06AX2201|Kestine|töflur|20|mg|30|stk|1|þpakki||R06AX22|01.10.2005||R|A|3|0|0|E|0|ALF|0|0|1|100|DKK|3604|5731|lyfalmen|||00|30|0|60|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||3604||3604|5731 018967|R06AX2201|Kestine|töflur|20|mg|100|stk|1|þpakki||R06AX22|01.10.2005||R|A|3|0|0|E|0|ALF|0|0|1|100|DKK|11150|15971|lyfalmen|||00|100|0|200|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||11150||11150|15971 018975|J05AE0701|Telzir|filmhtfl|700|mg|60|stk|1|glas||J05AE07|01.12.2004||R|A|3|0|1|0|1|GGL|0|0|0|100|GBP|62613|79821|lyfsjukr|||43|60|0|30|GlaxoSmithKline ehf|Glaxo Group Limited|Fosamprenavír||62613||62613|79821 018978|C03CA0101|Furix|töflur|20|mg|100|stk|1|glas||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|690|1777|lyfalmen|||00|100|0|50|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||690||690|1777 018980|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|1|hgl|20mg/ml+36mcg/ml|QN01BB52|01.02.2004||R|S|2|0|0|0|0|KEL|1|0|0|100|NOK|1368|2700|vetalmen|||27|100|0|0|Icepharma hf|Kela Laboratoria NV|||1368||1368|2700 018995|N02AB0301|Durogesic|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|13120|18519|lyfalmen|V1052|15684|00|5|0|62|Vistor hf|Janssen-Cilag AB|Fentanýl||13120||13120|18519 019065|N06DA0302|Exelon (Lyfjaver)|hylki|6|mg|56|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|17016|23370|lyfalmen|||00|56|0|37|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||17016||17016|23370 019079|N06DA0302|Exelon (Lyfjaver)|hylki|4,5|mg|56|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|17016|23370|lyfalmen|||00|56|0|28|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||17016||17016|23370 019082|N06DA0302|Exelon (Lyfjaver)|hylki|3|mg|56|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|16041|22156|lyfalmen|V1372|22156|00|56|0|19|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||16041||16041|22156 019094|N02AB0301|Durogesic|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|9437|13647|lyfalmen|V1051|11447|00|5|0|42|Vistor hf|Janssen-Cilag AB|Fentanýl||9437||9437|13647 019099|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|34555|44888|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||34555||34555|44888 019102|N06DA0302|Exelon (Lyfjaver)|hylki|1,5|mg|28|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|8508|12386|lyfalmen|||00|28|0|5|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||8508||8508|12386 019108|N02AB0301|Durogesic|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|5105|7768|lyfalmen|V1050|6349|00|5|0|21|Vistor hf|Janssen-Cilag AB|Fentanýl||5105||5105|7768 019112|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|41142|53089|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||41142||41142|53089 019121|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|41645|53716|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||41645||41645|53716 019132|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|47704|61259|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||47704||47704|61259 019167|N02AB0301|Durogesic|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|16167|22313|lyfalmen|V1053|18554|00|5|0|83|Vistor hf|Janssen-Cilag AB|Fentanýl||16167||16167|22313 019293|B02BC3001|TachoSil|svampur|5,5|mg|1|stk|1|pakki|+ 2,0 IU - 9,5x4,8 cm|B02BC30|01.05.2005||R|A|3|0|1|0|1|NYG|0|0|0|100|DKK|65873|83879|lyfsjukr|||00|1|0|0|Gróco ehf|Nycomed Danmark A/S|||65873||65873|83879 019295|B01AE0601|Angiox|sts/irs|250|mg|10|hgl|1|pakki|þykkni, lausn|B01AE06|01.05.2005||R|A|3|0|1|0|1|NYG|0|0|0|100|XEU|858582|1070802|lyfsjukr|||00|10|0|0|Gróco ehf|Nycomed Danmark A/S|Bívalirúdín||858582||858582|1070802 019339|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019421|N06AX2102|Yentreve|hylki|20|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|XEU|7897|11557|lyfalmen|||00|56|0|0|Icepharma hf|Eli Lilly Nederland -|||7897||7897|11557 019445|L01XC0701|Avastin|irþ|25|mg/ml|4|ml|1|hgl|lausn|L01XC07|01.05.2005||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|61456|78380|lyfsjukr|||AC|4|0|0|Icepharma hf|Roche Registration Limited|Bevacizúmab||61456||61456|78380 019469|N06AX2102|Yentreve|hylki|40|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|XEU|7897|11557|lyfalmen|||00|56|0|0|Icepharma hf|Eli Lilly Nederland -|||7897||7897|11557 019491|N06AX2102|Yentreve|hylki|40|mg|140|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|XEU|19432|26378|lyfalmen|||00|140|0|0|Icepharma hf|Eli Lilly Nederland -|||19432||19432|26378 019513|C03CA0101|Furix|töflur|40|mg|100|stk|1|glas||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|693|1781|lyfalmen|||00|100|0|100|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||693||693|1781 019589|C09CA0401|Aprovel|filmhtfl|150|mg|28|stk|1|þpakki||C09CA04|01.09.2005||R|A|3|0|0|0|0|SBM|0|0|0|100|NOK|4384|6790|lyfalmen|||00|28|0|28|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan||4384||4384|6790 019600|C09CA0401|Aprovel|filmhtfl|150|mg|98|stk|1|þpakki||C09CA04|01.09.2005||R|A|3|0|0|0|0|SBM|0|0|0|100|NOK|10953|15704|lyfalmen|||00|98|0|98|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan||10953||10953|15704 019611|C09CA0401|Aprovel|filmhtfl|300|mg|28|stk|1|þpakki||C09CA04|01.09.2005||R|A|3|0|0|0|0|SBM|0|0|0|100|NOK|6249|9321|lyfalmen|||00|28|0|56|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan||6249||6249|9321 019622|C09CA0401|Aprovel|filmhtfl|300|mg|98|stk|1|þpakki||C09CA04|01.09.2005||R|A|3|0|0|0|0|SBM|0|0|0|100|NOK|16802|23103|lyfalmen|||00|98|0|196|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan||16802||16802|23103 019659|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|13|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019670|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|0|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019672|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|13|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019681|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|2|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019699|C09DA0401|CoAprovel|filmhtfl|162,5|mg|28|stk|1|þpakki|150+12,5 mg|C09DA04|01.09.2005||R|A|3|0|0|0|0|SBM|0|0|0|100|NOK|4384|6790|lyfalmen|||00|28|0|28|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan og þvagræsilyf||4384||4384|6790 019710|C09DA0401|CoAprovel|filmhtfl|162,5|mg|98|stk|1|þpakki|150+12,5 mg|C09DA04|01.09.2005||R|A|3|0|0|0|0|SBM|0|0|0|100|NOK|15309|21245|lyfalmen|||00|98|0|98|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan og þvagræsilyf||15309||15309|21245 019711|L01BC0501|Gemzar|irs|200|mg|1|hgl|1|pakki||L01BC05|01.03.1999||R|A|3|0|1|0|1|ELI|0|0|0|100|XEU|6993|10012|lyfsjukr|||00|1|0|0|Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||6993||6993|10012 019713|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|14|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019721|C09DA0401|CoAprovel|filmhtfl|312,5|mg|28|stk|1|þpakki|300+12,5 mg|C09DA04|01.09.2005||R|A|3|0|0|0|0|SBM|0|0|0|100|NOK|6249|9321|lyfalmen|||00|28|0|56|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan og þvagræsilyf||6249||6249|9321 019724|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019732|C09DA0401|CoAprovel|filmhtfl|312,5|mg|98|stk|1|þpakki|300+12,5 mg|C09DA04|01.09.2005||R|A|3|0|0|0|0|SBM|0|0|0|100|NOK|17751|24285|lyfalmen|||00|98|0|196|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan og þvagræsilyf||17751||17751|24285 019739|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019745|C03CA0101|Furix|töflur|40|mg|250|stk|1|glas|til vélskömmtunar|C03CA01|01.04.2005||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|724|1823|lyfalmen|||00|250|0|250|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||724||724|1823 019760|L01BC0501|Gemzar|irs|1|g|1|hgl|1|pakki||L01BC05|01.03.1999||R|A|3|0|1|0|1|ELI|0|0|0|100|XEU|33902|44075|lyfsjukr|||00|1|0|0|Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||33902||33902|44075 019781|L01XC0701|Avastin|irþ|25|mg/ml|16|ml|1|hgl|lausn|L01XC07|01.05.2005||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|229158|287169|lyfsjukr|||AC|16|0|0|Icepharma hf|Roche Registration Limited|Bevacizúmab||229158||229158|287169 019782|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019786|J01CA0410|Amoxicillin Merck NM|hylki|500|mg|20|stk|1|glas||J01CA04|01.04.1993||R|A|4|0|0|0|0|MNA|0|0|1|100|SEK|1110|2347|lyfalmen|||10|20|0|10|Actavis Group PTC ehf|Merck NM AB|Amoxicillín||1110||1110|2347 019793|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|96|stk|1|pakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019797|L01BA0401|Alimta|irþ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.03.2005||R|A|2|0|1|0|1|ELD|0|0|0|100|XEU|249316|312266|lyfsjukr|||00|1|0|0|Icepharma hf|Eli Lilly Nederland -|Pemetrexed||249316||249316|312266 019811|N06BA0901|Strattera|hylki|10|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|14048|19675|lyfalmen|||00|28|0|4|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||14048||14048|19675 019833|N06BA0901|Strattera|hylki|18|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|14048|19675|lyfalmen|||00|28|0|6|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||14048||14048|19675 019837|G03GA0601|Puregon|stl|900|ae/rörly|1,08|ml|1|lykja||G03GA06|01.10.2005||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|64340|82288|lyfalmen|||00|1|0|12|Vistor hf|N.V. Organon|Follitrópín beta||64340||64340|82288 019857|N06BA0901|Strattera|hylki|25|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|14048|19675|lyfalmen|||00|28|0|9|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||14048||14048|19675 019882|N06BA0901|Strattera|hylki|40|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|14048|19675|lyfalmen|||00|28|0|14|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||14048||14048|19675 019904|N06BA0901|Strattera|hylki|60|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|14048|19675|lyfalmen|||00|28|0|21|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||14048||14048|19675 019916|V03AF0801|Kepivance|sts|6,25|mg/hgl|6|hgl|1|pakki|lausn|V03AF08|01.07.2006||R|K|4|0|1|0|1|BIA|0|0|0|100|DKK|908238|1132624|lyfsjukr|||02|6|0|9|Vistor hf|Biovitrum AB (publ)|Palifermín||908238||908238|1132624 019931|N04BC0403|Adartrel|filmhtfl|0,25|mg|12|stk|1|þpakki||N04BC04|01.12.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|413|1401|lyfalmen|||00|12|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||413||413|1401 019938|J05AR0201|Kivexa|filmhtfl|900|mg|30|stk|1|þpakki|600+300 mg|J05AR02|01.05.2004||R|A|3|0|1|0|1|GGL|0|0|0|100|GBP|70952|90203|lyfsjukr|||00|30|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|Lamívúdín og abacavír||70952||70952|90203 019968|J01CA0410|Amoxicillin Merck NM|hylki|500|mg|30|stk|1|glas||J01CA04|01.04.1995||R|A|4|0|0|0|0|MNA|0|0|1|100|SEK|1662|3096|lyfalmen|||10|30|0|15|Actavis Group PTC ehf|Merck NM AB|Amoxicillín||1662||1662|3096 020016|B03AA0704|Duroferon|forðatfl|100|mg|100|stk|1|glas||B03AA07|01.03.1979||L|A|3|0|0|0|0|GCO|0|0|1|100|IKR|||lyflausa|||43|100|0|50|Vistor hf|GlaxoSmithKline CH AB|Ferrósúlfat||||| 020048|M02AA1502|Voltaren|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.03.2009||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|100|0|0|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak||||| 020134|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|13|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 020180|C03CC0101|Edecrin|sts|50|mg|1|hgl|1|pakki||C03CC01|01.05.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|26861|35309|lyfsjukr|||00|50|1|1|Parlogis hf|Parlogis - óskráð lyf|||26861||26861|35309 020193|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 020238|G04CA0203|Omnic Ocas|forðatfl|0,4|mg|30|stk|1|þpakki||G04CA02|01.04.2006||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|5149|7828|lyfalmen|||00|30|0|30|Vistor hf|Astellas Pharma A/S|Tamsúlósín||5149||5149|7828 020244|J07CA0204|Boostrix Polio|stl|0| |0,5|ml|10|áf.spr|dreifa|J07CA02|01.09.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|27664|36627|lyfalmen|||00|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, kíghósti, mænusótt, stífkrampi||27664||27664|36627 020268|N04BX0202|Comtess (Lyfjaver)|töflur|200|mg|100|stk|1|glas||N04BX02|01.10.2009||R|A||0|0|E|0|LVR|0|0|0|100|DKK|12807|18130|lyfalmen|V0729|18130|00|100|0|20|Lyfjaver ehf|Lyfjaver ehf|Entakapón||12807||12807|18130 020276|A06AB0203|Dulcolax (Lyfjaver)|eþ-stil|10|mg|50|stk|1|þpakki||A06AB02|01.07.2005||R|A|5|0|0|0|0|LVR|0|0|0|100|NOK|2910|4789|lyfalmen|||04|50|0|50|Lyfjaver ehf|Lyfjaver ehf|Bisakódýl||2910||2910|4789 020277|N06AX1602|Efexor Depot|forðahlk|37,5|mg|7|stk|1|þpakki||N06AX16|01.02.2007||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|834|1972|lyfalmen|V0953|1621|00|7|0|3|Icepharma hf|Wyeth AB|Venlafaxín||834||834|1972 020338|G04CA0203|Omnic Ocas|forðatfl|0,4|mg|90|stk|1|þpakki||G04CA02|01.04.2006||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|7862|11510|lyfalmen|||00|90|0|90|Vistor hf|Astellas Pharma A/S|Tamsúlósín||7862||7862|11510 020355|L02AE0203|Eligard|sts|22,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|61363|78582|lyfalmen|||02|2|0|0|Vistor hf|Astellas Pharma A/S|Leuprórelín||61363||61363|78582 020364|N04BC0403|Adartrel|filmhtfl|0,5|mg|84|stk|1|þpakki||N04BC04|01.06.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|4352|6746|lyfalmen|||00|84|0|7|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||4352||4352|6746 020398|N06AB1001|Cipralex|dropar|10|mg/ml|28|ml|1|glas||N06AB10|01.11.2005||R|A|2|0|0|B|0|LBK|0|1|0|100|DKK|4192|6529|lyfalmen|||00|28|0|28|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||4192||4192|6529 020417|N04BC0403|Adartrel|filmhtfl|2|mg|84|stk|1|þpakki||N04BC04|01.12.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|12582|17850|lyfalmen|||00|84|0|28|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||12582||12582|17850 020427|L02AE0203|Eligard|sts|7,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|28451|37606|lyfalmen|||02|2|0|0|Vistor hf|Astellas Pharma A/S|Leuprórelín||28451||28451|37606 020444|D07AB0201|Locoid|krem|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|838|1978|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||838||838|1978 020456|M05BX0301|Protelos|mixt.kyr|2|g|28|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|7996|11691|lyfalmen|||00|28|0|28|Icepharma hf|Servier|Strontíum ranelat||7996||7996|11691 020457|D07AB0201|Locoid|krem|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|2443|4156|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||2443||2443|4156 020494|N03AX1102|Topimax (Lyfjaver)|töflur|25|mg|60|stk|1|plglas||N03AX11|01.08.2004||R|A|3|0|0|E|0|LVR|0|0|0|100|SEK|4477|6916|lyfalmen|V0709|6916|00|60|0|5|Lyfjaver ehf|Lyfjaver ehf|Tópíramat||4477||4477|6916 020510|N03AX1102|Topimax (Lyfjaver)|töflur|50|mg|60|stk|1|plglas||N03AX11|01.07.2005||R|A|3|0|0|E|0|LVR|0|0|0|100|SEK|7371|10843|lyfalmen|V0710|10843|00|60|0|10|Lyfjaver ehf|Lyfjaver ehf|Tópíramat||7371||7371|10843 020516|N03AX1102|Topimax (Lyfjaver)|töflur|100|mg|60|stk|1|plglas||N03AX11|01.09.2004||R|A|3|0|0|E|0|LVR|0|0|0|100|SEK|13313|18760|lyfalmen|V0711|18760|00|60|0|20|Lyfjaver ehf|Lyfjaver ehf|Tópíramat||13313||13313|18760 020523|N06AB1002|Cipralex (D.A.C.)|töflur|10|mg|28|stk|1|þpakki||N06AB10|01.07.2004|31.10.2009|R|A|3|0|0|B|0|DAC|0|1|0|100|DKK|3587|5661|lyfalmen|||00|28|0|28|D.A.C. ehf|D.A.C. ehf|Escítalópram||3552||3552|5661 020533|M05BX0301|Protelos|mixt.kyr|2|g|84|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|23459|31391|lyfalmen|||00|84|0|84|Icepharma hf|Servier|Strontíum ranelat||23459||23459|31391 020648|R06AX2201|Kestine|töflur|20|mg|10|stk|1|þpakki||R06AX22|01.10.2005||L|A|3|0|0|0|0|ALF|0|0|1|100|IKR|||lyflausa|||00|10|0|20|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||||| 020649|N03AX1203|Neurontin (D.A.C.)|hylki|300|mg|50|stk|1|þpakki||N03AX12|01.07.2004|31.08.2009|R|A|3|0|0|E|0|DAC|0|0|0|100|DKK||4446|lyfalmen|||10|50|0|8|D.A.C. ehf|D.A.C. ehf|Gabapentín||2657||2657|4446 020711|G03AC0302|Postinor|töflur|1500|mcg|1|stk|1|þpakki||G03AC03|01.01.2007||L|A|4|0|0|0|0|MEI|0|0|0|100|IKR|||lyflausa|||23|1|0|0|Icepharma hf|Medimpex UK Limited|Levonorgestrel||||| 020770|QP54AA5101|Eqvalan Duo|pasta|0| |7,74|g|1|sk-dæl||QP54AA51|01.10.2006||R|A|3|0|0|0|0|MES|0|0|0|100|XEU|2566|4441|vetorma|||16|8|0|0|Vistor hf|Merial SAS|||2566||2566|4441 020774|L04AB0101|Enbrel|sts|50|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.10.2005||R|K|3|0|1|0|1|WTE|0|0|0|100|USD|210116|263462|lyfsjukr|||00|200|0|29|Icepharma hf|Wyeth Europe|Etanercept||210116||210116|263462 020924|J01FA1003|Zithromax (D.A.C.)|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.09.2007||R|A|2|0|0|0|0|DAC|0|0|1|100|DKK|2911|4712|lyfalmen|V0429|4712|00|3|0|5|D.A.C. ehf|D.A.C. ehf|Azitrómýcín||2853||2853|4712 021048|R03DC0301|Singulair|filmhtfl|10|mg|28|stk|1|þpakki||R03DC03|01.09.1998||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|6967|10295|lyfalmen|||63|28|0|28|Icepharma hf|M.S.D.|Montelúkast||6967||6967|10295 021053|D10AD0301|Differin|hlaup|0,1|%|60|g|1|túpa||D10AD03|01.12.2007||R|A|3|0|0|0|0|GAN|0|0|0|100|SEK|2553|4305|lyfalmen|||00|60|0|60|Icepharma hf|Galderma Nordic AB|Adapalen||2553||2553|4305 021057|J01CR0203|Augmentine (D.A.C.)|töflur|625|mg|12|stk|1|þpakki|500+125 mg|J01CR02|01.05.2005||R|A|2|0|0|0|0|DAC|0|0|1|100|IKR|827|1809|lyfalmen|||00|12|0|8|D.A.C. ehf|D.A.C. ehf|Amoxicillín og ensímblokkar||714||714|1809 021091|S01ED5107|Xalacom (D.A.C.)|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.11.2004||R|K|2|0|0|*|0|DAC|0|0|0|100|DKK|3709|5874|lyfalmen|V0988|5874|06|2|0|0|D.A.C. ehf|D.A.C. ehf|Tímólól í blöndum||3709||3709|5874 021107|N05AH0403|Seroquel (D.A.C.)|töflur|100|mg|60|stk|1|þpakki||N05AH04|01.05.2005|31.08.2009|R|A|3|0|0|*|0|DAC|0|1|0|100|SEK|9953|12628|lyfalmen|||00|60|0|15|D.A.C. ehf|D.A.C. ehf|Quetíapín||8686||8686|12628 021149|J01CR0203|Augmentine (D.A.C.)|töflur|1000|mg|12|stk|1|þpakki|875+125 mg|J01CR02|01.05.2005||R|A|1,5|0|0|0|0|DAC|0|0|1|100|IKR|1093|2218|lyfalmen|V0466|2218|00|12|0|12|D.A.C. ehf|D.A.C. ehf|Amoxicillín og ensímblokkar||1015||1015|2218 021161|M01AB0513|Vostar-S|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.03.2005||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|453|1436|lyfalmen|V0609|1424|00|30|0|15|Actavis Group hf|Actavis hf|Díklófenak||439||439|1436 021169|S01XA1201|Corneregel|augnhl|50|mg/g|10|g|1|túpa||S01XA12|01.08.2005||R|A|2|0|0|E|0|GEM|0|0|0|100|XEU|1174|2434|lyfalmen|||00|10|0|0|Actavis Group hf|Gerhard Mann|Dexpantenól||1174||1174|2434 021226|N06AB0603|Zoloft (D.A.C.)|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.09.2007||R|A|5|0|0|B|0|DAC|0|1|0|100|DKK|3431|3803|lyfalmen|V0931|2220|00|28|0|28|D.A.C. ehf|D.A.C. ehf|Sertralín||2183||2183|3803 021227|M01AB0513|Vostar-S|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.2005||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|1187|2451|lyfalmen|V0610|2451|00|100|0|50|Actavis Group hf|Actavis hf|Díklófenak||1187||1187|2451 021232|N06AB0603|Zoloft (D.A.C.)|filmhtfl|100|mg|28|stk|1|þpakki||N06AB06|01.11.2004|31.10.2009|R|A|5|0|0|B|0|DAC|0|1|0|100|DKK|6935|5764|lyfalmen|||00|28|0|56|D.A.C. ehf|D.A.C. ehf|Sertralín||3628||3628|5764 021257|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|lykja||G03BA03|01.07.2005||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|18375|25062|lyfalmen|||02|4|0|56|Icepharma hf|Bayer Schering Pharma AG|Testósterón||18375||18375|25062 021278|S01EE0102|Xalatan (D.A.C.)|augndr|50|mcg/ml|2,5|ml|1|glas||S01EE01|01.03.2009||R|K|3|0|0|*|0|DAC|0|0|0|100|DKK|2947|4840|lyfalmen|V1989|4840|0|2|0|25|D.A.C. ehf|D.A.C. ehf|Latanóprost||2947||2947|4840 021325|R03BB0402|Spiriva (D.A.C.)|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.11.2004|31.08.2009|R|A|2|0|0|B|0|DAC|0|0|0|100|DKK|7972|10892|lyfalmen|||0|30|0|30|D.A.C. ehf|D.A.C. ehf|Tíótrópíumbrómíð||7407||7407|10892 021341|R03AK0603|Seretide Diskus (Lyfjaver)|innúðadu|550|mcg/sk|60|sk|1|pakki|50+500 mcg, discus|R03AK06|01.05.2009|31.10.2009|R|A|1,5|0|0|B|0|LVR|0|0|0|100|GBP|9715|14024|lyfalmen|||23|60|0|30|Lyfjaver ehf|Lyfjaver ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||||9715|14024 021345|R03DC0301|Singulair|filmhtfl|10|mg|98|stk|1|þpakki||R03DC03|01.09.1998||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|19890|26948|lyfalmen|||63|98|0|98|Icepharma hf|M.S.D.|Montelúkast||19890||19890|26948 021365|R03AK0603|Seretide Diskus (Lyfjaver)|innúðadu|300|mcg/sk|60|sk|1|pakki|50+250 mcg, discus|R03AK06|01.05.2009|31.10.2009|R|A|1,5|0|0|B|0|LVR|0|0|0|100|GBP|7422|10912|lyfalmen|||23|60|0|30|Lyfjaver ehf|Lyfjaver ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||||7422|10912 021373|A02BC0504|Nexium Mups (D.A.C.)|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.04.2006|31.08.2009|R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|5421|8197|lyfalmen|||00|28|0|37|D.A.C. ehf|D.A.C. ehf|Esómeprazól||5421||5421|8197 021375|M01AB0512|Voltaren Dolo|töflur|12,5|mg|20|stk|1|þpakki||M01AB05|01.10.2004||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|20|0|2|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak||||| 021398|L02BB0303|Casodex (D.A.C.)|filmhtfl|50|mg|30|stk|1|þpakki||L02BB03|01.11.2004|31.10.2009|R|A|5|0|0|*|0|DAC|0|0|0|100|XEU|20729|23466|lyfalmen|||00|30|0|30|D.A.C. ehf|D.A.C. ehf|Bíkalútamíð||17093||17093|23466 021426|N04BX0203|Comtan (D.A.C.)|filmhtfl|200|mg|100|stk|1|glas||N04BX02|01.11.2004|31.10.2009|R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|12698|17994|lyfalmen|||0|100|0|20|D.A.C. ehf|D.A.C. ehf|Entakapón||12698||12698|17994 021428|A06AB0201|Dulcolax|eþ-stil|10|mg|6|stk|1|pakki||A06AB02|01.01.1995||L|A|5|0|0|0|0|BOI|0|0|0|100|IKR|||lyflausa|||04|6|0|6|Vistor hf|Boehringer Ingelheim|Bisakódýl||||| 021447|N04BC0402|Requip (D.A.C.)|töflur|2|mg|84|stk|1|plglas||N04BC04|01.11.2004|30.09.2009|R|A|2|0|0|E|0|DAC|0|0|0|100|GBP|13081|18471|lyfalmen|||00|84|0|28|D.A.C. ehf|D.A.C. ehf|Rópíníról||13081||13081|18471 021469|R03DC0301|Singulair|tuggutfl|5|mg|98|stk|1|þpakki||R03DC03|01.09.1998||R|A|2|0|0|B|0|MSD|0|0|0|100|XEU|26079|34653|lyfalmen|||63|98|0|49|Icepharma hf|M.S.D.|Montelúkast||26079||26079|34653 021494|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|5|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3161|4526|lyfsjukr|||02|100|0|0|Icepharma hf|Fresenius Kabi|Própófól||3161||3161|4526 021548|R03BA0204|Pulmicort Turbuhaler (D.A.C.)|innúðadu|200|mcg/sk|100|sk|1|stauk||R03BA02|01.05.2005|31.08.2009|R|A|2|0|0|B|0|DAC|0|0|0|100|SEK|3142|5104|lyfalmen|||23|100|0|25|D.A.C. ehf|D.A.C. ehf|Búdesóníð||3142||3142|5104 021559|R03BA0204|Pulmicort Turbuhaler (D.A.C.)|innúðadu|400|mcg/sk|100|sk|1|stauk||R03BA02|01.05.2005|31.08.2009|R|A|2|0|0|B|0|DAC|0|0|0|100|SEK|5143|7820|lyfalmen|||23|100|0|50|D.A.C. ehf|D.A.C. ehf|Búdesóníð||5143||5143|7820 021593|H01BA0201|Minirin|frþ.tfl|60|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|5367|8124|lyfalmen|||00|30|0|4|Vistor hf|Ferring Lægemidler A/S|Desmópressín||5367||5367|8124 021604|H01BA0201|Minirin|frþ.tfl|60|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|16960|23300|lyfalmen|||00|100|0|15|Vistor hf|Ferring Lægemidler A/S|Desmópressín||16960||16960|23300 021613|C10AA0701|Crestor|filmhtfl|5|mg|98|stk|1|þpakki||C10AA07|01.01.2006||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|14419|20137|lyfalmen|||00|98|0|49|Vistor hf|AstraZeneca A/S DK|||14419||14419|20137 021614|H01BA0201|Minirin|frþ.tfl|120|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FAB|0|0|0|100|DKK|9609|13880|lyfalmen|||00|30|0|9|Vistor hf|Ferring AB, Svíþjóð|Desmópressín||9609||9609|13880 021636|N01AX1003|Propolipid|stl|10|mg/ml|100|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|31183|40690|lyfsjukr|||02|1000|0|0|Icepharma hf|Fresenius Kabi|Própófól||31183||31183|40690 021641|H01BA0201|Minirin|frþ.tfl|120|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|26524|35207|lyfalmen|||00|100|0|30|Vistor hf|Ferring Lægemidler A/S|Desmópressín||26524||26524|35207 021647|N01AX1003|Propolipid|stl|20|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|35314|45833|lyfsjukr|||02|500|0|0|Icepharma hf|Fresenius Kabi|Própófól||35314||35314|45833 021659|V01AA0304|Alutard SQ, derm. pter.|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|28097|37166|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|rykmaurar||28097||28097|37166 021674|C10AA0701|Crestor|filmhtfl|5|mg|28|stk|1|þpakki||C10AA07|01.01.2006||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|4532|6991|lyfalmen|||00|28|0|14|Vistor hf|AstraZeneca A/S DK|||4532||4532|6991 021676|N01AX1003|Propolipid|stl|10|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|19817|26540|lyfsjukr|||02|500|0|0|Icepharma hf|Fresenius Kabi|Própófól||19817||19817|26540 021677|B02AA0202|Tranexamsyre "Pfizer"|stl|100|mg/ml|5|ml|10|lykjur||B02AA02|01.11.2005||R|A|3|0|0|0|1|PFI|0|0|0|100|DKK|5297|7584|lyfsjukr|||02|50|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Tranexamsýra||5297||5297|7584 021709|V01AA0304|Alutard SQ, derm. pter.|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|22495|30191|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|rykmaurar||22495||22495|30191 021721|N06AX2101|Cymbalta|sh-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|A|3|0|0|B|0|ELD|0|1|0|100|XEU|4422|6841|lyfalmen|V1951|6840|00|28|0|14|Icepharma hf|Eli Lilly Nederland -|||4422||4422|6841 021862|A02BC0505|Nexium (D.A.C.)|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.02.2007|31.10.2009|R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|5913|8865|lyfalmen|||00|28|0|37|D.A.C. ehf|D.A.C. ehf|Esómeprazól||5913||5913|8865 021950|B05AA0705|HyperHAES|irl|0| |250|ml|10|pokar||B05AA07|01.07.2005||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|29525|38626|lyfsjukr|||00|2500|0|2|Icepharma hf|Fresenius Kabi|Hýdróxyetýl sterkja||29525||29525|38626 021967|N06AX2101|Cymbalta|sh-hylki|60|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|A|3|0|0|B|0|ELD|0|1|0|100|XEU|6111|9133|lyfalmen|||00|28|0|28|Icepharma hf|Eli Lilly Nederland -|||6111||6111|9133 021975|N06AX2101|Cymbalta|sh-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.04.2005||R|A|3|0|0|B|0|ELD|0|1|0|100|XEU|21060|28405|lyfalmen|||00|98|0|98|Icepharma hf|Eli Lilly Nederland -|||21060||21060|28405 022020|V01AA0304|Alutard SQ, derm. pter.|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|22495|30191|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|rykmaurar||22495||22495|30191 022045|L01XE0301|Tarceva|filmhtfl|25|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|104837|132390|lyfsjukr|||00|30|0|0|Icepharma hf|Roche Registration Limited|Erlótiníb||104837||104837|132390 022087|QG03DA0201|Perlutex, vet.|töflur|5|mg|20|stk|1|þpakki||QG03DA02|01.10.1995||R|A|5|0|0|0|0|LAH|0|0|0|100|DKK|821|1620|vetalmen|||16|20|0|0|Vistor hf|LEO Animal Health A/S|||821||821|1620 022128|A01AA0117|Fludent Banan|munnstfl|0,25|mg|200|stk|1|plglas||A01AA01|01.01.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||00|200|0|45|Actavis Group hf|Actavis Group hf|Natríumflúoríð||||| 022132|C10BA0201|Inegy|töflur|30|mg|98|stk|1|þpakki|10 mg + 20 mg|C10BA02|01.09.2005||R|A|1,5|0|0|0|0|MSD|0|0|0|100|XEU|27662|36624|lyfalmen|||00|98|0|131|Icepharma hf|M.S.D.|Ezetimíb og simvastatín||27662||27662|36624 022159|C10BA0201|Inegy|töflur|50|mg|98|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.09.2005||R|A|1,5|0|0|0|0|MSD|0|0|0|100|XEU|32279|42372|lyfalmen|||00|98|0|261|Icepharma hf|M.S.D.|Ezetimíb og simvastatín||32279||32279|42372 022181|C10BA0201|Inegy|töflur|90|mg|98|stk|1|þpakki|10 mg + 80 mg|C10BA02|01.09.2005||R|A|1,5|0|0|0|0|MSD|0|0|0|100|XEU|33266|43601|lyfalmen|||00|98|0|523|Icepharma hf|M.S.D.|Ezetimíb og simvastatín||33266||33266|43601 022191|L01XE0301|Tarceva|filmhtfl|100|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|362611|453318|lyfsjukr|||00|30|0|0|Icepharma hf|Roche Registration Limited|Erlótiníb||362611||362611|453318 022205|L01XE0301|Tarceva|filmhtfl|150|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|374094|467615|lyfsjukr|||00|30|0|0|Icepharma hf|Roche Registration Limited|Erlótiníb||374094||374094|467615 022215|N06AB0504|Paxetin|töflur|20|mg|20|stk|1|glas||N06AB05|01.01.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|584|1424|lyfalmen|V0917|1366|00|20|0|20|Actavis Group hf|Actavis hf|Paroxetín||430||430|1424 022218|QP52AA5102|Drontal Comp.vet.|töflur|0| |24|stk|1|þpakki||QP52AA51|01.01.2006||R|A|5|0|0|0|0|BAN|0|0|0|100|DKK|11853|20512|vetorma|||00|24|0|0|Vistor hf|Bayer Animal Health GmbH|||11853||11853|20512 022250|M03AX0103|Vistabel|sts|50|ein/hgl|1|hgl|1|pakki|4 Allerg.ein/0,1ml|M03AX01|01.02.2008||R|K|2|0|1|0|0|ALL|0|0|0|100|SEK|28683|37895|lyfalmen|||02|1|0|0|Vistor hf|Allergan|Clostridium botulinum toxín-A||28683||28683|37895 022261|QP52AA5107|Profender fyrir kisur 5-8 kg|bl.lausn|1,12|ml/sk|1,12|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BHC|0|0|0|100|DKK|2621|4536|vetorma|||00|2|0|0|Vistor hf|Bayer HealthCare AG|||2621||2621|4536 022269|C08CA0101|Norvasc|töflur|5|mg|30|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|3367|5410|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Amlódipín||3367||3367|5410 022281|QP52AA5102|Drontal Comp.vet.|töflur|0| |2|stk|1|þpakki||QP52AA51|01.10.1991||L|A|5|0|0|0|0|BAN|0|0|0|100|DKK|||vetorma|||00|2|0|0|Vistor hf|Bayer Animal Health GmbH||||||2184 022293|C08CA0101|Norvasc|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|4503|5076|lyfalmen|V0308|2679|00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Amlódipín||3121||3121|5076 022368|C08CA0101|Norvasc|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|7783|7571|lyfalmen|V0310|3776|00|100|0|200|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Amlódipín||4960||4960|7571 022407|QP52AA5106|Profender fyrir kisur 2,5-5 kg|bl.lausn|0,7|ml/sk|0,7|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BHC|0|0|0|100|DKK|2482|4295|vetorma|||00|1|0|0|Vistor hf|Bayer HealthCare AG|||2482||2482|4295 022440|D07AB0203|Locoid Lipid|krem|1|mg/g|30|g|1|túpa|feitt|D07AB02|01.07.1986||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|858|2005|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||858||858|2005 022451|D07AB0203|Locoid Lipid|krem|1|mg/g|100|g|1|túpa|feitt|D07AB02|01.04.1987||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|2494|4225|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||2494||2494|4225 022465|QP52AA5105|Profender fyrir kisur 0,5-2,5 kg|bl.lausn|0,35|ml/sk|0,35|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BHC|0|0|0|100|DKK|1607|2781|vetorma|||00|1|0|0|Vistor hf|Bayer HealthCare AG|||1607||1607|2781 022532|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|172,5|mg|28|stk|1|þpakki||C09DA03|01.11.2003||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|5408|8179|lyfalmen|||00|28|0|56|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||5408||5408|8179 022537|N06AB0504|Paxetin|töflur|20|mg|100|stk|1|glas||N06AB05|01.01.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2400|3240|lyfalmen|V0919|2999|00|100|0|100|Actavis Group hf|Actavis hf|Paroxetín||1768||1768|3240 022577|N06AB0504|Paxetin|töflur|20|mg|60|stk|1|glas||N06AB05|01.01.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1554|2385|lyfalmen|V0918|2230|00|60|0|60|Actavis Group hf|Actavis hf|Paroxetín||1138||1138|2385 022585|L04AX0304|Metotrexato Lederle (D.A.C.)|töflur|2,5|mg|50|stk|1|glas||L04AX03|01.08.2005||R|A|3|0|0|*|0|DAC|0|0|0|100|USD|1441|2649|lyfalmen|||00|50|0|50|D.A.C. ehf|D.A.C. ehf|Metótrexat||1333||1333|2649 022609|A07EC0205|Pentasa (D.A.C)|forðatfl|500|mg|60|stk|1|þpakki||A07EC02|01.08.2006|31.08.2009|R|A|3|0|0|B|0|DAC|0|0|0|100|DKK|4435|5692|lyfalmen|||10|60|0|20|D.A.C. ehf|D.A.C. ehf|Mesalazín (5-amínósalicýlsýra)||3575||3575|5692 022708|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|172,5|mg|98|stk|1|þpakki||C09DA03|01.11.2003||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|15685|21713|lyfalmen|V0192|21322|00|98|0|196|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||15685||15685|21713 022802|L01XC0401|MabCampath|irþ|30|mg/ml|1|ml|3|hgl||L01XC04|01.07.2007||R|K|2|0|1|0|1|GEU|0|0|0|100|SEK|271475|339854|lyfsjukr|||00|3|0|0|Icepharma hf|Genzyme Europe B.V. (I)|Alemtuzumab||271475||271475|339854 022845|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|30|sk-hyl||S01XA20|01.05.2007||L|A|3|0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen|||00|15|0|0|Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar sam­setningar|||||3013 022904|D10BA0102|Decutan|hylki|10|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|A|3|0|1|C|0|ACA|0|0|0|30|IKR|1407|2750|lyfalmen|V0409|2750|67|30|0|10|Actavis Group hf|Actavis hf|Ísótretínóín||1407||1407|2750 022915|D10BA0102|Decutan|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|A|3|0|1|C|0|ACA|0|0|0|30|IKR|2450|4165|lyfalmen|V0410|4165|67|30|0|20|Actavis Group hf|Actavis hf|Ísótretínóín||2450||2450|4165 022962|V01AA1104|Alutard SQ, hrossaværur|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|28097|37166|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|dýr||28097||28097|37166 022970|V01AA1104|Alutard SQ, hrossaværur|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|22495|30191|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|dýr||22495||22495|30191 023036|R03BB0101|Atrovent|innúðadu|40|mcg|100|stk|1|pakki|þp+M-úðari|R03BB01|01.07.1992||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|4548|7012|lyfalmen|||19|100|0|33|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||4548||4548|7012 023047|G04BD1001|Emselex|forðatfl|7,5|mg|28|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|6539|9714|lyfalmen|||00|28|0|28|Vistor hf|Novartis Europharm Ltd|Darífenacín||6539||6539|9714 023063|J05AR0301|Truvada|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.03.2006||R|A|3|0|1|0|1|GIS|0|0|0|100|DKK|138985|174904|lyfsjukr|||00|30|0|0|Gilead Sience Sweden AB|Gilead Science International ltd.|Tenófóvír dísóproxíl og emtrícítabín||138985||138985|174904 023066|V03AE0301|Fosrenol|tuggutfl|500|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|A|2|0|1|0|0|SHI|0|0|0|100|DKK|29736|39206|lyfalmen|||00|90|0|20|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||29736||29736|39206 023080|V03AE0301|Fosrenol|tuggutfl|750|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|A|2|0|1|0|0|SHI|0|0|0|100|DKK|46426|59985|lyfalmen|||00|90|0|30|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||46426||46426|59985 023124|G04BD1001|Emselex|forðatfl|7,5|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|23510|31455|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|Darífenacín||23510||23510|31455 023146|G04BD1001|Emselex|forðatfl|15|mg|28|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|6605|9804|lyfalmen|||00|28|0|56|Vistor hf|Novartis Europharm Ltd|Darífenacín||6605||6605|9804 023193|G04BD1001|Emselex|forðatfl|15|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|23749|31752|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|Darífenacín||23749||23749|31752 023325|V03AB2501|Lanexat|stl|0,1|mg/ml|5|ml|5|lykjur||V03AB25|01.07.1989||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|24106|31879|lyfsjukr|||02|25|0|0|Icepharma hf|Roche|Flúmazeníl||24106||24106|31879 023376|N03AX1204|Gabapentin Merck NM|hylki|400|mg|100|stk|1|glas||N03AX12|01.05.2004|30.09.2009|R|A|2|0|0|E|0|MNA|0|0|0|100|SEK|5610|8453|lyfalmen|||00|100|0|22|Actavis Group PTC ehf|Merck NM AB|Gabapentín||5610||5610|8453 023409|N01BB2004|Oraqix|thhlaup|5|%|1,7|g|20|rörlyk||N01BB20|01.09.2006||R|A|3|0|0|0|0|DED|0|0|1|100|XEU|19067|25923|lyfalmen|||00|34|0|0|Vistor hf|Dentsply DeTrey GmbH|Blöndur||19067||19067|25923 023414|B03XA0201|Aranesp|stl|20|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|9936|14226|lyfsjukr|||00|0|0|4|Vistor hf|Amgen|Darbepóetín alfa||9936||9936|14226 023419|B03XA0201|Aranesp|stl|80|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|39111|50561|lyfsjukr|||00|0|0|18|Vistor hf|Amgen|Darbepóetín alfa||39111||39111|50561 023425|B03XA0201|Aranesp|stl|60|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|29602|38722|lyfsjukr|||00|0|0|13|Vistor hf|Amgen|Darbepóetín alfa||29602||29602|38722 023441|B03XA0201|Aranesp|stl|150|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|70468|89600|lyfsjukr|||00|0|0|33|Vistor hf|Amgen|Darbepóetín alfa||70468||70468|89600 023447|B03XA0201|Aranesp|stl|100|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|47047|60441|lyfsjukr|||00|0|0|22|Vistor hf|Amgen|Darbepóetín alfa||47047||47047|60441 023448|J06BA0207|Kiovig|irl|100|mg/ml|10|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|9910|14189|lyfsjukr|||00|10|0|0|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||9910||9910|14189 023452|B03XA0201|Aranesp|stl|300|mcg/pen|0,6|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|140846|177221|lyfsjukr|||00|1|0|67|Vistor hf|Amgen|Darbepóetín alfa||140846||140846|177221 023459|J06BA0207|Kiovig|irl|100|mg/ml|25|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|24775|32712|lyfsjukr|||00|25|0|0|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||24775||24775|32712 023463|B03XA0201|Aranesp|stl|40|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|19347|25955|lyfsjukr|||00|0|0|9|Vistor hf|Amgen|Darbepóetín alfa||19347||19347|25955 023468|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|20|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|2|0|0|E|0|GGL|0|0|0|100|GBP|13609|19128|lyfalmen|||00|10|0|20|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||13609||13609|19128 023470|J06BA0207|Kiovig|irl|100|mg/ml|50|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|49550|63557|lyfsjukr|||00|50|0|0|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||49550||49550|63557 023476|J06BA0207|Kiovig|irl|100|mg/ml|100|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|99100|125247|lyfsjukr|||00|100|0|0|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||99100||99100|125247 023479|B01AX0501|Arixtra|stl|5|mg/spr|0,4|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|9527|13769|lyfalmen|||00|3|0|14|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||9527||9527|13769 023480|B03XA0201|Aranesp|stl|500|mcg/pen|1|ml|1|penni|áfyllur penni|B03XA02|01.07.2007||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|225265|282322|lyfsjukr|||00|1|0|111|Vistor hf|Amgen|Darbepóetín alfa||225265||225265|282322 023487|J06BA0207|Kiovig|irl|100|mg/ml|200|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|198201|248628|lyfsjukr|||00|200|0|0|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||198201||198201|248628 023491|B01AX0501|Arixtra|stl|10|mg/spr|0,8|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|19052|25905|lyfalmen|||00|6|0|28|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||19052||19052|25905 023501|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|14289|19975|lyfalmen|||00|4|0|21|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||14289||14289|19975 023506|J05AE0901|Aptivus|hylki|250|mg|120|stk|1|glas||J05AE09|01.03.2007||R|A|3|0|1|0|1|BII|0|0|0|100|DKK|161177|202533|lyfsjukr|||00|120|0|30|Vistor hf|Boehringer Ingelheim International |Tipranavír||161177||161177|202533 023509|B01AC0401|Plavix|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.07.2007||R|A|3|0|0|E|0|SBM|0|0|0|100|NOK|28533|37709|lyfalmen|||00|100|0|100|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||28533||28533|37709 023544|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|2|0|0|E|0|GGL|0|0|0|100|GBP|4637|7133|lyfalmen|||00|4|0|7|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||4637||4637|7133 023590|S01ED0106|Timosan Depot|augnhl|1|mg/g|0,4|g|30|sk-hyl||S01ED01|01.07.2007||R|A|2,5|0|0|*|0|SAO|0|0|0|100|XEU|4167|6495|lyfalmen|||00|12|0|60|Icepharma hf|Santen Oy|Tímólól||4167||4167|6495 023708|J05AE0101|Invirase|filmhtfl|500|mg|120|stk|1|glas||J05AE01|01.01.2006||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|71396|90756|lyfsjukr|||00|120|0|100|Icepharma hf|Roche|Saquínavír||71396||71396|90756 023809|A10AE0404|Lantus [OptiClik]|stl|100|ein/ml|3|ml|5|rörlyk|fyrir OptiClik|A10AE04|01.04.2007||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|11436|16360|lyfalmen|||00|15|0|38|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||11436||11436|16360 023968|G04BE0302|Revatio|filmhtfl|20|mg|90|stk|1|þpakki||G04BE03|01.08.2006||R|A|5|0|1|0|1|PFL|0|0|0|100|DKK|109037|137619|lyfsjukr|||00|90|0|36|Vistor hf|Pfizer Limited|Síldenafíl||109037||109037|137619 024018|N04BA0204|Sinemet 25/100|töflur|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.10.1985||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|3503|5594|lyfalmen|||00|100|0|17|Icepharma hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||3503||3503|5594 024024|J01AA1201|Tygacil|irs|50|mg|10|hgl|1|pakki||J01AA12|01.02.2007||R|A|1,5|0|0|0|1|WTE|0|0|0|100|USD|89562|113372|lyfsjukr|||00|10|0|5|Icepharma hf|Wyeth Europe|Tigecýklín||89562||89562|113372 024037|J01DB0401|Kefzol|sts|1|g|10|stk|1|hgl||J01DB04|01.09.2005||R|A|2|0|0|0|1|NOM|0|0|0|100|DKK|6765|9686|lyfsjukr|||03|10|0|3|Icepharma hf|NordMedica ApS|Cefazólín||6765||6765|9686 024056|N02AB0301|Durogesic|forðapl|12|mcg/klst|5|stk|1|þpakki||N02AB03|01.02.2006||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|3522|5620|lyfalmen|||00|5|0|10|Vistor hf|Janssen-Cilag AB|Fentanýl||3522||3522|5620 024090|N04BD0201|Azilect|töflur|1|mg|30|stk|1|glas||N04BD02|01.10.2005||R|A|3|0|0|E|0|TPG|0|0|0|100|DKK|22846|30628|lyfalmen|||00|30|0|30|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||22846||22846|30628 024135|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|0| |1000|ml|10|pokar|lausn|B05BB01|01.10.2005||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|2473|3541|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|Elektrólýtar||2473||2473|3541 024147|A10BD0301|Avandamet|filmhtfl|1002|mg|112|stk|1|þpakki|1000+2mg|A10BD03|01.10.2005||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|9540|13787|lyfalmen|||00|112|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Metformín og rosiglítazón||9540||9540|13787 024169|A10BD0301|Avandamet|filmhtfl|1004|mg|112|stk|1|þpakki|1000+4mg|A10BD03|01.10.2005||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|16359|22552|lyfalmen|||00|112|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Metformín og rosiglítazón||16359||16359|22552 024200|N04BD0201|Azilect|töflur|1|mg|100|stk|1|þpakki||N04BD02|01.10.2005||R|A|3|0|0|E|0|TPG|0|0|0|100|DKK|73900|94190|lyfalmen|||00|100|0|100|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||73900||73900|94190 024307|V01AA1105|Alutard SQ, hundahar|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|28097|37166|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|dýr||28097||28097|37166 024478|V04CL0016|Soluprick SQ ALK553 - hundahár|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8845|12843|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8845||8845|12843 024481|R03CC0301|Bricanyl|mixtúra|0,3|mg/ml|100|ml|1|fl||R03CC03|01.03.2006||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|442|1440|lyfalmen|||00|100|0|2|Vistor hf|AstraZeneca A/S DK|Terbútalín||442||442|1440 024482|V04CL0017|Soluprick SQ ALK555 - kattahár|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8845|12843|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8845||8845|12843 024504|V04CL0003|Soluprick SQ ALK106 - Rauðölur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|14904|20740|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||14904||14904|20740 024510|V04CL0004|Soluprick SQ ALK107 - Gráölur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|14904|20740|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||14904||14904|20740 024526|V04CL0006|Soluprick SQ ALK113 - Hesliviður|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|14929|20772|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||14929||14929|20772 024532|V04CL0007|Soluprick SQ ALK203 - Háliðagras|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|14904|20740|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||14904||14904|20740 024559|V04CL0008|Soluprick SQ ALK214 -Axhnoðapunktur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|14904|20740|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||14904||14904|20740 024565|V04CL0009|Soluprick SQ ALK218 - Hávingull|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|15082|20962|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||15082||15082|20962 024576|V04CL0010|Soluprick SQ ALK223 - Vallarrýgresi|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|14904|20740|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||14904||14904|20740 024583|V04CL0011|Soluprick SQ ALK225 - Vallarfoxgras|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8845|12843|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8845||8845|12843 024589|V04CL0012|Soluprick SQ ALK228 - Vallarsveifgras|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|14904|20740|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||14904||14904|20740 024590|M05BA0802|Aclasta|irl|5|mg|100|ml|1|fl|lausn|M05BA08|01.07.2005||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|84192|107004|lyfalmen|||00|100|0|360|Vistor hf|Novartis Europharm Ltd|||84192||84192|107004 024600|V04CL0013|Soluprick SQ ALK231 - Rúgur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|15082|20962|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||15082||15082|20962 024603|V04CL0001|Soluprick Negativ Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|3|0|0|0|0|ALK|0|0|0|100|DKK|1816|3305|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||1816||1816|3305 024622|V04CL0005|Soluprick SQ ALK108 - Birkifrjó|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8845|12843|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8845||8845|12843 024644|V04CL0015|Soluprick SQ ALK552 - Hrossaværur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8845|12843|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8845||8845|12843 024670|V04CL0014|Soluprick SQ ALK504 - Rykmaur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8845|12843|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8845||8845|12843 024681|V04CL0002|Soluprick Positiv Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|3|0|0|0|0|ALK|0|0|0|100|DKK|1816|3305|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||1816||1816|3305 025093|C01BD0102|Trangorex (D.A.C.)|töflur|200|mg|30|stk|1|þpakki||C01BD01|01.08.2006||R|A|3|0|0|B|0|DAC|0|0|0|100|NOK|1174|2273|lyfalmen|V0143|2273|70|30|0|30|D.A.C. ehf|D.A.C. ehf|Amíódarón||1056||1056|2273 025126|M05BB0301|Fosavance|töflur|0| |4|stk|1|þpakki|70mg+70mcg|M05BB03|01.10.2006||R|A|1,5|0|0|0|0|MSD|0|0|0|100|XEU|6650|9865|lyfalmen|||00|4|0|28|Icepharma hf|M.S.D.|Alendrónsýra og kólekalsíferól||6650||6650|9865 025142|D07AB0202|Locoid Crelo|lausn|1|mg/g|30|g|1|glas|á húð|D07AB02|01.04.1994||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|1060|2279|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1060||1060|2279 025155|V01AA1105|Alutard SQ, hundahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|22495|30191|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|dýr||22495||22495|30191 025174|D07AB0202|Locoid Crelo|lausn|1|mg/g|100|g|1|glas|á húð|D07AB02|01.04.1994||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|3033|4956|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||3033||3033|4956 025180|R03BA0201|Pulmicort|innúðal|100|mcg/sk|120|sk|1|stauk||R03BA02|01.01.2009||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|2168|3782|lyfalmen|||0|120|0|15|Vistor hf|AstraZeneca A/S DK|Búdesóníð||2168||2168|3782 025191|R03BA0201|Pulmicort|innúðal|200|mcg/sk|120|sk|1|stauk||R03BA02|01.01.2009||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|4125|6438|lyfalmen|||0|120|0|30|Vistor hf|AstraZeneca A/S DK|Búdesóníð||4125||4125|6438 025262|V01AA1105|Alutard SQ, hundahar|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|22495|30191|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|dýr||22495||22495|30191 025300|J01DB0101|Keflex|mixtúrud|50|mg/ml|100|ml|1|glas||J01DB01|01.03.1983||R|A|3|0|0|0|0|NMA|0|0|1|100|DKK|1104|2339|lyfalmen|||08|100|0|2|Icepharma hf|NordMedica A/S|Cefalexín||1104||1104|2339 025306|M05BB0301|Fosavance|töflur|0| |12|stk|1|þpakki|70mg+70mcg|M05BB03|01.10.2006||R|A|1,5|0|0|0|0|MSD|0|0|0|100|XEU|15943|22034|lyfalmen|||00|12|0|84|Icepharma hf|M.S.D.|Alendrónsýra og kólekalsíferól||15943||15943|22034 025311|J01DB0101|Keflex|töflur|500|mg|14|stk|1|þpakki||J01DB01|01.07.1988||R|A|3|0|0|0|0|NMA|0|0|1|100|IKR|794|1918|lyfalmen|||00|14|0|4|Icepharma hf|NordMedica A/S|Cefalexín||794||794|1918 025317|J05AF1001|Baraclude|filmhtfl|1|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|115707|145923|lyfsjukr|||00|30|0|60|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||115707||115707|145923 025323|J05AF1001|Baraclude|filmhtfl|0,5|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|114390|144283|lyfsjukr|||00|30|0|30|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||114390||114390|144283 025388|QM01AC0601|Metacam|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.10.2006||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|11147|21405|vetalmen|||00|20|0|0|Vistor hf|Boehringer Ingelheim|||11147||11147|21405 025425|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|30|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|A|3|0|1|0|0|ALK|0|0|0|100|DKK|20649|27893|lyfalmen|||00|30|0|0|Vistor hf|ALK-Abello A/S|grasfrjó||20649||20649|27893 025444|C09CA0301|Diovan|filmhtfl|320|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.04.2007||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|25114|33452|lyfalmen|||00|98|0|392|Vistor hf|Novartis Healthcare A/S-|Valsartan||25114||25114|33452 025455|C09CA0301|Diovan|töflur|320|mg|28|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.04.2007||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|7326|10782|lyfalmen|||00|28|0|112|Vistor hf|Novartis Healthcare A/S-|Valsartan||7326||7326|10782 025555|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki||N05AX08|01.04.2003||R|K|3|0|0|*|0|JAS|0|1|0|100|SEK|34791|45500|lyfalmen|||00|1|0|28|Vistor hf|Janssen-Cilag AB|Risperídón||34791||34791|45500 025578|S01EC0302|Trusopt (D.A.C.)|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.01.2007||R|A|2|0|0|*|0|DAC|0|0|0|100|XEU|2175|3792|lyfalmen|V1090|3792|06|5|0|17|D.A.C. ehf|D.A.C. ehf|Dorzólamíð||2175||2175|3792 025588|M05BA0602|Bonviva|filmhtfl|150|mg|1|stk|1|þpakki||M05BA06|01.01.2006||R|A|2|0|0|0|0|RRL|0|0|0|100|DKK|6104|9124|lyfalmen|||00|1|0|30|Icepharma hf|Roche Registration Limited|||6104||6104|9124 025599|M05BA0602|Bonviva|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.01.2006||R|A|2|0|0|0|0|RRL|0|0|0|100|DKK|15920|22005|lyfalmen|||00|3|0|90|Icepharma hf|Roche Registration Limited|||15920||15920|22005 025676|L01CB0201|Vumon|stl|10|mg/ml|5|ml|10|lykjur||L01CB02|01.05.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|34429|44732|lyfsjukr|||00|50|1|0|Distica|Distica - óskráð lyf|||34429||34429|44732 025698|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki||N05AX08|01.04.2003||R|K|3|0|0|*|0|JAS|0|1|0|100|SEK|18574|25310|lyfalmen|||00|1|0|14|Vistor hf|Janssen-Cilag AB|Risperídón||18574||18574|25310 025709|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki||N05AX08|01.04.2003||R|K|3|0|0|*|0|JAS|0|1|0|100|SEK|26865|35632|lyfalmen|||00|1|0|21|Vistor hf|Janssen-Cilag AB|Risperídón||26865||26865|35632 025736|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|100|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|A|3|0|1|0|0|ALK|0|0|0|100|DKK|64466|82445|lyfalmen|||00|100|0|0|Vistor hf|ALK-Abello A/S|grasfrjó||64466||64466|82445 025747|C01BB0101|Xylocard 100 mg/ 5 ml|stl|20|mg/ml|5|ml|5|gl-lyk||C01BB01|01.12.2006||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|7395|10588|lyfsjukr|||02|25|0|0|Vistor hf|AstraZeneca A/S DK|Lídókaín||7395||7395|10588 025841|V01AA1106|Alutard SQ, kattahar|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|28097|37166|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|dýr||28097||28097|37166 025958|M01AE0215|Naproxen Merck NM|töflur|250|mg|100|stk|1|glas||M01AE02|01.01.1991||R|A|4|0|0|E|0|MNA|0|0|1|100|SEK|1007|2207|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck NM AB|Naproxen||1007||1007|2207 025965|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|1|l|1|fl||QP54AA01|01.04.1992||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|4059|7024|vetorma|||16|1|0|0|Vistor hf|Merial (MSD)|||4059||4059|7024 025985|M01AE0215|Naproxen Merck NM|töflur|500|mg|50|stk|1|þpakki||M01AE02|01.01.1991||R|A|4|0|0|E|0|MNA|0|0|1|100|SEK|1038|2249|lyfalmen|||00|50|0|50|Actavis Group PTC ehf|Merck NM AB|Naproxen||1038||1038|2249 025994|M01AE0218|Naproxen Mylan|töflur|500|mg|100|stk|1|glas||M01AE02|01.01.1991||R|A|4|0|0|E|0|MNA|0|0|1|100|SEK|1852|3354|lyfalmen|||00|100|0|100|Actavis Group PTC ehf|Merck NM AB|Naproxen||1852||1852|3354 026021|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.04.1992||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|9186|15897|vetorma|||16|2|0|0|Vistor hf|Merial (MSD)|||9186||9186|15897 026096|V01AA1106|Alutard SQ, kattahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|22495|30191|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|dýr||22495||22495|30191 026682|J01XE0101|Furadantin|töflur|50|mg|100|stk|1|glas||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|2078|3660|lyfalmen|||00|100|0|25|Vistor hf|Recip AB|Nítrófúrantóín||2078||2078|3660 027094|J01XE0101|Furadantin|töflur|5|mg|50|stk|1|glas||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|432|1427|lyfalmen|||00|50|0|1|Vistor hf|Recip AB|Nítrófúrantóín||432||432|1427 027144|M01CC0101|Atamir|hylki|150|mg|50|stk|1|þpakki||M01CC01|01.06.1982||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|3141|5103|lyfalmen|||10|50|0|15|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||3141||3141|5103 027202|S01ED5111|Azarga|augndr|15|mg/ml|5|ml|1|glas|10+5 mg/ml|S01ED51|01.10.2009||R|A||0|0|*|0|ALA|0|0|0|100|USD|2513|4251|lyfalmen|||00|5|0|0|Vistor hf|Alcon Laboratories Ltd.|Tímólól í blöndum||2513||2513|4251 027235|G03HA0103|Cyproteron Merck NM|töflur|50|mg|50|stk|1|glas||G03HA01|01.04.1997||R|A|5|0|0|*|0|MNA|0|0|0|100|SEK|8315|12124|lyfalmen|||00|50|0|25|Actavis Group PTC ehf|Merck NM AB|Cýpróterón||8315||8315|12124 027281|N06DA0204 |Donepezil Actavis|filmhtfl|5|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|A|3|0|0|E|0|ACA|0|0|0|100|XEU|34355|44957|lyfalmen|V0375|44957|00|100|0|67|Actavis Group hf|Actavis hf|Dónepezíl||||34355|44957 027294|M03AC0902|Esmeron (Lyfjaver)|stl|10|mg/ml|5|ml|10|hgl||M03AC09|01.10.2009||R|K||0|0|0|1|LVR|0|0|0|100|NOK|11873|16649|lyfsjukr|||00|50|0|0|Lyfjaver ehf|Lyfjaver ehf|Rókúrón, brómíð||11873||11873|16649 027305|N06DA0204 |Donepezil Actavis|filmhtfl|10|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|A|3|0|0|E|0|ACA|0|0|0|100|XEU|38555|50186|lyfalmen|V0376|50186|00|100|0|133|Actavis Group hf|Actavis hf|Dónepezíl||||38555|50186 027306|N03AX1205|Neurontin (Lyfjaver)|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.10.2009||R|A||0|0|E|0|LVR|0|0|0|100|DKK|5395|8162|lyfalmen|V0714|8162|00|100|0|17|Lyfjaver ehf|Lyfjaver ehf|Gabapentín||5395||5395|8162 027317|N03AX1205|Neurontin (Lyfjaver)|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.10.2009||R|A||0|0|E|0|LVR|0|0|0|100|DKK|7380|10855|lyfalmen|V0715|10855|00|100|0|22|Lyfjaver ehf|Lyfjaver ehf|Gabapentín||7380||7380|10855 027328|N03AX1205|Neurontin (Lyfjaver)|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.10.2009||R|A||0|0|E|0|LVR|0|0|0|100|DKK|19881|26937|lyfalmen|V2160|26441|00|100|0|33|Lyfjaver ehf|Lyfjaver ehf|Gabapentín||19881||19881|26937 027339|L01XE0502|Nexavar (Lyfjaver)|filmhtfl|200|mg|112|stk|1|þpakki||L01XE05|01.10.2009||R|A||0|1|0|1|LVR|0|0|0|100|SEK|664333|804453|lyfsjukr|||00|112|0|0|Lyfjaver ehf|Lyfjaver ehf|Sorafeníb||644647||644647|804453 027362|L01AX0302 |Temodal (Lyfjaver)|hylki|20|mg|20|stk|1|glas||L01AX03|01.05.2009||R|A|3|0|1|0|1|LVR|0|0|0|100|NOK|80942|102640|lyfsjukr|||00|20|0|0|Lyfjaver ehf|Lyfjaver ehf|Temozolomid||||80942|102640 027373|L01AX0302 |Temodal (Lyfjaver)|hylki|100|mg|5|stk|1|glas||L01AX03|01.05.2009||R|A|3|0|1|0|1|LVR|0|0|0|100|NOK|98956|125068|lyfsjukr|||00|5|0|0|Lyfjaver ehf|Lyfjaver ehf|Temozolomid||||98956|125068 027385|L01AX0302 |Temodal (Lyfjaver)|hylki|250|mg|5|stk|1|glas||L01AX03|01.05.2009||R|A|3|0|1|0|1|LVR|0|0|0|100|NOK|213585|267781|lyfsjukr|||00|5|0|0|Lyfjaver ehf|Lyfjaver ehf|Temozolomid||||213585|267781 027397|G02CX0102 |Tractocile (Lyfjaver)|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.05.2009||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|6477|9273|lyfsjukr|||00|1|0|0|Lyfjaver ehf|Lyfjaver ehf|Atosíban||||6477|9273 027408|G02CX0102 |Tractocile (Lyfjaver)|irþ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.05.2009||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|19293|25887|lyfsjukr|||00|5|0|0|Lyfjaver ehf|Lyfjaver ehf|Atosíban||||19293|25887 027559|N03AX1501|Zonegran|hylki|25|mg|14|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|2113|3708|lyfalmen|||00|14|0|2|Vistor hf|Eisai Ltd|||2113||2113|3708 027586|N03AX1501|Zonegran|hylki|25|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|8453|12312|lyfalmen|||00|56|0|7|Vistor hf|Eisai Ltd|||8453||8453|12312 027595|N03AX1501|Zonegran|hylki|50|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|11160|15985|lyfalmen|||00|56|0|14|Vistor hf|Eisai Ltd|||11160||11160|15985 027604|N03AX1501|Zonegran|hylki|100|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|14945|20792|lyfalmen|||00|56|0|28|Vistor hf|Eisai Ltd|||14945||14945|20792 027649|H03AA0105|Levaxin|töflur|0,05|mg|100|stk|1|glas||H03AA01|01.04.2004||R|A|2|0|0|B|0|NYG|0|0|0|100|DKK|977|2166|lyfalmen|V0431|2020|00|100|0|33|Gróco ehf|Nycomed Danmark A/S|Levótýroxínnatríum||977||977|2166 027656|H03AA0105|Levaxin|töflur|0,1|mg|100|stk|1|glas||H03AA01|01.03.2003||R|A|2|0|0|B|0|NYG|0|0|0|100|DKK|977|2166|lyfalmen|V0430|1865|00|100|0|67|Gróco ehf|Nycomed Danmark A/S|Levótýroxínnatríum||977||977|2166 027795|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|fl||J02AC04|01.08.2006||R|A|2|0|1|0|1|SCP|0|0|0|100|DKK|143244|180206|lyfsjukr|||00|105|0|1|Icepharma hf|SP Europe|Posacónazól||143244||143244|180206 027968|N05AX1201|Abilify|munndr.t|10|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|A|1,5|0|0|*|0|OTS|0|1|0|100|DKK|27570|36510|lyfalmen|||00|28|0|19|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||27570||27570|36510 027977|N05AX1201|Abilify|munndr.t|15|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|A|1,5|0|0|*|0|OTS|0|1|0|100|DKK|27570|36510|lyfalmen|||00|28|0|28|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||27570||27570|36510 028045|G03AB0001|Qlaira|töflur|0||84|stk|1|þpakki|3x28 stk|G03AB|01.11.2009||R|A||0|0|0|0|BAP|0|0|0|100|SEK|5199|7896|lyfalmen|||00|84|0||Icepharma hf|Bayer Schering Pharma AG|||||5199|7896 028168|C09XA5201|Rasilez HCT|filmhtfl|162,5|mg|28|stk|1|þpakki|150/12,5 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|4574|7048|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|Aliskiren og þvagræsilyf||||4574|7048 028179|C09XA5201|Rasilez HCT|filmhtfl|162,5|mg|98|stk|1|þpakki|150/12,5 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|15899|21979|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|Aliskiren og þvagræsilyf||||15899|21979 028190|C09XA5201|Rasilez HCT|filmhtfl|175|mg|28|stk|1|þpakki|150/25 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|4574|7048|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|Aliskiren og þvagræsilyf||||4574|7048 028201|C09XA5201|Rasilez HCT|filmhtfl|175|mg|98|stk|1|þpakki|150/25 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|15899|21979|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|Aliskiren og þvagræsilyf||||15899|21979 028212|C09XA5201|Rasilez HCT|filmhtfl|312,5|mg|28|stk|1|þpakki|300/12,5 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|5272|7995|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|Aliskiren og þvagræsilyf||||5272|7995 028224|C09XA5201|Rasilez HCT|filmhtfl|312,5|mg|98|stk|1|þpakki|300/12,5 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|18338|25016|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|Aliskiren og þvagræsilyf||||18338|25016 028235|C09XA5201|Rasilez HCT|filmhtfl|325|mg|28|stk|1|þpakki|300/25 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|5272|7995|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|Aliskiren og þvagræsilyf||||5272|7995 028246|C09XA5201|Rasilez HCT|filmhtfl|325|mg|98|stk|1|þpakki|300/25 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|18338|25016|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|Aliskiren og þvagræsilyf||||18338|25016 028314|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áf.spr|m/ aðsk. nál|J07AP03|01.05.2008||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|2940|4830|lyfalmen|||02|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsaðir mótefna­vakar||2940||2940|4830 028351|J07BL0101|Stamaril|sts|0| |0,5|ml|10|hgl|+ 10 áf.spr. með leysi|J07BL01|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|24679|32910|lyfalmen|||02|5|0|0|Icepharma hf|Sanofi Pasteur MSD|Gulusótt, veikluð veira||24679||24679|32910 028360|J07BG0101|Rabies - Imovax|bóluefni|0| |1|ml|1|hgl||J07BG01|01.01.1996||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|9443|13655|lyfalmen|||02|1|0|0|Icepharma hf|Aventis Pasteur MSD A/S|Hundaæði, dauð veira||9443||9443|13655 028387|M03BX0104|Baklofen Merck NM|töflur|25|mg|50|stk|1|glas|0|M03BX01|01.10.2008||R|A|3|0|0|E|0|MNA|0|0|1|100|SEK|1492|2865|lyfalmen|V0712|2865|00|50|0|25|Actavis Group PTC ehf|Merck NM AB|Baklófen||1492||1492|2865 028405|M01AE0216|Naproxen-E Merck NM|sh-tfl|500|mg|50|stk|1|plglas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|2125|3724|lyfalmen|||10|50|0|50|Actavis Group PTC ehf|Merck NM AB|Naproxen||2125||2125|3724 028498|C08DB0102|Cardizem Retard|forðatfl|120|mg|60|stk|1|glas||C08DB01|01.04.1987||R|A|3|0|0|B|0|FRO|0|0|0|100|DKK|3821|6026|lyfalmen|||10|60|0|30|Vistor hf|Ferrosan A/S|Diltíazem||3821||3821|6026 028575|N03AX0901 |Lamictal|dreifit.|5|mg|56|stk|1|þpakki||N03AX09|01.05.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|1278|2575|lyfalmen|||00|56|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||||1278|2575 028586|N03AX0901 |Lamictal|dreifit.|100|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|5812|8728|lyfalmen|||00|98|0|33|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||||5812|8728 028597|D07BB0401|Locoidol|krem|0| |30|g|1|túpa||D07BB04|01.01.1990|31.08.2009|R|A|4|0|0|B|0|ASP|0|0|1|100|XEU|1026|2233|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat og sýkla­eyðandi lyf||1026||1026|2233 028598|N03AX0901 |Lamictal|dreifit.|200|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|10358|14897|lyfalmen|||00|98|0|65|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||||10358|14897 028606|QN05CM1801|Dexdomitor|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.11.2007||R|A|3|0|0|0|0|OCO|0|0|0|100|DKK|9251|17793|vetalmen|||27|10|0|0|Icepharma hf|Orion Corporation (I)|||9251||9251|17793 028761|A03FA0101|Primperan|stl|5|mg/ml|2|ml|12|lykjur||A03FA01|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|1083|2310|lyfalmen|||02|24|0|4|Vistor hf|Sanofi-aventis Norge AS|Metóklópramíð||1083||1083|2310 028787|A04AA0201|Kytril|töflur|1|mg|10|stk|1|þpakki||A04AA02|01.10.1994||R|A|3|0|0|E|0|ROA|0|0|0|100|DKK|13813|19382|lyfalmen|||00|10|0|5|Icepharma hf|Roche A.S.|Granisetrón||13813||13813|19382 029025|D07AC0301|Ibaril|smyrsli|2,5|mg/g|50|g|1|túpa||D07AC03|01.12.1978||R|A|1,5|0|0|B|0|SNO|0|0|1|100|NOK|2484|4211|lyfalmen|||20|50|0|50|Vistor hf|Sanofi-aventis Norge AS|Desoxímetasón||2484||2484|4211 029066|R01AD0801|Flixonase|nefúði|50|mcg/sk|16|ml|1|stauk|120 sk|R01AD08|01.04.1992||R|A|2|0|0|E|0|GSK|0|0|1|100|GBP|1152|2404|lyfalmen|||24|16|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||||1152|2404 029116|A03FA0101|Primperan|töflur|10|mg|40|stk|1|þpakki||A03FA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|642|1712|lyfalmen|||00|40|0|13|Vistor hf|Sanofi-aventis Norge AS|Metóklópramíð||642||642|1712 029287|C03DB0105 |Amiloride|töflur|5|mg|28|stk|1|þpakki||C03DB01|01.04.2009||R|A|3|0|0|E|0|AUK|0|0|0|100|GBP|269|1205|lyfalmen|||00|28|0|14|Actavis Group hf|Actavis UK Ltd.|||||269|1205 029307|A07EA0603|Entocort enema (D.A.C.)|endaþ.dr|0,02|mg/ml|7|stk|1|þpakki||A07EA06|01.01.2007|31.08.2009|R|A|2|0|0|B|0|DAC|0|0|0|100|SEK|7702|11292|lyfalmen|||0|7|0|0|D.A.C. ehf|D.A.C. ehf|Búdesóníð||||7702|11292 029352|C10AA0103|Zocor (Lyfjaver)|töflur|10|mg|98|stk|1|þpakki||C10AA01|01.09.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|XEU|9724|6562|lyfalmen|||00|98|0|33|Lyfjaver ehf|Lyfjaver ehf|Simvastatín||4216||4216|6562 029361|C10AA0103|Zocor (Lyfjaver)|töflur|20|mg|98|stk|1|þpakki||C10AA01|01.09.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|XEU|8800|10380|lyfalmen|||00|98|0|65|Lyfjaver ehf|Lyfjaver ehf|Simvastatín||7030||7030|10380 029370|C10AA0103|Zocor (Lyfjaver)|töflur|40|mg|98|stk|1|þpakki||C10AA01|01.09.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|XEU|13829|14049|lyfalmen|||00|98|0|131|Lyfjaver ehf|Lyfjaver ehf|Simvastatín||9733||9733|14049 029379|C10AA0103|Zocor (Lyfjaver)|töflur|80|mg|98|stk|1|þpakki||C10AA01|01.09.2005||R|A|1,5|0|0|0|0|LVR|0|0|0|100|XEU|19447|26396|lyfalmen|||00|98|0|261|Lyfjaver ehf|Lyfjaver ehf|Simvastatín||19447||19447|26396 029517|L01BB0503 |Fludarabin Actavis|sts/irs|25|mg/ml|50|mg|1|hgl||L01BB05|01.04.2009||R|A|2|0|1|0|1|AGP|0|0|0|100|XEU|36473|47276|lyfsjukr|||00|50|0|0|Actavis Group hf|Actavis Group PTC ehf|Flúdarabín||||36473|47276 029528|L01CA0402 |Vinorelbin Actavis|irþ|10|mg/ml|5|ml|1|hgl||L01CA04|01.04.2009||R|K|3|0|1|0|1|AGP|0|0|0|100|XEU|23473|31091|lyfsjukr|||00|5|0|0|Actavis Group hf|Actavis Group PTC ehf|Vínorelbín||||23473|31091 029574|L01XX1904 |Irinotecan Actavis|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.04.2009||R|A|3|0|1|0|1|AGT|0|0|0|100|XEU|23512|31140|lyfsjukr|||00|5|0|0|Actavis Group hf|Actavis Group hf|Írinótekan||||23512|31140 029860|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2|Vistor hf|McNeil Denmark ApS|Nikótín||||| 029869|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|7|Vistor hf|McNeil Denmark ApS|Nikótín||||| 029878|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14|Vistor hf|McNeil Denmark ApS|Nikótín||||| 029887|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|4|Vistor hf|McNeil Denmark ApS|Nikótín||||| 029896|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|14|Vistor hf|McNeil Denmark ApS|Nikótín||||| 029905|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28|Vistor hf|McNeil Denmark ApS|Nikótín||||| 030054|J05AE0302|Norvir (D.A.C.)|hylki|100|mg|84|stk|1|glas|mjúk hylki|J05AE03|01.12.2008||R|K|2|0|1|0|1|DAC|0|0|0|100|DKK|21840|29058|lyfsjukr|||00|84|0|7|D.A.C. ehf|D.A.C. ehf|Ritonavír||||21840|29058 030315|N03AX1501|Zonegran|hylki|100|mg|98|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|26141|34731|lyfalmen|||00|98|0|49|Vistor hf|Eisai Ltd|||26141||26141|34731 030361|D07AB0101|Emovat|smyrsli|0,5|mg/g|25|g|1|túpa||D07AB01|01.01.1985|31.10.2009|R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|531|1561|lyfalmen|||20|25|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasón||531||531|1561 030387|D07AB0101|Emovat|smyrsli|0,5|mg/g|100|g|1|túpa||D07AB01|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|2016|3576|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasón||2016||2016|3576 030588|M01AX0501|Glucomed|töflur|625|mg|60|stk|1|þpakki||M01AX05|01.07.2006||L|A|3|0|0|0|0|NAV|0|0|1|100|IKR|||lyflausa|||00|60|0|25|Icepharma hf|Navamedic ASA|Glúkósamín||||| 030627|N05AH0201|Leponex|töflur|100|mg|100|stk|1|glas||N05AH02|01.04.1993||R|A|5|0|0|*|0|NOH|0|1|0|100|DKK|10751|15430|lyfalmen|V1400|15429|00|100|0|33|Vistor hf|Novartis Healthcare A/S-|Klózapín||10751||10751|15430 030635|N05AH0201|Leponex|töflur|25|mg|100|stk|1|glas||N05AH02|01.04.1993||R|A|5|0|0|*|0|NOH|0|1|0|100|DKK|3429|5494|lyfalmen|V1401|5492|00|100|0|8|Vistor hf|Novartis Healthcare A/S-|Klózapín||3429||3429|5494 030754|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|770|l|1|hylki|kælt|V03AN01|01.03.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|770|0|0|Strandmöllen A/S|Strandmöllen A/S|Súrefni||||| 030765|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|11000|l|1|hylki|kælt|V03AN01|01.03.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|11000|0|0|Strandmöllen A/S|Strandmöllen A/S|Súrefni||||| 030940|C07AB0207|Metoprolol Merck NM|töflur|50|mg|100|stk|1|glas||C07AB02|01.10.1995||R|A|3|0|0|B|0|MNA|0|0|0|100|SEK|996|2192|lyfalmen|||00|100|0|33|Actavis Group PTC ehf|Merck NM AB|Metóprólól||996||996|2192 031039|C07AB0207|Metoprolol Merck NM|töflur|100|mg|100|stk|1|glas||C07AB02|01.10.1995||R|A|3|0|0|B|0|MNA|0|0|0|100|SEK|1452|2811|lyfalmen|||00|100|0|67|Actavis Group PTC ehf|Merck NM AB|Metóprólól||1452||1452|2811 031070|A04AD0101|Scopoderm|forðapl|1|mg/72kls|2|stk|1|pakki||A04AD01|01.07.1985||R|A|2|0|0|E|0|NHE|0|0|1|100|DKK|970|2157|lyfalmen|||23|2|0|2|Artasan ehf|Novartis Healthcare A/S-A|Skópólamín||970||970|2157 031088|A10AB0401|Humalog|stl|100|ae/ml|10|ml|1|hgl||A10AB04|01.01.1997||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|3671|5822|lyfalmen|||17|10|0|25|Icepharma hf|Eli Lilly Nederland -|Insúlín lispró||3671||3671|5822 031261|A10AB0604|Apidra [opticlik]|stl|100|ein/ml|3|ml|5|rörlyk||A10AB06|01.04.2007||R|K|2|0|0|*|0|SAA|0|0|0|100|NOK|5519|8330|lyfalmen|||02|15|0|38|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||5519||5519|8330 031773|C01DA0801|Sorbangil|töflur|20|mg|100|stk|1|glas||C01DA08|01.01.1985||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|2330|4002|lyfalmen|||00|100|0|33|Vistor hf|Recip AB|Ísósorbíð dínítrat||2330||2330|4002 031849|A10AB0503|NovoRapid Penfill|stl|100|ein/ml|3|ml|5|rörlyk||A10AB05|01.07.2002||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|7310|10760|lyfalmen|||02|15|0|38|Vistor hf|Novo-Nordisk|Insúlín aspart||7310||7310|10760 031942|H01BA0401|Glypressin|sts|1|mg/hgl|1|mg|5|hgl|og leysir|H01BA04|01.01.1998||R|A|3|0|0|0|1|FEL|0|0|0|100|DKK|43043|55456|lyfsjukr|||00|5|0|0|Vistor hf|Ferring Lægemidler A/S|Terlípressín||43043||43043|55456 031971|C07AA0705|Sotalol Mylan|töflur|160|mg|100|stk|1|plglas||C07AA07|01.01.1994||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|2034|3601|lyfalmen|||00|100|0|100|Actavis Group PTC ehf|Merck NM AB|Sótalól||2034||2034|3601 032122|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.02.2009||R|A|3|0|0|0|1|STM|0|0|0|100|DKK|11223|15840|lyfsjukr|||0|4|0|0|Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíð||||11223|15840 032145|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.02.2009||R|A|3|0|0|0|1|STM|0|0|0|100|DKK|16404|22290|lyfsjukr|||0|10|0|0|Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíð||||16404|22290 032179|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.02.2009||R|A|3|0|0|0|1|STM|0|0|0|100|DKK|56760|72534|lyfsjukr|||0|50|0|0|Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíð||||56760|72534 032190|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|1|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|1|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|1|0|0|Strandmøllen A/S|Strandmøllen A/S|Súrefni||||| 032202|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|2|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|2|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|2|0|0|Strandmøllen A/S|Strandmøllen A/S|Súrefni||||| 032236|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|4|0|0|Strandmøllen A/S|Strandmøllen A/S|Súrefni||||| 032247|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|5|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|5|0|0|Strandmøllen A/S|Strandmøllen A/S|Súrefni||||| 032258|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|10|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|10|0|0|Strandmöllen A/S|Strandmöllen A/S|Súrefni||||| 032270|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|20|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|20|0|0|Strandmøllen A/S|Strandmøllen A/S|Súrefni||||| 032281|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|50|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|50|0|0|Strandmøllen A/S|Strandmøllen A/S|Súrefni||||| 032304|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|50|l|12|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|600|0|0|Strandmøllen A/S|Strandmøllen A/S|Súrefni||||| 032523|N05AX1201|Abilify|mixtúra|1|mg/ml|150|ml|1|fl||N05AX12|01.02.2007||R|K|2|0|0|*|0|OTS|0|1|0|100|DKK|28630|37829|lyfalmen|||00|150|0|10|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||28630||28630|37829 032649|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|50|ml|1|hgl|plast|QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|4427|7661|vetorma|||27|50|0|0|Vistor hf|Merial (MSD)|||4427||4427|7661 032660|L03AB0702|Rebif|stl|0||0,5|ml|12|áf.spr|8,88+22 mcg|L03AB07|01.02.2009||R|K|2|0|1|0|1|SEN|0|0|0|100|SEK|155217|195113|lyfsjukr|||0|6|0|0|Gróco ehf|Serono Nordic|Interferón beta-1a||||155217|195113 032664|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|200|ml|1|fl||QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|15742|27242|vetorma|||27|200|0|0|Vistor hf|Merial (MSD)|||15742||15742|27242 033159|S01FA0103|Isopto Atropin 1 %|augndr|1|%|5|ml|1|glas||S01FA01|01.05.1983|31.10.2009|R|A|3|0|0|E|0|ALC|0|0|0|100|USD|490|1505|lyfalmen|||06|5|0|0|K.Pétursson hf|Alcon|Atrópín||490||490|1505 033251|S01CA0102|Tobradex|augndr|0| |5|ml|1|glas|3+1 mg/ml|S01CA01|01.06.2007||R|A|3|0|0|E|0|ALC|0|0|1|100|USD|1293|2595|lyfalmen|||00|5|0|0|K.Pétursson hf|Alcon|Dexametasón||1293||1293|2595 033884|J05AE1001|Prezista|filmhtfl|400|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|A||0|1|0|1|JCI|0|0|0|100|SEK|95842|121191|lyfsjukr|||43|60|0||Vistor hf|Janssen-Cilag International N.V.|||95842||95842|121191 033895|J05AE1001|Prezista|filmhtfl|600|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|A||0|1|0|1|JCI|0|0|0|100|SEK|141522|178062|lyfsjukr|||43|60|0||Vistor hf|Janssen-Cilag International N.V.|||141522||141522|178062 033918|L04AC0501|Stelara|stl|45|mg/hgl|0,5|ml|1|hgl||L04AC05|01.06.2009||R|K|1|0|1|0|1|JCI|0|0|0|100|SEK|619192|772762|lyfsjukr|||AC|0|0|0|Vistor hf|Janssen-Cilag International N.V.|||||619192|772762 034033|QJ01M0001|Baytril vet.|töflur|50|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|2892|5680|vetalmen|||0|10|0|0|Vistor hf|Bayer Animal Health GmbH|||||2892|5680 034157|J07AM5104|Diftavax|bóluefni|0| |0,5|ml|1|spr|einnota sprauta|J07AM51|01.01.2000||R|K|3|0|0|0|0|SPM|0|0|1|100|XEU|870|2021|lyfalmen|||AC|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Stífkrampatoxóíð í blöndum með barnaveikistoxóíðum||870||870|2021 034401|J06BA0208|Privigen|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.10.2009||R|A||0|0|0|1|CSB|0|0|0|100|SEK|24640|32544|lyfsjukr|||00|25|0|0|Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||24640||24640|32544 034616|N05CM0201|Heminevrin|mixtúra|50|mg/ml|300|ml|1|glas||N05CM02|01.07.2006||R|K|2|0|0|0|0|ARA|0|0|1|100|SEK|2378|4067|lyfalmen|||00|300|0|10|Vistor hf|Astra|Clómetíazól||2378||2378|4067 034934|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|20|sk-hyl||S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|2138|3742|lyfalmen|||00|6|0|0|Vistor hf|Novartis Healthcare A/S-|Díklófenak||2138||2138|3742 034983|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|40|sk-hyl||S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|3665|5814|lyfalmen|||00|12|0|0|Vistor hf|Novartis Healthcare A/S-|Díklófenak||3665||3665|5814 035024|V03AB1402|Protaminsulfat Leo Pharma|stl|10|mg/ml|5|ml|5|hgl||V03AB14|01.06.2007||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|10335|14735|lyfsjukr|||02|25|0|0|Vistor hf|LEO Pharma A/S|Prótamín||10335||10335|14735 035099|C02CA0404 |Carduran CR (D.A.C.)|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.05.2009||R|A|2|0|0|E|0|DAC|0|0|0|100|DKK|3798|5994|lyfalmen|V2120|5500|00|100|0|100|D.A.C. ehf|D.A.C. ehf|Doxazósín||3798||3798|5994 035155|N03AX1403 |Keppra (D.A.C.)|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.05.2009|31.10.2009|R|A|3|0|1|E|0|DAC|0|0|0|100|DKK|20456|27653|lyfalmen|||00|100|0|25|D.A.C. ehf|D.A.C. ehf|Levetíracetam||20456||20456|27653 035177|N03AX1203 |Neurontin (D.A.C.)|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|6981|8212|lyfalmen|V0714|8162|10|100|0|17|D.A.C. ehf|D.A.C. ehf|Gabapentín||5432||5432|8212 035200|N03AX1203 |Neurontin (D.A.C.)|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|19483|26441|lyfalmen|V2160|26441|00|100|0|33|D.A.C. ehf|D.A.C. ehf|Gabapentín||||19483|26441 035212|A07EC0202|Pentasa|forðatfl|500|mg|300|stk|1|þpakki||A07EC02|01.04.1992||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|18664|25422|lyfalmen|||10|300|0|100|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||18664||18664|25422 035222|N06DA0403 |Reminyl (D.A.C.)|forðahlk|8|mg|28|stk|1|þpakki||N06DA04|01.05.2009||R|A|2|0|0|E|0|DAC|0|0|0|100|SEK|13122|18522|lyfalmen|V1370|18522|00|28|0|14|D.A.C. ehf|D.A.C. ehf|Galantamín||13122||13122|18522 035234|M01AB5502 |Arthrotec (D.A.C.)|töflur|50,2|mg|100|stk|1|þpakki|0,2+50 mg|M01AB55|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|1|100|DKK|5642|8497|lyfalmen|V2130|8497|0|100|0|50|D.A.C. ehf|D.A.C. ehf|Díklófenaknatríum í blöndum||5642||5642|8497 035506|N03AX0903|Lamotrin|dreifit.|25|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1435|2788|lyfalmen|||00|56|0|5|Actavis Group hf|Actavis hf|Lamótrigín||1435||1435|2788 035515|N03AX0903|Lamotrin|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1844|3343|lyfalmen|V0703|3343|00|56|0|9|Actavis Group hf|Actavis hf|Lamótrigín||1844||1844|3343 035524|N03AX0903|Lamotrin|dreifit.|100|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|3321|5347|lyfalmen|||00|56|0|19|Actavis Group hf|Actavis hf|Lamótrigín||||3321|5347 035533|N03AX0903|Lamotrin|dreifit.|200|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|5919|8873|lyfalmen|||00|56|0|37|Actavis Group hf|Actavis hf|Lamótrigín||||5919|8873 035542|S01LA0301|Macugen|stl|0,3|mg/spr|1|spr|1|pakki|lausn|S01LA03|01.06.2006||R|A|1,5|0|1|0|1|PFI|0|0|0|100|DKK|140450|176728|lyfsjukr|||00|1|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Pegaptaníb||140450||140450|176728 035824|C01AA0503|Lanoxin|stl|0,25|mg/ml|2|ml|5|lykjur||C01AA05|01.07.2000||R|A||0|0|0|1|PCO|0|0|0|100|IKR|926|1326|lyfsjukr|||00|10|1|0|Distica|Distica - óskráð lyf|Digoxín||926||926|1326 035832|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|500|ml|12|fl||B05BA02|01.08.1980||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|52609|67366|lyfsjukr|||00|6000|0|6|Icepharma hf|Fresenius Kabi|Fitusambönd||52609||52609|67366 035840|C01AA0503|Lanoxin|mixtúra|50|mcg/ml|60|ml|1|glas||C01AA05|01.03.1978||R|A|3|0|0|B|0|GSK|0|0|0|100|GBP|1013|2215|lyfalmen|||00|60|0|12|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Digoxín||1013||1013|2215 035865|C01AA0503|Lanoxin|töflur|0,25|mg|100|stk|1|glas||C01AA05|01.08.1978||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|540|1573|lyfalmen|||00|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Digoxín||540||540|1573 036145|M01AC0202|Tilcotil|töflur|20|mg|60|stk|1|glas||M01AC02|01.04.1988||R|A|3|0|0|E|0|MAS|0|0|1|100|SEK|6413|9543|lyfalmen|||00|60|0|60|Vistor hf|Meda AS|Tenoxíkam||6413||6413|9543 036332|L01XE0401|Sutent|hylki|12,5|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|PFL|0|0|0|100|DKK|255221|319618|lyfsjukr|||00|30|0|0|Vistor hf|Pfizer Limited|Sunitíníb||255221||255221|319618 036341|L01XE0401|Sutent|hylki|25|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|PFL|0|0|0|100|DKK|455838|569386|lyfsjukr|||00|30|0|0|Vistor hf|Pfizer Limited|Sunitíníb||455838||455838|569386 036351|L01XE0401|Sutent|hylki|50|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|PFL|0|0|0|100|DKK|911235|1136355|lyfsjukr|||00|30|0|0|Vistor hf|Pfizer Limited|Sunitíníb||911235||911235|1136355 036442|J01CE0204|Kaavepenin|töflur|800|mg|20|stk|1|þpakki||J01CE02|01.01.1988||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|859|2006|lyfalmen|||00|20|0|8|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||859||859|2006 036517|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|60|ml|1|glas||J01CE02|01.07.1992||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|1451|2809|lyfalmen|||08|60|0|3|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1451||1451|2809 036541|A03AX1301|Minifom|dropar|0| |30|ml|1|glas|+drteljari|A03AX13|01.12.1975||L|S|3|0|0|0|0|GCO|0|0|0|100|IKR|||lyflausa|||00|30|0|6|Vistor hf|GlaxoSmithKline CH AB|Silíkonsambönd||||| 036616|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|125|ml|1|glas||J01CE02|01.07.1992||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|2863|4726|lyfalmen|||08|125|0|6|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||2863||2863|4726 036665|J01CE0204|Kaavepenin|töflur|800|mg|30|stk|1|þpakki||J01CE02|01.01.1988||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|868|2018|lyfalmen|||00|30|0|12|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||868||868|2018 037278|N04BC0404|Requip Depot|forðatfl|2|mg|42|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|7229|10650|lyfalmen|||00|42|0|14|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||7229||7229|10650 037287|N04BC0404|Requip Depot|forðatfl|2|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|14458|20185|lyfalmen|||00|84|0|28|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||14458||14458|20185 037305|N04BC0404|Requip Depot|forðatfl|4|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|28357|37489|lyfalmen|||00|84|0|56|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||28357||28357|37489 037323|N04BC0404|Requip Depot|forðatfl|8|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|55706|71539|lyfalmen|||00|84|0|112|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||55706||55706|71539 037358|N04BA0201|Madopar|töflur|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.07.1990||R|A|4|0|0|E|0|ROC|0|0|0|100|DKK|2935|4823|lyfalmen|||00|100|0|17|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2935||2935|4823 037531|D07AC1301|Elocon|húðlausn|0,1|%|30|ml|1|glas||D07AC13|01.01.2009||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1304|2610|lyfalmen|||0|30|0|30|Vistor hf|Schering-Plough|Mómetasón||1304||1304|2610 037754|J01EA0102|Monotrim|töflur|100|mg|30|stk|1|glas||J01EA01|01.03.1980|31.10.2009|R|A|5|0|0|0|0|HEX|0|0|1|100|DKK|778|1896|lyfalmen|||00|30|0|8|Vistor hf|Hexal A/S|Trímetóprím||778||778|1896 037846|A12BA0101|Kaleorid|forðatfl|750|mg|100|stk|1|glas||A12BA01|01.12.1972||L|A|5|0|0|E|0|LEP|0|0|0|100|DKK|||lyfalmen|||10|100|0|25|Vistor hf|LEO Pharma A/S|Kalíumklóríð|||||2315 037853|A12BA0101|Kaleorid|forðatfl|750|mg|250|stk|1|glas||A12BA01|01.12.1972||L|A|5|0|0|E|0|LEP|0|0|0|100|DKK|||lyfalmen|||10|250|0|62|Vistor hf|LEO Pharma A/S|Kalíumklóríð|||||3933 037929|J01EA0102|Monotrim|töflur|100|mg|100|stk|1|glas||J01EA01|01.03.1980|31.10.2009|R|A|5|0|0|0|0|HEX|0|0|1|100|DKK|2093|3681|lyfalmen|||00|100|0|25|Vistor hf|Hexal A/S|Trímetóprím||2093||2093|3681 038174|N06AB0501|Seroxat|töflur|20|mg|20|stk|1|þpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|100|IKR|664|1489|lyfalmen|V0917|1366|00|20|0|20|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||478||478|1489 038257|N06AB0501|Seroxat|töflur|20|mg|60|stk|1|þpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|100|IKR|1766|2556|lyfalmen|V0918|2230|00|60|0|60|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1264||1264|2556 038448|N06AB0501|Seroxat|töflur|20|mg|100|stk|1|þpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|100|IKR|2667|3506|lyfalmen|V0919|2999|00|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1964||1964|3506 038513|D06BA0101|Flamazine|krem|10|mg/g|50|g|1|túpa||D06BA01|01.10.1988||R|A|3|0|0|0|0|SON|0|0|1|100|DKK|1215|2489|lyfalmen|||00|50|0|50|Icepharma hf|Smith & Nephew|Silfursúlfadíazín||1215||1215|2489 038607|L03AA1301|Neulasta|stl|6|mg/penna|0,6|ml|1|penni|áfylltur penni, lausn|L03AA13|01.07.2006||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|248742|311551|lyfsjukr|||00|1|0|0|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||248742||248742|311551 038828|C09AA0401|Coversyl|töflur|4|mg|90|stk|1|þpakki||C09AA04|01.01.1992||R|A|2|0|0|0|0|SEV|0|0|0|100|DKK|7255|10686|lyfalmen|||00|90|0|90|Icepharma hf|Servier|Perindópríl||7255||7255|10686 038877|N07CA0101|Betaserc|töflur|8|mg|100|stk|1|þpakki||N07CA01|01.12.1982||R|A|5|0|0|E|0|SOL|0|0|0|100|DKK|5118|7786|lyfalmen|||00|100|0|33|Medico ehf|Solvay Duphar |Betahistín||5118||5118|7786 038915|J01FA1004|Zitromax UNO|forðakyr|0| |2|g|1|fl||J01FA10|01.10.2007||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|3459|5534|lyfalmen|||00|2|0|7|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Azitrómýcín||3459||3459|5534 039005|L01XA0301|Eloxatin|irþ|5|mg/ml|10|ml|1|hgl||L01XA03|01.03.2007||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|45542|58567|lyfsjukr|||00|10|0|0|Vistor hf|Sanofi-aventis Norge AS|Oxalíplatín||45542||45542|58567 039014|L01XA0301|Eloxatin|irþ|5|mg/ml|20|ml|1|hgl||L01XA03|01.03.2007||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|79246|100529|lyfsjukr|||00|20|0|0|Vistor hf|Sanofi-aventis Norge AS|Oxalíplatín||79246||79246|100529 039575|D01AE1503 |Lamisil (D.A.C.)|krem|10|mg/g|15|g|1|túpa||D01AE15|01.05.2009||L|A|5|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|15|0|15|D.A.C. ehf|D.A.C. ehf|Terbínafín||||| 039669|C01BA0302|Durbis Retard|forðatfl|250|mg|100|stk|1|glas||C01BA03|01.05.1983||R|A|1|0|0|B|0|SNO|0|0|0|100|NOK|5842|8768|lyfalmen|||10|100|0|62|Vistor hf|Sanofi-aventis Norge AS|Dísópýramíð||5842||5842|8768 039698|C07AB0311|Atenolol Mylan|töflur|25|mg|98|stk|1|þpakki||C07AB03|01.04.1992||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|659|1735|lyfalmen|V0290|1589|00|98|0|33|Actavis Group PTC ehf|Merck NM AB|Atenólól||659||659|1735 039776|J01FA1001|Zitromax|mixtúrud|40|mg/ml|15|ml|1|glas||J01FA10|01.07.1994||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|1629|3051|lyfalmen|||00|15|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Azitrómýcín||1629||1629|3051 039784|J01FA1001|Zitromax|mixtúrud|40|mg/ml|22,5|ml|1|glas||J01FA10|01.01.1995||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|2631|4411|lyfalmen|||00|22|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Azitrómýcín||2631||2631|4411 039909|L01AA0101|Sendoxan|sts|200|mg|1|stk|1|hgl||L01AA01|01.07.1992||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|425|608|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter Medical AB|Cýklófosfamíð||425||425|608 039935|C10AA0105|Simvastatin Actavis|filmhtfl|40|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|1630|3025|lyfalmen|V0367|3025|00|98|0|131|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||1610||1610|3025 039958|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.01.1988||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|976|1397|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter Medical AB|Cýklófosfamíð||976||976|1397 040089|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.07.1994||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|1733|2481|lyfsjukr|||02|1|0|0|Icepharma hf|Baxter Medical AB|Cýklófosfamíð||1733||1733|2481 040287|N03AF0104|Tegretol|töflur|200|mg|200|stk|1|þpakki||N03AF01|01.04.1993||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|3525|5624|lyfalmen|||00|200|0|40|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||3525||3525|5624 040543|S01XA2012|Dacriosol|augndr|3|mg/ml|15|ml|1|glas||S01XA20|01.03.2000||L|A|4|0|0|E|0|ALC|0|0|0|100|IKR|||lyfalmen|||06|15|0|0|K.Pétursson hf|Alcon|Gervitár og aðrar óvirkar sam­setningar|||||1579 041059|J07BH0101|Rotarix|mixtduft|0| |1|hgl|1|pakki|+áf.munnspr.m/leysi|J07BH01|01.07.2007||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|9369|13555|lyfalmen|||00|1|0|0|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Rota-veira, veikluð veira||9369||9369|13555 041423|G03AA1203|Yasminelle|töflur|0||63|stk|1|þpakki|3+0,02 mg|G03AA12|01.12.2006||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|3349|5385|lyfalmen|||00|63|0|0|Icepharma hf|Bayer Schering Pharma AG|Dróspírenón og östrógen||3349||3349|5385 041488|N06AB1002 |Cipralex (D.A.C.)|filmhtfl|20|mg|98|stk|1|þpakki||N06AB10|01.05.2009||R|A|3|0|0|B|0|DAC|0|1|0|100|DKK|23373|30705|lyfalmen|V2172|30660|00|98|0|196|D.A.C. ehf|D.A.C. ehf|Escítalópram||22908||22908|30705 041749|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|1|fl|dreifa|QI04AB01|01.04.2007||R|K|3|0|0|0|0|INI|0|0|0|100|DKK|5110|8843|vetorma|||AA|100|0|0|Icepharma hf|Intervet International B.V.|||5110||5110|8843 041795|M02AA1503 |Voltaren Emulgel (D.A.C.)|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.05.2009||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||0|100|0|0|D.A.C. ehf|D.A.C. ehf|Díklófenak||||| 041815|V08CA1101|Vasovist|stl|0,25|mmol/ml|10|ml|10|hgl|lausn|V08CA11|01.12.2006||R|A|3|0|0|0|0|TMC|0|0|0|100|SEK|205674|258249|lyfalmen|||02|100|0|0|TMC Pharma Services Ltd|TMC Pharma Services Ltd|Gadófosveset||205674||205674|258249 041996|A06AG1101|Microlax|innhl|0| |5|ml|4|túpa||A06AG11|01.12.1972||L|A|5|0|0|0|0|MCN|0|0|0|100|IKR|||lyflausa|||56|20|0|4|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum||||| 042036|C07AB0205|Seloken|stl|1|mg/ml|5|ml|5|lykjur||C07AB02|01.01.1985||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|1541|2932|lyfalmen|||02|25|0|0|Vistor hf|AstraZeneca A/S DK|Metóprólól||1541||1541|2932 042101|N01BB0902|Naropin|irl|2|mg/ml|100|ml|5|plpok||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|12964|18008|lyfsjukr|||00|500|0|0|Vistor hf|AstraZeneca A/S DK|Rópívakaín||12964||12964|18008 042305|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4236|6065|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||4236||4236|6065 042309|N01BB0902|Naropin|stl/irl|2|mg/ml|200|ml|5|plpok||N01BB09|01.07.2009||R|A||0|0|0|1|AZD|0|0|0|100|SEK|23187|30735|lyfsjukr|||00|1000|0|0|Vistor hf|AstraZeneca A/S DK|Rópívakaín||||23187|30735 042314|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|5342|7648|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||5342||5342|7648 042323|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|5049|7229|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||5049||5049|7229 042332|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|7655|10960|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||7655||7655|10960 042346|N07BA0137 |Nicorette (D.A.C.)|innsogsl|10|mg|42|rör|1|pakki|þp+munnstk|N07BA01|01.05.2009||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|42|0|7|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 042357|N07BA0141 |Nicotinell Fruktsmak (D.A.C.)|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|204|0|14|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 042360|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|8787|12581|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||8787||8787|12581 042368|A06AB0602 |Senokot|töflur|7,5|mg|500|stk|1|glas||A06AB06|01.04.2009||R|A|3|0|0|0|0|REB|0|0|0|100|GBP|2402|4100|lyfalmen|||00|500|0|0|Icepharma hf|Reckitt Benckiser Healthcare Ltd.|Senna||||2402|4100 042369|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|40|plpok|Excel umbúðir|B05BA03|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|9611|13761|lyfsjukr|||00|4000|0|4|Icepharma hf|Fresenius Kabi|Kolvetni||9611||9611|13761 042387|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|5104|7308|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||5104||5104|7308 042396|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3745|5362|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||3745||3745|5362 042405|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|0| |1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3228|4622|lyfsjukr|||02|10000|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||3228||3228|4622 042442|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|50|ml|40|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|11281|15912|lyfsjukr|||00|2000|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar||11281||11281|15912 042460|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|3439|4924|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar||3439||3439|4924 042469|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|2546|3645|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar||2546||2546|3645 042478|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|40|plpok|Excel umbúðir|B05BB01|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|8098|11594|lyfsjukr|||00|4000|0|4|Icepharma hf|Fresenius Kabi|Elektrólýtar||8098||8098|11594 042524|B05BB0115|Ringer-acetat Fresenius Kabi|irl|0| |1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2612|3740|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar||2612||2612|3740 042549|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|1|dæla|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|898|2059|lyfalmen|||02|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Mænusótt, dauð veira||898||898|2059 042551|B05BB0209 |Glucos 100 mg/ml med Na40 + K20 Fres|irl|0||1000|ml|10|plpok||B05BB02|01.04.2009||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3657|5236|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||||3657|5236 042556|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|20|dælur|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|17168|23559|lyfalmen|||02|10|0|0|Icepharma hf|Sanofi Pasteur MSD|Mænusótt, dauð veira||17168||17168|23559 042615|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|0| |1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3968|5681|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||3968||3968|5681 042669|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|0| |100|ml|40|plastl|fyrir stungulyf|V07AB|01.04.2008||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|4000|0|0|Icepharma hf|Fresenius Kabi|||||| 043232|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|30|stk|1|þpakki||N05CD03|01.10.1992||R|A|5|1|0|0|0|MNA|0|0|0|100|SEK|381|1357|lyfalmen|||00|30|0|30|Actavis Group PTC ehf|Merck NM AB|Flúnítrazepam||381||381|1357 043257|N01BB0902|Naropin|stl/irl|2|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|3606|5163|lyfsjukr|||00|100|0|0|Vistor hf|AstraZeneca A/S DK|Rópívakaín||3606||3606|5163 043379|R03AC1201|Serevent|innúðal|25|mcg/sk|120|sk|1|stauk|HFA 134a|R03AC12|01.04.2007||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|4018|6293|lyfalmen|||24|120|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||4018||4018|6293 043547|N01BB0902|Naropin|stl|7,5|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|6629|9491|lyfsjukr|||00|100|0|0|Vistor hf|AstraZeneca A/S DK|Rópívakaín||6629||6629|9491 043729|N05CD0503|Halcion|töflur|0,125|mg|30|stk|1|þpakki||N05CD05|01.12.1983||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|655|1729|lyfalmen|||00|30|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Tríazólam||655||655|1729 043745|G03CA0401|Ovestin|töflur|2|mg|30|stk|1|þpakki||G03CA04|01.07.1989||R|A|5|0|0|E|0|ORG|0|0|0|100|DKK|1401|2742|lyfalmen|||10|30|0|30|Vistor hf|N.V. Organon|Estríól||1401||1401|2742 043919|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|10|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|200|0|0|Icepharma hf|Fresenius Kabi|||||| 043935|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|0| |10|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|200|0|0|Icepharma hf|Fresenius Kabi|||||| 043988|B03AA0705|Ferrous Sulphate|töflur|200|mg|100|stk|1|glas|sykurhúðaðar|B03AA07|01.09.2009||L|A||0|0|0|0|AUK|0|0|1|100|IKR|||lyflausa|||00|100|0|100|Actavis Group hf|Actavis UK Ltd.|||||| 044360|B03AC0203|Venofer (Lyfjaver)|stl|20|mg/ml|5|ml|5|lykjur||B03AC02|01.05.2006||R|A|3|0|0|E|0|LVR|0|0|1|100|NOK|15229|21145|lyfalmen|V0011|20759|00|25|0|5|Lyfjaver ehf|Lyfjaver ehf|Járnoxíð (sykurflétta)||15229||15229|21145 044624|G04BE0303|Viagra (D.A.C.)|filmhtfl|100|mg|4|stk|1|þpakki||G04BE03|01.11.2006|31.10.2009|R|A|5|0|0|0|0|DAC|0|0|0|100|DKK|6389|9511|lyfalmen|||00|4|0|8|D.A.C. ehf|D.A.C. ehf|Síldenafíl||6389||6389|9511 045013|L01XX1902|Campto|irþ|20|mg/ml|5|ml|1|hgl||L01XX19|01.01.1999||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|44023|56676|lyfsjukr|||00|5|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Írinótekan||44023||44023|56676 045104|L04AX0102|Imurel|töflur|25|mg|50|stk|1|þpakki||L04AX01|01.10.1995||R|A|5|0|0|*|0|GSK|0|0|0|100|GBP|1421|2769|lyfalmen|||10|50|0|8|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Azatíóprín||1421||1421|2769 045379|N07BA0128|Nicorette Classic (Lyfjaver)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2006||L|A|2.5|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|210|0|14|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045385|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|10|dælur|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|8582|12487|lyfalmen|||02|5|0|0|Icepharma hf|Sanofi Pasteur MSD|Mænusótt, dauð veira||8582||8582|12487 045388|N07BA0128|Nicorette Classic (Lyfjaver)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2006||L|A|2.5|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|210|0|28|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045397|N07BA0127|Nicorette Mint (Lyfjaver)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2006||L|A|2.5|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|210|0|14|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045406|N07BA0127|Nicorette Mint (Lyfjaver)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2006||L|A|2.5|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|210|0|28|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045510|C10AA0105|Simvastatin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|1050|2265|lyfalmen|V0362|2265|00|98|0|65|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||||1050|2265 045533|C10AA0105|Simvastatin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|868|2018|lyfalmen|V0361|2018|00|98|0|33|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||||868|2018 045578|N07BA0122|Nicorette (Lyfjaver)|nefúði|500|mcg/sk|200|skammtar|1|glas||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|200|0|3|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045587|N07BA0122|Nicorette (Lyfjaver)|tungur.t|2|mg|105|stk|1|þpakki||N07BA01|01.03.2006||L|A|3|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|105|0|7|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045596|N07BA0122|Nicorette (Lyfjaver)|innsogsl|10|mg|18|rör|1|þpakki|+ munnstk|N07BA01|01.03.2006||L|A|3|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|18|0|3|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045605|N07BA0122|Nicorette (Lyfjaver)|innsogsl|10|mg|42|rör|1|þpakki|+ munnstk|N07BA01|01.03.2006||L|A|3|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|42|0|7|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045614|N07BA0123|Nicotinell (Lyfjaver)|forðapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|21|0|32|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045896|N07BA0124|Nicotinell Mint (Lyfjaver)|tyggigúm|2|mg|84|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|84|0|6|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045905|N07BA0124|Nicotinell Mint (Lyfjaver)|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|204|0|14|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045915|N07BA0124|Nicotinell Mint (Lyfjaver)|tyggigúm|4|mg|84|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|84|0|11|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045924|N07BA0124|Nicotinell Mint (Lyfjaver)|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|204|0|27|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045933|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|2|mg|84|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|84|0|6|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045942|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|204|0|14|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045951|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|4|mg|84|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|84|0|11|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045960|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|204|0|27|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 046077|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.01.2008||R|K|2|0|0|0|0|PFV|0|0|0|100|DKK|24579|46990|vetalmen|||27|10|0|0|Icepharma hf|Pfizer vet.|||24579||24579|46990 046269|C09AA0502|Ramil|töflur|2,5|mg|100|stk|1|þpakki||C09AA05|01.03.2006||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1943|3477|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|Ramipríl||1943||1943|3477 046396|A04AA0102|Ondansetron Vian|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.02.2008||R|A|3|0|0|E|0|VIS|0|0|0|100|DKK|6071|9079|lyfalmen|V1088|9079|02|10|0|1|Icepharma hf|Vian SA|Ondansetrón||6071||6071|9079 046405|A10BB1202|Glimeryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|IKR|769|1884|lyfalmen|V0001|1884|00|90|0|45|Actavis Group hf|Actavis hf|Glímepíríð||769||769|1884 046414|A10BB1202|Glimeryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|IKR|1215|2489|lyfalmen|V0002|2489|00|90|0|90|Actavis Group hf|Actavis hf|Glímepíríð||1215||1215|2489 046423|A10BB1202|Glimeryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|IKR|1622|3042|lyfalmen|V0003|3042|00|90|0|135|Actavis Group hf|Actavis hf|Glímepíríð||1622||1622|3042 046687|A04AA0102|Ondansetron Vian|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.02.2008||R|A|3|0|0|E|0|VIS|0|0|0|100|DKK|9737|14054|lyfalmen|V1089|14054|02|20|0|2|Icepharma hf|Vian SA|Ondansetrón||9737||9737|14054 047042|L04AB0101|Enbrel|stl|25|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.05.2008||R|K|2|0|1|0|1|WTE|0|0|0|100|USD|85427|108224|lyfsjukr|||00|100|0|14|Icepharma hf|Wyeth Europe|Etanercept||85427||85427|108224 047159|C07AA0704|Sotalol Merck NM|töflur|40|mg|100|stk|1|glas||C07AA07|01.01.1994||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|1027|2234|lyfalmen|||00|100|0|25|Actavis Group PTC ehf|Merck NM AB|Sótalól||1027||1027|2234 047340|J01CA0406|Flemoxin Solutab|lausnart|500|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|1107|2343|lyfalmen|||23|14|0|7|Vistor hf|Astellas Pharma A/S|Amoxicillín||1107||1107|2343 047442|N01AX1301|Niontix|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.06.2008||R|A|5|0|0|0|1|AGA|0|0|0|100|IKR|13388|18536|lyfsjukr|||00|10|0|0|Ísaga ehf|AGA AB|di-Nitrogen oxíð||13388||13388|18536 047460|N01AX1301|Niontix|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.06.2008||R|A|5|0|0|0|1|AGA|0|0|0|100|IKR|47555|61073|lyfsjukr|||00|50|0|0|Ísaga ehf|AGA AB|di-Nitrogen oxíð||47555||47555|61073 047560|L04AB0101|Enbrel|stl|50|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.05.2008||R|K|2|0|1|0|1|WTE|0|0|0|100|USD|217246|272339|lyfsjukr|||00|200|0|29|Icepharma hf|Wyeth Europe|Etanercept||217246||217246|272339 047563|R03DC0101|Accolate|töflur|20|mg|98|stk|1|þpakki||R03DC01|01.04.1998||R|A|3|0|0|B|0|ASZ|0|0|0|100|SEK|10459|15034|lyfalmen|||00|98|0|49|Vistor hf|AstraZeneca UK Ltd|Zafírlúkast||10459||10459|15034 048015|B05AA0111|Albumin Baxter|irl|50|g/líter|250|ml|1|hgl||B05AA01|01.06.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|5336|7640|lyfsjukr|||02|250|0|0|Icepharma hf|Baxter Medical AB|Albúmín||5336||5336|7640 048043|B05AA0111|Albumin Baxter|irl|200|g/líter|100|ml|1|hgl||B05AA01|01.06.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|8423|12060|lyfsjukr|||02|100|0|0|Icepharma hf|Baxter Medical AB|Albúmín||8423||8423|12060 048199|A03CA0201|Librax|töflur|0| |100|stk|1|glas||A03CA02|01.12.1972||R|A|5|0|0|E|0|MAB|0|0|0|100|DKK|1361|2687|lyfalmen|||00|100|0|0|Vistor hf|Meda AB|Klídín og geðlyf||1361||1361|2687 048297|C09DA0101|Cozaar Comp|filmhtfl|112,5|mg|98|stk|1|þpakki|100+12,5 mg|C09DA01|01.06.2007||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|16138|22277|lyfalmen|||00|98|0|196|Icepharma hf|M.S.D.|Lósartan og þvagræsilyf||16138||16138|22277 048355|C01DA0801|Sorbangil|töflur|40|mg|100|stk|1|glas||C01DA08|01.10.1988||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|4744|7278|lyfalmen|||00|100|0|67|Vistor hf|Recip AB|Ísósorbíð dínítrat||4744||4744|7278 048447|G03AA0901|Marvelon|töflur|0| |63|stk|1|þpakki||G03AA09|01.07.1986||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|2086|3671|lyfalmen|||23|63|0|84|Vistor hf|N.V. Organon|Desógestrel og östrógen||2086||2086|3671 048452|M01AE5101|Ibukod|töflur|0| |30|stk|1|glas|10+200 mg|M01AE51|01.11.2006||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|650|1722|lyfalmen|||00|30|0|5|Actavis Group hf|Actavis hf|Íbúprófen í blöndum||650||650|1722 048488|L04AA0601|Cellcept|töflur|500|mg|150|stk|1|þpakki||L04AA06|01.03.1999||R|A|3|0|1|*|0|ROC|0|0|0|100|DKK|75466|96140|lyfalmen|||00|150|0|38|Icepharma hf|Roche|Mýcófenólsýra||75466||75466|96140 048611|N04BD0104|Selegilin Merck NM|töflur|10|mg|100|stk|1|glas||N04BD01|01.07.1994||R|A|1.5|0|0|E|0|MNA|0|0|0|100|SEK|9900|14275|lyfalmen|||00|100|0|200|Actavis Group PTC ehf|Merck NM AB|Selegilín||9900||9900|14275 048744|N02BE0101|Panodil|töflur|500|mg|100|stk|1|glas||N02BE01|01.03.1984||R|A|4|0|0|0|0|GCH|0|0|1|100|DKK|560|1600|lyfalmen|V0772|1355|00|100|0|17|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||560||560|1600 049015|A02BA0201|Asyran|töflur|300|mg|100|stk|1|þpakki||A02BA02|01.10.1987||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|3269|5277|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|Ranitidín||3269||3269|5277 049169|M05BA0602|Bonviva|stl|1|mg/ml|3|ml|1|spr||M05BA06|01.10.2006||R|A|2|0|0|0|0|RRL|0|0|0|100|DKK|19691|26700|lyfalmen|||00|3|0|90|Icepharma hf|Roche Registration Limited|||19691||19691|26700 049395|B01AC0701|Persantin|töflur|100|mg|100|stk|1|glas||B01AC07|01.10.1985||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|3028|4950|lyfalmen|||00|100|0|25|Vistor hf|Boehringer Ingelheim|Dípýrídamól||3028||3028|4950 049502|D01AC0801|Fungoral|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1993||L|A|3|0|0|0|0|JAS|0|0|1|100|IKR|||lyflausa|||23|60|0|60|Vistor hf|Janssen-Cilag AB|Ketókónazól||||| 049524|S01ED5110|Duotrav|augndr|0| |2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.06.2007||R|A|3|0|0|*|0|ALC|0|0|0|100|USD|3641|5781|lyfalmen|||00|2|0|0|K.Pétursson hf|Alcon|Tímólól í blöndum||3641||3641|5781 049533|S01ED5110|Duotrav|augndr|0| |2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.06.2007||R|A|3|0|0|*|0|ALC|0|0|0|100|USD|10716|15383|lyfalmen|||00|8|0|0|K.Pétursson hf|Alcon|Tímólól í blöndum||10716||10716|15383 049551|D01AE1601|Loceryl|lakk|50|mg/ml|5|ml|1|glas||D01AE16|01.10.1992||R|A|3|0|0|0|0|GAN|0|0|1|100|CHF|9148|13255|lyfalmen|||23|5|0|5|Icepharma hf|Galderma Nordic AB|Amorolfín||9148||9148|13255 049561|C10AA0104|Simvastatin (Portfarma)|filmhtfl|10|mg|98|stk|1|þpakki||C10AA01|01.07.2006||R|A|2|0|0|E|0|POF|0|0|0|100|IKR|1059|2018|lyfalmen|V0361|2018|00|98|0|33|Portfarma ehf|Portfarma|Simvastatín||868||868|2018 049579|C10AA0104|Simvastatin (Portfarma)|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.07.2006||R|A|2|0|0|E|0|POF|0|0|0|100|IKR|1154|2265|lyfalmen|V0362|2265|00|98|0|65|Portfarma ehf|Portfarma|Simvastatín||1050||1050|2265 049597|C10AA0104|Simvastatin (Portfarma)|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.07.2006||R|A|2|0|0|E|0|POF|0|0|0|100|IKR|1827|3097|lyfalmen|V0367|3097|00|100|0|133|Portfarma ehf|Portfarma|Simvastatín||1663||1663|3097 049650|D01BA0201|Lamisil|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|8006|4829|lyfalmen|V0343|4435|00|28|0|28|Vistor hf|Novartis Healthcare A/S-|Terbínafín||2939||2939|4829 049678|C09AA0502|Ramil|töflur|5|mg|100|stk|1|þpakki||C09AA05|01.04.2006||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1681|3122|lyfalmen|||00|100|0|200|Actavis Group hf|Actavis hf|Ramipríl||1681||1681|3122 049684|D01AE1501|Lamisil|krem|10|mg/g|30|g|1|túpa||D01AE15|01.04.1993||R|A|5|0|0|0|0|NHE|0|0|1|100|DKK|2350|4029|lyfalmen|||00|30|0|30|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín||2350||2350|4029 049687|C09AA0502|Ramil|töflur|10|mg|100|stk|1|þpakki||C09AA05|01.08.2005||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|4132|6448|lyfalmen|||00|100|0|400|Actavis Group hf|Actavis hf|Ramipríl||4132||4132|6448 049750|L04AD0103|Sandimmun Neoral (D.A.C.)|hylki|25|mg|30|stk|1|þpakki||L04AD01|01.04.2006||R|A|3|0|0|*|0|DAC|0|0|0|100|DKK|5834|8308|lyfalmen|||10|30|0|3|D.A.C. ehf|D.A.C. ehf|Ciklospórín||5503||5503|8308 049760|L04AD0103|Sandimmun Neoral (D.A.C.)|hylki|100|mg|30|stk|1|þpakki||L04AD01|01.04.2006||R|A|3|0|0|*|0|DAC|0|0|0|100|DKK|21407|27634|lyfalmen|||10|30|0|12|D.A.C. ehf|D.A.C. ehf|Ciklospórín||20441||20441|27634 049778|M05BA0405|Fosamax (D.A.C.)|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.04.2006||R|A|3|0|0|E|0|DAC|0|0|0|100|XEU|15110|7528|lyfalmen|V0718|7528|00|12|0|84|D.A.C. ehf|D.A.C. ehf|Alendrónsýra||4928||4928|7528 049908|L04AA0601|Cellcept|hylki|250|mg|300|stk|1|þpakki||L04AA06|01.03.1999||R|A|3|0|1|*|0|ROC|0|0|0|100|DKK|86785|110232|lyfalmen|||00|300|0|38|Icepharma hf|Roche|Mýcófenólsýra||86785||86785|110232 050179|N01AF0301|Pentothal Natrium|sts|2,5|g|1|stk|12|hgl||N01AF03|01.07.1990||R|A|4|0|0|0|1|HOS|0|0|0|100|DKK|9273|13277|lyfsjukr|||02|12|0|0|Vistor hf|Hospira Enterprises B.V.|Tíópentalnatríum||9273||9273|13277 050342|L01XE0501|Nexavar|filmhtfl|200|mg|112|stk|1|þpakki||L01XE05|01.12.2006||R|A|2,5|0|1|0|1|BAV|0|0|0|100|SEK|664334|804454|lyfsjukr|||00|112|0|0|Vistor hf|Bayer Schering Pharma AG (V)|Sorafeníb||644648||644648|804454 050605|N03AX1601|Lyrica|hylki|225|mg|14|stk|1|þpakki||N03AX16|01.04.2007||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|4363|6761|lyfalmen|||00|14|0|56|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4363||4363|6761 050614|N03AX1601|Lyrica|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.04.2007||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|15559|21556|lyfalmen|||00|56|0|42|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||15559||15559|21556 050660|C02CA0402|Carduran Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.01.2007||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|6402|9280|lyfalmen|V2120|5500|00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Doxazósín||6219||6219|9280 050914|N02BE0101|Panodil|eþ-stil|1|g|10|stk|1|pakki||N02BE01|01.10.1989||R|A|5|0|0|0|0|GCH|0|0|1|100|DKK|555|1594|lyfalmen|||04|10|0|3|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||555||555|1594 051011|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa|+sk.dæla|D06BB03|01.07.1994||L|A|2|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|2|0|2|Icepharma hf|GlaxoSmithKline CH A/S|Acíklóvír||||| 051029|N03AG0102|Orfiril|sh-tfl|150|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|1979|3526|lyfalmen|||10|100|0|10|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1979||1979|3526 051058|M02AA1002|Orudis (D.A.C.)|hlaup|25|mg/g|60|g|1|túpa||M02AA10|01.01.2007||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|60|0|0|D.A.C. ehf|D.A.C. ehf|Ketóprófen||||| 051076|D05AX5202|Daivobet (D.A.C.)|smyrsli|0| |60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.01.2007|31.10.2009|R|A|2|0|0|B|0|DAC|0|0|0|100|DKK|10451|12116|lyfalmen|||00|60|0|0|D.A.C. ehf|D.A.C. ehf|Kalcípótríól í blöndum||8308||8309|12116 051110|N03AG0102|Orfiril|sh-tfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|2381|4072|lyfalmen|||10|100|0|20|Vistor hf|Desitin Artzneimittel|Valpróínsýra||2381||2381|4072 051331|R06AX2602|Nefoxef|töflur|120|mg|30|stk|1|þpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MYL|0|0|1|100|SEK|1202|2472|lyfalmen|V1910|2408|00|30|0|30|Actavis Group PTC ehf|Mylan AB|Fexófenadín||1202||1202|2472 051340|R06AX2602|Nefoxef|filmhtfl|120|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MYL|0|0|1|100|SEK|3623|5279|lyfalmen|V1911|5279|00|100|0|100|Actavis Group PTC ehf|Mylan AB|Fexófenadín||3271||3271|5279 051349|R06AX2602|Nefoxef|filmhtfl|180|mg|30|stk|1|þpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MYL|0|0|1|100|SEK|1851|3352|lyfalmen|V1912|3345|00|30|0|45|Actavis Group PTC ehf|Mylan AB|Fexófenadín||1851||1851|3352 051358|R06AX2602|Nefoxef|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MYL|0|0|1|100|SEK|5354|7551|lyfalmen|V1913|7551|00|100|0|150|Actavis Group PTC ehf|Mylan AB|Fexófenadín||4945||4945|7551 051550|N03AX1401|Keppra|irþ|100|mg/ml|5|ml|10|hgl||N03AX14|01.02.2007||R|A|2|0|1|0|1|UCB|0|0|0|100|DKK|40720|52564|lyfsjukr|||00|50|0|3|Vistor hf|U.C.B|Levetíracetam||40720||40720|52564 051713|A02BC0504|Nexium Mups (D.A.C.)|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.04.2006|31.08.2009|R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|4108|6304|lyfalmen|||00|28|0|19|D.A.C. ehf|D.A.C. ehf|Esómeprazól||4026||4026|6304 051732|C08CA0104|Amlódipín Portfarma|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.12.2006||R|A|3|0|0|B|0|POF|0|0|0|100|IKR|1909|2679|lyfalmen|V0308|2679|00|100|0|100|Portfarma ehf|Portfarma|Amlódipín||1355||1355|2679 051750|C08CA0104|Amlódipín Portfarma|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.12.2006||R|A|3|0|0|B|0|POF|0|0|0|100|IKR|3111|3776|lyfalmen|V0310|3776|00|100|0|200|Portfarma ehf|Portfarma|Amlódipín||2163||2163|3776 052286|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|20|stk|1|þpakki||N05BA12|01.10.2009||R|A||0|0|0|0|MYL|0|0|0|100|SEK|216|1133|lyfalmen|V0858|1133|00|20|0|5|Actavis Group PTC ehf|Mylan AB|Alprazólam||216||216|1133 052297|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|50|stk|1|þpakki||N05BA12|01.10.2009||R|A||0|0|0|0|MYL|0|0|0|100|SEK|577|1623|lyfalmen|V0859|1623|00|50|0|12|Actavis Group PTC ehf|Mylan AB|Alprazólam||577||577|1623 052305|L01XE0601|Sprycel|filmhtfl|20|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|3|0|1|0|1|BSP|0|0|0|100|DKK|448422|560153|lyfsjukr|||00|60|0|0|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||448422||448422|560153 052309|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.07.2009||R|A||0|0|0|0|RAN|0|0|1|100|SEK|360|1329|lyfalmen|V0856|1329|00|20|0|10|Actavis Group PTC ehf|Mylan AB|Alprazólam||||360|1329 052320|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|50|stk|1|þpakki||N05BA12|01.10.2009||R|A||0|0|0|0|MYL|0|0|0|100|SEK|1155|2408|lyfalmen|||00|50|0|25|Actavis Group PTC ehf|Mylan AB|Alprazólam||1155||1155|2408 052331|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|100|stk|1|glas||N05BA12|01.08.2009||R|A||0|0|0|0|RAN|0|0|0|100|SEK|892|2051|lyfalmen|V0855|2051|00|100|0|25|Actavis Group PTC ehf|Mylan AB|Alprazólam||||892|2051 052333|L01XE0601|Sprycel|filmhtfl|50|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|3|0|1|0|1|BSP|0|0|0|100|DKK|903497|1126721|lyfsjukr|||00|60|0|0|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||903497||903497|1126721 052360|L01XE0601|Sprycel|filmhtfl|70|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|3|0|1|0|1|BSP|0|0|0|100|DKK|913830|1139586|lyfsjukr|||00|60|0|0|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||913830||913830|1139586 052478|D06BB0305|Zovirax (D.A.C.)|krem|50|mg/g|2|g|1|túpa|+sk.dæla|D06BB03|01.03.2007||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|2|0|2|D.A.C. ehf|D.A.C. ehf|Acíklóvír||||| 052498|V03AF0302|Rescuvolin|sts|15|mg|1|stk|25|hgl||V03AF03|01.01.1995||R|A|3|0|0|0|1|PHC|0|0|0|100|XEU|38524|49830|lyfsjukr|||63|25|0|6|Actavis Group hf|Pharmachemie|Kalsíumfólínat||38524||38524|49830 052505|B05BA1014|Kabiven|irl|1900|kcal|2053|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|47528|61040|lyfsjukr|||00|8212|0|8|Icepharma hf|Fresenius Kabi|Blöndur||47528||47528|61040 052515|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|3|pokar||B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|38185|49408|lyfsjukr|||00|7698|0|8|Icepharma hf|Fresenius Kabi|Blöndur||38185||38185|49408 052522|V03AF0302|Rescuvolin|sts|50|mg|1|stk|10|hgl||V03AF03|01.01.1995||R|A|3|0|0|0|1|PHC|0|0|0|100|XEU|51433|65902|lyfsjukr|||63|10|0|8|Actavis Group hf|Pharmachemie|Kalsíumfólínat||51433||51433|65902 052524|B05BA1010|Kabiven Peripheral|irl|1400|kcal|1920|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|44184|56877|lyfsjukr|||00|7680|0|8|Icepharma hf|Fresenius Kabi|Blöndur||44184||44184|56877 052533|B05BA1010|Kabiven Peripheral|irl|1700|kcal|2400|ml|3|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|31008|40472|lyfsjukr|||00|7200|0|7|Icepharma hf|Fresenius Kabi|Blöndur||31008||31008|40472 052542|B05BA1015|StructoKabiven|irl|2100|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|49767|63827|lyfsjukr|||00|7880|0|8|Icepharma hf|Fresenius Kabi|Blöndur||49767||49767|63827 052560|B05BA1019|StructoKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|46301|59512|lyfsjukr|||00|7616|0|8|Icepharma hf|Fresenius Kabi|Blöndur||46301||46301|59512 053006|N05CF0203|Zolpidem Merck NM|filmhtfl|10|mg|100|stk|1|þpakki||N05CF02|01.11.2006||R|A|2|0|0|0|0|MYL|0|0|0|100|SEK|3003|4916|lyfalmen|V0903|4916|00|100|0|100|Actavis Group PTC ehf|Mylan AB|Zolpidem||3003||3003|4916 053025|G03HB0102|Diane mite|töflur|0| |63|stk|1|þpakki||G03HB01|01.07.1989||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|2476|4200|lyfalmen|||23|63|0|63|Icepharma hf|Bayer Schering Pharma AG|Cýpróterón og östrógen||2476||2476|4200 053043|J05AE0601|Kaletra|filmhtfl|250|mg|120|stk|1|glös|200+50 mg|J05AE06|01.11.2006||R|A|2|0|1|0|1|ABT|0|0|0|100|DKK|88967|112631|lyfsjukr|||00|120|0|30|Vistor hf|Abbott Laboratories Ltd|Lopinavír||88967||88967|112631 053231|J07BB0201|Fluarix|bóluefni|0| |0,5|ml|10|spr|einnotaspr|J07BB02|01.10.1994||R|K|1|0|0|0|0|GSK|0|0|0|100|GBP|6473|9625|lyfalmen|||02|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsaðir mótefnavakar||6473||6473|9625 053371|L04AA1301|Arava|töflur|10|mg|100|stk|1|glas||L04AA13|01.11.2000||R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|41226|53511|lyfalmen|||00|100|0|50|Vistor hf|Sanofi - aventis Deutschland GmbH|LeflúnómíðFvöðva||41226||41226|53511 053397|L04AA1301|Arava|töflur|20|mg|30|stk|1|glas||L04AA13|01.11.2000||R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|12773|18087|lyfalmen|||00|30|0|30|Vistor hf|Sanofi - aventis Deutschland GmbH|LeflúnómíðFvöðva||12773||12773|18087 053413|L04AA1301|Arava|töflur|20|mg|100|stk|1|glas||L04AA13|01.11.2000||R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|39440|51288|lyfalmen|||00|100|0|100|Vistor hf|Sanofi - aventis Deutschland GmbH|LeflúnómíðFvöðva||39440||39440|51288 053546|L04AA1301|Arava|töflur|100|mg|3|stk|1|þpakki||L04AA13|01.11.2000||R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|6128|9156|lyfalmen|||00|3|0|20|Vistor hf|Sanofi - aventis Deutschland GmbH|LeflúnómíðFvöðva||6128||6128|9156 053680|J05AE1001|Prezista|filmhtfl|300|mg|120|stk|1|plglas||J05AE10|01.04.2007||R|A|2|0|1|0|1|JCI|0|0|0|100|SEK|123175|155220|lyfsjukr|||43|120|0|30|Vistor hf|Janssen-Cilag International N.V.|||123175||123175|155220 053689|N05CF0203|Zolpidem Merck NM|filmhtfl|10|mg|20|stk|1|þpakki||N05CF02|01.11.2006||R|A|2|0|0|0|0|MYL|0|0|1|100|SEK|640|1709|lyfalmen|V0902|1709|00|20|0|20|Actavis Group PTC ehf|Mylan AB|Zolpidem||640||640|1709 053905|N02AA0305|Hydromorphone Hydrochloride Inj. USP|stl|20|mg/ml|1|ml|10|lykjur||N02AA03|01.05.2006||R|A|2|1|0|0|0|MAP|0|0|0|100|GBP|16540|22777|lyfalmen|||00|10|0|50|Icepharma hf|Martindale Pharmaceuticals|Hýdrómorphón||16540||16540|22777 053991|D10AF0101|Dalacin|lausn|10|mg/ml|30|ml|1|glas|Áburður, lausn|D10AF01|01.07.1985||R|A|2,5|0|0|0|0|PFI|0|0|0|100|DKK|1347|2668|lyfalmen|||20|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||1347||1347|2668 054148|J01CA0405|Flemoxin|dropar|100|mg/ml|20|ml|1|glas||J01CA04|01.11.1979||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|930|2102|lyfalmen|||28|20|0|2|Vistor hf|Astellas Pharma A/S|Amoxicillín||930||930|2102 054213|J07AG0101|Act-Hib|bóluefni|34|mcg/hgl|0,5|ml|1|hgl|+ leysir (10+24 mcg)|J07AG01|01.07.1994||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|3042|4969|lyfalmen|||02|0|0|0|Icepharma hf|Aventis Pasteur MSD A/S|Haemophilus influenzae B||3042||3042|4969 054247|R01AA0503|Nezeril|nefdr|0,25|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|3|0|0|0|0|GCO|0|0|1|100|IKR|||lyflausa|||23|2|0|1|Vistor hf|GlaxoSmithKline CH AB|Oxýmetazólín||||| 054278|D01AE1502|Lamisil Once|húðlausn|1|%|4|g|1|túpa||D01AE15|01.12.2006||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|4|0|0|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín||||| 054369|J05AB0402|Copegus|filmhtfl|400|mg|56|stk|1|plglas||J05AB04|01.05.2007||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|76596|97230|lyfsjukr|||00|56|0|22|Icepharma hf|Roche Registration Limited|Ribavirin||76596||76596|97230 054403|R01AA0503|Nezeril|nefdr|0,5|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|3|0|0|0|0|GCO|0|0|1|100|IKR|||lyflausa|||23|2|0|2|Vistor hf|GlaxoSmithKline CH AB|Oxýmetazólín||||| 054533|N05BB0101|Atarax|mixtúra|2|mg/ml|200|ml|1|glas||N05BB01|01.10.1994||R|A|3|0|0|0|0|UCN|0|0|1|100|SEK|1489|2861|lyfalmen|||00|200|0|5|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1489||1489|2861 054552|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|30|stk|1|þpakki||N06AB03|01.10.2006||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|949|2128|lyfalmen|V0914|2128|10|30|0|30|Actavis Group hf|Actavis hf|Flúoxetín||949||949|2128 054601|QB03AC9001|Idofer, vet.|stl|200|mg/ml|100|ml|5|fl|plastfl.|QB03AC90|01.05.1999||R|A|2|0|0|0|0|BID|1|0|0|100|DKK|15001|28746|vetalmen|||27|500|0|0|Vistor hf|Boehringer Ingelheim Danmark|||15001||15001|28746 054650|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|20|stk||QG03DA02|01.12.1978||R|A|5|0|0|0|0|PAL|1|0|0|100|DKK|9070|15696|vetorma|||16|20|0|0|Icepharma hf|Pfizer Oy Animal Health|||9070||9070|15696 054936|N06AB1003|Cipralex (Lyfjaver)|filmhtfl|10|mg|98|stk|1|þpakki||N06AB10|01.10.2009||R|A||0|0|B|0|LVR|0|1|0|100|DKK|11893|16980|lyfalmen|V0938|16950|00|98|0|98|Lyfjaver ehf|Lyfjaver ehf|Escítalópram||11893||11893|16980 055186|J01FA0103|Ery-Max|sh-hylki|250|mg|20|stk|1|þpakki||J01FA01|01.01.1986||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|837|1976|lyfalmen|||10|20|0|5|Vistor hf|Recip AB|Erýtrómýcín||837||837|1976 055277|N02AA0101|Contalgin|forðatfl|60|mg|100|stk|1|þpakki||N02AA01|01.10.1995||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|10865|15585|lyfalmen|||10|100|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||10865||10865|15585 055392|J04AK0102|Pyrazinamid|töflur|500|mg|100|stk|1|glas||J04AK01|01.04.2005||R|A||0|0|E|0|LDR|0|0|0|100|IKR|5310|8046|lyfalmen|||00|100|1|33|Parlogis hf|Parlogis - óskráð lyf|||5310||5310|8046 055749|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|pakki||N07BA01|01.06.2000||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|36|0|1|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 055939|N07BA0107|Nicotinell Mint|munnstfl|1|mg|96|stk|1|pakki||N07BA01|01.06.2000||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|96|0|3|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 056015|C10AA0503|Atacor|filmhtfl|10|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|E|0|ACA|0|0|0|100|IKR|4359|2377|lyfalmen|||00|100|0|50|Actavis Group hf|Actavis hf|Atorvastatín||1132||1132|2377 056024|C10AA0503|Atacor|filmhtfl|20|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|E|0|ACA|0|0|0|100|IKR|6185|3089|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|Atorvastatín||1657||1657|3089 056033|C10AA0503|Atacor|filmhtfl|40|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|7867|5868|lyfalmen|V0339|5868|00|100|0|200|Actavis Group hf|Actavis hf|Atorvastatín||3705||3705|5868 056514|L03AB0103|Multiferon|stl|3|millj ae|0,5|ml|6|áf.spr|lausn|L03AB01|01.11.2009||R|K||0|1|0|1|SOI|0|0|0|100|SEK|98876|124968|lyfsjukr|||00|3|0||Swedish Orphan International AB|Swedish Orphan International AB|||||98876|124968 056523|J01FA0103|Ery-Max|sh-hylki|250|mg|40|stk|1|þpakki||J01FA01|01.01.1986||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|1352|2675|lyfalmen|||10|40|0|10|Vistor hf|Recip AB|Erýtrómýcín||1352||1352|2675 056879|V07AY02|Palacos cum Gentamicin (Paranova)|sement|500|mg|40,5|g|2|pakkar|+ leysir|V07AY|01.06.1997||R|A|4|0|0|0|1|PAN|0|0|0|100|DKK|30783|40192|lyfsjukr|||00|81|0|0|xxxxx|Paranova A/S|||30783||30783|40192 056915|L04AA2301|Tysabri|irþ|300|mg/hgl|15|ml|1|hgl|lausn|L04AA23|01.09.2007||R|K|4|0|1|0|1|EPI|0|0|0|100|XEU|284214|355714|lyfsjukr|||00|15|0|30|Icepharma hf|Elan Pharma International|Natalizumab||284214||284214|355714 056961|J05AF0702|Viread (Paranova)|filmhtfl|245|mg|30|stk|1|plglas||J05AF07|01.05.2008||R|A|3|0|1|0|1|POF|0|0|0|100|DKK|78323|99380|lyfsjukr|||00|30|0|30|Portfarma ehf|Portfarma|Tenófóvír dísóproxíl||78323||78323|99380 057307|H01CB0201|Sandostatin|stl|200|mcg/ml|5|ml|1|hgl||H01CB02|01.01.1991||R|K|4|0|1|0|1|NOH|0|0|0|100|DKK|21922|29160|lyfsjukr|||02|5|0|1|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||21922||21922|29160 057349|H01CB0201|Sandostatin|stl|100|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|11649|16371|lyfsjukr|||02|5|0|1|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||11649||11649|16371 057422|B05XA3102|Tracel|irþ|0| |10|ml|20|plastl||B05XA31|01.01.1987||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|7584|10858|lyfsjukr|||00|200|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með öðrum efnum||7584||7584|10858 057455|H01CB0201|Sandostatin|stl|50|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|6271|8979|lyfsjukr|||02|5|0|0|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||6271||6271|8979 057703|J01DD0401|Rocephalin|irþ|2|g|5|hgl|1|pakki|lausn|J01DD04|01.10.1985||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|29199|38220|lyfsjukr|||00|5|0|5|Icepharma hf|Roche|Ceftríaxón||29199||29199|38220 057924|C09DA0401|CoAprovel|filmhtfl|325|mg|28|stk|1|þpakki|300+25 mg|C09DA04|01.03.2007||R|A|2|0|0|0|0|SBM|0|0|0|100|NOK|5980|8956|lyfalmen|||00|28|0|56|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan og þvagræsilyf||5980||5980|8956 057933|C09DA0401|CoAprovel|filmhtfl|325|mg|98|stk|1|þpakki|300+25 mg|C09DA04|01.03.2007||R|A|2|0|0|0|0|SBM|0|0|0|100|NOK|21279|28677|lyfalmen|||00|98|0|196|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan og þvagræsilyf||21279||21279|28677 058014|N07BA0301|Champix|filmhtfl|1|mg|112|stk|1|þpakki||N07BA03|01.03.2009||R|A|2|0|0|0|0|PFL|0|0|1|100|DKK|23769|31777|lyfalmen|||0|112|0|56|Vistor hf|Pfizer Limited|||||23769|31777 058164|A03BB0101|Buscopan|stl|20|mg/ml|1|ml|5|lykjur||A03BB01|01.10.1995||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|502|1522|lyfalmen|||02|5|0|2|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||502||502|1522 058283|QI01AD040|Avipro Thymovac|frþlyf|||500|sk|10|pakkar||QI01AD04|01.07.2009||R|A||0|0|0|0|LOH|0|0|0|100|XEU|190933|330419|vetorma|||00|5000|0|0|Icepharma hf|Lohmann Animal Health|||||190933|330419 058294|QI01AD040|Avipro Thymovac|frþlyf|||1000|sk|10|pakkar||QI01AD04|01.07.2009||R|A||0|0|0|0|LOH|0|0|0|100|XEU|290046|501939|vetorma|||00|10000|0|0|Icepharma hf|Lohmann Animal Health|||||290046|501939 058397|J07BM0101|Gardasil|stl|0| |0,5|ml|1|áf.spr|dreifa|J07BM01|01.01.2007||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|23690|31679|lyfalmen|||02|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerð 6, 11, 16, 18)||23690||23690|31679 058503|J01EA0105|Trimetoprim AstraZeneca|mixtúra|10|mg/ml|100|ml|1|fl|dreifa|J01EA01|01.01.2004||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|1037|2248|lyfalmen|||00|100|0|2|Vistor hf|Recip AB|Trímetóprím||1037||1037|2248 058506|J05AF1001|Baraclude|mixtúra|0,05|mg/ml|210|ml|1|fl||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|133454|168018|lyfsjukr|||00|210|0|21|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||133454||133454|168018 058735|C03CA0105|Lasix Retard|forðahlk|30|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|1739|3200|lyfalmen|||43|100|0|75|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||1739||1739|3200 058768|C03CA0105|Lasix Retard|forðahlk|60|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|2742|4561|lyfalmen|||43|100|0|150|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||2742||2742|4561 058958|J07CA0601|Infanrix-Polio + Hib|bóluefni|0| |0,5|ml|1|dæla|einnota dæla|J07CA06|01.03.1999||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|4579|7054|lyfalmen|||51|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||4579||4579|7054 059204|C01DA0801|Sorbangil|töflur|5|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|1731|3189|lyfalmen|||00|250|0|21|Vistor hf|Recip AB|Ísósorbíð dínítrat||1731||1731|3189 059295|S01AA0104|Kloramfenikol|augnsm|1|%|5|g|1|túpa||S01AA01|01.10.2009||R|A||0|0|E|0|LVE|0|0|1|100|IKR|1556|2952|lyfalmen|||07|5|1|0|Lyfjaver ehf|Lyfjaver - óskráð lyf|Klóramfeníkól||1556||1556|2952 059569|L02AE0203|Eligard|sts|45|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.05.2008||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|122112|154214|lyfalmen|||02|2|0|0|Vistor hf|Astellas Pharma A/S|Leuprórelín||122112||122112|154214 059659|J07CA0601|Infanrix-Polio + Hib|bóluefni|0| |0,5|ml|10|spr||J07CA06|01.01.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|34963|45714|lyfalmen|||51|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||34963||34963|45714 059687|J05AR0302|Truvada (Paranova)|filmhtfl|445|mg|30|stk|1|plglas|200+245 mg|J05AR03|01.05.2008||R|A|3|0|1|0|1|POF|0|0|0|100|DKK|134816|169713|lyfsjukr|||00|30|0|0|Portfarma ehf|Portfarma|Tenófóvír dísóproxíl og emtrícítabín||134816||134816|169713 059823|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|þpakki|2+0,5 mg|N07BC51|01.05.2007||R|A|3|1|1|0|1|SCP|0|0|0|100|DKK|8521|12200|lyfsjukr|||00|28|0|7|Vistor hf|Schering-Plough|Búprenorfín í blöndum||8521||8521|12200 059842|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|þpakki|8+2 mg|N07BC51|01.07.2007||R|A|3|1|1|0|1|SCP|0|0|0|100|DKK|19320|25921|lyfsjukr|||00|28|0|28|Vistor hf|Schering-Plough|Búprenorfín í blöndum||19320||19320|25921 060560|V03AC0301|Exjade|dreifit.|500|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|460812|575896|lyfalmen|||00|84|0|0|Vistor hf|Novartis Europharm Ltd|Deferasírox||460812||460812|575896 060569|V03AC0301|Exjade|dreifit.|250|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|233369|292729|lyfalmen|||00|84|0|0|Vistor hf|Novartis Europharm Ltd|Deferasírox||233369||233369|292729 060578|V03AC0301|Exjade|dreifit.|125|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|116685|147458|lyfalmen|||00|84|0|0|Vistor hf|Novartis Europharm Ltd|Deferasírox||116685||116685|147458 060848|N06AA0402|Anafranil Retard|forðatfl|75|mg|100|stk|1|þpakki||N06AA04|01.10.1989||R|A|5|0|0|B|0|NOH|0|1|0|100|DKK|8970|13013|lyfalmen|||10|100|0|75|Vistor hf|Novartis Healthcare A/S-|Klómípramín||8970||8970|13013 060905|C01DA0204|Nitromex|tungur.t|0,5|mg|120|stk|1|glas||C01DA02|01.01.1993||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|120|0|24|Actavis Group hf|Actavis Group hf|Glýcerýltrínítrat|||||2055 060913|C01DA0204|Nitromex|tungur.t|0,25|mg|120|stk|1|glas||C01DA02|01.01.1993||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|120|0|12|Actavis Group hf|Actavis Group hf|Glýcerýltrínítrat|||||2055 061414|QA04AD901|Cerenia|töflur|60|mg|4|stk|1|þpakki||QA04AD90|01.02.2009||R|A|2|0|0|0|0|PFA|0|0|0|100|DKK|3237|6337|vetalmen|||0|4|0|0|Icepharma hf|Pfizer Animal Health|||||3237|6337 061442|QA04AD901|Cerenia|töflur|24|mg|4|stk|1|þpakki||QA04AD90|01.02.2009||R|A|2|0|0|0|0|PFA|0|0|0|100|DKK|1696|3347|vetalmen|||0|4|0|0|Icepharma hf|Pfizer Animal Health|||||1696|3347 061451|QA04AD901|Cerenia|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.02.2009||R|A|2|0|0|0|0|PFA|1|0|0|100|DKK|10019|19256|vetalmen|||00|20|0|0|Icepharma hf|Pfizer Animal Health|||||10019|19256 061460|G03CX0102|Livial (D.A.C.)|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.05.2009|31.10.2009|R|A|2|0|0|E|0|DAC|0|0|0|100|DKK|8230|12009|lyfalmen|||00|84|0|84|D.A.C. ehf|D.A.C. ehf|Tíbólón||8230||8230|12009 061465|M02AA0701|Felden gel|hlaup|5|mg/g|50|g|1|glas||M02AA07|01.04.1996||L|A|3|0|0|0|0|PFI|0|0|1|100|IKR|||lyflausa|||23|50|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Píroxíkam||||| 061481|G03CX0101|Livial|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.07.1998||R|A|2|0|0|E|0|ORG|0|0|0|100|DKK|8302|12107|lyfalmen|||00|84|0|84|Vistor hf|N.V. Organon|Tíbólón||8302||8302|12107 061580|QP52AF0201|Banminth, vet.|pasta|11,4|g/skdæla|26|g|1|spr||QP52AF02|01.04.1992||L|A|1|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|26|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||2158 061715|L01XE0901|Torisel|irþ|25|mg/ml|1|hgl|1|pakki||L01XE09|01.05.2008||R|A|2|0|1|0|1|WTE|0|0|0|100|USD|183810|230711|lyfsjukr|||00|1|0|0|Icepharma hf|Wyeth Europe|Temsirolímus||183810||183810|230711 061762|N02BA0106|Magnyl|töflur|500|mg|50|stk|1|þpakki||N02BA01|01.12.1983||L|A|1|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|50|0|8|Actavis Group hf|Actavis hf|Acetýlsalicýlsýra||||| 061937|L04AD0101|Sandimmun|irþ|50|mg/ml|1|ml|10|lykjur||L04AD01|01.10.1985||R|A|4|0|0|0|1|NOH|0|0|0|100|DKK|7766|11119|lyfsjukr|||00|10|0|2|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||7766||7766|11119 061961|J01XX0901|Cubicin|sts/irs|350|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|K|3|0|1|0|1|NOE|0|0|0|100|DKK|20402|27268|lyfsjukr|||00|1|0|1|Vistor hf|Novartis Europharm Ltd|Daptomýcín||20402||20402|27268 061970|J01XX0901|Cubicin|sts/irs|500|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|K|3|0|1|0|1|NOE|0|0|0|100|DKK|28878|37821|lyfsjukr|||00|1|0|2|Vistor hf|Novartis Europharm Ltd|Daptomýcín||28878||28878|37821 062117|N05BA1204|Tafil Retard|forðatfl|0,5|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|596|1649|lyfalmen|||10|30|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||596||596|1649 062343|A10BD0401|Avaglim|filmhtfl|0| |28|stk|1|þpakki|4+4 mg|A10BD04|01.03.2008||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|5315|8053|lyfalmen|||00|28|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Glímepíríð og rosiglítazón||5315||5315|8053 062376|C05AA0103|Proctosedyl (D.A.C.)|eþ-smyr|0||30|g|1|túpa||C05AA01|01.10.2009||L|A||0|0|0|0|DAC|0|0|0|100|IKR|||lyflausa|||00|30|0|0|D.A.C. ehf|D.A.C. ehf|Hýdrókortisón||||| 062379|A10BD0401|Avaglim|filmhtfl|0| |28|stk|1|þpakki|8+4 mg|A10BD04|01.03.2008||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|7952|11632|lyfalmen|||00|28|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Glímepíríð og rosiglítazón||7952||7952|11632 062638|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|20|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|7838|11222|lyfsjukr|||02|20|0|0|Icepharma hf|Wyeth AB|Metótrexat||7838||7838|11222 062661|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|1|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|551|789|lyfsjukr|||02|1|0|0|Icepharma hf|Wyeth AB|Metótrexat||551||551|789 062729|N05BA1204|Tafil Retard|forðatfl|0,5|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|0|100|DKK|1091|2321|lyfalmen|||10|60|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||1091||1091|2321 062737|B03BA0102|Betolvex|töflur|1|mg|100|stk|1|glas||B03BA01|01.03.2008||R|A|5|0|0|E|0|AGT|0|0|1|100|XEU|2406|4105|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis Group hf|Cyanocobalamin||2406||2406|4105 062745|QP53AF0102|Sebacil vet.|húðlausn|500|mg/ml|1000|ml|1|fl||QP53AF01|01.05.2005||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|21206|36698|vetorma|||16|1000|0|0|Vistor hf|Bayer Animal Health GmbH|||21206||21206|36698 062935|G03AA1005|Harmonet|töflur|0| |63|stk|1|pakki|þp 20+75 mcg|G03AA10|01.11.1998||R|A|3|0|0|0|0|WEM|0|0|0|100|USD|2039|3607|lyfalmen|||23|63|0|63|Icepharma hf|Wyeth Medica|Gestóden og östrógen||2039||2039|3607 062987|J07BM0201|Cervarix|stl|0| |0,5|ml|1|áf.spr|dreifa|J07BM02|01.11.2007||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|17593|24088|lyfalmen|||02|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerð 16, 18)||17593||17593|24088 063057|J05AB0901|Famvir|töflur|125|mg|10|stk|1|þpakki||J05AB09|01.10.1995||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|6048|9048|lyfalmen|||00|10|0|2|Vistor hf|Novartis Healthcare A/S-|Famcíclóvír||6048||6048|9048 063453|J01CA0406|Flemoxin Solutab|lausnart|750|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|2438|4149|lyfalmen|||23|14|0|10|Vistor hf|Astellas Pharma A/S|Amoxicillín||2438||2438|4149 063661|A06AD1107|Medilax|mixtúra|667|mg/ml|500|ml|1|plastf||A06AD11|01.06.2007||L|A|2|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||00|500|0|50|Vistor hf|Medic Team|Laktúlósa|||||3141 063697|D01BA0203|Terbinafin Actavis|töflur|250|mg|28|stk|1|glas||D01BA02|01.11.2006||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|2649|4435|lyfalmen|V0343|4435|00|28|0|28|Actavis Group hf|Actavis hf|Terbínafín||2649||2649|4435 063706|R06AX2702|Aerius (D.A.C.)|töflur|5|mg|30|stk|1|þpakki||R06AX27|01.11.2006||R|A|2|0|0|E|0|DAC|0|0|1|100|DKK|1901|3420|lyfalmen|V1901|3420|00|30|0|30|D.A.C. ehf|D.A.C. ehf|Deslóratadín||1901||1901|3420 063715|R06AX2702|Aerius (D.A.C.)|töflur|5|mg|100|stk|1|þpakki||R06AX27|01.05.2009|31.10.2009|R|A|2|0|0|E|0|DAC|0|0|1|100|DKK|5275|7999|lyfalmen|||00|100|0|100|D.A.C. ehf|D.A.C. ehf|Deslóratadín||5275||5275|7999 063818|J06BB0102|Rhesonativ|stl|625|ae/ml|2|ml|1|lykja||J06BB01|01.05.2008||R|K|2,5|0|0|0|1|OCT|0|0|0|100|DKK|12072|16897|lyfsjukr|||17|2|0|0|Vistor hf|Octapharma AB|And-D(rh) immúnóglóbúlín||12072||12072|16897 063923|QP54AB5207|Equest Pramox vet|hlaup|0| |11,8|g|1|sk-dæl|19,5mg/g+121,7mg/g|QP54AB52|01.12.2006||R|A|2|0|0|0|0|FDV|0|0|0|100|XEU|2983|5162|vetorma|||16|12|0|0|Vistor hf|Fort Dodge Veterinär GmbH|||2983||2983|5162 063941|N05BA1204|Tafil Retard|forðatfl|1|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|1254|2542|lyfalmen|||10|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||1254||1254|2542 063958|N05BA1204|Tafil Retard|forðatfl|1|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|0|100|DKK|2400|4097|lyfalmen|||10|60|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||2400||2400|4097 064069|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2.5|0|1|0|1|UTE|0|0|0|100|XEU|1276762|1591436|lyfsjukr|||00|1|0|12|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||1276762|1591436 064106|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2.5|0|1|0|1|UTE|0|0|0|100|XEU|510704|637694|lyfsjukr|||00|1|0|5|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||510704|637694 064170|N05BA1204|Tafil Retard|forðatfl|2|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|2760|4586|lyfalmen|||10|30|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||2760||2760|4586 064224|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2.5|0|1|0|1|UTE|0|0|0|100|XEU|5107050|6360145|lyfsjukr|||00|1|0|47|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||5107050|6360145 064233|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2.5|0|1|0|1|UTE|0|0|0|100|XEU|2553526|3181007|lyfsjukr|||00|1|0|23|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||2553526|3181007 064733|J07BB0203|Vaxigrip|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07BB02|01.10.1985||R|K|1|0|0|0|0|SPM|0|0|0|100|XEU|1028|2235|lyfalmen|||51|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsaðir mótefnavakar||1028||1028|2235 065032|D10AF5101|Duac|hlaup|0| |25|g|1|túpa|50 mg/g + 10 mg/g|D10AF51|01.01.2007||R|A|1,5|0|0|0|0|SLL|0|0|0|100|DKK|2299|3960|lyfalmen|||38|25|0|0|Vistor hf|Stiefel Laboratories (UK) Ltd.|Klindamýcín í blöndum||2299||2299|3960 065060|J07BD5202|MMR II|bóluefni|0| |0,5|ml|10|hgl|+ leysir|J07BD52|01.11.1998||R|K|2|0|0|0|0|MEX|0|0|0|100|XEU|15379|21332|lyfalmen|||51|5|0|0|Icepharma hf|Aventis Pasteur MSD A/S|mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||15379||15379|21332 065314|G01AF0201|Canesten|sk-stil|100|mg|6|stk|1|pakki|+stjaka|G01AF02|01.12.1982||L|A|4|0|0|0|0|BAS|0|0|0|100|IKR|||lyflausa|||25|6|0|6|Vistor hf|Bayer A/S|Klótrímazól||||| 065332|G01AF0201|Canesten|sk-stil|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.04.1985||L|A|5|0|0|0|0|BAS|0|0|0|100|IKR|||lyflausa|||25|1|0|5|Vistor hf|Bayer A/S|Klótrímazól||||| 065706|S01EE0101|Xalatan|augndr|50|mcg/sk|2,5|ml|1|glas||S01EE01|01.10.1999||R|K|3|0|0|*|0|PFI|0|0|0|100|DKK|2948|4841|lyfalmen|V1989|4840|06|2|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Latanóprost||2948||2948|4841 065722|S01EE0101 |Xalatan|augndr|50|mcg/ml|2,5|ml|3|glas||S01EE01|01.05.2009||R|K|3|0|0|*|0|PFI|0|0|0|100|DKK|8836|12831|lyfalmen|||06|8|0|75|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Latanóprost||||8836|12831 065979|C09CA0101|Cozaar|töflur|12,5|mg|28|stk|1|þpakki||C09CA01|01.03.1999||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|2510|4247|lyfalmen|V0195|2187|00|28|0|7|Icepharma hf|M.S.D.|Lósartan||2510||2510|4247 066241|C03EA0103|Hydramil|töflur|55|mg|100|stk|1|glas|5+50 mg|C03EA01|01.08.1984||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|238|1163|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|Hýdróklórtíazíð og kalíumsparandi lyf||238||238|1163 066278|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|pakki|lausn|R03BB04|01.04.2008||R|A|2|0|0|B|0|BII|0|0|0|100|DKK|8483|12352|lyfalmen|||00|60|0|30|Vistor hf|Boehringer Ingelheim International |Tíótrópíumbrómíð||8483||8483|12352 066287|B05AA0704|Voluven|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05AA07|01.05.2008||R|A|5|0|0|0|1|FRP|0|0|0|100|DKK|34383|44674|lyfsjukr|||00|10000|0|10|Icepharma hf|Fresenius Kabi|Hýdróxyetýl sterkja||34383||34383|44674 066399|N07BA0106|Nicotinell|forðapl|7|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|21|0|10|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 066407|N07BA0106|Nicotinell|forðapl|14|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|21|0|21|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 066423|N07BA0106|Nicotinell|forðapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|21|0|32|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 066548|QG03FA0401|Prid, vet.|lykkja|10|mg|10|stk|1|pakki|m. hylki|QG03FA04|01.08.1984||R|A|2|0|0|0|0|CES|1|0|0|100|XEU|24623|47074|vetalmen|||16|10|0|0|Icepharma hf|Ceva Sante Animale|||24623||24623|47074 066563|N06AA0405|Klomipramin Merck NM|töflur|10|mg|100|stk|1|glas||N06AA04|01.10.1992||R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|1036|2246|lyfalmen|||00|100|0|10|Actavis Group PTC ehf|Merck NM AB|Klómípramín||1036||1036|2246 066621|N06AA0405|Klomipramin Merck NM|töflur|25|mg|100|stk|1|glas||N06AA04|01.10.1992|31.08.2009|R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|873|2025|lyfalmen|||00|100|0|25|Actavis Group PTC ehf|Merck NM AB|Klómípramín||873||873|2025 066688|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|6|glerfl||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|4575|6550|lyfsjukr|||02|120|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||4575||4575|6550 066751|C01BD0103|Cordarone (D.A.C.)|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.11.2006||R|K|5|0|0|B|0|DAC|0|0|0|100|NOK|1997|3550|lyfalmen|V0144|3550|70|30|0|15|D.A.C. ehf|D.A.C. ehf|Amíódarón||1997||1997|3550 067025|J01CA0406|Flemoxin Solutab|lausnart|125|mg|20|stk|1|þpakki||J01CA04|01.01.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|757|1868|lyfalmen|||23|20|0|2|Vistor hf|Astellas Pharma A/S|Amoxicillín||757||757|1868 067124|N07CA0101|Betaserc|töflur|16|mg|84|stk|1|þpakki||N07CA01|01.04.1993||R|A|5|0|0|E|0|SOL|0|0|0|100|DKK|8368|12196|lyfalmen|||00|84|0|56|Medico ehf|Solvay Duphar |Betahistín||8368||8368|12196 067587|N05BB0101|Atarax|töflur|25|mg|100|stk|1|þpakki||N05BB01|01.07.1994||R|A|5|0|0|0|0|UCN|0|0|0|100|SEK|1489|2861|lyfalmen|||00|100|0|33|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1489||1489|2861 067632|QN05CM9501|Dorbene vet.|stl|1|mg/ml|10|mg|1|hgl||QN05CM95|01.05.2009||R|A|3|0|0|0|0|LAS|1|0|0|100|XEU|8009|15427|vetalmen|||0|10|0|0|Dýraheilsa ehf|Laboratorios SYVA S.A.|||||8009|15427 067641|N05CD0204|Mogadon (D.A.C.)|töflur|5|mg|50|stk|1|þpakki||N05CD02|01.11.2006||R|A|5|0|0|0|0|DAC|0|0|1|100|DKK|891|2050|lyfalmen|V0901|2050|00|50|0|50|D.A.C. ehf|D.A.C. ehf|Nítrazepam||891||891|2050 067751|J02AC0102|Candizol|hylki|50|mg|7|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1740|3202|lyfalmen|V0551|3202|10|7|0|2|Actavis Group hf|Actavis hf|Flúkónazól||1740||1740|3202 067769|J02AC0102|Candizol|hylki|50|mg|30|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|5834|8757|lyfalmen|V0552|8757|10|30|0|8|Actavis Group hf|Actavis hf|Flúkónazól||5834||5834|8757 067785|J02AC0102|Candizol|hylki|150|mg|1|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|754|1864|lyfalmen|V0554|1864|10|1|0|1|Actavis Group hf|Actavis hf|Flúkónazól||754||754|1864 067793|J02AC0102|Candizol|hylki|150|mg|2|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1441|2796|lyfalmen|V0555|2796|10|2|0|2|Actavis Group hf|Actavis hf|Flúkónazól||1441||1441|2796 067801|J02AC0102|Candizol|hylki|150|mg|4|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|2500|4233|lyfalmen|V0556|4233|10|4|0|3|Actavis Group hf|Actavis hf|Flúkónazól||2500||2500|4233 067827|J02AC0102|Candizol|hylki|200|mg|30|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|22063|29653|lyfalmen|V0557|29653|10|30|0|30|Actavis Group hf|Actavis hf|Flúkónazól||22063||22063|29653 068312|QN01AX0302|Narketan, vet.|stl|100|mg/ml|50|ml|1|hgl||QN01AX03|01.01.1991||R|A|2,5|1|0|0|0|VEQ|1|0|0|100|XEU|7179|13846|vetalmen|||27|50|0|0|Icepharma hf|Vétoquinol AG|||7179||7179|13846 068437|C01BC0401|Tambocor|töflur|100|mg|20|stk|1|þpakki||C01BC04|01.04.1987||R|A|5|0|1|B|0|MEB|0|0|0|100|SEK|2504|4238|lyfalmen|||00|20|0|10|Vistor hf|Meda AB (V)|Flekaíníð||2504||2504|4238 068445|C01BC0401|Tambocor|töflur|100|mg|100|stk|1|þpakki||C01BC04|01.04.1987||R|A|5|0|1|B|0|MEB|0|0|0|100|SEK|7068|10432|lyfalmen|||00|100|0|50|Vistor hf|Meda AB (V)|Flekaíníð||7068||7068|10432 068923|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|10|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|200|0|0|Actavis Group hf|Braun|||||| 068933|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|20|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|400|0|0|Actavis Group hf|Braun|||||| 068951|V07AB09|Sterilt Vann B. Braun|leysir|0||10|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|200|0|0|Actavis Group hf|Braun|||||| 068960|V07AB09|Sterilt Vann B. Braun|leysir|0||20|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|400|0|0|Actavis Group hf|Braun|||||| 069799|D01AE1501|Lamisil|krem|10|mg/g|15|g|1|túpa||D01AE15|01.04.1993||L|A|5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|15|0|15|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín||||| 069807|D01BA0201|Lamisil|töflur|250|mg|14|stk|1|þpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|4952|3211|lyfalmen|||00|14|0|14|Vistor hf|Novartis Healthcare A/S-|Terbínafín||1747||1747|3211 069815|D01BA0201|Lamisil|töflur|250|mg|98|stk|1|þpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|31896|16993|lyfalmen|||00|98|0|98|Vistor hf|Novartis Healthcare A/S-|Terbínafín||11903||11903|16993 069833|J01DB0101|Keflex|töflur|500|mg|40|stk|1|þpakki||J01DB01|01.07.2007||R|A|3|0|0|0|0|NMA|0|0|1|100|DKK|3675|5828|lyfalmen|||00|40|0|10|Icepharma hf|NordMedica A/S|Cefalexín||3675||3675|5828 069842|J01DB0101|Keflex|töflur|500|mg|20|stk|1|þpakki||J01DB01|01.07.2007||R|A|3|0|0|0|0|NMA|0|0|1|100|DKK|1851|3352|lyfalmen|||00|20|0|5|Icepharma hf|NordMedica A/S|Cefalexín||1851||1851|3352 070342|V08AB0201|Omnipaque|stl|350|mg J/ml|100|ml|10|glerfl||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|76493|97101|lyfsjukr|||02|1000|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||76493||76493|97101 070359|L01DB0701|Novantrone|irþ|2|mg/ml|10|ml|1|hgl||L01DB07|01.07.1987||R|A|3|0|1|0|1|MEB|0|0|0|100|USD|32910|42840|lyfsjukr|||00|10|0|0|Icepharma hf|Meda AB (V)|Mítoxantrón||32910||32910|42840 070514|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|30|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|6353|9096|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar||6353||6353|9096 070523|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|5928|8487|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar||5928||5928|8487 070533|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|30|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|10410|14828|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||10410||10410|14828 070542|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|20|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|6625|9485|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||6625||6625|9485 070557|QH01BB0203|Partoxin vet.|stl|17|mcg|10|ml|10|hgl||QH01BB02|01.12.2006||R|A|2|0|0|0|0|PSW|1|0|0|100|SEK|5991|11583|vetalmen|||27|100|0|0|Vistor hf|Pharmaxim Sweden AB|||5991||5991|11583 070797|N05AX0801|Risperdal|mixtúra|1|mg/ml|100|ml|1|fl|með skammtasprautu|N05AX08|01.01.1997||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|18883|25694|lyfalmen|||00|100|0|20|Vistor hf|Janssen-Cilag AB|Risperídón||18883||18883|25694 071076|QA12CE9902|Selevitan, vet.|kyrni|0| |1250|g|1|plbrús||QA12CE99|01.12.2006||R|A|3|0|0|0|0|PSW|0|0|0|100|SEK|6343|12254|vetalmen|||16|1250|0|0|Vistor hf|Pharmaxim Sweden AB|||6343||6343|12254 071134|N05AN0104|Litiumsitrat Actavis|töflur|500|mg|100|stk|1|glas||N05AN01|01.10.1995||R|A|5|0|0|*|0|ACA|0|1|0|100|IKR|728|1828|lyfalmen|||00|100|0|22|Actavis Group hf|Actavis hf|Litíum||728||728|1828 071217|C03EA0104|Hydramil mite|töflur|27,5|mg|100|stk|1|glas|2.5+25 mg|C03EA01|01.08.1984||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|158|1055|lyfalmen|V2175|1055|00|100|0|100|Actavis Group hf|Actavis hf|Hýdróklórtíazíð og kalíumsparandi lyf||158||158|1055 071223|N02BG0801|Prialt|irl|100|mcg/ml|1|ml|1|hgl||N02BG08|01.06.2007||R|K|3|0|1|0|1|EIS|0|0|0|100|SEK|66984|85263|lyfsjukr|||00|1|0|8|Vistor hf|Eisai Ltd|Ziconotíð||66984||66984|85263 071232|N02BG0801|Prialt|irl|100|mcg/ml|5|ml|1|hgl||N02BG08|01.06.2007||R|K|3|0|1|0|1|EIS|0|0|0|100|SEK|334920|418843|lyfsjukr|||00|5|0|42|Vistor hf|Eisai Ltd|Ziconotíð||334920||334920|418843 072132|QN05CM9001|Domosedan, vet.|stl|10|mg/ml|5|ml|1|hgl||QN05CM90|01.01.1991||R|A|3|0|0|0|0|ORF|1|0|0|100|DKK|9165|17629|vetalmen|||27|5|0|0|Vistor hf|Orion-Farmos|||9165||9165|17629 072371|A04AA0201|Kytril|stl|1|mg/ml|3|ml|5|lykjur||A04AA02|01.04.1993||R|A|3|0|0|E|0|ROA|0|0|0|100|DKK|16039|22154|lyfalmen|||00|15|0|5|Icepharma hf|Roche A.S.|Granisetrón||16039||16039|22154 072520|V01AA1104|Alutard SQ, hrossaværur|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|22495|30191|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|dýr||22495||22495|30191 072751|N01AH0301|Sufenta|stl|5|mcg/ml|2|ml|5|lykjur||N01AH03|01.06.2000||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|673|964|lyfsjukr|||02|10|0|0|Vistor hf|Janssen-Cilag AB|Súfentaníl||673||673|964 072770|L04AB0401|Humira|stl|40|mg/penna|0,8|ml|2|pennar||L04AB04|01.06.2007||R|K|1,5|0|1|0|1|ABB|0|0|0|100|DKK|195346|245073|lyfsjukr|||00|2|0|28|Vistor hf|Abbott|Adalimumab||195346||195346|245073 072892|N01AH0301|Sufenta|stl|50|mcg/ml|1|ml|5|lykjur||N01AH03|01.10.1992||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|2061|2951|lyfsjukr|||02|5|0|0|Vistor hf|Janssen-Cilag AB|Súfentaníl||2061||2061|2951 072978|A10BX0401|Byetta|stl|5|mcg/sk|1,2|ml|1|penni|lausn|A10BX04|01.05.2007||R|K|2|0|0|*|0|ELN|0|0|0|100|XEU|17511|23986|lyfalmen|||00|1|0|20|Icepharma hf|Eli Lilly Nederland|Exenatíð||17511||17511|23986 072996|A10BX0401|Byetta|stl|10|mcg/sk|2,4|ml|1|penni|lausn|A10BX04|01.05.2007||R|K|2|0|0|*|0|ELN|0|0|0|100|XEU|17511|23986|lyfalmen|||00|2|0|40|Icepharma hf|Eli Lilly Nederland|Exenatíð||17511||17511|23986 073205|N05AF0103|Fluanxol Mite|filmhtfl|0,5|mg|100|stk|1|glas||N05AF01|01.12.1972||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|1537|2926|lyfalmen|||00|100|0|8|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1537||1537|2926 073224|A09AA0205|Creon|sh-hylki|150|mg|100|stk|1|plglas||A09AA02|01.01.2008||R|A|2|0|0|E|0|SOY|0|0|0|100|XEU|4528|5988|lyfalmen|||10|100|0|100|Medico ehf|Solvay Pharmaceuticals GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||3793||3793|5988 073684|N05AF0103|Fluanxol Mite|filmhtfl|1|mg|100|stk|1|glas||N05AF01|01.12.1972||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|1925|3453|lyfalmen|||00|100|0|17|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1925||1925|3453 073825|N05BA1203|Tafil|töflur|0,25|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|359|1328|lyfalmen|V0858|1133|00|20|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||359||359|1328 073833|N05BA1203|Tafil|töflur|0,25|mg|50|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|967|2153|lyfalmen|V0859|1623|00|50|0|12|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||967||967|2153 073841|N05BA1203|Tafil|töflur|0,25|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|1401|2742|lyfalmen|V0855|2051|00|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||1401||1401|2742 073858|N05BA1203|Tafil|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|607|1664|lyfalmen|V0856|1329|00|20|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||607||607|1664 073866|N05BA1203|Tafil|töflur|0,5|mg|50|stk|1|þpakki||N05BA12|01.04.1987|31.08.2009|R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|1030|2238|lyfalmen|||00|50|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||1030||1030|2238 073874|N05BA1203|Tafil|töflur|0,5|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|2091|3678|lyfalmen|||00|100|0|50|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||2091||2091|3678 074042|C09DB0101|Exforge|filmhtfl|85|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|4224|6573|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||4224||4224|6573 074051|C09DB0101|Exforge|filmhtfl|85|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|12300|17498|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||12300||12300|17498 074060|C09DB0101|Exforge|filmhtfl|165|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|5389|8154|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||5389||5389|8154 074069|C09DB0101|Exforge|filmhtfl|165|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|15862|21933|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||15862||15862|21933 074078|C09DB0101|Exforge|filmhtfl|170|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|5389|8154|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||5389||5389|8154 074087|C09DB0101|Exforge|filmhtfl|170|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|17804|24351|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||17804||17804|24351 074229|A08AA1001|Reductil|hylki|10|mg|28|stk|1|þpakki||A08AA10|01.08.2001||R|A|3|0|0|0|0|ABL|0|0|0|100|DKK|6455|9600|lyfalmen|||00|28|0|28|Vistor hf|Abbott Laboratories A/S|Sibutramin||6455||6455|9600 074443|V08CA0301|Omniscan|stl|0,5|mmol/ml|5|ml|10|hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|22740|30179|lyfsjukr|||00|50|0|0|Icepharma hf|GE Healthcare AS|Gadódíamíð||22740||22740|30179 074468|N05BA0105|Stesolid|töflur|5|mg|25|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|270|1207|lyfalmen|||00|25|0|12|Actavis Group hf|Actavis Group hf|Díazepam||270||270|1207 074484|N05BA0105|Stesolid|töflur|5|mg|50|stk|1|glas||N05BA01|01.12.1980||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|548|1584|lyfalmen|||00|50|0|25|Actavis Group hf|Actavis Group hf|Díazepam||548||548|1584 074617|QI06AA0402|Fel-O-Vax PCT vet.|bóluefni|0| |1|ml|25|spr|áfyllt sprauta|QI06AA04|01.06.2000||R|K|2|0|0|0|0|SCA|1|0|0|100|DKK|24356|42149|vetorma|||58|25|0|0|Vistor hf|Scan Vet Animal Health AS|||24356||24356|42149 074674|D06BB0401|Condyline|áburður|5|mg/ml|3,5|ml|1|glas|til penslu|D06BB04|01.07.1988||R|A|2|0|0|0|0|GAN|0|0|1|100|XEU|2560|4314|lyfalmen|||23|4|0|4|Icepharma hf|Galderma Nordic AB|Pódófýllótoxín||2560||2560|4314 074732|A08AA1001|Reductil|hylki|15|mg|28|stk|1|þpakki||A08AA10|01.08.2001||R|A|3|0|0|0|0|ABL|0|0|0|100|DKK|6455|9600|lyfalmen|||00|28|0|42|Vistor hf|Abbott Laboratories A/S|Sibutramin||6455||6455|9600 074922|R06AX2601|Telfast|töflur|120|mg|30|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|1651|2408|lyfalmen|V1910|2408|00|30|0|30|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1155||1155|2408 075044|J02AB0201|Fungoral|töflur|200|mg|10|stk|1|þpakki||J02AB02|01.01.1985||R|A|5|0|0|0|0|JAS|0|0|1|100|SEK|1709|3160|lyfalmen|||69|10|0|10|Vistor hf|Janssen-Cilag AB|Ketókónazól||1709||1709|3160 075068|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|20|stk|1|þpakki||N07BA01|01.10.2008||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|20|0|1|Vistor hf|McNeil Denmark ApS|Nikótín||||| 075069|R06AX2601|Telfast|töflur|180|mg|30|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|2336|3345|lyfalmen|V1912|3345|00|30|0|45|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1846||1846|3345 075078|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|90|stk|1|þpakki||N07BA01|01.10.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|90|0|6|Vistor hf|McNeil Denmark ApS|Nikótín||||| 075087|N02BE5102|Parkodin|töflur|510|mg|300|stk|1|plglas|10+500 mg|N02BE51|01.07.2007||R|A|5|1|0|0|0|ACA|0|0|1|100|IKR|1500|2876|lyfalmen|||00|300|0|50|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||1500||1500|2876 075096|N02AA5902|Parkodin forte|töflur|530|mg|300|stk|1|plglas|30+500 mg|N02AA59|01.07.2007||R|A|5|1|0|0|0|ACA|0|0|1|100|NOK|2947|4840|lyfalmen|||00|300|0|300|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||2947||2947|4840 075305|N02BE0108|Paratabs Retard|forðatfl|500|mg|300|stk|1|plglas||N02BE01|01.10.2007||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|1536|2925|lyfalmen|||10|300|0|50|Actavis Group hf|Actavis hf|Paracetamól||1536||1536|2925 075382|V04CL0030|Soluprick SQ, rauðölur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8733|12691|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|trjáfrjó||8733||8733|12691 075408|V04CL0022|Soluprick SQ, graölur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8733|12691|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|trjáfrjó||8733||8733|12691 075424|V04CL0019|Soluprick SQ, birkifrjo|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8733|12691|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|trjáfrjó||8733||8733|12691 075440|V04CL0026|Soluprick SQ, hesliviður|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8733|12691|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|trjáfrjó||8733||8733|12691 075465|V04CL0024|Soluprick SQ, haliðagras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8733|12691|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8733||8733|12691 075481|V04CL0023|Soluprick SQ, hafrar|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8733|12691|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8733||8733|12691 075507|V04CL0018|Soluprick SQ, axhnoðapunktur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8733|12691|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8733||8733|12691 075523|V04CL0025|Soluprick SQ, havingull|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8733|12691|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8733||8733|12691 075549|V04CL0033|Soluprick SQ, vallarrygresi|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8733|12691|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8733||8733|12691 075564|V04CL0032|Soluprick SQ, vallarfoxgras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8733|12691|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8733||8733|12691 075580|V04CL0034|Soluprick SQ, vallarsveifgras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8733|12691|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8733||8733|12691 075606|V04CL0031|Soluprick SQ, rugur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8733|12691|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8733||8733|12691 075663|V04CL0021|Soluprick SQ, derm.pter.|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8733|12691|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|rykmaurar||8733||8733|12691 075689|V04CL0027|Soluprick SQ, hrossaværur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8733|12691|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|dýr||8733||8733|12691 075705|V04CL0028|Soluprick SQ, hundahar|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8733|12691|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|dýr||8733||8733|12691 075721|V04CL0029|Soluprick SQ, kattahar|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8733|12691|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|dýr||8733||8733|12691 075724|B02BD0901|BeneFIX|sts|0| |1000|ae|1|hgl|+leysir|B02BD09|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|USD|136205|171443|lyfsjukr|||00|1000|0|3|Icepharma hf|Wyeth Europe|Storkuþáttur IX||136205||136205|171443 075787|QS02CA0102|Canaural|eyrnadr|0| |25|ml|1|glas||QS02CA01|01.12.1982||R|A|3|0|0|0|0|VEX|0|0|0|100|DKK|2447|4829|vetalmen|||13|25|0|0|Vistor hf|VetXX A/S|||2447||2447|4829 075869|B05BD0001|Balance|kvið.sk|1,5|%|5000|ml|2|pokar|lausn|B05BD|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|8623|12346|lyfsjukr|||00|10000|0|10|Icepharma hf|Fresenius Medical Care Deutschland GmbH|||8623||8623|12346 075888|B05BD0001|Balance|kvið.sk|2,3|%|5000|ml|2|pokar|lausn|B05BD|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|7014|10042|lyfsjukr|||00|10000|0|10|Icepharma hf|Fresenius Medical Care Deutschland GmbH|||7014||7014|10042 075906|B05BD0001|Balance|kvið.sk|4,25|%|5000|ml|2|pokar|lausn|B05BD|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|6887|9860|lyfsjukr|||00|10000|0|10|Icepharma hf|Fresenius Medical Care Deutschland GmbH|||6887||6887|9860 076033|A10BH0101|Januvia|filmhtfl|100|mg|98|stk|1|þpakki||A10BH01|01.11.2007||R|A|3|0|0|*|0|MSD|0|0|0|100|XEU|26614|35319|lyfalmen|||00|98|0|98|Icepharma hf|M.S.D.|Sítagliptín||26614||26614|35319 076281|R01AX0301|Atrovent|nefúði|21|mcg/sk|30|ml|1|stauk|380 sk.|R01AX03|01.01.2000||R|A|2|0|0|E|0|BOI|0|0|1|100|DKK|3014|4931|lyfalmen|||24|30|0|33|Vistor hf|Boehringer Ingelheim|Ípratrópínbrómíð||3014||3014|4931 076369|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|20|stk|1|þpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|738|1792|lyfalmen|V1070|1792|00|20|0|2|Portfarma ehf|Portfarma|Risperídón||701||701|1792 076378|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|2033|3185|lyfalmen|V1075|3185|00|60|0|6|Portfarma ehf|Portfarma|Risperídón||1728||1728|3185 076387|N05AX0805|Risperidon Portfarma|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|2876|4040|lyfalmen|V0791|4040|00|60|0|12|Portfarma ehf|Portfarma|Risperídón||2358||2358|4040 076533|N05AB0301 |Trilafon|filmhtfl|2|mg|100|stk|1|þpakki||N05AB03|01.04.2009||R|A|2|0|0|*|0|SCP|0|1|0|100|DKK|1046|2260|lyfalmen|||00|100|0|7|Vistor hf|Schering-Plough|Perfenazín||||1046|2260 076542|N05AB0301 |Trilafon|filmhtfl|4|mg|100|stk|1|þpakki||N05AB03|01.04.2009||R|A|2|0|0|*|0|SCP|0|1|0|100|DKK|1450|2808|lyfalmen|||00|100|0|13|Vistor hf|Schering-Plough|Perfenazín||||1450|2808 076551|N05AB0301 |Trilafon|filmhtfl|8|mg|100|stk|1|þpakki||N05AB03|01.04.2009||R|A|2|0|0|*|0|SCP|0|1|0|100|DKK|2067|3645|lyfalmen|||00|100|0|27|Vistor hf|Schering-Plough|Perfenazín||||2067|3645 076752|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|100|ml|1|hgl|plast|QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|8380|14502|vetorma|||27|100|0|0|Vistor hf|Merial (MSD)|||8380||8380|14502 077215|A06AH0101|Relistor|stl|20|mg/ml|0,6|ml|1|hgl|lausn|A06AH01|01.01.2009||R|A|2|0|0|0|0|WTE|0|0|0|100|USD|6599|9796|lyfalmen|||0|12|0|0|Icepharma hf|Wyeth Europe|Metýlnaltrexónbrómíð||6599||6599|9796 077420|N02BE5102|Parkodin|töflur|510|mg|30|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1985||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|200|1112|lyfalmen|||00|30|0|5|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||200||200|1112 077446|N02BE5102|Parkodin|töflur|510|mg|100|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1985||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|505|1526|lyfalmen|||00|100|0|17|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||505||505|1526 077875|A02BA0205|Zantac|stl|25|mg/ml|2|ml|5|lykjur||A02BA02|01.10.1987||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|753|1862|lyfalmen|||02|10|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín||753||753|1862 077951|M01AB0514|Voltfast (D.A.C.)|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.04.2007||R|A|5|0|0|0|0|DAC|0|0|1|100|IKR|881|1424|lyfalmen|V0609|1424|10|30|0|15|D.A.C. ehf|D.A.C. ehf|Díklófenak||430||430|1424 078568|J01CE0204|Kaavepenin|töflur|250|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|535|1566|lyfalmen|||00|20|0|2|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||535||535|1566 078576|J01CE0204|Kaavepenin|töflur|250|mg|40|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|815|1946|lyfalmen|||00|40|0|5|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||815||815|1946 078709|N06AB0303|Serol|töflur|10|mg|30|stk|1|glas||N06AB03|01.04.1994||R|A|5|0|0|B|0|ACA|0|1|0|100|IKR|998|2195|lyfalmen|||00|30|0|15|Actavis Group hf|Actavis hf|Flúoxetín||998||998|2195 078717|N06AB0303|Serol|töflur|10|mg|100|stk|1|glas||N06AB03|01.04.1994||R|A|5|0|0|B|0|ACA|0|1|0|100|IKR|4110|6418|lyfalmen|||00|100|0|50|Actavis Group hf|Actavis hf|Flúoxetín||4110||4110|6418 078741|N06AX0306|Mianserin Merck NM|töflur|30|mg|100|stk|1|glas||N06AX03|01.01.1994||R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|3350|5386|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck NM AB|Míanserín||3350||3350|5386 078782|L01XA0208|Carboplatin Mayne|irþ|10|mg/ml|5|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|6318|9046|lyfsjukr|||00|5|0|0|Icepharma hf|Mayne Pharma Plc|Karbóplatín||6318||6318|9046 078790|L01XA0208|Carboplatin Mayne|irþ|10|mg/ml|15|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|18611|25038|lyfsjukr|||00|15|0|0|Icepharma hf|Mayne Pharma Plc|Karbóplatín||18611||18611|25038 078824|L01XA0208|Carboplatin Mayne|irþ|10|mg/ml|45|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|20668|27599|lyfsjukr|||00|45|0|0|Icepharma hf|Mayne Pharma Plc|Karbóplatín||20668||20668|27599 078933|L03AB0801|Betaferon|sts|8|mi.ae/ml|15|spr|1|pakki|+leysir|L03AB08|01.01.2002||R|A|2|0|1|0|1|SAG|0|0|0|100|SEK|160476|201660|lyfsjukr|||00|15|0|30|Icepharma hf|Schering AG|Interferón beta-1b||160476||160476|201660 079061|C09CA0101|Cozaar|töflur|50|mg|98|stk|1|þpakki||C09CA01|01.01.1995||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|10432|6776|lyfalmen|||00|98|0|98|Icepharma hf|M.S.D.|Lósartan||4374||4374|6776 079103|L01AA0601|Holoxan|sts/irs|500|mg|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|2662|3811|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter Medical AB|Ífosfamíð||2662||2662|3811 079111|L01AA0601|Holoxan|sts/irs|1|g|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|4729|6771|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter Medical AB|Ífosfamíð||4729||4729|6771 079129|L01AA0601|Holoxan|sts/irs|2|g|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|7959|11395|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter Medical AB|Ífosfamíð||7959||7959|11395 079202|J05AH0201|Tamiflu|hylki|75|mg|10|stk|1|þpakki||J05AH02|01.11.2002||R|A|5|0|0|0|0|RRL|0|0|0|100|DKK|3930|6174|lyfalmen|||00|10|0|5|Icepharma hf|Roche Registration Limited|Oseltamivír||3930||3930|6174 079236|L01CA0206|Vincristine Mayne|stl|1|mg/ml|1|ml|5|hgl||L01CA02|01.01.1991||R|K|2|0|1|0|1|MAY|0|0|0|100|SEK|8443|12088|lyfsjukr|||02|5|0|0|Icepharma hf|Mayne Pharma Plc|Vínkristín||8443||8443|12088 079269|N05AB0302|Trilafon decanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.01.1988||R|A|3|0|0|*|0|SCP|0|1|0|100|DKK|21637|29123|lyfalmen|||02|10|0|155|Vistor hf|Schering-Plough|Perfenazín||21637||21637|29123 079616|L01CA0206|Vincristine Mayne|stl|1|mg/ml|2|ml|5|hgl||L01CA02|01.07.2004||R|K|2|0|1|0|1|MAY|0|0|0|100|SEK|13215|18320|lyfsjukr|||02|10|0|0|Icepharma hf|Mayne Pharma Plc|Vínkristín||13215||13215|18320 079749|J01CF0101|Diclocil|sts/irs|1|g|1|stk|5|hgl||J01CF01|01.04.1987||R|A|3|0|0|0|1|BRS|0|0|0|100|DKK|2429|3478|lyfsjukr|||03|5|0|2|Vistor hf|Bristol-Myers Squibb|Díkloxacillín||2429||2429|3478 080106|J01MA0203|Siprox|töflur|250|mg|10|stk|1|þpakki||J01MA02|01.10.1992||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|393|1374|lyfalmen|V0514|1374|00|10|0|2|Actavis Group hf|Actavis hf|Cíprófloxacín||393||393|1374 080115|J01MA0203|Siprox|töflur|250|mg|20|stk|1|þpakki||J01MA02|01.10.1992||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|638|1706|lyfalmen|V0518|1706|00|20|0|5|Actavis Group hf|Actavis hf|Cíprófloxacín||638||638|1706 080124|J01MA0203|Siprox|töflur|500|mg|10|stk|1|þpakki||J01MA02|01.05.2008||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|647|1718|lyfalmen|V0522|1718|00|10|0|5|Actavis Group hf|Actavis hf|Cíprófloxacín||647||647|1718 080133|J01MA0203|Siprox|töflur|500|mg|20|stk|1|þpakki||J01MA02|01.01.1994||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1168|2425|lyfalmen|V0526|2425|00|20|0|10|Actavis Group hf|Actavis hf|Cíprófloxacín||1168||1168|2425 080424|G01AF0502|Pevaryl Depot|sk-stil|150|mg|1|stk|1|still||G01AF05|01.04.1989||L|A|3|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||05|1|0|2|Vistor hf|Janssen-Cilag AB|Ekónazól||||| 080507|N06AA1001|Noritren|töflur|50|mg|100|stk|1|glas||N06AA10|01.04.1986||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|2635|4416|lyfalmen|||00|100|0|67|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||2635||2635|4416 080524|N06AX1202|Wellbutrin Retard|töflur|300|mg|30|stk|1|þpakki|m/br. losunarhraða|N06AX12|01.07.2007||R|A|1,5|0|0|B|0|GSK|0|1|1|100|GBP|6568|9753|lyfalmen|||00|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Buprofienum||6568||6568|9753 080542|N06AX1202|Wellbutrin Retard|töflur|150|mg|30|stk|1|þpakki|m/br. losunarhraða|N06AX12|01.07.2007||R|A|1,5|0|0|B|0|GSK|0|1|1|100|GBP|3263|5268|lyfalmen|||00|30|0|15|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Buprofienum||3263||3263|5268 080549|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|500|ml|1|fl||QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|35671|61730|vetorma|||27|500|0|0|Vistor hf|Merial (MSD)|||35671||35671|61730 080564|L01DB0601|Zavedos|sts|5|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|28183|36955|lyfsjukr|||00|1|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ídarúbicín||28183||28183|36955 080820|L01DB0601|Zavedos|sts|10|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|46825|60165|lyfsjukr|||00|1|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ídarúbicín||46825||46825|60165 081315|M09AX0101|Artzal|stl|10|mg/ml|2,5|ml|5|dælur|einnota dælur plast|M09AX01|01.11.1998||R|A|3,5|0|0|E|0|AZD|0|0|0|100|SEK|43193|55960|lyfalmen|||02|12|0|35|Vistor hf|AstraZeneca A/S DK|Natríumhýalúrónat||43193||43193|55960 081507|G04BE0802|Cialis (D.A.C.)|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.05.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|XEU|6801|10070|lyfalmen|V1350|10070|00|4|0|8|D.A.C. ehf|D.A.C. ehf|Tadalafíl||||6801|10070 081525|V03AN0101|Conoxia|innö.gas|100|%|10|l|1|hylki|MO10|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|10|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081534|V03AN0101|Conoxia|innö.gas|100|%|20|l|1|hylki|MO20|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|20|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081543|V03AN0101|Conoxia|innö.gas|100|%|50|l|1|hylki|Mo50|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|50|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081552|V03AN0101|Conoxia|innö.gas|100|%|5|l|1|hylki|MO5|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|5|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081561|V03AN0101|Conoxia|innö.gas|100|%|50|l|12|hylki|MS5I|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|600|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081571|V03AN0101|Conoxia|innö.gas|100|%|2|l|1|hylki|MO2c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|2|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081589|V03AN0101|Conoxia|innö.gas|100|%|1|l|1|hylki|MO1|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|1|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081598|V03AN0101|Conoxia|innö.gas|100|%|2,5|l|1|hylki|MO2,5c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|2|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081625|V03AN0101|Conoxia|innö.gas|100|%|2|l|1|hylki|MO2|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|2|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081634|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4b|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|4|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081671|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|4|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081680|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|4|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081689|V03AN0101|Conoxia|innö.gas|100|%|1|l|1|hylki|MO1c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|1|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081745|N05CD0801|Dormicum|stl|5|mg/ml|1|ml|10|lykjur||N05CD08|01.07.1985||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|2423|3469|lyfsjukr|||02|10|0|3|Icepharma hf|Roche|Mídazólam||2423||2423|3469 081897|N05AH0305|Zyprexa Velotab (D.A.C.)|munndr.t|10|mg|28|stk|1|þpakki||N05AH03|01.05.2007||R|A|3|0|0|*|0|DAC|0|1|0|100|XEU|22469|30159|lyfalmen|V0813|30159|00|28|0|28|D.A.C. ehf|D.A.C. ehf|Olanzapín||22469||22469|30159 081987|A10AB0602|Apidra [solostar]|stl|100|ein/ml|3|ml|5|lyfjap|áflylltir|A10AB06|01.01.2008||R|K|2|0|0|*|0|SAA|0|0|0|100|NOK|6174|9219|lyfalmen|||02|15|0|38|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||6174||6174|9219 081996|A10AE0403|Lantus [SoloStar]|stl|100|ein/ml|3|ml|5|lyfjap||A10AE04|01.01.2008||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|10448|15019|lyfalmen|||00|15|0|38|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||10448||10448|15019 082040|D07XC0101|Diprosalic|áburður|0||100|ml|1|glas||D07XC01|01.01.1987||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|3894|6125|lyfalmen|||20|100|0|100|Vistor hf|Schering-Plough|Betametasón||||3894|6125 082233|V03AN0101|Conoxia|innö.gas|100|%|36|l|1|hylki|Hemlox|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|36|0|0|Ísaga ehf|AGA AB|Súrefni||||| 082685|R03BA0502|Flixotide Diskus|innúðadu|250|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|0|100|GBP|3367|5410|lyfalmen|||23|60|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||3367||3367|5410 082701|J01CA0410|Amoxicillin Merck NM|mixt.kyr|50|mg/ml|60|ml|1|glas||J01CA04|01.07.1998||R|A|2|0|0|0|0|MNA|0|0|1|100|SEK|706|1798|lyfalmen|||00|60|0|3|Actavis Group PTC ehf|Merck NM AB|Amoxicillín||706||706|1798 082719|R03BA0502|Flixotide Diskus|innúðadu|500|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|0|100|GBP|5501|8306|lyfalmen|||23|60|0|50|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||5501||5501|8306 082792|J01CA0410|Amoxicillin Merck NM|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CA04|01.07.1998||R|A|2|0|0|0|0|MNA|0|0|1|100|SEK|1104|2339|lyfalmen|||00|125|0|6|Actavis Group PTC ehf|Merck NM AB|Amoxicillín||1104||1104|2339 082842|J01CA0410|Amoxicillin Merck NM|mixt.kyr|50|mg/ml|200|ml|1|glas||J01CA04|01.07.1998||R|A|2|0|0|0|0|MNA|0|0|1|100|SEK|1764|3234|lyfalmen|||00|200|0|10|Actavis Group PTC ehf|Merck NM AB|Amoxicillín||1764||1764|3234 082883|R03BA0201|Pulmicort|innúðal|0,125|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|5546|8367|lyfalmen|||00|100|0|6|Vistor hf|AstraZeneca A/S DK|Búdesóníð||5546||5546|8367 082933|R03BA0201|Pulmicort|innúðal|0,25|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|6094|9110|lyfalmen|||00|40|0|12|Vistor hf|AstraZeneca A/S DK|Búdesóníð||6094||6094|9110 082958|N06DA0301|Exelon|hylki|1,5|mg|56|stk|1|þpakki||N06DA03|01.10.2008||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|15360|21308|lyfalmen|||00|56|0|9|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||15360||15360|21308 083113|L02BG0301|Arimidex|töflur|1|mg|28|stk|1|þpakki||L02BG03|01.03.1998||R|A|5|0|0|*|0|ASZ|0|0|0|100|SEK|19316|26233|lyfalmen|||00|28|0|28|Vistor hf|AstraZeneca UK Ltd|Anastrózól||19316||19316|26233 083121|N06DA0301|Exelon|hylki|3|mg|56|stk|1|þpakki||N06DA03|01.10.2008||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|16042|22157|lyfalmen|V1372|22156|00|56|0|19|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||16042||16042|22157 083154|R03BA0201|Pulmicort|innúðal|0,5|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|7749|11356|lyfalmen|||00|40|0|25|Vistor hf|AstraZeneca A/S DK|Búdesóníð||7749||7749|11356 083360|G03GA0501|Gonal-F|sts|75|ae/lykju|10|lykjur|1|pakki|+ leysir 1 ml|G03GA05|01.04.1997||R|A|2|0|1|E|0|SEN|0|0|0|100|SEK|53114|68312|lyfalmen|||03|10|0|10|Gróco ehf|Serono Nordic|Follitrópín alfa||53114||53114|68312 083451|G03GA0501|Gonal-F|sts|150|ae/lykju|10|lykjur|1|pakki|+ leysir 1 ml|G03GA05|01.04.1997||R|A|2|0|1|E|0|SEN|0|0|0|100|SEK|107913|136537|lyfalmen|||03|10|0|20|Gróco ehf|Serono Nordic|Follitrópín alfa||107913||107913|136537 083592|J05AE0301|Norvir|mixtúra|80|mg/ml|90|ml|5|glös||J05AE03|01.08.2003||R|K|0,5|0|1|0|1|ABL|0|0|0|100|DKK|89649|113481|lyfsjukr|||00|450|0|30|Vistor hf|Abbott Laboratories A/S|Ritonavír||89649||89649|113481 083634|N06DA0301|Exelon|hylki|6|mg|112|stk|1|þpakki||N06DA03|01.01.1999||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|34811|45525|lyfalmen|||00|112|0|75|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||34811||34811|45525 083980|L02AE0101|Suprefact|stl|1|mg/ml|5,5|ml|2|hgl||L02AE01|01.10.1987||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|9462|13547|lyfsjukr|||02|11|0|7|Vistor hf|Sanofi-aventis Norge AS|Búserelín||9462||9462|13547 084160|C03CA0101|Furix|stl|10|mg/ml|2|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|314|1266|lyfalmen|||02|10|0|2|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||314||314|1266 084376|C03CA0101|Furix|stl|10|mg/ml|4|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|605|1661|lyfalmen|||02|20|0|5|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||605||605|1661 084669|B03XA0301|Mircera|stl|150|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|74132|94162|lyfsjukr|||00|0|0|38|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||74132||74132|94162 084673|P01BC0103|Kinin Actavis|töflur|100|mg|100|stk|1|glas||P01BC01|01.10.1995||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1161|2416|lyfalmen|||00|100|0|7|Actavis Group hf|Actavis hf|Kínín||1161||1161|2416 084678|B03XA0301|Mircera|stl|200|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|96667|122218|lyfsjukr|||00|0|0|50|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||96667||96667|122218 084687|B03XA0301|Mircera|stl|250|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|115253|145357|lyfsjukr|||00|0|0|62|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||115253||115253|145357 084696|B03XA0301|Mircera|stl|50|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|24863|32822|lyfsjukr|||00|0|0|12|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||24863||24863|32822 084699|P01BC0103|Kinin Actavis|töflur|250|mg|100|stk|1|glas||P01BC01|01.10.1995||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|2458|4176|lyfalmen|||00|100|0|17|Actavis Group hf|Actavis hf|Kínín||2458||2458|4176 084705|B03XA0301|Mircera|stl|75|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|37205|48188|lyfsjukr|||00|0|0|19|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||37205||37205|48188 084714|B03XA0301|Mircera|stl|100|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|49490|63483|lyfsjukr|||00|0|0|25|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||49490||49490|63483 084751|B03XA0301 |Mircera|stl|30|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|14754|20236|lyfsjukr|||00|0|0|8|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||14754|20236 084778|B03XA0301 |Mircera|stl|120|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|56242|71889|lyfsjukr|||00|0|0|30|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||56242|71889 084787|B03XA0301 |Mircera|stl|360|mcg/spr|0,6|ml|1|áf.spr||B03XA03|01.05.2009||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|173221|217528|lyfsjukr|||00|0|0|90|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||173221|217528 084878|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|þpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|1135|2381|lyfalmen|||00|10|0|1|Vistor hf|Eisai Ltd|Rúfínamíð||1135||1135|2381 084887|N03AF0301|Inovelon|filmhtfl|200|mg|60|stk|1|þpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|13126|18527|lyfalmen|||00|60|0|9|Vistor hf|Eisai Ltd|Rúfínamíð||13126||13126|18527 084896|N03AF0301|Inovelon|filmhtfl|400|mg|100|stk|1|þpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|43761|56667|lyfalmen|||00|100|0|29|Vistor hf|Eisai Ltd|Rúfínamíð||43761||43761|56667 085068|N02AA0101|Contalgin|forðatfl|100|mg|100|stk|1|þpakki||N02AA01|01.10.1985||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|18060|24670|lyfalmen|||10|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||18060||18060|24670 085105|A02BC0108|Omeprazol Actavis|sh-hylki|10|mg|98|stk|1|þpakki||A02BC01|01.02.2009||R|A|3|0|0|E|0|AGT|0|0|0|100|IKR|6411|7407|lyfalmen|||0|98|0|49|Actavis Group hf|Actavis Group hf|Ómeprazól||4839||4839|7407 085132|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|56|stk|1|þpakki||A02BC01|01.02.2009||R|A|3|0|0|E|0|AGT|0|0|0|100|IKR|2540|4287|lyfalmen|V2170|4287|0|56|0|56|Actavis Group hf|Actavis Group hf|Ómeprazól||||2540|4287 085141|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|98|stk|1|þpakki||A02BC01|01.02.2009||R|A|3|0|0|E|0|AGT|0|0|0|100|IKR|4530|6988|lyfalmen|V2171|6988|0|98|0|98|Actavis Group hf|Actavis Group hf|Ómeprazól||||4530|6988 085160|A02BC0108|Omeprazol Actavis|sh-hylki|40|mg|28|stk|1|þpakki||A02BC01|01.02.2009||R|A|3|0|0|0|0|AGT|0|0|0|100|IKR|3291|5306|lyfalmen|||0|28|0|56|Actavis Group hf|Actavis Group hf|Ómeprazól||||3291|5306 085205|S01AX1901|Oftaquix|augndr|5|mg/ml|0,5|ml|30|sk-hyl||S01AX19|01.03.2008||R|A|2|0|0|0|0|SAO|0|0|1|100|XEU|3544|5650|lyfalmen|||00|15|0|0|Icepharma hf|Santen Oy|Levófloxacín||3544||3544|5650 085316|N06DA0301|Exelon|hylki|4,5|mg|112|stk|1|þpakki||N06DA03|01.01.1999||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|34811|45525|lyfalmen|||00|112|0|56|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||34811||34811|45525 085407|R03AC0206|Ventoline|lausn|1|mg/ml|2,5|ml|20|lykjur|f. vél|R03AC02|01.04.1992||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|828|1964|lyfalmen|||00|50|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||828||828|1964 085423|B01AB0401|Fragmin|stl|25000|ae/ml|4|ml|1|hgl|með rotvörn|B01AB04|01.04.1993||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|15280|20891|lyfsjukr|||00|4|0|40|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||15280||15280|20891 085542|G03GA0202|Menopur|sts|0| |75|ae|5|hgl|+ leysir|G03GA02|01.03.2001||R|A|2|0|1|E|0|FEL|0|0|0|100|DKK|23690|31679|lyfalmen|||00|375|0|12|Vistor hf|Ferring Lægemidler A/S|Menótrópín||23690||23690|31679 085551|G03GA0202|Menopur|sts|0| |75|ae|10|hgl|+ leysir|G03GA02|01.03.2001||R|A|2|0|1|E|0|FEL|0|0|0|100|DKK|42146|54657|lyfalmen|||00|750|0|25|Vistor hf|Ferring Lægemidler A/S|Menótrópín||42146||42146|54657 085829|S01EB0104|Pilokarpin|augndr|2|%|0,15|ml|20|skammt|án rotvarnar|S01EB01|01.01.1998||R|A||0|1|E|0|LDR|0|0|0|100|IKR|1929|3458|lyfalmen|||00|3|1|8|Parlogis hf|Parlogis - óskráð lyf|Pílókarpín||1929||1929|3458 085969|R06AX2601|Telfast|töflur|120|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|5736|5745|lyfalmen|V1911|5279|00|100|0|100|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||3614||3614|5745 086108|R06AX2601|Telfast|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|6897|8048|lyfalmen|V1913|7551|00|100|0|150|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||5311||5311|8048 086207|J01DD0202|Fortum|sts|1|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|9174|13135|lyfsjukr|||03|5|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||9174||9174|13135 086231|J01DD0202|Fortum|sts|2|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|15150|20729|lyfsjukr|||03|5|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||15150||15150|20729 086434|L04AA2401|Orencia|stl/irþ|250|mg/hgl|1|hgl|1|hgl|+ sprauta|L04AA24|01.02.2008||R|K|2|0|1|0|1|BSP|0|0|0|100|DKK|74087|94106|lyfsjukr|||00|1|0|9|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |||74087||74087|94106 086969|J05AB1401|Valcyte|mixtúrud|50|mg/ml|100|ml|1|glerfl|lausn|J05AB14|01.09.2009||R|A||0|0|0|1|ROA|0|0|0|100|DKK|56064|71667|lyfsjukr|||00|100|0|6|Icepharma hf|Roche A.S.|||||56064|71667 087014|J05AF1101|Sebivo|filmhtfl|600|mg|28|stk|1|þpakki||J05AF11|01.07.2008|31.08.2009|R|A|2|0|1|0|1|NOH|0|0|0|100|DKK|84530|107107|lyfsjukr|||00|28|0|28|Vistor hf|Novartis Healthcare A/S-|||84530||84530|107107 087114|G03CX0101|Livial|töflur|2,5|mg|28|stk|1|þpakki||G03CX01|01.07.1998||R|A|2|0|0|E|0|ORG|0|0|0|100|DKK|3773|5961|lyfalmen|||00|28|0|28|Vistor hf|N.V. Organon|Tíbólón||3773||3773|5961 087215|A03AX1335|Imogaze|hylki|240|mg|30|stk|1|þpakki|mjúk hylki|A03AX13|01.12.2008||L|A|3|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||00|30|0|14|Vistor hf|Janssen-Cilag AB|Silíkonsambönd||||| 087260|J05AX0901|Celsentri|filmhtfl|150|mg|60|stk|1|þpakki||J05AX09|01.04.2008||R|A|3|0|1|0|1|PFL|0|0|0|100|DKK|187561|235381|lyfsjukr|||00|60|0|15|Vistor hf|Pfizer Limited|Maravíroc||187561||187561|235381 087304|N05CF0101|Imovane|töflur|7,5|mg|10|stk|1|þpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|1|100|NOK|308|1258|lyfalmen|||00|10|0|10|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||308||308|1258 087312|N05CF0101|Imovane|töflur|7,5|mg|30|stk|1|þpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|271|1208|lyfalmen|V0886|1195|00|30|0|30|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||271||271|1208 087320|N05CF0101|Imovane|töflur|7,5|mg|100|stk|1|þpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|3208|5194|lyfalmen|||00|100|0|100|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||3208||3208|5194 087445|A02BX1301|Gaviscon|mixtúra|0| |500|ml|1|glas||A02BX13|01.08.1984||L|A|2|0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa|||01|500|0|0|Vistor hf|Nordic Drugs AB|Algínsýra||||| 087759|G03GB0202|Pergotime|töflur|50|mg|5|stk|1|þpakki||G03GB02|01.07.1986||R|A|5|0|0|E|0|EME|0|0|0|100|SEK|883|2039|lyfalmen|||00|5|0|28|MedFarm ehf|E. Merck AB|Klómífen||883||883|2039 087760|N07BA0129|Nicorette Freshmint (Lyfjaver)|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|105|0|7|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 087769|N07BA0129|Nicorette Freshmint (Lyfjaver)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.06.2004||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|210|0|14|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 087778|N07BA0129|Nicorette Freshmint (Lyfjaver)|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|105|0|14|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 087787|N07BA0129|Nicorette Freshmint (Lyfjaver)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|210|0|28|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 087796|N07BA0130|Nicorette Fruitmint (Lyfjaver)|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|105|0|7|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 087805|N07BA0130|Nicorette Fruitmint (Lyfjaver)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|210|0|14|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 087814|N07BA0130|Nicorette Fruitmint (Lyfjaver)|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|105|0|14|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 087823|N07BA0130|Nicorette Fruitmint (Lyfjaver)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|210|0|28|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 087832|L02BB0304|Bicalutamid Actavis|filmhtfl|50|mg|30|stk|1|þpakki||L02BB03|01.09.2007||R|A|3|0|0|*|0|AGP|0|0|0|100|XEU|17241|23650|lyfalmen|V0560|19271|00|30|0|30|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíð||17241||17241|23650 087932|A02BX1301|Gaviscon|tuggutfl|0| |20|stk|1|þpakki||A02BX13|01.10.1993||L|A|1,5|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||00|20|0|0|Vistor hf|Nordic Drugs AB|Algínsýra|||||1633 088006|N07BA0126|Nicotinell Mint (Lyfjaver)|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|96|0|6|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 088015|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|2|mg|96|stk|1|pakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|96|0|6|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 088033|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|14|stk|1|þpakki||A02BC01|01.09.2009||L|A||0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||00|14|0|14|Actavis Group hf|Actavis Group hf|Ómeprazól||||| 088051|L03AB0503|IntronA (Lyfjaver)|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.06.2007||R|K|1,25|0|1|0|1|LVR|0|0|0|100|NOK|29927|39127|lyfsjukr|||00|1|0|9|Lyfjaver ehf|Lyfjaver ehf|Interferón alfa-2b||29927||29927|39127 088224|L03AB0503|IntronA (Lyfjaver)|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.06.2007||R|K|1,25|0|1|0|1|LVR|0|0|0|100|NOK|48745|62555|lyfsjukr|||00|1|0|15|Lyfjaver ehf|Lyfjaver ehf|Interferón alfa-2b||48745||48745|62555 088233|L03AB0503|IntronA (Lyfjaver)|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.06.2007||R|K|1,25|0|1|0|1|LVR|0|0|0|100|NOK|99777|126090|lyfsjukr|||00|1|0|30|Lyfjaver ehf|Lyfjaver ehf|Interferón alfa-2b||99777||99777|126090 088261|R01AD1201|Avamys|nefúði|27,5|mcg/sk|120|sk|1|glas||R01AD12|01.04.2008||R|A|3|0|0|E|0|GGL|0|0|1|100|GBP|1443|2799|lyfalmen|||00|120|0|30|GlaxoSmithKline ehf|Glaxo Group Limited|Flútíkasón fúróat||1443||1443|2799 088310|M01AX0101|Relifex|lausnart|1|g|20|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|1856|3359|lyfalmen|||14|20|0|20|Vistor hf|Meda AB|Nabúmeton||1856||1856|3359 088328|M01AX0101|Relifex|lausnart|1|g|100|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|9199|13324|lyfalmen|||14|100|0|100|Vistor hf|Meda AB|Nabúmeton||9199||9199|13324 088393|A03FA0101|Primperan|eþ-stil|20|mg|6|stk|1|pakki||A03FA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|563|1604|lyfalmen|||04|6|0|4|Vistor hf|Sanofi-aventis Norge AS|Metóklópramíð||563||563|1604 088632|C09CA0302|Diovan (D.A.C.)|töflur|160|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.05.2007|31.08.2009|R|A|3|0|0|0|0|DAC|0|0|0|100|DKK|17060|18882|lyfalmen|||00|98|0|196|D.A.C. ehf|D.A.C. ehf|Valsartan||13411||13411|18882 088723|L01XE0701|Tyverb|filmhtfl|250|mg|70|stk|1|þpakki||L01XE07|01.11.2008||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|178151|223665|lyfsjukr|||00|70|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|||||178151|223665 088814|L02BB0304|Bicalutamid Actavis|filmhtfl|150|mg|30|stk|1|þpakki||L02BB03|01.12.2008||R|A|3|0|0|*|0|AGP|0|0|0|100|XEU|48985|60989|lyfalmen|V0561|52494|00|30|0|30|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíð||47232||47232|60989 089003|G03CA0308|Progynon|töflur|2|mg|84|stk|1|þpakki||G03CA03|01.12.1972||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|1474|2841|lyfalmen|V0408|1921|00|84|0|84|Icepharma hf|Bayer Schering Pharma AG|Estradíól||1474||1474|2841 089094|A02BX1301|Gaviscon|tuggutfl|0| |120|stk|1|þpakki||A02BX13|01.01.1989||L|A|1,5|0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa|||00|120|0|0|Vistor hf|Nordic Drugs AB|Algínsýra||||| 089114|J05AX0901|Celsentri|filmhtfl|300|mg|60|stk|1|þpakki||J05AX09|01.04.2008||R|A|3|0|1|0|1|PFL|0|0|0|100|DKK|187561|235381|lyfsjukr|||00|60|0|30|Vistor hf|Pfizer Limited|Maravíroc||187561||187561|235381 090159|C08DB0101|Cardizem|töflur|60|mg|100|stk|1|glas||C08DB01|01.10.1995||R|A|3|0|0|B|0|FRO|0|0|0|100|DKK|2422|4127|lyfalmen|||00|100|0|25|Vistor hf|Ferrosan A/S|Diltíazem||2422||2422|4127 090232|L01XC0601|Erbitux|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.04.2007||R|K|3|0|1|0|1|MRK|0|0|0|100|XEU|47396|60876|lyfsjukr|||00|20|0|0|Vistor hf|Merck KgaA (V)|Cetúxímab||47396||47396|60876 090242|L01XC0601|Erbitux|irl|5|mg/ml|100|ml|1|hgl|lausn|L01XC06|01.04.2007||R|K|3|0|1|0|1|MRK|0|0|0|100|XEU|236976|296903|lyfsjukr|||00|100|0|0|Vistor hf|Merck KgaA (V)|Cetúxímab||236976||236976|296903 090460|L04AB0102|Enbrel (Lyfjaver)|stl|0| |25|mg|4|áf.spr|lausn|L04AB01|01.06.2007|31.10.2009|R|K|3|0|1|0|1|LVR|0|0|0|100|NOK|94493|119511|lyfsjukr|||00|100|0|14|Lyfjaver ehf|Lyfjaver ehf|Etanercept||94493||94493|119511 090469|L04AB0102|Enbrel (Lyfjaver)|stl|0| |50|mg|4|áf.spr|lausn|L04AB01|01.06.2007|31.10.2009|R|K|3|0|1|0|1|LVR|0|0|0|100|NOK|197035|247176|lyfsjukr|||00|200|0|29|Lyfjaver ehf|Lyfjaver ehf|Etanercept||197035||197035|247176 090662|R01AD1101|Nasacort|nefúði|55|mcg/sk|16,5|ml|1|stauk|120 sk|R01AD11|01.11.1998||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|1878|3389|lyfalmen|||24|16|0|30|Vistor hf|Sanofi-aventis Norge AS|Tríamcínólón||1878||1878|3389 090688|A06AB0602|Senokot|töflur|7,5|mg|60|stk|1|þpakki||A06AB06|01.10.1990||R|A|3|0|0|0|0|REB|0|0|0|100|GBP|922|2092|lyfalmen|||00|60|0|0|Icepharma hf|Reckitt Benckiser Healthcare Ltd.|Senna||922||922|2092 091360|C08DB0108|Korzem-R|forðatfl|120|mg|60|stk|1|þpakki||C08DB01|01.04.2008|31.10.2009|R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|2253|3898|lyfalmen|||10|60|0|30|Actavis Group hf|Actavis hf|Diltíazem||2253||2253|3898 091642|L03AX1302|Copaxone (Lyfjaver)|stl|20|mg/spr|28|spr|1|pakki|lausn|L03AX13|01.06.2007|31.10.2009|R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|155237|195138|lyfsjukr|||00|28|0|28|Lyfjaver ehf|Lyfjaver ehf|Glatíramer acetat||155237||155237|195138 091751|A10BB1201|Amaryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|2088|2519|lyfalmen|V0001|1884|00|90|0|45|Vistor hf|Aventis Pharma |Glímepíríð||1237||1237|2519 091769|A10BB1201|Amaryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|3758|3503|lyfalmen|V0002|2489|00|90|0|90|Vistor hf|Aventis Pharma |Glímepíríð||1962||1962|3503 092005|N06AB1001 |Cipralex|dropar|20|mg/ml|15|ml|1|glerfl||N06AB10|01.04.2009||R|A|2|0|0|0|0|LBK|0|0|0|100|DKK|4493|6938|lyfalmen|||00|15|0|30|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||||4493|6938 092014|L03AB0703|Rebif (Lyfjaver)|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.06.2007|31.10.2009|R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|155258|195164|lyfsjukr|||00|6|0|61|Lyfjaver ehf|Lyfjaver ehf|Interferón beta-1a||155258||155258|195164 092024|L03AB0703|Rebif (Lyfjaver)|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.06.2007|31.10.2009|R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|199928|250778|lyfsjukr|||00|6|0|123|Lyfjaver ehf|Lyfjaver ehf|Interferón beta-1a||199928||199928|250778 092130|QJ01CA0401|Clamoxyl, vet.|töflur|200|mg|100|stk|1|þpakki||QJ01CA04|01.10.1987||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|8485|16334|vetalmen|||16|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||8485||8485|16334 092361|B01AC0401|Plavix|töflur|75|mg|28|stk|1|þpakki||B01AC04|01.12.1999||R|A|3|0|0|E|0|SBM|0|0|0|100|NOK|8362|12188|lyfalmen|||00|28|0|28|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||8362||8362|12188 092750|N05AH0203|Leponex (D.A.C.)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2007||R|A|5|0|0|*|0|DAC|0|1|0|100|DKK|10750|15429|lyfalmen|V1400|15429|00|100|0|33|D.A.C. ehf|D.A.C. ehf|Klózapín||10750||10750|15429 092769|C09DA0305|Diovan Comp 320/12,5 mg|filmhtfl|332,5|mg|98|stk|1|þpakki|320/12,5 mg|C09DA03|01.11.2008||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|30732|40446|lyfalmen|||00|98|0|392|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||||30732|40446 092787|C09DA0306|Diovan Comp 320/25 mg|filmhtfl|345|mg|98|stk|1|þpakki|320/25 mg|C09DA03|01.11.2008||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|30732|40446|lyfalmen|||00|98|0|392|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||||30732|40446 093260|N02CC0101|Imigran|stl|12|mg/ml|0,5|ml|2|spr|+ penni|N02CC01|01.10.1992||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|5715|8596|lyfalmen|||00|1|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||5715||5715|8596 093617|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|100|stk||QG03DA02|01.10.1991||R|A|5|0|0|0|0|PAL|1|0|0|100|DKK|30688|53107|vetorma|||00|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||30688||30688|53107 093708|L01DB0701|Novantrone|irþ|2|mg/ml|5|ml|1|hgl||L01DB07|01.07.1987||R|A|3|0|1|0|1|MEB|0|0|0|100|USD|16593|22526|lyfsjukr|||00|5|0|0|Icepharma hf|Meda AB (V)|Mítoxantrón||16593||16593|22526 093757|N02AA0501|Oxycontin|forðatfl|80|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|20555|27776|lyfalmen|||10|28|0|30|Icepharma hf|Norpharma |Oxýcódon||20555||20555|27776 093799|N02AA0501|Oxycontin|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|52814|67938|lyfalmen|||10|98|0|261|Icepharma hf|Norpharma |Oxýcódon||52814||52814|67938 093823|S01EC0102|Diamox Depot|forðahlk|250|mg|100|stk|1|hylki||S01EC01|01.04.1998||R|A|2|0|0|*|0|GPL|0|0|0|100|USD|2164|3777|lyfalmen|||10|100|0|33|Icepharma hf|Goldshield Pharmaceuticals Ltd|Acetazólamíð||2164||2164|3777 093824|N06AB0403|Cipramil (D.A.C.)|filmhtfl|20|mg|28|stk|1|þpakki||N06AB04|01.03.2009|31.08.2009|R|A|3|0|0|B|0|DAC|0|1|0|100|DKK|3607|3894|lyfalmen|||0|28|0|28|D.A.C. ehf|D.A.C. ehf|Cítalópram||2250||2250|3894 093849|S01EC0102|Diamox Depot|forðahlk|500|mg|100|stk|1|hylki||S01EC01|01.12.1972||R|A|2|0|0|*|0|GPL|0|0|0|100|USD|4327|6712|lyfalmen|||10|100|0|67|Icepharma hf|Goldshield Pharmaceuticals Ltd|Acetazólamíð||4327||4327|6712 093969|G03FB0507|Trisekvens (D.A.C.)|töflur|0| |84|stk|1|skífup||G03FB05|01.05.2007||R|A|4|0|0|E|0|DAC|0|0|0|100|DKK|3041|4967|lyfalmen|V0385|4967|23|84|0|84|D.A.C. ehf|D.A.C. ehf|Noretísterón og östrógen||3041||3041|4967 094132|QM01A0001|Metacam fyrir ketti|mixtúra|0,5|mg/ml|15|ml|1|fl||QM01AC06|01.01.2009||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|2068|4081|vetalmen|||00|8|0|0|Vistor hf|Boehringer Ingelheim|||2068||2068|4081 094287|L04AD0201|Advagraf|forðahlk|0,5|mg|50|stk|1|þpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|15080|20960|lyfalmen|||00|50|0|5|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||15080||15080|20960 094296|L04AD0201|Advagraf|forðahlk|1|mg|50|stk|1|þpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|21601|29078|lyfalmen|||00|50|0|10|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||21601||21601|29078 094305|L04AD0201|Advagraf|forðahlk|5|mg|50|stk|1|þpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|97196|123194|lyfalmen|||00|50|0|50|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||97196||97196|123194 094933|A06AH0101|Relistor|stl|20|mg/ml|0,6|ml|7|hgl|lausn|A06AH01|01.01.2009||R|A|2|0|0|0|0|WTE|0|0|0|100|USD|46148|59639|lyfalmen|||0|84|0|0|Icepharma hf|Wyeth Europe|Metýlnaltrexónbrómíð||46148||46148|59639 095208|G04BX0101|Emgesan|töflur|250|mg|100|stk|1|glas||G04BX01|01.03.2001||R|A||0|0|0|0|PCO|0|0|0|100|IKR|1577|2980|lyfalmen|||00|100|1|50|Distica|Distica - óskráð lyf|||1577||1577|2980 095588|N07BB0101|Antabus|freyðit|400|mg|50|stk|1|glas||N07BB01|01.12.1972||R|A|5|0|0|E|0|AGT|0|0|0|100|DKK|3837|6047|lyfalmen|||00|50|0|100|Actavis Group hf|Actavis Group hf|Dísúlfíram||3837||3837|6047 095652|N05AX1301|Invega|forðatfl|3|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|17946|24528|lyfalmen|||00|28|0|14|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||17946||17946|24528 095662|N05AX1301|Invega|forðatfl|3|mg|56|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|43219|55993|lyfalmen|||00|56|0|28|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||43219||43219|55993 095680|N05AX1301|Invega|forðatfl|6|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|17946|24528|lyfalmen|||00|28|0|28|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||17946||17946|24528 095689|N05AX1301|Invega|forðatfl|6|mg|56|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|39163|50943|lyfalmen|||00|56|0|56|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||39163||39163|50943 095707|N05AX1301|Invega|forðatfl|9|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|17946|24528|lyfalmen|||00|28|0|42|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||17946||17946|24528 095716|N05AX1301|Invega|forðatfl|9|mg|56|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|68955|88034|lyfalmen|||00|56|0|84|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||68955||68955|88034 095924|QM01AE9102|Canidryl|töflur|20|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHD|0|0|0|100|XEU|4220|8210|vetalmen|||00|100|0|0|Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||4220||4220|8210 095933|QM01AE9102|Canidryl|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHD|0|0|0|100|XEU|5568|10777|vetalmen|||00|100|0|0|Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||5568||5568|10777 095942|QM01AE9102|Canidryl|töflur|100|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHD|0|0|0|100|XEU|10139|19484|vetalmen|||00|100|0|0|Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||10139||10139|19484 096115|V03AF0101|Uromitexan|stl|100|mg/ml|4|ml|15|lykjur||V03AF01|01.10.1990||R|A|5|0|0|0|1|BAM|0|0|0|100|SEK|2887|4133|lyfsjukr|||02|60|0|0|Icepharma hf|Baxter Medical AB|Mesna||2887||2887|4133 096169|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|1|hgl|0|J06BA01|01.10.2008||R|K|3|0|0|0|1|OCT|0|0|0|100|DKK|15858|21611|lyfsjukr|||17|10|0|0|Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í æð||15858||15858|21611 096178|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|10|hgl|0|J06BA01|01.10.2008||R|K|3|0|0|0|1|OCT|0|0|0|100|DKK|142722|179556|lyfsjukr|||17|100|0|0|Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í æð||142722||142722|179556 096251|D06AX1301|Altargo|smyrsli|1|%|5|g|1|túpa||D06AX13|01.11.2007||R|A|2|0|0|0|0|GGL|0|0|1|100|GBP|1530|2917|lyfalmen|||00|5|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|Retapamúlín||1530||1530|2917 096260|N06DA0301|Exelon|forðapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|18648|25402|lyfalmen|||00|30|0|15|Vistor hf|Novartis Europharm Ltd|Rívastigmín||18648||18648|25402 096351|S01AA1302|Fucithalmic (D.A.C.)|augndr|10|mg/g|5|g|1|túpa||S01AA13|01.06.2007||R|A|3|0|0|E|0|DAC|0|0|1|100|DKK|828|1945|lyfalmen|V1500|1945|07|5|0|0|D.A.C. ehf|D.A.C. ehf|Fúsidínsýra||814||814|1945 096488|L04AX0401|Revlimid|hylki|5|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|A|3|0|1|0|1|CEE|0|0|0|100|XEU|1123762|1400951|lyfsjukr|||0|21|0|0|Celgene Europe ltd|Celgene Europe ltd|||||1123762|1400951 096497|L04AX0401|Revlimid|hylki|10|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|A|3|0|1|0|1|CEE|0|0|0|100|XEU|1031794|1286451|lyfsjukr|||0|21|0|0|Celgene Europe ltd|Celgene Europe ltd|||||1031794|1286451 096506|L04AX0401|Revlimid|hylki|15|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|A|3|0|1|0|1|CEE|0|0|0|100|XEU|1085763|1353642|lyfsjukr|||0|21|0|0|Celgene Europe ltd|Celgene Europe ltd|||||1085763|1353642 096515|L04AX0401|Revlimid|hylki|25|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|A|3|0|1|0|1|CEE|0|0|0|100|XEU|1192255|1486225|lyfsjukr|||0|21|0|0|Celgene Europe ltd|Celgene Europe ltd|||||1192255|1486225 096679|N06DA0301|Exelon|forðapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|18648|25402|lyfalmen|||00|30|0|30|Vistor hf|Novartis Europharm Ltd|Rívastigmín||18648||18648|25402 096685|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|30|stk|1|þpakki||C03BA11|01.03.1999||R|A|2|0|0|E|0|SEV|0|0|0|100|DKK|1783|3260|lyfalmen|||00|30|0|18|Icepharma hf|Servier|Indapamíð||1783||1783|3260 096688|N06DA0301|Exelon|forðapl|9,5|mg/sólh|60|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|37298|48621|lyfalmen|||00|60|0|60|Vistor hf|Novartis Europharm Ltd|Rívastigmín||37298||37298|48621 096896|J02AX0601|Ecalta|irs|100|mg/hgl|1|hgl|1|pakki|+ leysir, lausn|J02AX06|01.03.2008||R|A|3|0|1|0|1|PFL|0|0|0|100|DKK|102846|129911|lyfsjukr|||00|1|0|1|Vistor hf|Pfizer Limited|Anidulafungin||102846||102846|129911 097269|J01FF0103|Dalacin (D.A.C.)|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.06.2007||R|A|5|0|0|0|0|DAC|0|0|1|100|DKK|2529|4203|lyfalmen|V0426|4203|00|20|0|5|D.A.C. ehf|D.A.C. ehf|Klindamýcín||2478||2478|4203 097288|R06AX2701|Aerius|mixtúra|0,5|mg/ml|120|ml|1|fl||R06AX27|01.10.2008||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|1288|2588|lyfalmen|||00|120|0|12|Vistor hf|Schering-Plough|Deslóratadín||1288||1288|2588 097297|L02BG0402|Femar (D.A.C.)|töflur|2,5|mg|100|stk|1|þpakki||L02BG04|01.06.2007||R|A|5|0|0|*|0|DAC|0|0|0|100|DKK|64084|81970|lyfalmen|V0563|81970|00|100|0|100|D.A.C. ehf|D.A.C. ehf|Letrózól||64084||64084|81970 097442|L01CB0101|Vepesid|hylki|50|mg|20|stk|1|glas||L01CB01|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|21486|28618|lyfsjukr|||00|20|1|0|Distica|Distica - óskráð lyf|||21486||21486|28618 097642|J07AJ5201|Infanrix|bóluefni|0| |0,5|ml|1|spr|einnota glerspr.|J07AJ52|01.04.1998||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|1902|3421|lyfalmen|||02|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Kíghósti, í blöndum með öðrum toxóíðum||1902||1902|3421 097790|N03AX1201|Neurontin|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.04.1995|31.08.2009|R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|7967|8049|lyfalmen|||10|100|0|17|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gabapentín||5312||5312|8049 097816|N03AX1201|Neurontin|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.04.1995|31.08.2009|R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|12953|10701|lyfalmen|||10|100|0|22|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gabapentín||7266||7266|10701 097881|A10BB1201|Amaryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|4878|4359|lyfalmen|V0003|3042|00|90|0|135|Vistor hf|Aventis Pharma |Glímepíríð||2593||2593|4359 097887|N02CC0104|Sumacta|húðuðtfl|50|mg|12|stk|1|þpakki||N02CC01|01.11.2007||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|2738|4556|lyfalmen|V0831|4556|00|12|0|12|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||2738||2738|4556 097896|N02CC0104|Sumacta|húðuðtfl|100|mg|6|stk|1|þpakki||N02CC01|01.11.2007||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|1917|3442|lyfalmen|V0832|3442|00|6|0|12|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||1917||1917|3442 097905|N06AX1104|Miron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|A|2|0|0|B|0|AGP|0|1|0|100|XEU|1271|2565|lyfalmen|V1151|2565|00|30|0|15|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1271||1271|2565 098059|C09CA0303|Valpress|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|7494|3811|lyfalmen|||00|98|0|98|Actavis Group hf|Actavis hf|Valsartan||2189||2189|3811 098068|C09CA0303|Valpress|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|A|2|0|0|0|0|ACA|0|0|0|100|XEU|11017|6874|lyfalmen|V1111|6874|00|98|0|196|Actavis Group hf|Actavis hf|Valsartan||4446||4446|6874 098228|J07AJ5201|Infanrix|bóluefni|0| |0,5|ml|10|spr|einnota glerspr.|J07AJ52|01.04.1998||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|18499|25216|lyfalmen|||02|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Kíghósti, í blöndum með öðrum toxóíðum||18499||18499|25216 098459|N06AB0309 |Fontex (D.A.C.)|dreifit.|20|mg|30|stk|1|þpakki||N06AB03|01.05.2009||R|A|2|0|0|B|0|DAC|0|1|0|100|XEU|3673|5753|lyfalmen|||00|30|0|30|D.A.C. ehf|D.A.C. ehf|Flúoxetín||3620||3620|5753 098468|N06AB0309 |Fontex (D.A.C.)|dreifit.|20|mg|100|stk|1|þpakki||N06AB03|01.05.2009||R|A|2|0|0|B|0|DAC|0|1|0|100|XEU|12224|16980|lyfalmen|||00|100|0|100|D.A.C. ehf|D.A.C. ehf|Flúoxetín||11893||11893|16980 098486|G03GA3001|Pergoveris|sts|225|ae|1|hgl|1|pakki|+ leysir|G03GA30|01.03.2009||R|A|3|0|1|E|0|SEE|0|0|0|100|SEK|13942|19543|lyfalmen|||0|1|0|0|Gróco ehf|Serono Europe|||||13942|19543 098504|G03GA3001|Pergoveris|sts|225|ae|10|hgl|1|pakki|+ leysir|G03GA30|01.03.2009||R|A|3|0|1|E|0|SEE|0|0|0|100|SEK|129328|163198|lyfalmen|||0|1|0|0|Gróco ehf|Serono Europe|||||129328|163198 098582|S01ED0201|Betoptic|augndr|5|mg/ml|5|ml|1|glas||S01ED02|01.04.2006||R|A|3|0|0|*|0|PCO|0|0|0|100|IKR|1186|2450|lyfalmen|||06|5|1|25|Distica|Distica - óskráð lyf|||1186||1186|2450 098722|J07BM0101|Gardasil|stl|0| |0,5|ml|1|áf.spr|dreifa|J07BM01|01.08.2008||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|23443|31372|lyfalmen|||02|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerð 6, 11, 16, 18)||23443||23443|31372 099242|S01AA1301|Fucithalmic|augndr|10|mg/g|5|g|1|túpa||S01AA13|01.04.1988||R|A|3|0|0|E|0|LEP|0|0|1|100|DKK|829|1965|lyfalmen|V1500|1945|07|5|0|0|Vistor hf|LEO Pharma A/S|Fúsidínsýra||829||829|1965 099476|N05AH0406|Quetiapin Mylan|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MEK|0|1|0|100|SEK|6202|9257|lyfalmen|V0725|9257|00|100|0|6|Actavis Group PTC ehf|Merck NM AB (A)|Quetíapín||6202||6202|9257 099485|N05AH0404|Quetiapin Merck NM|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MEK|0|1|0|100|SEK|14163|19818|lyfalmen|V0726|19818|00|100|0|25|Actavis Group PTC ehf|Merck NM AB (A)|Quetíapín||14163||14163|19818 099494|N05AH0404|Quetiapin Merck NM|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MEK|0|1|0|100|SEK|22919|30719|lyfalmen|V0727|30719|00|100|0|50|Actavis Group PTC ehf|Merck NM AB (A)|Quetíapín||22919||22919|30719 099620|N02AX0210|Nobligan (D.A.C.)|hylki|50|mg|20|stk|1|pakki||N02AX02|01.09.2007||R|A|5|0|0|E|0|DAC|0|0|1|100|DKK|662|1739|lyfalmen|V0730|1238|10|20|0|3|D.A.C. ehf|D.A.C. ehf|Tramadól||662||662|1739 099705|D08AG0201|Betadine|áburður|100|mg/ml|500|ml|1|brusar|vatnsl|D08AG02|01.04.1985||L|A|3|0|0|0|0|MUN|0|0|0|100|IKR|||lyflausa|||00|500|0|500|Icepharma hf|Mundipharma|Joð/pólývídón||||| 099721|D08AG0201|Betadine|lyf.sápa|75|mg/ml|500|ml|1|brusar||D08AG02|01.04.1985||L|A|3|0|0|0|0|MUN|0|0|0|100|IKR|||lyflausa|||00|500|0|500|Icepharma hf|Mundipharma|Joð/pólývídón||||| 099746|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.09.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|96|0|13|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 099755|N07BA0124|Nicotinell Mint (Lyfjaver)|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.09.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|96|0|13|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 100008|V08AB0501|Ultravist|stl/irl|300|mg J/ml|50|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|51949|66544|lyfsjukr|||02|500|0|0|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||51949||51949|66544 100016|V08AB0501|Ultravist|stl/irl|300|mg J/ml|100|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|76899|97607|lyfsjukr|||02|1000|0|0|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||76899||76899|97607 100024|V08AB0501|Ultravist|stl/irl|370|mg J/ml|50|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|56250|71899|lyfsjukr|||02|500|0|0|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||56250||56250|71899 100032|V08AB0501|Ultravist|stl/irl|370|mg J/ml|100|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|124894|157361|lyfsjukr|||02|1000|0|0|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||124894||124894|157361 100291|G04BE0801|Cialis|filmhtfl|2,5|mg|28|stk|1|þpakki||G04BE08|01.11.2008||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|15203|21113|lyfalmen|||00|28|0|7|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||15203|21113 100300|G04BE0801|Cialis|filmhtfl|5|mg|28|stk|1|þpakki||G04BE08|01.11.2008||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|15203|21113|lyfalmen|||00|28|0|14|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||15203|21113 100305|G03GA0701|Luveris|sts|75|ae/hgl|1|hgl|1|pakki|+ leysir í hgl|G03GA07|01.08.2001||R|A|3|0|1|E|0|ARS|0|0|0|100|SEK|15021|20886|lyfalmen|||00|1|0|1|Gróco ehf|Ares-Serono|Lutropin alfa||15021||15021|20886 101106|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|19881|26937|lyfalmen|V2160|26441|0|100|0|33|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gabapentín||19881||19881|26937 101115|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|33513|43909|lyfalmen|||0|100|0|44|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gabapentín||33513||33513|43909 101386|R06AX1301|Clarityn|saft|1|mg/ml|100|ml|1|glas||R06AX13|01.10.1995||L|A|2|0|0|0|0|SCP|0|0|1|100|IKR|||lyflausa|||00|100|0|10|Vistor hf|Schering-Plough|Lóratadín||||| 101543|G03GA0701|Luveris|sts|75|ae/hgl|3|hgl|1|pakki|+ leysir í hgl|G03GA07|01.08.2001||R|A|3|0|1|E|0|ARS|0|0|0|100|SEK|45060|58285|lyfalmen|||00|3|0|3|Gróco ehf|Ares-Serono|Lutropin alfa||45060||45060|58285 101550|G03GA0701|Luveris|sts|75|ae/hgl|10|hgl|1|pakki|+ leysir í hgl|G03GA07|01.08.2001||R|A|3|0|1|E|0|ARS|0|0|0|100|SEK|150203|189188|lyfalmen|||00|10|0|10|Gróco ehf|Ares-Serono|Lutropin alfa||150203||150203|189188 101691|C08CA0502|Adalat Oros|forðatfl|20|mg|28|stk|1|þpakki||C08CA05|01.10.1999||R|A|4|0|0|B|0|BAV|0|0|0|100|SEK|2242|3883|lyfalmen|||00|28|0|19|Vistor hf|Bayer Schering Pharma AG (V)|Nífedipín||2242||2242|3883 101709|C08CA0502|Adalat Oros|forðatfl|20|mg|98|stk|1|þpakki||C08CA05|01.10.1999||R|A|4|0|0|B|0|BAV|0|0|0|100|SEK|7035|10387|lyfalmen|||00|98|0|65|Vistor hf|Bayer Schering Pharma AG (V)|Nífedipín||7035||7035|10387 101742|N06AX1104|Miron Smelt|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|A|2|0|0|B|0|AGP|0|1|0|100|XEU|2791|4628|lyfalmen|V1152|4628|00|30|0|30|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||2791||2791|4628 101751|N06AX1104|Miron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.11.2007||R|A|2|0|0|B|0|AGP|0|1|0|100|XEU|4891|7478|lyfalmen|V1153|7478|00|96|0|96|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||4891||4891|7478 101769|N02AX0211|Nobligan Retard (D.A.C.)|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.09.2007||R|A|5|0|0|E|0|DAC|0|0|1|100|DKK|10199|14681|lyfalmen|V0736|9650|00|100|0|50|D.A.C. ehf|D.A.C. ehf|Tramadól||10199||10199|14681 101823|QM01AC0602|Metacam fyrir hesta|mixtúra|15|mg/ml|250|ml|1|fl||QM01AC06|01.02.2009||R|A|2|0|0|0|0|BOI|0|0|0|100|DKK|12755|24468|vetalmen|||0|250|0|0|Vistor hf|Boehringer Ingelheim|||||12755|24468 102863|C01DA1401|Imdur|forðatfl|60|mg|28|stk|1|þpakki||C01DA14|01.07.1989||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|1633|3056|lyfalmen|||43|28|0|42|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||1633||1633|3056 102871|C01DA1401|Imdur|forðatfl|60|mg|98|stk|1|þpakki||C01DA14|01.07.1989||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3739|5914|lyfalmen|V0139|2746|43|98|0|147|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||3739||3739|5914 102905|N01AX1001|Diprivan|stl|10|mg/ml|50|ml|1|dæla|einnota dæla|N01AX10|01.01.1994||R|A|2|0|0|0|1|ASZ|0|0|0|100|SEK|2609|3735|lyfsjukr|||02|50|0|0|Vistor hf|AstraZeneca UK Ltd|Própófól||2609||2609|3735 102939|N01AX1001|Diprivan|stl|20|mg/ml|50|ml|1|dæla|einnota dæla|N01AX10|01.01.1988||R|A|2|0|0|0|1|ASZ|0|0|0|100|SEK|5414|7751|lyfsjukr|||00|50|0|0|Vistor hf|AstraZeneca UK Ltd|Própófól||5414||5414|7751 103633|C09DA0105|Presmin Combo|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.02.2008||R|A|2,25|0|0|B|0|POF|0|0|0|100|IKR|8135|5169|lyfalmen|||00|98|0|98|Portfarma ehf|Portfarma|Lósartan og þvagræsilyf||3190||3190|5169 103642|C09DA0105|Presmin Combo|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.02.2008||R|A|2,25|0|0|B|0|POF|0|0|0|100|IKR|13469|5169|lyfalmen|||00|98|0|196|Portfarma ehf|Portfarma|Lósartan og þvagræsilyf||3190||3190|5169 103651|C09CA0104|Presmin|filmhtfl|50|mg|98|stk|1|þpakki||C09CA01|01.02.2008||R|A|3|0|0|B|0|POF|0|0|0|100|IKR|4295|3812|lyfalmen|V0197|3812|00|98|0|98|Portfarma ehf|Portfarma|Lósartan||2190||2190|3812 103660|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.02.2008||R|A|3|0|0|E|0|POF|0|0|1|100|GBP|2672|3941|lyfalmen|V0507|3941|00|10|0|2|Portfarma ehf|Portfarma|Valacíklóvír||2285||2285|3941 103669|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|40|stk|1|þpakki||J05AB11|01.02.2008||R|A|3|0|0|E|0|POF|0|0|1|100|GBP|11106|13717|lyfalmen|V0508|13677|00|40|0|7|Portfarma ehf|Portfarma|Valacíklóvír||9489||9489|13717 103678|N06AX1604|Venlafaxin Portfarma|forðahlk|75|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|A|3|0|0|B|0|POF|0|1|0|100|XEU|15693|13483|lyfalmen|V0955|13112|00|100|0|75|Portfarma ehf|Portfarma|Venlafaxín||9316||9316|13483 103687|N06AX1604|Venlafaxin Portfarma|forðahlk|150|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|A|3|0|0|B|0|POF|0|1|0|100|XEU|29868|21431|lyfalmen|V0956|20887|00|100|0|150|Portfarma ehf|Portfarma|Venlafaxín||15459||15459|21431 103937|A06AG0201|Toilax|innhl|2|mg/ml|5|ml|5|túpa||A06AG02|01.12.1975||L|A|2|0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen|||56|25|0|5|Vistor hf|Orion Pharma|Bisakódýl|||||1908 103952|A06AG0201|Toilax|innhl/tf|0| |1|stk|1|pakki|túpa+4 tfl|A06AG02|01.12.1972||L|A|2|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||00|1|0|1|Vistor hf|Orion Pharma|Bisakódýl||||| 104179|N06AB0603|Zoloft (D.A.C.)|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.05.2009||R|A|5|0|0|B|0|DAC|0|1|0|100|DKK|8918|10511|lyfalmen|V0933|4933|00|98|0|98|D.A.C. ehf|D.A.C. ehf|Sertralín||7126||7126|10511 104471|H01BA0201|Minirin|nefdr|0,1|mg/ml|2,5|ml|1|glas|+2 slöngur|H01BA02|01.01.1988||R|K|3|0|0|E|0|FEL|0|0|0|100|DKK|4302|6678|lyfalmen|||23|2|0|10|Vistor hf|Ferring Lægemidler A/S|Desmópressín||4302||4302|6678 104498|N05CH0101|Circadin|forðatfl|2|mg|21|stk|1|þpakki||N05CH01|01.11.2007||R|A|5|0|0|0|0|NEU|0|0|1|100|DKK|2191|3814|lyfalmen|||00|21|0|21|Gróco ehf|Neurim Pharmaceuticals EEC Ltd|Melatonin||2191||2191|3814 104760|A07EC0202|Pentasa|eþ-stil|1|g|28|stk|1|pakki||A07EC02|01.07.1991||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|9590|13854|lyfalmen|||04|28|0|19|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||9590||9590|13854 104836|A07EC0202|Pentasa|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.01.1990||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|6298|9387|lyfalmen|||56|700|0|5|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||6298||6298|9387 104851|A07EC0202|Pentasa|forðatfl|500|mg|100|stk|1|þpakki||A07EC02|01.04.1992||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|6095|9112|lyfalmen|||10|100|0|33|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||6095||6095|9112 105278|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.09.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|4407|6821|lyfalmen|V0084|6821|00|28|0|19|D.A.C. ehf|D.A.C. ehf|Esómeprazól||4407||4407|6821 105287|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|56|stk|1|veski||A02BC05|01.09.2009||R|A||0|0|0|0|DAC|0|0|0|100|SEK|8615|12299|lyfalmen|V0086|12299|00|56|0|37|D.A.C. ehf|D.A.C. ehf|Esómeprazól||8444||8444|12299 105297|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.09.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|15164|21064|lyfalmen|V0087|21064|00|100|0|67|D.A.C. ehf|D.A.C. ehf|Esómeprazól||15164||15164|21064 105306|A02BC0505|Nexium (D.A.C.)|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.09.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|21155|28523|lyfalmen|V0089|28523|00|100|0|133|D.A.C. ehf|D.A.C. ehf|Esómeprazól||21155||21155|28523 105315|G03AA0705 |Microgynon (D.A.C.)|töflur|0||63|stk|1|þpakki||G03AA07|01.05.2009||R|A|5|0|0|0|0|DAC|0|0|0|100|SEK|1204|2474|lyfalmen|V2200|2474|23|63|0|84|D.A.C. ehf|D.A.C. ehf|Levónorgestrel og östrógen||||1204|2474 105379|N03AG0601|Gabitril|töflur|10|mg|100|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|23428|31353|lyfalmen|||00|100|0|33|Icepharma hf|Cephalon France|Tíagabín||23428||23428|31353 105387|N03AG0601|Gabitril|töflur|15|mg|50|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|19328|26248|lyfalmen|||00|50|0|25|Icepharma hf|Cephalon France|Tíagabín||19328||19328|26248 105395|N03AG0601|Gabitril|töflur|15|mg|100|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|35144|45939|lyfalmen|||00|100|0|50|Icepharma hf|Cephalon France|Tíagabín||35144||35144|45939 105403|N03AG0601|Gabitril|töflur|5|mg|50|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|9664|13955|lyfalmen|||00|50|0|8|Icepharma hf|Cephalon France|Tíagabín||9664||9664|13955 105437|N03AG0601|Gabitril|töflur|5|mg|100|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|17571|24061|lyfalmen|||00|100|0|17|Icepharma hf|Cephalon France|Tíagabín||17571||17571|24061 105445|N03AG0601|Gabitril|töflur|10|mg|50|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|12885|18227|lyfalmen|||00|50|0|17|Icepharma hf|Cephalon France|Tíagabín||12885||12885|18227 105586|C09XA0201|Rasilez|filmhtfl|150|mg|28|stk|1|þpakki||C09XA02|01.01.2008||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|4574|7048|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|Aliskiren||4574||4574|7048 105597|C09XA0201|Rasilez|filmhtfl|150|mg|98|stk|1|þpakki|2 x 49 töflur|C09XA02|01.01.2008||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|15899|21979|lyfalmen|||00|98|0|98|Vistor hf|Novartis Europharm Ltd|Aliskiren||15899||15899|21979 105608|C09XA0201|Rasilez|filmhtfl|300|mg|28|stk|1|þpakki||C09XA02|01.01.2008||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|5272|7995|lyfalmen|||00|28|0|56|Vistor hf|Novartis Europharm Ltd|Aliskiren||5272||5272|7995 105620|C09XA0201|Rasilez|filmhtfl|300|mg|98|stk|1|þpakki|2 x 49 töflur|C09XA02|01.01.2008||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|18338|25016|lyfalmen|||00|98|0|196|Vistor hf|Novartis Europharm Ltd|Aliskiren||18338||18338|25016 105785|N01BB0301|Carbocain|stl|10|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2639|4422|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|Mepívakaín||2639||2639|4422 105796|N01BB0301|Carbocain|stl|20|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2874|4741|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|Mepívakaín||2874||2874|4741 106021|J01FA0901|Klacid|töflur|250|mg|14|stk|1|þpakki||J01FA09|01.04.1992||R|A|5|0|0|0|0|ABS|0|0|1|100|DKK|3863|6083|lyfalmen|||63|14|0|7|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||3863||3863|6083 106486|C09AA0207|Enalapril Portfarma|töflur|5|mg|100|stk|1|þpakki||C09AA02|01.01.2009||R|A|2|0|0|B|0|POF|0|0|0|100|IKR|802|1556|lyfalmen|V0167|1556|0|100|0|50|Portfarma ehf|Portfarma|Enalapríl||527||527|1556 106497|C09AA0207|Enalapril Portfarma|töflur|10|mg|100|stk|1|þpakki||C09AA02|01.01.2009||R|A|2|0|0|B|0|POF|0|0|0|100|IKR|1153|2032|lyfalmen|V0168|2032|0|100|0|100|Portfarma ehf|Portfarma|Enalapríl||878||878|2032 106508|C09AA0207|Enalapril Portfarma|töflur|20|mg|100|stk|1|þpakki||C09AA02|01.01.2009||R|A|2|0|0|B|0|POF|0|0|0|100|IKR|2725|2325|lyfalmen|V0169|2325|0|100|0|200|Portfarma ehf|Portfarma|Enalapríl||1094||1094|2325 106567|J05AB0102|Zovir|irs|500|mg/hgl|5|hgl|1|pakki||J05AB01|01.01.1995||R|A|5|0|0|0|1|GSK|0|0|0|100|GBP|19635|26313|lyfsjukr|||00|5|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||19635||19635|26313 106898|J05AB0102|Zovir|irs|250|mg/hgl|5|hgl|1|pakki||J05AB01|01.07.1989||R|A|5|0|0|0|1|GSK|0|0|0|100|GBP|10859|15387|lyfsjukr|||00|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||10859||10859|15387 106963|M05BA0201|Bonefos|töflur|800|mg|30|stk|1|þpakki||M05BA02|01.03.2004||R|A|3|0|0|0|0|LEI|0|0|0|100|SEK|20069|27171|lyfalmen|V0342|27171|10|30|0|15|Icepharma hf|Leiras Oy|Klódrónsýra||20069||20069|27171 107050|A10BD0401|Avaglim|filmhtfl|0| |84|stk|1|þpakki|4+4 mg|A10BD04|01.03.2008||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|15747|21790|lyfalmen|||00|84|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Glímepíríð og rosiglítazón||15747||15747|21790 107061|A10BD0401|Avaglim|filmhtfl|0| |84|stk|1|þpakki|8+4 mg|A10BD04|01.03.2008||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|23707|31700|lyfalmen|||00|84|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Glímepíríð og rosiglítazón||23707||23707|31700 107219|A07EC0102|Salazopyrin EN|sh-tfl|500|mg|100|stk|1|glas||A07EC01|01.04.1987||R|A|5|0|0|B|0|PFI|0|0|0|100|DKK|2072|3652|lyfalmen|||10|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Súlfasalazín||2072||2072|3652 107268|M05BA0201|Bonefos|töflur|800|mg|30|stk|1|glas||M05BA02|01.01.1997||R|A|3|0|0|0|0|LEI|0|0|0|100|SEK|20069|27171|lyfalmen|V0342|27171|10|30|0|15|Icepharma hf|Leiras Oy|Klódrónsýra||20069||20069|27171 107532|N02BE0106|Parasupp|eþ-stil|60|mg|10|stk|1|pakki||N02BE01|01.06.1984||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||04|10|0|0|Actavis Group hf|Actavis hf|Paracetamól||||| 107583|N03AF0202 |Trileptal (D.A.C.)|filmhtfl|300|mg|100|stk|1|þpakki||N03AF02|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|5642|8497|lyfalmen|V2150|8497|00|100|0|30|D.A.C. ehf|D.A.C. ehf|Oxkarbazepín||5642||5642|8497 107594|QP54AA0104|Bimectin Horse Oral Paste|pasta|18,7|mg/g|6,42|g|1|áf.spr||QP54AA01|01.04.2008||L|A|2|0|0|0|0|ICV|0|0|0|100|XEU|||vetorma|||16|6|0|0|Icepharma hf|Icevet ehf||||||3087 107607|A02BA0201|Asyran|töflur|150|mg|60|stk|1|þpakki||A02BA02|01.07.1986||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|982|2173|lyfalmen|||00|60|0|30|Actavis Group hf|Actavis hf|Ranitidín||982||982|2173 108308|C08CA0501|Adalat|töflur|10|mg|100|stk|1|þpakki||C08CA05|01.01.1991||R|A|4|0|0|B|0|BAV|0|0|0|100|SEK|3443|5513|lyfalmen|||63|100|0|33|Vistor hf|Bayer Schering Pharma AG (V)|Nífedipín||3443||3443|5513 108540|A10BH0201|Galvus|töflur|50|mg|30|stk|1|þpakki||A10BH02|01.09.2008||R|A|2|0|0|*|0|NOE|0|0|0|100|DKK|5063|7711|lyfalmen|||00|30|0|15|Vistor hf|Novartis Europharm Ltd|Vildagliptín||5063||5063|7711 108562|A10BH0201|Galvus|töflur|50|mg|90|stk|1|þpakki||A10BH02|01.09.2008||R|A|2|0|0|*|0|NOE|0|0|0|100|DKK|13812|19381|lyfalmen|||00|90|0|45|Vistor hf|Novartis Europharm Ltd|Vildagliptín||13812||13812|19381 108845|R01AD0501|Rhinocort Aqua|nefúði|32|mcg/sk|120|sk|1|fl||R01AD05|01.10.1988||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|1175|2435|lyfalmen|||24|120|0|19|Vistor hf|AstraZeneca A/S DK|Búdesóníð||1175||1175|2435 108852|R01AD0501|Rhinocort Aqua|nefúði|64|mcg/sk|120|sk|1|fl||R01AD05|01.10.1988||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|1788|3267|lyfalmen|||24|120|0|38|Vistor hf|AstraZeneca A/S DK|Búdesóníð||1788||1788|3267 108860|N02AX0203|Tramol|hylki|50|mg|20|stk|1|glas||N02AX02|01.03.1998||R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|293|1238|lyfalmen|V0730|1238|00|20|0|3|Actavis Group hf|Actavis hf|Tramadól||293||293|1238 108878|N02AX0203|Tramol|hylki|50|mg|100|stk|1|glas||N02AX02|01.03.1998||R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|504|1524|lyfalmen|V0731|1524|00|100|0|17|Actavis Group hf|Actavis hf|Tramadól||504||504|1524 109207|N02AA5901|Panocod|töflur|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.01.1992||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|259|1192|lyfalmen|V0775|1181|00|20|0|7|Vistor hf|Sanofi-aventis Norge AS|Kódein í blöndum nema með geðlyfjum||259||259|1192 109223|N02AA5901|Panocod|töflur|530|mg|100|stk|1|pakki|þp 30+500 mg|N02AA59|01.01.1992||R|A|5|1|0|0|0|SNO|0|0|1|100|NOK|992|2187|lyfalmen|V0780|2163|00|100|0|33|Vistor hf|Sanofi-aventis Norge AS|Kódein í blöndum nema með geðlyfjum||992||992|2187 109421|V01AA0303|Alutard SQ, derm.farinae|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|28097|37166|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|rykmaurar||28097||28097|37166 109439|V01AA0303|Alutard SQ, derm.farinae|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|22495|30191|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|rykmaurar||22495||22495|30191 109462|V04CL0020|Soluprick SQ, derm.farinae|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8733|12691|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|rykmaurar||8733||8733|12691 109678|N02BE0107|Paratabs|töflur|500|mg|20|stk|1|þpakki||N02BE01|01.12.1983||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|20|0|3|Actavis Group hf|Actavis hf|Paracetamól||||| 109728|N02BE0107|Paratabs|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.07.1992||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|5|Actavis Group hf|Actavis hf|Paracetamól||||| 109751|N02BE0107|Paratabs|töflur|500|mg|100|stk|1|þpakki||N02BE01|01.11.1981||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|379|1355|lyfalmen|V0772|1355|00|100|0|17|Actavis Group hf|Actavis hf|Paracetamól||379||379|1355 110072|S01ED0105|Optimol|augndr|2,5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|740|1845|lyfalmen|||06|5|0|25|Icepharma hf|Santen Oy|Tímólól||740||740|1845 110080|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|825|1960|lyfalmen|||06|5|0|25|Icepharma hf|Santen Oy|Tímólól||825||825|1960 110242|V03AN0101|Conoxia|innö.gas|100|%|3|l|1|hylki|MO3c|V03AN01|01.04.2008||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|3|0|0|Ísaga ehf|AGA AB|Súrefni||||| 110395|G03AA0902|Mercilon|töflur|0| |63|stk|1|þpakki||G03AA09|01.07.1990||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|1782|3259|lyfalmen|||23|63|0|84|Vistor hf|N.V. Organon|Desógestrel og östrógen||1782||1782|3259 110635|C08DA0104|Veraloc Retard|forðatfl|200|mg|100|stk|1|glas||C08DA01|01.10.1988||R|A|4|0|0|B|0|ORC|0|0|0|100|DKK|5221|7926|lyfalmen|||10|100|0|83|Vistor hf|Orion Corporation|Verapamíl||5221||5221|7926 111505|G04BE0802|Cialis (D.A.C.)|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.10.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|XEU|13396|18863|lyfalmen|V1351|18863|00|8|0|16|D.A.C. ehf|D.A.C. ehf|Tadalafíl||||13396|18863 111955|N02BE0101|Panodil|töflur|1|g|100|stk|1|glas||N02BE01|01.05.2003||R|A|5|0|0|0|0|GCH|0|0|1|100|DKK|868|2018|lyfalmen|||00|100|0|33|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||868||868|2018 112359|S01AA1101|Garamycin|augndr|3|mg/ml|5|ml|1|glas||S01AA11|01.03.1977||R|A|4|0|0|E|0|SCP|0|0|1|100|DKK|933|2107|lyfalmen|||06|5|0|0|Vistor hf|Schering-Plough|Gentamícín||933||933|2107 112441|A10BB0701|Mindiab|töflur|2,5|mg|100|stk|1|þpakki||A10BB07|01.07.1990||R|A|5|0|0|*|0|PFI|0|0|0|100|DKK|1482|2852|lyfalmen|||68|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Glípízíð||1482||1482|2852 112615|C01DA0201|Discotrine|forðapl|15|mg/sólh|30|stk|1|þpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|SEK|4288|6659|lyfalmen|||23|30|0|90|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||4288||4288|6659 112641|M05BA0407 |Alendronat Ranbaxy|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.04.2009||R|A|2|0|0|E|0|RAN|0|0|0|100|XEU|9505|6859|lyfalmen|V0718|6859|00|12|0|84|Gróco ehf|Ranbaxy (UK) Ltd|Alendrónsýra||4435||4435|6859 113394|A10BD0801|Eucreas|filmhtfl|0||60|stk|1|þpakki|50mg/850mg|A10BD08|01.11.2008||R|A|1.5|0|0|*|0|NOE|0|0|0|100|DKK|11165|15992|lyfalmen|||00|60|0|0|Vistor hf|Novartis Europharm Ltd|||||11165|15992 113403|A10BD0801|Eucreas|filmhtfl|0||180|stk|1|þpakki|50mg/850mg|A10BD08|01.11.2008||R|A|1.5|0|0|*|0|NOE|0|0|0|100|DKK|30732|40446|lyfalmen|||00|180|0|0|Vistor hf|Novartis Europharm Ltd|||||30732|40446 113412|A10BD0801|Eucreas|filmhtfl|0||60|stk|1|þpakki|50mg/1000mg|A10BD08|01.11.2008||R|A|1.5|0|0|*|0|NOE|0|0|0|100|DKK|11165|15992|lyfalmen|||00|60|0|0|Vistor hf|Novartis Europharm Ltd|||||11165|15992 113415|B01AB0501|Klexane|stl|100|mg/ml|0,2|ml|10|stk|einnota dæla|B01AB05|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|3984|6247|lyfalmen|||00|2|0|10|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3984||3984|6247 113421|A10BD0801|Eucreas|filmhtfl|0||180|stk|1|þpakki|50mg/1000mg|A10BD08|01.11.2008||R|A|1.5|0|0|*|0|NOE|0|0|0|100|DKK|30732|40446|lyfalmen|||00|180|0|0|Vistor hf|Novartis Europharm Ltd|||||30732|40446 113704|B01AB0501|Klexane|stl|100|mg/ml|0,4|ml|10|stk|einnota dæla|B01AB05|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|6460|9607|lyfalmen|||00|4|0|20|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||6460||6460|9607 113796|L01XC0602|Erbitux (Lyfjaver)|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.04.2008||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|42600|54905|lyfsjukr|||00|20|0|0|Lyfjaver ehf|Lyfjaver ehf|Cetúxímab||42600||42600|54905 113818|L01XE0801|Tasigna|hylki|200|mg|112|stk|1|þpakki||L01XE08|01.06.2008||R|A|3|0|1|0|1|NOE|0|0|0|100|DKK|852245|1062913|lyfsjukr|||00|112|0|0|Vistor hf|Novartis Europharm Ltd|Nilotiníb||852245||852245|1062913 113894|J01CE0204|Kaavepenin|töflur|1|g|20|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|719|1816|lyfalmen|||00|20|0|10|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||719||719|1816 113902|J01CE0204|Kaavepenin|töflur|1|g|30|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|913|2079|lyfalmen|||00|30|0|15|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||913||913|2079 113910|J01CE0204|Kaavepenin|töflur|1|g|40|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|1393|2731|lyfalmen|||00|40|0|20|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1393||1393|2731 114033|R03AC0210|Ventolin Diskus|innúðadu|200|mcg/sk|60|skammtar|1|stk|Diskus tæki|R03AC02|01.03.1999||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|832|1969|lyfalmen|||23|60|0|15|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||832||832|1969 114395|N06AB0505|Paroxetin Ranbaxy|filmhtfl|20|mg|100|stk|1|þpakki||N06AB05|01.11.2008||R|A|3|0|0|B|0|RAN|0|1|0|100|IKR|2160|2999|lyfalmen|V0919|2999|00|100|0|100|Gróco ehf|Ranbaxy (UK) Ltd|Paroxetín||1591||1591|2999 114406|N06AB0505|Paroxetin Ranbaxy|filmhtfl|20|mg|60|stk|1|þpakki||N06AB05|01.11.2008||R|A|3|0|0|B|0|RAN|0|1|0|100|IKR|1390|2230|lyfalmen|V0918|2230|00|60|0|60|Gróco ehf|Ranbaxy (UK) Ltd|Paroxetín||1024||1024|2230 114417|N06AB0505|Paroxetin Ranbaxy|filmhtfl|20|mg|20|stk|1|þpakki||N06AB05|01.11.2008||R|A|3|0|0|B|0|RAN|0|1|0|100|IKR|526|1366|lyfalmen|V0917|1366|00|20|0|20|Gróco ehf|Ranbaxy (UK) Ltd|Paroxetín||387||387|1366 114447|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamíð 20 mg|S01ED51|01.03.1999||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|2723|4536|lyfalmen|||06|5|0|0|Icepharma hf|M.S.D.|Tímólól í blöndum||2723||2723|4536 115163|B01AE0701|Pradaxa|hylki|75|mg|10|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|4083|6381|lyfalmen|||0|750|0|3|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||4083||4083|6381 115285|J01CA0410|Amoxicillin Merck NM|töflur|750|mg|20|stk|1|þpakki||J01CA04|01.10.1998||R|A|4|0|0|0|0|MNA|0|0|1|100|SEK|2028|3592|lyfalmen|||00|20|0|15|Actavis Group PTC ehf|Merck NM AB|Amoxicillín||2028||2028|3592 115318|B01AE0701|Pradaxa|hylki|75|mg|30|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|12237|17420|lyfalmen|||0|2250|0|10|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||12237||12237|17420 115330|B01AE0701|Pradaxa|hylki|75|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|24477|32659|lyfalmen|||0|4500|0|20|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||24477||24477|32659 115341|B01AE0701|Pradaxa|hylki|110|mg|10|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|4083|6381|lyfalmen|||0|1100|0|5|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||4083||4083|6381 115353|B01AE0701|Pradaxa|hylki|110|mg|30|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|12237|17420|lyfalmen|||0|3300|0|15|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||12237||12237|17420 115364|B01AE0701|Pradaxa|hylki|110|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|24477|32659|lyfalmen|||0|6600|0|30|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||24477||24477|32659 115642|S01EC0301|Trusopt|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.04.1996||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|2220|3853|lyfalmen|V1090|3792|06|5|0|17|Icepharma hf|M.S.D.|Dorzólamíð||2220||2220|3853 115808|R06AX0201|Periactin|töflur|4|mg|100|stk|1|þpakki||R06AX02|01.10.2005|31.10.2009|R|A|3|0|0|E|0|MSD|0|0|1|100|XEU|1392|2729|lyfalmen|||00|100|0|33|Icepharma hf|M.S.D.|Cýpróheptadín||1392||1392|2729 115931|R03AC1202|Serevent Diskus|innúðadu|50|mcg/sk|60|sk|1|pakki||R03AC12|01.01.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|3843|6056|lyfalmen|||23|60|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||3843||3843|6056 115980|P03AX0301|Prioderm|húðlausn|5|mg/ml|55|ml|1|glas||P03AX03|01.12.1983||L|A|3|0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa|||23|55|0|0|Icepharma hf|Norpharma |Malatíón||||| 116004|J01DC0202|Zinacef|sts|1,5|g|5|hgl|1|pakki||J01DC02|01.06.2005||R|A|2|0|0|0|1|GSK|0|0|0|100|GBP|4123|5903|lyfsjukr|||03|5|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||4123||4123|5903 116046|J01DC0202|Zinacef|sts|750|mg|1|stk|5|hgl||J01DC02|01.09.1983||R|A|2|0|0|0|1|GSK|0|0|0|100|GBP|2155|3085|lyfsjukr|||03|5|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2155||2155|3085 116244|D11AF01|Verucid|áburður|0| |10|ml|1|glas||D11AF|01.11.1981||L|K|2|0|0|0|0|GAN|0|0|0|100|IKR|||lyflausa|||23|10|0|10|Icepharma hf|Galderma Nordic AB|||||| 116327|D07AC1301 |Elocon|krem|0,1|%|100|g|1|túpa||D07AC13|01.04.2009||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|3466|5544|lyfalmen|||0|100|0|100|Vistor hf|Schering-Plough|Mómetasón||||3466|5544 116418|D07AC1301 |Elocon|smyrsli|0,1|%|100|g|1|túpa||D07AC13|01.04.2009||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|3466|5544|lyfalmen|||0|100|0|100|Vistor hf|Schering-Plough|Mómetasón||||3466|5544 116551|M01AE0102|Ibufen|töflur|200|mg|20|stk|1|þpakki||M01AE01|01.12.2008||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|20|0|3|Actavis Group hf|Actavis hf|Íbúprófen||||| 116573|M01AE0102|Ibufen|töflur|400|mg|30|stk|1|þpakki||M01AE01|01.05.2008||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|10|Actavis Group hf|Actavis hf|Íbúprófen||||| 116584|M01AE0102|Ibufen|töflur|400|mg|100|stk|1|þpakki||M01AE01|01.08.2008||R|A|5|0|0|E|0|ACA|0|0|1|100|XEU|915|2082|lyfalmen|||00|100|0|33|Actavis Group hf|Actavis hf|Íbúprófen||915||915|2082 116595|M01AE0102|Ibufen|töflur|600|mg|30|stk|1|þpakki||M01AE01|01.07.2008||R|A|2|0|0|E|0|ACA|0|0|1|100|XEU|512|1535|lyfalmen|||00|30|0|15|Actavis Group hf|Actavis hf|Íbúprófen||512||512|1535 116606|M01AE0102|Ibufen|töflur|600|mg|100|stk|1|þpakki||M01AE01|01.05.2008||R|A|2|0|0|E|0|ACA|0|0|1|100|XEU|1186|2450|lyfalmen|||00|100|0|50|Actavis Group hf|Actavis hf|Íbúprófen||1186||1186|2450 116694|G04BD1101|Toviaz|forðatfl|4|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|PFL|0|0|0|100|DKK|21085|28436|lyfalmen|||00|84|0|84|Vistor hf|Pfizer Limited|||||21085|28436 116705|G04BD1101|Toviaz|forðatfl|4|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|PFL|0|0|0|100|DKK|7462|10967|lyfalmen|||00|28|0|28|Vistor hf|Pfizer Limited|||||7462|10967 116716|G04BD1101|Toviaz|forðatfl|8|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|PFL|0|0|0|100|DKK|7926|11596|lyfalmen|||00|28|0|56|Vistor hf|Pfizer Limited|||||7926|11596 116727|G04BD1101|Toviaz|forðatfl|8|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|PFL|0|0|0|100|DKK|23882|31918|lyfalmen|||00|84|0|168|Vistor hf|Pfizer Limited|||||23882|31918 116985|N06AX1607 |Efexor Depot (D.A.C.)|forðahlk|75|mg|98|stk|1|þpakki||N06AX16|01.05.2009||R|A|3|0|0|B|0|DAC|0|1|0|100|USD|12859|18194|lyfalmen|V0955|12850|00|98|0|74|D.A.C. ehf|D.A.C. ehf|Venlafaxín||12859||12859|18194 116997|N05AX1203|Abilify (Lyfjaver)|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.05.2008||R|A|3|0|0|*|0|LVR|0|1|0|100|DKK|39604|51492|lyfalmen|V1702|51492|00|56|0|37|Lyfjaver ehf|Lyfjaver ehf|Aripiprazól||39604||39604|51492 117008|N05AX1203|Abilify (Lyfjaver)|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.05.2008||R|A|3|0|0|*|0|LVR|0|1|0|100|DKK|39334|51156|lyfalmen|V1703|51156|00|56|0|56|Lyfjaver ehf|Lyfjaver ehf|Aripiprazól||39334||39334|51156 117408|QA12AX0001|Calcimag vet. Kela|irl|0| |500|ml|12|plastf||QA12AX00|01.04.2004||R|A|2|0|0|0|0|KEL|1|0|0|100|NOK|11079|21275|vetalmen|||00|6000|0|0|Icepharma hf|Kela Laboratoria NV|||11079||11079|21275 117515|M01AE0303|Orudis|forðahlk|200|mg|100|stk|1|hylki||M01AE03|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|9461|13679|lyfalmen|||10|100|0|133|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen||9461||9461|13679 117531|N04BA0201|Madopar|hylki|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.07.1974||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|6755|10007|lyfalmen|||00|100|0|33|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||6755||6755|10007 117550|N05AH0405|Seroquel Prolong|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|14815|20630|lyfalmen|||00|100|0|12|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||14815|20630 117561|N05AH0405|Seroquel Prolong|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|26184|34784|lyfalmen|||00|100|0|50|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||26184|34784 117564|N04BA0201|Madopar|hylki|62,5|mg|100|stk|1|glas|50+12.5 mg|N04BA02|01.06.1981||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|2785|4620|lyfalmen|||10|100|0|8|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2785||2785|4620 117573|N05AH0405|Seroquel Prolong|forðatfl|300|mg|10|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|4528|6985|lyfalmen|||00|10|0|8|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||4528|6985 117584|N05AH0405|Seroquel Prolong|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|45276|58554|lyfalmen|||00|100|0|75|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||45276|58554 117595|N05AH0405|Seroquel Prolong|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|52368|67383|lyfalmen|||00|100|0|100|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||52368|67383 117721|D11AF01|Verucid|hlaup|0| |5|g|1|túpa||D11AF|01.08.1984||L|A|3|0|0|0|0|GAN|0|0|0|100|IKR|||lyflausa|||23|5|0|5|Icepharma hf|Galderma Nordic AB|||||| 117770|QP51AJ0101|Baycox Vet.|mixtúra|50|mg/ml|250|ml|1|fl||QP51AJ01|01.12.2005||R|A|5|0|0|0|0|BAN|0|0|0|100|DKK|11251|19470|vetorma|||00|250|0|0|Vistor hf|Bayer Animal Health GmbH|||11251||11251|19470 117788|C08CA0502|Adalat Oros|forðatfl|30|mg|28|stk|1|þpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BAV|0|0|0|100|SEK|3155|5122|lyfalmen|||61|28|0|28|Vistor hf|Bayer Schering Pharma AG (V)|Nífedipín||3155||3155|5122 117796|C08CA0502|Adalat Oros|forðatfl|30|mg|98|stk|1|þpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BAV|0|0|0|100|SEK|5551|8373|lyfalmen|||61|98|0|98|Vistor hf|Bayer Schering Pharma AG (V)|Nífedipín||5551||5551|8373 117820|C08CA0502|Adalat Oros|forðatfl|60|mg|98|stk|1|þpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BAV|0|0|0|100|SEK|9024|13086|lyfalmen|||61|98|0|196|Vistor hf|Bayer Schering Pharma AG (V)|Nífedipín||9024||9024|13086 117929|QA12AA0001|Calci-kel vet. Kela|irl|20,8|mg/ml|100|ml|12|fl||QA12AA00|01.04.2004||R|A|2|0|0|0|0|KEL|0|0|0|100|NOK|7739|14913|vetalmen|||00|1200|0|0|Icepharma hf|Kela Laboratoria NV|||7739||7739|14913 117937|QA12AA0001|Calci-kel vet. Kela|irl|20,8|mg/ml|500|ml|12|plastf||QA12AA00|01.04.2004||R|A|2|0|0|0|0|KEL|0|0|0|100|NOK|13574|26028|vetalmen|||00|6000|0|0|Icepharma hf|Kela Laboratoria NV|||13574||13574|26028 118020|N05AH0306|Olanzapin Actavis|filmhtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.05.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|4622|4652|lyfalmen|V0809|4652|00|28|0|7|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||2809||2809|4652 118043|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|6570|5834|lyfalmen|V0810|5834|00|28|0|14|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||3680||3680|5834 118076|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|25481|21919|lyfalmen|V0812|21919|00|56|0|56|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||15851||15851|21919 118087|N05AH0306|Olanzapin Actavis|filmhtfl|15|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|19466|17259|lyfalmen|V0815|17259|00|28|0|42|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||12108||12108|17259 118158|J01DC0203|Zinnat|mixt.kyr|25|mg/ml|100|ml|1|glas||J01DC02|01.10.1990||R|A|2|0|0|0|0|GSK|0|0|1|100|GBP|1856|3359|lyfalmen|||65|100|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||1856||1856|3359 118231|N01AX1301|Niontix|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.06.2008||R|A|3|0|0|0|1|AGA|0|0|0|100|IKR|9512|13619|lyfsjukr|||00|4|0|0|Ísaga ehf|AGA AB|di-Nitrogen oxíð||9512||9512|13619 118307|A02BA0201|Asyran|töflur|150|mg|30|stk|1|þpakki||A02BA02|01.04.1994||L|A|3|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||00|30|0|15|Actavis Group hf|Actavis hf|Ranitidín||||| 118315|M01AB0505|Voltaren|eþ-stil|100|mg|5|stk|1|pakki||M01AB05|01.01.1986||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|824|1959|lyfalmen|||04|5|0|5|Vistor hf|Novartis Healthcare A/S-|Díklófenak||824||824|1959 118323|M01AB0505|Voltaren|eþ-stil|100|mg|50|stk|1|pakki||M01AB05|01.01.1986||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|8254|12041|lyfalmen|||04|50|0|50|Vistor hf|Novartis Healthcare A/S-|Díklófenak||8254||8254|12041 118406|A02BA0201|Asyran|töflur|300|mg|30|stk|1|þpakki||A02BA02|01.04.1994||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1062|2282|lyfalmen|||00|30|0|30|Actavis Group hf|Actavis hf|Ranitidín||1062||1062|2282 118484|N05AH0306|Olanzapin Actavis|filmhtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|20032|17695|lyfalmen|V0811|17695|00|56|0|42|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||12458||12458|17695 118570|A07EC0203|Pentasa Sachets|forðakyr|1|g|50|stk|1|pakki||A07EC02|01.04.1998||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|10640|15279|lyfalmen|||00|50|0|33|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||10640||10640|15279 118612|A07EC0203|Pentasa Sachets|forðakyr|1|g|150|stk|1|pakki|3 x 50 stk|A07EC02|01.04.1998||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|31296|41148|lyfalmen|||00|150|0|100|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||31296||31296|41148 118674|N05AH0204|Leponex (Lyfjaver)|töflur|25|mg|100|stk|1|glas||N05AH02|01.05.2008||R|A|5|0|0|*|0|LVR|0|1|0|100|DKK|3428|5492|lyfalmen|V1401|5492|00|100|0|8|Lyfjaver ehf|Lyfjaver ehf|Klózapín||3428||3428|5492 118685|N05AH0204|Leponex (Lyfjaver)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2008||R|A|5|0|0|*|0|LVR|0|1|0|100|DKK|10750|15429|lyfalmen|V1400|15429|00|100|0|33|Lyfjaver ehf|Lyfjaver ehf|Klózapín||10750||10750|15429 119031|L01XC0801|Vectibix|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XC08|01.06.2008||R|K|3|0|1|0|1|AEU|0|0|0|100|DKK|97274|122974|lyfsjukr|||00|5|0|0|Vistor hf|Amgen Europe B.V.|Panitúmúmab||97274||97274|122974 119719|C09BA0801|Inhibace Comp.|töflur|17,5|mg|98|stk|1|pakki|þp ( 5+ 12,5 mg)|C09BA08|01.12.1997||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|11793|16844|lyfalmen|||00|98|0|98|Icepharma hf|Roche|Cílazapríl og þvagræsilyf||11793||11793|16844 119962|M01AE0109|Ibuprofen Portfarma|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.03.2008||L|A|3|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||00|30|0|10|Portfarma ehf|Portfarma|Íbúprófen||||| 119984|C02KX0201|Volibris|filmhtfl|5|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|A|2|0|1|0|0|GGL|0|0|0|100|GBP|510734|638049|lyfalmen|||00|30|0|20|GlaxoSmithKline ehf|Glaxo Group Limited|||||510734|638049 120007|C02KX0201|Volibris|filmhtfl|10|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|A|2|0|1|0|0|GGL|0|0|0|100|GBP|510734|638049|lyfalmen|||00|30|0|40|GlaxoSmithKline ehf|Glaxo Group Limited|||||510734|638049 120022|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|10|ml|1|glas||S01FA04|01.10.2003||R|A|2|0|0|E|0|ALC|0|0|0|100|USD|999|2196|lyfalmen|||06|10|0|0|K.Pétursson hf|Alcon|Cýklópentólat||999||999|2196 120062|L01BA0401|Alimta|irþ|100|mg/hgl|1|hgl|1|pakki||L01BA04|01.11.2008||R|A|2|0|1|0|1|LIL|0|0|0|100|XEU|54419|69619|lyfsjukr|||00|1|0|0|Icepharma hf|Lilly ICOS Limited|Pemetrexed||||54419|69619 120341|N06DA0402|Reminyl (Lyfjaver)|forðahlk|8|mg|28|stk|1|þpakki||N06DA04|01.05.2008||R|A|2|0|0|E|0|LVR|0|0|0|100|SEK|13122|18522|lyfalmen|V1370|18522|00|28|0|14|Lyfjaver ehf|Lyfjaver ehf|Galantamín||13122||13122|18522 120353|N06DA0402|Reminyl (Lyfjaver)|forðahlk|16|mg|84|stk|1|þpakki||N06DA04|01.05.2008||R|A|2|0|0|E|0|LVR|0|0|0|100|SEK|41935|54394|lyfalmen|V1371|54394|00|84|0|84|Lyfjaver ehf|Lyfjaver ehf|Galantamín||41935||41935|54394 120950|N06AB1003|Cipralex (Lyfjaver)|filmhtfl|10|mg|28|stk|1|þpakki||N06AB10|01.05.2008||R|A|3|0|0|B|0|LVR|0|1|0|100|DKK|3618|5750|lyfalmen|V0939|5750|00|28|0|28|Lyfjaver ehf|Lyfjaver ehf|Escítalópram||3618||3618|5750 120961|N06AB1003|Cipralex (Lyfjaver)|filmhtfl|10|mg|200|stk|1|plglas||N06AB10|01.05.2008||R|A|3|0|0|B|0|LVR|0|1|0|100|NOK|24828|33096|lyfalmen|||00|200|0|200|Lyfjaver ehf|Lyfjaver ehf|Escítalópram||24828||24828|33096 120973|N03AX1402|Keppra (Lyfjaver)|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.05.2008||R|A|3|0|1|E|0|LVR|0|0|0|100|DKK|20632|27872|lyfalmen|V1710|27872|00|100|0|25|Lyfjaver ehf|Lyfjaver ehf|Levetíracetam||||20632|27872 121164|A02BC0501 |Nexium|mixt.kyr|10|mg|28|sk-pokar|1|pakki|dreifa|A02BC05|01.04.2009||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|6058|9061|lyfalmen|||00|28|0|9|Vistor hf|AstraZeneca A/S DK|Esómeprazól||||6058|9061 121269|N05CD0505|Triazolam NM Pharma|töflur|0,25|mg|100|stk|1|glas||N05CD05|01.07.1991||R|A|4|0|0|0|0|MNA|0|0|0|100|SEK|863|2012|lyfalmen|||00|100|0|100|Actavis Group PTC ehf|Merck NM AB|Tríazólam||863||863|2012 121286|M03AC0901 |Esmeron|stl|10|mg/ml|5|ml|10|hgl||M03AC09|01.04.2009||R|K|3|0|0|0|1|ORG|0|0|0|100|DKK|11422|16088|lyfsjukr|||00|50|0|0|Vistor hf|N.V. Organon|Rókúrón, brómíð||||11422|16088 121327|R03AC0204|Ventolin|innúðal|0,1|mg/sk|200|sk|1|stauk||R03AC02|01.12.1972||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|378|1353|lyfalmen|||24|200|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||378||378|1353 121562|B03BB0104|Folic Acid|töflur|5|mg|28|stk|1|þpakki||B03BB01|01.01.2008||R|A|2|0|0|E|0|AUK|0|0|1|100|GBP|428|1421|lyfalmen|||00|28|0|28|Actavis Group hf|Actavis UK Ltd.|Fólínsýra||428||428|1421 121582|N06AA0401|Anafranil|töflur|25|mg|100|stk|1|þpakki||N06AA04|01.03.1977||R|A|5|0|0|B|0|NOH|0|1|0|100|DKK|2319|3987|lyfalmen|||00|100|0|25|Vistor hf|Novartis Healthcare A/S-|Klómípramín||2319||2319|3987 121863|A07EC0204|Asacol|eþ-stil|500|mg|30|stk|1|pakki||A07EC02|01.01.2000||R|A|3|0|0|B|0|TIL|0|0|0|100|SEK|3744|5921|lyfalmen|||98|30|0|10|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||3744||3744|5921 123166|M01AE5101|Ibukod|töflur|0| |100|stk|1|glas|10+200 mg|M01AE51|01.10.1998||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|1507|2885|lyfalmen|||00|100|0|17|Actavis Group hf|Actavis hf|Íbúprófen í blöndum||1507||1507|2885 123216|N05BA0105|Stesolid|eþ-stil|5|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|638|1706|lyfalmen|||04|10|0|5|Actavis Group hf|Actavis Group hf|Díazepam||638||638|1706 123224|N05BA0105|Stesolid|eþ-stil|10|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|995|2191|lyfalmen|||04|10|0|10|Actavis Group hf|Actavis Group hf|Díazepam||995||995|2191 123253|L02BB0301|Casodex|töflur|150|mg|28|stk|1|þpakki||L02BB03|01.06.2009||R|A|4|0|0|*|0|ASZ|0|0|0|100|SEK|37598|48994|lyfalmen|V0561|48994|00|28|0|84|Vistor hf|AstraZeneca UK Ltd|Bíkalútamíð||37598||37598|48994 123264|A07AA0904|Vancomycin Alpharma|hylki|125|mg|28|stk|1|þpakki|hart hylki|A07AA09|01.04.1996||R|A|2|0|0|E|0|ALP|0|0|1|100|DKK|14008|19625|lyfalmen|||0|28|0|2|Actavis Group hf|Alpharma ApS|Vankómýcín||||14008|19625 123273|N05BA0603|Temesta|töflur|1|mg|100|stk|1|þpakki||N05BA06|01.11.2005||R|A|3|0|0|0|0|LDR|0|0|1|100|USD|2463|4183|lyfalmen|||00|100|1|40|Parlogis hf|Parlogis - óskráð lyf|||2463||2463|4183 123275|A07AA0904|Vancomycin Alpharma|hylki|250|mg|28|stk|1|þpakki|hart hylki|A07AA09|01.04.1996||R|A|2|0|0|E|0|ALP|0|0|1|100|DKK|28054|37112|lyfalmen|||00|28|0|4|Actavis Group hf|Alpharma ApS|Vankómýcín||||28054|37112 123308|R03BB0404 |Spiriva (Lyfjaver)|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.05.2009|31.10.2009|R|A|2|0|0|B|0|LVR|0|0|0|100|DKK|7127|10512|lyfalmen|||00|30|0|30|Lyfjaver ehf|Lyfjaver ehf|Tíótrópíumbrómíð||7127||7127|10512 123319|M05BA0704|Optinate Septimum (Lyfjaver)|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.05.2008|31.10.2009|R|A|3|0|0|0|0|LVR|0|0|0|100|NOK|14675|20455|lyfalmen|||00|12|0|84|Lyfjaver ehf|Lyfjaver ehf|||14675||14675|20455 123414|C01AA0504|Lanoxin mite|töflur|62,5|mcg|100|stk|1|glas||C01AA05|01.03.1978||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|341|1303|lyfalmen|||00|100|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Digoxín||341||341|1303 123992|N07XX0201|Rilutek|töflur|50|mg|56|stk|1|þpakki||N07XX02|01.05.1998||R|A|3|0|0|E|0|AVS|0|0|0|100|NOK|48041|61996|lyfalmen|||00|56|0|28|Vistor hf|Aventis Pharma SA|Rílúzól||48041||48041|61996 124020|QM01AC0603|Rheumocam|mixtúra|1,5|mg/ml|42|ml|1|plastf||QM01AC06|01.08.2009||R|A||0|0|0|0|CHP|0|0|0|100|XEU|2108|4160|vetalmen|||00|42|0|0|Icepharma hf|Chanelle Pharmaceuticals|||||2108|4160 124119|B01AC0401|Plavix|töflur|300|mg|30|stk|1|þpakki||B01AC04|01.09.2009||R|A||0|0|0|0|SBM|0|0|0|100|NOK|40098|52107|lyfalmen|||00|30|0|120|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||||40098|52107 124248|R06AD0301|Torecan|töflur|6,5|mg|20|stk|1|þpakki||R06AD03|01.10.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|1242|2526|lyfalmen|||00|20|1|10|Parlogis hf|Parlogis - óskráð lyf|||1242||1242|2526 124354|G02AB0101|Methergin|töflur|0,125|mg|30|stk|1|þpakki||G02AB01|01.03.1980||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|1158|2412|lyfalmen|||00|30|0|19|Vistor hf|Novartis Healthcare A/S-|Metýlergómetrín||1158||1158|2412 124727|C09AA0201|Daren|töflur|10|mg|30|stk|1|glas||C09AA02|01.01.1994||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|612|1671|lyfalmen|||00|30|0|30|Actavis Group hf|Actavis hf|Enalapríl||612||612|1671 125054|C09AA0201|Daren|töflur|10|mg|100|stk|1|glas||C09AA02|01.01.1994||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|878|2032|lyfalmen|V0168|2032|00|100|0|100|Actavis Group hf|Actavis hf|Enalapríl||878||878|2032 125163|C01BD0104|Cordarone (Lyfjaver)|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.01.2009||R|A|5|0|0|B|0|LVR|0|0|0|100|NOK|1997|3550|lyfalmen|V0144|3550|0|30|0|15|Lyfjaver ehf|Lyfjaver ehf|Amíódarón||1997||1997|3550 126163|N05AX1202|Abilify (D.A.C)|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.05.2008||R|A|3|0|0|*|0|DAC|0|1|0|100|DKK|20273|27425|lyfalmen|V1701|27425|00|28|0|6|D.A.C. ehf|D.A.C. ehf|Aripiprazól||20273||20273|27425 126231|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|15565|21563|lyfalmen|V1732|21563|00|100|0|11|Lyfjaver ehf|Lyfjaver ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||15565||15565|21563 126242|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|15401|21359|lyfalmen|V1730|21359|00|100|0|22|Lyfjaver ehf|Lyfjaver ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||15401||15401|21359 126253|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|16826|23133|lyfalmen|V1731|23133|00|100|0|33|Lyfjaver ehf|Lyfjaver ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||16826||16826|23133 126326|A07DA0301|Imodium|töflur|2|mg|16|stk|1|þpakki||A07DA03|01.10.1991||L|A|5|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||10|16|0|3|Vistor hf|Janssen-Cilag AB|Lóperamíð||||| 126374|L01XX1702|Hycamtin|hylki|1|mg|10|stk|1|þpakki|hart|L01XX17|01.11.2008||R|K|3|0|1|0|1|GSK|0|0|0|100|GBP|119104|150152|lyfsjukr|||00|10|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Tópótecan||||119104|150152 126385|L01XX1702|Hycamtin|hylki|0,25|mg|10|stk|1|þpakki|hart|L01XX17|01.11.2008||R|K|3|0|1|0|1|GSK|0|0|0|100|GBP|30566|39922|lyfsjukr|||00|10|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Tópótecan||||30566|39922 126540|J01GB0303|Gentacoll|vsvamp|1,3|mg/fercm|1|stk|1|pakki|10X10 cm|J01GB03|01.10.1995||R|A|3|0|0|0|1|INN|0|0|0|100|XEU|29336|38391|lyfsjukr|||00|1|0|1|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|Gentamícín||29336||29336|38391 126594|A02BC0305|Lansoprazol Ranbaxy|sþ-hylki|30|mg|56|stk|1|þpakki||A02BC03|01.09.2008||R|A|1,5|0|0|0|0|RAN|0|0|0|100|IKR|3045|4973|lyfalmen|||00|56|0|56|Gróco ehf|Ranbaxy (UK) Ltd|Lansóprazól||3045||3045|4973 126649|J01GB0303|Gentacoll|vsvamp|1,3|mg/fercm|1|stk|1|pakki|5X5 cm|J01GB03|01.10.1995||R|A|3|0|0|0|1|INN|0|0|0|100|XEU|9778|14000|lyfsjukr|||00|1|0|0|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|Gentamícín||9778||9778|14000 126684|J06BA0208|Privigen|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.10.2009||R|A||0|0|0|1|CSB|0|0|0|100|SEK|49281|63222|lyfsjukr|||00|50|0|0|Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||49281||49281|63222 126695|J06BA0208|Privigen|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.10.2009||R|A||0|0|0|1|CSB|0|0|0|100|SEK|98561|124576|lyfsjukr|||00|100|0|0|Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||98561||98561|124576 126707|J06BA0208|Privigen|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.10.2009||R|A||0|0|0|1|CSB|0|0|0|100|SEK|197122|247284|lyfsjukr|||00|200|0|0|Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||197122||197122|247284 126953|A07DA0301|Imodium|töflur|2|mg|100|stk|1|þpakki||A07DA03|01.10.1991||R|A|5|0|0|E|0|JAS|0|0|0|100|SEK|1215|2489|lyfalmen|||10|100|0|20|Vistor hf|Janssen-Cilag AB|Lóperamíð||1215||1215|2489 126974|N06AX2104|Cymbalta (D.A.C.)|sh-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.07.2008||R|A|3|0|0|B|0|DAC|0|1|0|100|XEU|4421|6840|lyfalmen|V1951|6840|00|28|0|14|D.A.C. ehf|D.A.C. ehf|||4421||4421|6840 127383|R02AA0302|Strepsils med honning og citron|sogtfl|0||36|stk|1|þpakki||R02AA03|01.01.2009||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|36|0|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||| 128058|N05AH0301|Zyprexa|húðuðtfl|5|mg|28|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|10084|6833|lyfalmen|V0810|5834|00|28|0|14|Icepharma hf|Eli Lilly Nederland -|Olanzapín||4416||4416|6833 128131|QG51BE0002|Sulfa-Streptocillin vet.|legstil|0||30|stk|1|þpakki||QG51BE00|01.03.2009||R|A|2|0|0|0|0|BID|1|0|0|100|DKK|7019|13541|vetalmen|||0|30|0|0|Vistor hf|Boehringer Ingelheim Danmark|||||7019|13541 128173|C08DA0107|Verapamil Merck NM|töflur|40|mg|100|stk|1|glas||C08DA01|01.01.1990||R|A|5|0|0|B|0|MNA|0|0|0|100|SEK|554|1592|lyfalmen|||00|100|0|17|Actavis Group PTC ehf|Merck NM AB|Verapamíl||554||554|1592 128348|C03AB0102|Centyl mite med kaliumklorid|töflur|0| |100|stk|1|glas||C03AB01|01.05.1999||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|1426|2776|lyfalmen|||10|100|0|50|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíð og kalíum||1426||1426|2776 128864|N07BA0136|Nicorette Spicemint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|30|0|2|Vistor hf|McNeil Denmark ApS|Nikótín||||| 128875|N07BA0136|Nicorette Spicemint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|30|0|4|Vistor hf|McNeil Denmark ApS|Nikótín||||| 128886|N07BA0136|Nicorette Spicemint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14|Vistor hf|McNeil Denmark ApS|Nikótín||||| 128897|N07BA0136|Nicorette Spicemint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28|Vistor hf|McNeil Denmark ApS|Nikótín||||| 128934|V03AF0101|Uromitexan|stl|100|mg/ml|10|ml|10|lykjur||V03AF01|01.10.1990||R|A|5|0|0|0|1|BAM|0|0|0|100|SEK|4797|6868|lyfsjukr|||02|100|0|0|Icepharma hf|Baxter Medical AB|Mesna||4797||4797|6868 129098|N05AH0301|Zyprexa|húðuðtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|34057|20798|lyfalmen|V0811|17695|00|56|0|42|Icepharma hf|Eli Lilly Nederland -|Olanzapín||14950||14950|20798 129106|N05AH0301|Zyprexa|húðuðtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|39512|25866|lyfalmen|V0812|21919|00|56|0|56|Icepharma hf|Eli Lilly Nederland -|Olanzapín||19021||19021|25866 129668|A02AH0002|Natriumbikarbonat|töflur|1|g|100|stk|1|glas||A02AH00|01.08.2005||L|A|5|0|0|0|0|REP|0|0|0|100|SEK|||lyfalmen|||00|100|0|0|Vistor hf|Recip AB|Natríumhýdrógenkarbonat|||||3055 129817|R03BB0101|Atrovent|innúðal|0,25|mg/ml|2|ml|60|plastl|í vél|R03BB01|01.04.1989||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|5403|8173|lyfalmen|||00|120|0|100|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||5403||5403|8173 130013|N05AH0401|Seroquel|töflur|100|mg|100|stk|1|þpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|18534|22320|lyfalmen|V0726|19818|00|100|0|25|Vistor hf|AstraZeneca UK Ltd|Quetíapín||16173||16173|22320 130021|N05AH0401|Seroquel|töflur|200|mg|100|stk|1|þpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|29338|34062|lyfalmen|V0727|30719|00|100|0|50|Vistor hf|AstraZeneca UK Ltd|Quetíapín||25604||25604|34062 130286|C01CA2406|Adrenalin Mylan|stl|1|mg/ml|1|ml|10|gl-lyk||C01CA24|01.06.2009||R|K|3|0|0|0|0|MYL|0|0|1|100|SEK|2333|4006|lyfalmen|||63|10|0|20|Actavis Group PTC ehf|Mylan AB|Adrenalín tartrat||||2333|4006 130575|C03CA0101|Furix|stl|10|mg/ml|25|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|4626|7118|lyfalmen|||02|125|0|31|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||4626||4626|7118 130591|A03BA0103|Atropin Mylan|stl|0,5|mg/ml|1|ml|10|gl-lyk||A03BA01|01.06.2009||R|A|5|0|0|0|0|MYL|0|0|1|100|SEK|2429|4137|lyfalmen|||63|10|0|3|Actavis Group PTC ehf|Mylan AB|Atrópínsúlfat||||2429|4137 130596|N07BA0301|Champix|filmhtfl|0||53|stk|1|þpakki|0,5 mg og 1 mg|N07BA03|01.02.2009||R|A|2|0|0|0|0|PFL|0|0|1|100|DKK|13164|18574|lyfalmen|||0|53|0|21|Vistor hf|Pfizer Limited|||||13164|18574 130772|QI10A0001 |Alpha Ject 3000|stl|||500|ml|1|plpoki||QI10A|01.05.2009||R|K|1,25|0|0|0|0|PHA|0|0|0|100|NOK|67826|129370|vetalmen|||0|500|0|0|Vistor hf|PHARMAQ AS|||||67826|129370 131136|R03CA0202|Efedrin Mylan|stl|50|mg/ml|1|ml|10|gl-lyk||R03CA02|01.06.2009||R|A|5|0|0|0|0|MYL|0|0|0|100|SEK|3339|5372|lyfalmen|||00|10|0|10|Actavis Group PTC ehf|Mylan AB|Efedrínhýdróklóríð||||3339|5372 131334|N03AB0205|Fenantoin Recip|töflur|100|mg|100|stk|1|glas||N03AB02|01.06.2004||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|471|1480|lyfalmen|||00|100|0|33|Vistor hf|Recip AB|Fenýtóín||471||471|1480 131383|N03AA0204|Fenemal Recip|töflur|15|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|903|2066|lyfalmen|||00|100|0|15|Vistor hf|Recip AB|||903||903|2066 131417|N03AA0204|Fenemal Recip|töflur|50|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|989|2182|lyfalmen|||00|100|0|50|Vistor hf|Recip AB|||989||989|2182 131441|N03AA0204|Fenemal Recip|töflur|100|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|1094|2325|lyfalmen|||00|100|0|100|Vistor hf|Recip AB|||1094||1094|2325 131565|G03CA0306|Evorel|forðapl|100|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|6597|9793|lyfalmen|||23|26|0|182|Vistor hf|Janssen-Cilag AB|Estradíól||6597||6597|9793 131729|N07BA0132|Nicorette Microtab Lemon|tungur.t|2|mg|20|stk|1|þpakki||N07BA01|01.10.2008||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|20|0|1|Vistor hf|McNeil Denmark ApS|Nikótín||||| 131740|N07BA0132|Nicorette Microtab Lemon|tungur.t|2|mg|90|stk|1|þpakki||N07BA01|01.10.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|90|0|6|Vistor hf|McNeil Denmark ApS|Nikótín||||| 131817|B01AX0601 |Xarelto|filmhtfl|10|mg|10|stk|1|þpakki||B01AX06|01.05.2009||R|A|3|0|0|E|0|BHC|0|0|0|100|SEK|8980|13027|lyfalmen|||0|10|0|0|Vistor hf|Bayer HealthCare AG|Rivaroxaban||||8980|13027 131828|B01AX0601 |Xarelto|filmhtfl|10|mg|30|stk|1|þpakki||B01AX06|01.05.2009||R|A|3|0|0|E|0|BHC|0|0|0|100|SEK|26939|35724|lyfalmen|||0|30|0|0|Vistor hf|Bayer HealthCare AG|Rivaroxaban||||26939|35724 131840|B01AX0601 |Xarelto|filmhtfl|10|mg|100|stk|1|þpakki||B01AX06|01.05.2009||R|A|3|0|0|E|0|BHC|0|0|0|100|SEK|89796|113981|lyfalmen|||0|100|0|0|Vistor hf|Bayer HealthCare AG|Rivaroxaban||||89796|113981 132229|N06AA0905|Amitriptyline|töflur|10|mg|28|stk|1|þpakki||N06AA09|01.04.2008||R|A|3|0|0|B|0|AUK|0|1|0|100|GBP|267|1119|lyfalmen|||00|28|0|4|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||205||205|1119 132240|N06AA0905|Amitriptyline|töflur|25|mg|28|stk|1|þpakki||N06AA09|01.04.2008||R|A|3|0|0|B|0|AUK|0|1|0|100|GBP|278|1218|lyfalmen|||00|28|0|9|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||278||278|1218 132361|C09DA0309|Valpress Comp|filmhtfl|172,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|A|2,5|0|0|B|0|AGP|0|0|0|100|IKR|14144|5244|lyfalmen|||00|98|0|196|Actavis Group hf|Actavis Group PTC ehf|Valsartan og þvagræsilyf||3245||3245|5244 132372|C09DA0309|Valpress Comp|filmhtfl|92,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|A|2,5|0|0|B|0|AGP|0|0|0|100|IKR|9789|4982|lyfalmen|||00|98|0|98|Actavis Group hf|Actavis Group PTC ehf|Valsartan og þvagræsilyf||3052||3052|4982 132662|R05DA0403|Kodein Recip|töflur|25|mg|100|stk|1|glas||R05DA04|01.08.2005||R|A|5|1|0|E|0|REP|0|0|1|100|SEK|1737|3198|lyfalmen|||00|100|0|25|Vistor hf|Recip AB|Kódein||1737||1737|3198 132663|N06BA0402|Concerta|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.02.2009||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|8911|12933|lyfalmen|||0|30|0|27|Vistor hf|Janssen-Cilag AB|Metýlfenídat||||8911|12933 132761|D08AG0201|Betadine|áburður|100|mg/ml|8|ml|1|glas||D08AG02|01.01.1986||L|A|3|0|0|0|0|NAP|0|0|0|100|IKR|||lyflausa|||23|8|0|8|Icepharma hf|Napp|Joð/pólývídón||||| 132845|S01HA0401|Alcaine|augndr|5|mg/ml|15|ml|1|glas||S01HA04|01.09.2003||R|K|2|0|0|0|0|ALC|0|0|0|100|USD|1139|2386|lyfalmen|||06|15|0|0|K.Pétursson hf|Alcon|Proxýmetakaín||1139||1139|2386 132852|A07BA0104|Kolsuspension|mixtúra|150|mg/ml|100|ml|1|fl|dreifa|A07BA01|01.08.2005||L|A|3|0|0|0|0|ABI|0|0|0|100|IKR|||lyflausa|||00|100|0|3|Vistor hf|Abigo Medical AB|Lyfjakol||||| 132902|G03AB0402|Trinovum 28|töflur|0| |84|stk|1|þpakki||G03AB04|01.01.1993||R|A|2,5|0|0|0|0|JAS|0|0|0|100|SEK|1378|2710|lyfalmen|||23|84|0|84|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||1378||1378|2710 133097|M03AX0104|NeuroBloc|stl|5000|ein/ml|0,5|ml|1|hgl||M03AX01|01.02.2009||R|K|0|0|1|0|1|EIS|0|0|0|100|SEK|39443|50974|lyfsjukr|||0|1|0|0|Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||39443|50974 133109|M03AX0104|NeuroBloc|stl|5000|ein/ml|1|ml|1|hgl||M03AX01|01.02.2009||R|K|0|0|1|0|1|EIS|0|0|0|100|SEK|44067|56731|lyfsjukr|||0|1|0|0|Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||44067|56731 133120|M03AX0104|NeuroBloc|stl|5000|ein/ml|2|ml|1|hgl||M03AX01|01.02.2009||R|K|0|0|1|0|1|EIS|0|0|0|100|SEK|48963|62826|lyfsjukr|||0|1|0|0|Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||48963|62826 133736|J04AB0201|Rimactan|hylki|150|mg|100|stk|1|glas||J04AB02|01.04.1993||R|A|4|0|0|E|0|SAD|0|0|0|100|DKK|10379|14925|lyfalmen|||10|100|0|25|Icepharma hf|Sandoz GmbH|Rífampicín||10379||10379|14925 134274|J02AC0302|Vfend (D.A.C.)|filmhtfl|200|mg|14|stk|1|þpakki||J02AC03|01.05.2008||R|A|3|0|0|0|1|DAC|0|0|0|100|DKK|127840|161028|lyfsjukr|||00|14|0|7|D.A.C. ehf|D.A.C. ehf|Voricónazól||127840||127840|161028 134338|J01FA0901|Klacid|mixt.kyr|50|mg/ml|50|ml|1|glas|pl.fl. m/sk.sprautu|J01FA09|01.07.1998||R|A|2|0|0|0|0|ABS|0|0|1|100|DKK|2743|4563|lyfalmen|||00|50|0|5|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||2743||2743|4563 134498|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|5|ml|1|hgl||L01DB03|01.04.2009||R|K|3|0|1|0|1|AGT|0|0|0|100|XEU|2944|4215|lyfsjukr|||0|5|0|0|Actavis Group hf|Actavis Group hf|Epírúbicín||||2944|4215 134509|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|10|ml|1|hgl||L01DB03|01.04.2009||R|K|3|0|1|0|1|AGT|0|0|0|100|XEU|4400|6300|lyfsjukr|||0|10|0|0|Actavis Group hf|Actavis Group hf|Epírúbicín||||4400|6300 134520|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|25|ml|1|hgl||L01DB03|01.04.2009||R|K|3|0|1|0|1|AGT|0|0|0|100|XEU|12313|17197|lyfsjukr|||0|25|0|0|Actavis Group hf|Actavis Group hf|Epírúbicín||||12313|17197 134862|J05AR0601|Atripla|filmhtfl|0| |30|stk|1|glas|600+200+245 mg|J05AR06|01.07.2008||R|A|2|0|1|0|1|GSI|0|0|0|100|DKK|191082|239659|lyfsjukr|||00|30|0|0|Lyfjaver ehf|Gilead Science International (L)|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||190997||190997|239659 135111|H01AC0101|Genotropin|sts|12|mg|1|rörlyk|1|pakki|tvíhólfa|H01AC01|01.04.1992||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|79091|100336|lyfsjukr|||00|12|0|18|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sómatrópín||79091||79091|100336 135319|C08DA0107|Verapamil Merck NM|töflur|80|mg|100|stk|1|glas||C08DA01|01.01.1990||R|A|5|0|0|B|0|MNA|0|0|0|100|SEK|1098|2330|lyfalmen|||00|100|0|33|Actavis Group PTC ehf|Merck NM AB|Verapamíl||1098||1098|2330 135434|R03BA0502|Flixotide Diskus|innúðadu|100|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|2357|4039|lyfalmen|||23|60|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2357||2357|4039 136168|G03AB0401|Trinovum|töflur|0| |63|stk|1|þpakki||G03AB04|01.10.1988||R|A|2,5|0|0|0|0|JAS|0|0|0|100|SEK|1822|3313|lyfalmen|||23|63|0|84|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||1822||1822|3313 136200|J04AC0102|Tibinide|töflur|300|mg|100|stk|1|glas||J04AC01|01.07.2005||R|A|5|0|0|0|0|REP|0|0|0|100|SEK|7339|10800|lyfalmen|||00|100|0|100|Vistor hf|Recip AB|Ísóníazíð||7339||7339|10800 136564|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|10|hgl|röntgenskuggaefni|V08CA01|01.01.1993||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|120533|151931|lyfsjukr|||02|150|0|0|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||120533||120533|151931 136572|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|10|hgl|röntgenskuggaefni|V08CA01|01.06.1997||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|89254|112989|lyfsjukr|||02|100|0|0|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||89254||89254|112989 136964|L01CD0103|Paclitaxel Hospira|irþ|6|mg/ml|5|ml|1|hgl||L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|19378|25993|lyfsjukr|||00|5|0|0|Icepharma hf|Mayne Pharma Plc|Paklítaxel||||19378|25993 136975|L01CD0103|Paclitaxel Hospira|irþ|6|mg/ml|16,7|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|39032|50462|lyfsjukr|||00|17|0|0|Icepharma hf|Mayne Pharma Plc|Paklítaxel||||39032|50462 136987|L01CD0103|Paclitaxel Hospira|irþ|6|mg/ml|25|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|95821|121165|lyfsjukr|||00|25|0|0|Icepharma hf|Mayne Pharma Plc|Paklítaxel||||95821|121165 136998|L01CD0103|Paclitaxel Hospira|irþ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|111989|141294|lyfsjukr|||00|50|0|0|Icepharma hf|Mayne Pharma Plc|Paklítaxel||||111989|141294 137141|N02BA5102|Treo|freyðit|0| |20|stk|1|glas||N02BA51|01.07.1988||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||14|20|0|3|Vistor hf|McNeil Denmark ApS|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole||||| 137158|N02BA5102|Treo|freyðit|0| |60|stk|1|glas||N02BA51|01.07.1988||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||14|60|0|10|Vistor hf|McNeil Denmark ApS|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole||||| 137513|S01XA2011|Oculac|augndr|0| |10|ml|1|glas|með rotvörn|S01XA20|01.10.1999||L|A|2|0|0|E|0|NOH|0|0|0|100|DKK|||lyfalmen|||00|10|0|0|Vistor hf|Novartis Healthcare A/S-|Gervitár og aðrar óvirkar sam­setningar|||||1638 137521|S01XA2011|Oculac|augndr|0| |0,4|ml|20|sk-hyl|án rotvarnar|S01XA20|01.10.1999||L|A|2|0|0|E|0|NOH|0|0|0|100|DKK|||lyfalmen|||00|8|0|0|Vistor hf|Novartis Healthcare A/S-|Gervitár og aðrar óvirkar sam­setningar|||||2073 137641|S01LA0401|Lucentis|stl|10|mg/ml|0,23|ml|1|hgl|lausn|S01LA04|01.03.2007||R|A|2|0|1|0|1|NOE|0|0|0|100|DKK|169253|212587|lyfsjukr|||00|0|0|0|Vistor hf|Novartis Europharm Ltd|Ranibizumab||169253||169253|212587 137679|A09AA0205|Creon|sh-hylki|0| |100|stk|1|glas|plastglas|A09AA02|01.04.1990||R|A|2|0|0|E|0|KAC|0|0|0|100|XEU|5034|7672|lyfalmen|||10|100|0|100|Medico ehf|Kali-Chemie|Hvatablöndur (lípasi, próteasi o.s.frv.)||5034||5034|7672 137809|M05BA0302|Pamidronatdinatrium Hospira|irþ|3|mg/ml|5|ml|5|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|33943|44127|lyfsjukr|||00|25|0|1|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||33943||33943|44127 137820|M05BA0302|Pamidronatdinatrium Hospira|irþ|3|mg/ml|10|ml|1|hgl|lausn |M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|13998|19295|lyfsjukr|||00|10|0|0|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||13998||13998|19295 137831|M05BA0303|Pamidronatdinatrium Hospira|irþ|6|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|18350|24713|lyfsjukr|||00|10|0|1|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||18350||18350|24713 137842|M05BA0304|Pamidronatdinatrium Hospira|irþ|9|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|24110|31884|lyfsjukr|||00|10|0|2|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||24110||24110|31884 137992|J01XA0106|Vancomycin Hospira|irs|500|mg/hgl|500|mg|1|hgl||J01XA01|01.04.1997||R|A|2|0|0|0|1|HOS|0|0|0|100|DKK|1906|2729|lyfsjukr|||00|500|0|0|Vistor hf|Hospira Enterprises B.V.|Vankómýcín||1906||1906|2729 138073|J01XA0106|Vancomycin Hospira|irs|1|g/hgl|1|g|1|hgl||J01XA01|01.04.1997||R|A|2|0|0|0|1|HOS|0|0|0|100|DKK|3093|4428|lyfsjukr|||00|1|0|0|Vistor hf|Hospira Enterprises B.V.|Vankómýcín||3093||3093|4428 138560|S01ED0105|Optimol|augndr|2,5|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|2321|3990|lyfalmen|||00|15|0|60|Icepharma hf|Santen Oy|Tímólól||2321||2321|3990 138594|S01ED0105|Optimol|augndr|5|mg/ml|0,5|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|2465|4186|lyfalmen|||00|30|0|60|Icepharma hf|Santen Oy|Tímólól||2465||2465|4186 139410|QP52AC1302|Panacur, vet.|mixtúra|100|mg/ml|250|ml|1|fl||QP52AC13|01.07.1987||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|3138|5430|vetorma|||13|250|0|0|Icepharma hf|Intervet International B.V.|||3138||3138|5430 139840|R06AA0401|Tavegyl|töflur|1|mg|100|stk|1|þpakki||R06AA04|01.08.1981||R|A|5|0|0|E|0|NHE|0|0|1|100|DKK|3450|5522|lyfalmen|||00|100|0|50|Artasan ehf|Novartis Healthcare A/S-A|Klemastín||3450||3450|5522 140118|A10BA0202|Glucophage (Lyfjaver)|töflur|1000|mg|180|stk|1|glas||A10BA02|01.07.2008|31.10.2009|R|A|3|0|0|*|0|LVR|0|0|0|100|NOK|3230|5224|lyfalmen|||00|180|0|90|Lyfjaver ehf|Lyfjaver ehf|Metformín||3230||3230|5224 140130|V03AB3501 |Bridion|stl|100|mg/ml|2|ml|10|hgl||V03AB35|01.04.2009||R|A|3|0|1|0|1|ORG|0|0|0|100|DKK|196836|246928|lyfsjukr|||00|20|0|0|Vistor hf|N.V. Organon|||||196836|246928 140141|V03AB3501 |Bridion|stl|100|mg/ml|5|ml|10|hgl||V03AB35|01.04.2009||R|A|3|0|1|0|1|ORG|0|0|0|100|DKK|492092|614522|lyfsjukr|||00|50|0|0|Vistor hf|N.V. Organon|||||492092|614522 140186|R03BB0101|Atrovent|innúðadu|40|mcg|100|stk|1|þpakki||R03BB01|01.10.1988||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|2902|4779|lyfalmen|||19|100|0|33|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||2902||2902|4779 140327|N04BC0502|Sifrol|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|1963|3504|lyfalmen|||00|30|0|1|Vistor hf|Boehringer Ingelheim International |Pramipexól||1963||1963|3504 140442|N05AF0503|Cisordinol-Acutard|stl|50|mg/ml|1|ml|10|lykjur||N05AF05|01.01.1991||R|A|2|0|0|0|1|LBK|0|1|0|100|DKK|16271|22125|lyfsjukr|||02|10|0|33|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||16271||16271|22125 140566|H01BB0201|Syntocinon|stl|10|ae/ml|1|ml|5|lykjur||H01BB02|01.12.1972||R|K|5|0|0|0|1|NOH|0|0|0|100|DKK|733|1049|lyfsjukr|||02|5|0|3|Vistor hf|Novartis Healthcare A/S-|Oxýtócín||733||733|1049 140954|N07BA0103|Nicorette|nefúði|10|mg/ml|10|ml|1|glas||N07BA01|01.04.1994||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|10|0|3|Vistor hf|McNeil Denmark ApS|Nikótín||||| 141044|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|spr|einnotaspr|H02AB04|01.04.1994||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|1552|2947|lyfalmen|||03|2|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metýlprednisólón||1552||1552|2947 141164|N01BB2005|Emla (D.A.C.)|krem|5|%|5|g|5|túpa|0|N01BB20|01.11.2008||R|A|3|0|0|0|0|DAC|0|0|1|100|SEK|3640|5780|lyfalmen|V2002|5780|00|25|0|5|D.A.C. ehf|D.A.C. ehf|Blöndur||||3640|5780 141175|J01CA0409|Flemoxin (D.A.C.)|mixtúrud|50|mg/ml|100|ml|1|glas||J01CA04|01.10.2008||R|A|4|0|0|0|0|DAC|0|0|1|100|XEU|1564|2963|lyfalmen|||08|80|0|0|D.A.C. ehf|D.A.C. ehf|Amoxicillín||||1564|2963 141197|N02BE0112|Perfalgan (D.A.C.)|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.05.2008||R|A|2|0|0|0|1|DAC|0|0|0|100|DKK|10240|14616|lyfsjukr|||00|1200|0|4|D.A.C. ehf|D.A.C. ehf|Paracetamól||10240||10240|14616 141208|B03AC0204|Venofer (D.A.C.)|stl|20|mg/ml|5|ml|5|lykjur||B03AC02|01.10.2008||R|A|3|0|0|E|0|DAC|0|0|1|100|CHF|14919|20759|lyfalmen|V0011|20759|00|25|0|5|D.A.C. ehf|D.A.C. ehf|Járnoxíð (sykurflétta)||14919||14919|20759 141219|J02AC0302|Vfend (D.A.C.)|irs|200|mg|1|hgl|1|pakki||J02AC03|01.05.2008||R|A|3|0|0|0|1|DAC|0|0|0|100|DKK|31037|40509|lyfsjukr|||00|1|0|0|D.A.C. ehf|D.A.C. ehf|Voricónazól||31037||31037|40509 141432|N04BC0502|Sifrol|töflur|0,18|mg|30|stk|1|þpakki||N04BC05|01.05.2005||R|A||0|0|E|0|BII|0|0|0|100|DKK|3795|5990|lyfalmen|||00|30|0|2|Vistor hf|Boehringer Ingelheim International |Pramipexól||3795||3795|5990 141684|G03AA1205|Yaz|filmhtfl|0||84|stk|1|þpakki|0,02mg/3mg|G03AA12|01.02.2009||R|A|5|0|0|0|0|BAB|0|0|0|100|SEK|4858|5946|lyfalmen|||0|84|0|0|Icepharma hf|Bayer AB|Dróspírenón og östrógen||3762||3762|5946 141751|J01EE0106|Co-trimoxazole|töflur|480|mg|28|stk|1|glas|80+400 mg|J01EE01|01.02.2008||R|A|5|0|0|0|0|AUK|0|0|1|100|GBP|709|1803|lyfalmen|||00|28|0|7|Actavis Group hf|Actavis UK Ltd.|Súlfametoxazól og trímetóprím||||709|1803 141945|N04BC0502|Sifrol|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|9912|14291|lyfalmen|||00|100|0|7|Vistor hf|Boehringer Ingelheim International|Pramipexól||9912||9912|14291 142059|C07AA0509|Propranolol Merck NM|töflur|10|mg|100|stk|1|glas||C07AA05|01.10.1992||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|525|1553|lyfalmen|||00|100|0|6|Actavis Group PTC ehf|Merck NM AB|Própranólól||525||525|1553 142190|C07AA0509|Propranolol Merck NM|töflur|40|mg|100|stk|1|glas||C07AA05|01.10.1992||R|A|5|0|0|B|0|MNA|0|0|0|100|SEK|675|1756|lyfalmen|||00|100|0|25|Actavis Group PTC ehf|Merck NM AB|Própranólól||675||675|1756 142299|C01BD0101|Cordarone|stl|50|mg/ml|3|ml|10|lykjur||C01BD01|01.04.1987||R|A|2|0|0|0|1|SNO|0|0|0|100|NOK|9100|13029|lyfsjukr|||02|30|0|8|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||9100||9100|13029 142307|C01BD0101|Cordarone|töflur|200|mg|30|stk|1|þpakki||C01BD01|01.04.1987||R|A|5|0|0|B|0|SNO|0|0|0|100|NOK|1175|2435|lyfalmen|V0143|2273|70|30|0|30|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1175||1175|2435 142323|J01XX0501|Haiprex|töflur|1|g|100|stk|1|glas||J01XX05|01.10.1995||R|A|5|0|0|0|0|MEB|0|0|1|100|SEK|2870|4735|lyfalmen|||00|100|0|50|Vistor hf|Meda AB (V)|Metenamín||2870||2870|4735 142596|C07AA0509|Propranolol Merck NM|töflur|80|mg|100|stk|1|glas||C07AA05|01.10.1992||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|934|2108|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck NM AB|Própranólól||934||934|2108 143339|H02AB0403|Solu-Medrol|sts|125|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.07.1974||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|2365|4050|lyfalmen|||03|1|0|6|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metýlprednisólón||2365||2365|4050 143347|H02AB0403|Solu-Medrol|sts|500|mg|1|stk|1|hgl|+ leysir|H02AB04|01.07.1974||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|4974|7122|lyfsjukr|||03|1|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metýlprednisólón||4974||4974|7122 143412|S01BA0401|Ultracortenol|augnsm|5|mg/g|5|g|1|túpa||S01BA04|01.12.1972||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|841|1982|lyfalmen|||07|5|0|0|Vistor hf|Novartis Healthcare A/S-|Prednisólón||841||841|1982 143413|S01JX|Methocel 2%|lausn|20|mg/ml|30|ml|1|glas||S01|01.05.1998||R|A||0|0|0|0|PCO|0|0|1|100|IKR|1370|2700|lyfalmen|||00|30|1|0|Distica|Distica - óskráð lyf|||1370||1370|2700 143511|J07BC2002|Twinrix Peadriatric|bóluefni|0| |0,5|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|3639|5779|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|blöndur||3639||3639|5779 143586|S01FA0601|Mydriacyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA06|01.09.2003||R|A|3|0|0|0|0|ALC|0|0|0|100|USD|941|2117|lyfalmen|||06|15|0|0|K.Pétursson hf|Alcon|Trópíkamíð||941||941|2117 143602|J01FA1001|Zitromax|töflur|500|mg|2|stk|1|þpakki||J01FA10|01.11.1998||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|2007|3526|lyfalmen|||00|2|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Azitrómýcín||1979||1979|3526 143610|N02CX0201|Catapresan|töflur|25|mcg|100|stk|1|þpakki||N02CX02|01.04.1974||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|2568|4325|lyfalmen|||00|100|0|25|Vistor hf|Boehringer Ingelheim|Klónidín||2568||2568|4325 143631|A10BD0701|Janumet|filmhtfl|0||56|stk|1|þpakki|50/1000mg|A10BD07|01.03.2009||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|9989|14396|lyfalmen|||0|56|0|0|Icepharma hf|M.S.D.|||||9989|14396 143653|N06AB0403|Cipramil (D.A.C.)|töflur|20|mg|98|stk|1|glas||N06AB04|01.11.2008||R|A|3|0|0|B|0|DAC|0|1|0|100|DKK|10809|6620|lyfalmen|V0926|4223|00|98|0|98|D.A.C. ehf|D.A.C. ehf|Cítalópram||4259||4259|6620 143727|D07AB0201|Locoid|smyrsli|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|A|5|0|0|B|0|ASP|0|0|1|100|XEU|1060|2279|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1060||1060|2279 143800|N05AN0101|Litarex|forðatfl|564|mg|100|stk|1|glas||N05AN01|01.04.1974||R|A|5|0|0|*|0|AGT|0|1|0|100|DKK|1386|2721|lyfalmen|||10|100|0|25|Actavis Group hf|Actavis Group hf|Litíum||1386||1386|2721 143891|J01FA1001|Zitromax|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.11.1998||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|2912|4792|lyfalmen|V0429|4712|00|3|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Azitrómýcín||2912||2912|4792 143917|L01DB0301|Farmorubicin|stl|2|mg/ml|5|ml|1|hgl|plasthgl|L01DB03|01.09.1998||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|4862|6961|lyfsjukr|||02|5|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Epírúbicín||4862||4862|6961 143933|L01DB0301|Farmorubicin|stl|2|mg/ml|10|ml|1|hgl|plasthgl|L01DB03|01.09.1998||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|9344|13378|lyfsjukr|||02|10|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Epírúbicín||9344||9344|13378 144030|N04BA0207|Sinemet depot mite|forðatfl|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.04.1992||R|A|2|0|0|E|0|MSD|0|0|0|100|XEU|2962|4860|lyfalmen|||10|100|0|17|Icepharma hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2962||2962|4860 144089|J07BC0203|Vaqta|bóluefni|50|ein|1|ml|1|spr|áfyllt spr. með nál|J07BC02|01.03.2001||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|5473|8268|lyfalmen|||51|1|0|0|Icepharma hf|Sanofi Pasteur MSD|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||5473||5473|8268 144105|L01DB0301|Farmorubicin|stl|2|mg/ml|25|ml|1|hgl|plasthgl|L01DB03|01.09.1998||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|16438|22333|lyfsjukr|||02|25|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Epírúbicín||16438||16438|22333 144139|H01AC0106|Norditropin Simplexx|stl|10|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|92867|117487|lyfsjukr|||AC|2|0|22|Vistor hf|Novo-Nordisk|Sómatrópín||92867||92867|117487 144330|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|28|stk|1|þpakki||A02BC01|01.02.2009||L|A|3|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||0|28|0|28|Actavis Group hf|Actavis Group hf|Ómeprazól||||| 144436|H01AC0106|Norditropin Simplexx|stl|6,7|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|69409|88282|lyfsjukr|||AC|2|0|15|Vistor hf|Novo-Nordisk|Sómatrópín||69409||69409|88282 144725|H01AC0106|Norditropin Simplexx|stl|3,3|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|45129|58053|lyfsjukr|||AC|2|0|7|Vistor hf|Novo-Nordisk|Sómatrópín||45129||45129|58053 144808|D07AB0201|Locoid|lausn|1|mg/ml|30|ml|1|glas||D07AB02|01.10.1986||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|1035|2245|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1035||1035|2245 144964|N05BA0205|Risolid|filmhtfl|10|mg|24|stk|1|plglas||N05BA02|01.04.2008||R|A|5|0|0|0|0|AGT|0|0|1|100|XEU|481|1493|lyfalmen|||00|24|0|8|Actavis Group hf|Actavis Group hf|Klórdíazepoxíð||481||481|1493 144980|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|plglas||N05BA02|01.04.2008||R|A|5|0|0|0|0|AGT|0|0|1|100|XEU|831|1968|lyfalmen|||00|24|0|20|Actavis Group hf|Actavis Group hf|Klórdíazepoxíð||831||831|1968 145292|J07BC0203|Vaqta|bóluefni|25|ein|0,5|ml|1|spr|áfyllt spr. með nál|J07BC02|01.03.2001||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|3664|5813|lyfalmen|||51|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3664||3664|5813 145508|D07AC0104|Diproderm|krem|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|A|5|0|0|B|0|SCP|0|0|1|100|DKK|5686|8557|lyfalmen|||20|100|0|100|Vistor hf|Schering-Plough|Betametasón||5686||5686|8557 145540|P02CX0101|Vanquin|mixtúra|10|mg/ml|30|ml|1|glas||P02CX01|01.12.1972||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||24|30|0|0|Vistor hf|Recip AB|Pýrvín||||| 145607|P02CX0101|Vanquin|töflur|50|mg|8|stk|1|þpakki||P02CX01|01.12.1972||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||23|8|0|0|Vistor hf|Recip AB|Pýrvín||||| 145631|P02CX0101|Vanquin|töflur|50|mg|32|stk|1|þpakki||P02CX01|01.01.1995||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||23|32|0|0|Vistor hf|Recip AB|Pýrvín||||| 145698|N05AH0301|Zyprexa|húðuðtfl|10|mg|28|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|20578|27805|lyfalmen|||00|28|0|28|Icepharma hf|Eli Lilly Nederland -|Olanzapín||20578||20578|27805 146207|L01XX1903|Irinotecan Hospira|irþ|20|mg/ml|2|ml|1|hgl|lausn|L01XX19|01.03.2009||R|A|3|0|1|0|1|HUK|0|0|0|100|XEU|11969|16769|lyfsjukr|||0|2|0|0|Icepharma hf|Hospira UK Ltd|Írinótekan||||11969|16769 146218|L01XX1903|Irinotecan Hospira|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.03.2009||R|A|3|0|1|0|1|HUK|0|0|0|100|XEU|28354|37168|lyfsjukr|||0|5|0|0|Icepharma hf|Hospira UK Ltd|Írinótekan||||28354|37168 146530|P01AB0102|Flagyl|töflur|400|mg|10|stk|1|þpakki||P01AB01|01.10.1995||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|918|2086|lyfalmen|||41|10|0|2|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||918||918|2086 147241|L01BC0102|Arabine|stl/irl|100|mg/ml|1|ml|5|hgl||L01BC01|01.03.2009||R|A|3|0|1|0|1|MAY|0|0|0|100|XEU|5559|7959|lyfsjukr|||0|5|0|0|Icepharma hf|Mayne Pharma Plc|Cýtarabín||||5559|7959 147252|L01BC0102|Arabine|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.03.2009||R|A|3|0|1|0|1|MAY|0|0|0|100|XEU|4689|6713|lyfsjukr|||0|10|0|0|Icepharma hf|Mayne Pharma Plc|Cýtarabín||||4689|6713 147702|B05AA0501|Macrodex 60 mg/ml med glukos|irl|0| |500|ml|12|pokar||B05AA05|01.07.1991||R|A|2|0|0|0|1|MAB|0|0|0|100|SEK|14618|20067|lyfsjukr|||00|6000|0|6|Vistor hf|Meda AB|Dextran||14618||14618|20067 147728|B05AA0508|Rheomacrodex med glukos|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991||R|A|2|0|0|0|1|MAB|0|0|0|100|SEK|23368|30961|lyfsjukr|||00|6000|0|6|Vistor hf|Meda AB|Dextran||23368||23368|30961 147926|J01GB0301|Garamycin|stl|40|mg/ml|2|ml|100|hgl||J01GB03|01.12.1975||R|A|5|0|0|0|1|SCP|0|0|0|100|DKK|39642|51222|lyfsjukr|||02|200|0|33|Vistor hf|Schering-Plough|Gentamícín||39642||39642|51222 148213|R05CB1301|Pulmozyme|innúðal|1|mg/ml|2,5|ml|30|lykjur||R05CB13|01.01.1997||R|K|2|0|0|0|0|ROA|0|0|1|100|DKK|130181|164260|lyfalmen|||00|750|0|30|Icepharma hf|Roche A.S.|Dornase alfa||130181||130181|164260 148452|N04AA0201|Akineton|töflur|2|mg|100|stk|1|þpakki||N04AA02|01.11.2005||R|A|5|0|0|*|0|LFS|0|1|0|100|DKK|1222|2499|lyfalmen|||00|100|0|20|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||1222||1222|2499 148917|L01BA0301|Tomudex|irs|2|mg/hgl|1|hgl|1|pakki||L01BA03|01.03.1998||R|A|3|0|1|0|1|HON|0|0|0|100|SEK|25482|33593|lyfsjukr|||00|1|0|0|Vistor hf|Hospira Nordic AB (V)|Raltítrexed||25482||25482|33593 148939|D05AX5202|Daivobet (D.A.C.)|smyrsli|0||120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.11.2008||R|A|2|0|0|B|0|DAC|0|0|0|100|DKK|14208|19874|lyfalmen|V2001|19874|00|120|0|120|D.A.C. ehf|D.A.C. ehf|Kalcípótríól í blöndum||14208||14208|19874 148950|N06DA0203 |Aricept (D.A.C.)|töflur|5|mg|98|stk|1|þpakki||N06DA02|01.05.2009|31.08.2009|R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|52739|67845|lyfalmen|||00|98|0|65|D.A.C. ehf|D.A.C. ehf|Dónepezíl||||52739|67845 148961|N06DA0203 |Aricept (D.A.C.)|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|55533|71324|lyfalmen|V0376|49182|00|98|0|131|D.A.C. ehf|D.A.C. ehf|Dónepezíl||||55533|71324 148972|C09DA0304|Diovan Comp 160/12,5 mg (D.A.C.)|filmhtfl|172,5|mg|98|stk|1|þpakki|160/12,5 mg|C09DA03|01.11.2008||R|A|3|0|0|0|0|DAC|0|0|0|100|DKK|15684|21322|lyfalmen|V0192|21322|00|98|0|196|D.A.C. ehf|D.A.C. ehf|Valsartan og þvagræsilyf||15371||15371|21322 148999|QN05CM9201|Rompun, vet.|stl|20|mg/ml|25|ml|1|hgl||QN05CM92|01.12.1972||R|A|3,25|0|0|0|0|BAN|1|0|0|100|DKK|4192|8156|vetalmen|||27|25|0|0|Vistor hf|Bayer Animal Health GmbH|||4192||4192|8156 149146|N05AG0201|Orap|töflur|1|mg|75|stk|1|þpakki||N05AG02|01.03.2004||R|A|5|0|0|0|0|PCO|0|1|0|100|SEK|1919|3445|lyfalmen|||00|75|1|19|Distica|Distica - óskráð lyf|||1919||1919|3445 150243|J04AB0201|Rimactan|hylki|300|mg|100|stk|1|glas||J04AB02|01.04.1993||R|A|4|0|0|E|0|SAD|0|0|0|100|DKK|18195|24838|lyfalmen|||10|100|0|50|Icepharma hf|Sandoz GmbH|Rífampicín||18195||18195|24838 150996|J07AH0401|Mencevax ACWY|stl|50|mcg|0,5|ml|1|hgl||J07AH04|01.11.2008||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|3823|6028|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||||3823|6028 151191|N05AF0102|Fluanxol Depot|stl|20|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1977||R|A|4|0|0|*|0|LBK|0|1|0|100|DKK|8276|12071|lyfalmen|||02|10|0|50|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||8276||8276|12071 151217|G01AF0102|Flagyl|sk-stil|500|mg|10|stk|1|pakki|+ hanskar|G01AF01|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1238|2520|lyfalmen|||05|10|0|10|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1238||1238|2520 151518|N06DX0101|Ebixa|filmhtfl|20|mg|28|stk|1|þpakki||N06DX01|01.11.2008||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|18404|25098|lyfalmen|||00|28|0|28|Lundbeck Export A/S - útibú Íslandi|H. Lundbeck A/S|Memantín||||18404|25098 151529|N06DX0101|Ebixa|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.11.2008||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|56827|72935|lyfalmen|||00|28|0|98|Lundbeck Export A/S - útibú Íslandi|H. Lundbeck A/S|Memantín||||56827|72935 151640|G04CA0204|Tamsulogen|hylki|0,4|mg|90|stk|1|þpakki|með br. losunarhraða|G04CA02|01.05.2006||R|A|3|0|0|E|0|MYL|0|0|0|100|SEK|7270|6749|lyfalmen|V0437|6694|00|90|0|90|Actavis Group PTC ehf|Mylan AB|Tamsúlósín||4354||4354|6749 151928|N06AA1201|Sinquan|hylki|25|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|1855|3358|lyfalmen|||10|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Doxepín||1855||1855|3358 151944|N06AA1201|Sinquan|hylki|10|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|1279|2576|lyfalmen|||10|100|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Doxepín||1279||1279|2576 152223|M03BX0103|Lioresal|stl|50|mcg/ml|1|ml|5|lykjur|stl.intrathecal.|M03BX01|01.10.1995||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|807|1155|lyfsjukr|||02|5|0|0|Vistor hf|Novartis Healthcare A/S-|Baklófen||807||807|1155 152348|M02AA0701|Felden gel|hlaup|5|mg/g|25|g|1|glas||M02AA07|01.04.1996||L|A|3|0|0|0|0|PFI|0|0|1|100|IKR|||lyflausa|||23|25|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Píroxíkam||||| 152397|R03BA0202|Pulmicort Turbuhaler|innúðadu|100|mcg/sk|200|sk|1|stauk||R03BA02|01.04.1991||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|4536|6996|lyfalmen|||23|200|0|25|Vistor hf|AstraZeneca A/S DK|Búdesóníð||4536||4536|6996 152413|R03BA0202|Pulmicort Turbuhaler|innúðadu|200|mcg/sk|200|sk|1|stauk||R03BA02|01.10.1989||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|6788|10052|lyfalmen|||23|200|0|50|Vistor hf|AstraZeneca A/S DK|Búdesóníð||6788||6788|10052 152421|R03BA0202|Pulmicort Turbuhaler|innúðadu|400|mcg/sk|200|sk|1|stauk||R03BA02|01.10.1989||R|A|2|0|0|B|0|ASZ|0|0|0|100|SEK|11754|16791|lyfalmen|||23|200|0|100|Vistor hf|AstraZeneca UK Ltd|Búdesóníð||11754||11754|16791 152991|J02AC0201|Sporanox|hylki|100|mg|4|stk|1|þpakki||J02AC02|01.01.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|1909|3431|lyfalmen|||10|4|0|2|Vistor hf|Janssen-Cilag AB|Ítracónazól||1909||1909|3431 153080|R06AE0704|Histasin|töflur|10|mg|10|stk|1|þpakki||R06AE07|01.01.1998||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|10|0|10|Actavis Group hf|Actavis hf|Cetirizín||||| 153122|N01BB5203|Xylocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|(10mg+5míkróg)/ml|N01BB52|01.10.1995||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|1787|3265|lyfalmen|||17|100|0|0|Vistor hf|AstraZeneca A/S DK|||1787||1787|3265 153197|R06AE0704|Histasin|töflur|10|mg|30|stk|1|þpakki||R06AE07|01.01.1998||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|30|Actavis Group hf|Actavis hf|Cetirizín||||| 153254|N01BB0203|Xylocain|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2312|3978|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|Lídókaín||2312||2312|3978 153270|N01BB0203|Xylocain|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|1596|3006|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|Lídókaín||1596||1596|3006 153288|R06AE0704|Histasin|töflur|10|mg|100|stk|1|þpakki||R06AE07|01.01.1998||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|2189|3811|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|Cetirizín||2189||2189|3811 153379|J02AA0104|AmBisome|irs|50|mg/hgl|10|hgl|1|pakki||J02AA01|01.07.2001||R|A|3|0|0|0|1|GIS|0|0|0|100|DKK|427826|534511|lyfsjukr|||00|10|0|14|Gilead Sience Sweden AB|Gilead Science International ltd.|Amfóterícín||427826||427826|534511 153536|J02AC0201|Sporanox|hylki|100|mg|15|stk|1|þpakki||J02AC02|01.04.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|6395|9519|lyfalmen|||10|15|0|8|Vistor hf|Janssen-Cilag AB|Ítracónazól||6395||6395|9519 153575|M01AH0102 |Celebra (D.A.C.)|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|1|100|DKK|15621|21633|lyfalmen|V2140|21633|00|100|0|100|D.A.C. ehf|D.A.C. ehf|Celekoxíb||15621||15621|21633 153593|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|5|lykjur||B03BA03|01.12.1972||R|A|2|0|0|E|0|HEX|0|0|1|100|DKK|7400|10883|lyfalmen|||02|5|0|250|Vistor hf|Hexal A/S|Hýdroxókóbalamín||7400||7400|10883 153734|L01CA0101|Velbe|sts|10|mg/hgl|1|sk|1|hgl||L01CA01|01.01.1998||R|K||0|1|0|1|LDR|0|0|0|100|IKR|2880|4123|lyfsjukr|||00|1|1|0|Parlogis hf|Parlogis - óskráð lyf|||2880||2880|4123 154464|D05AX5203 |Xamiol|hlaup|0||30|g|1|plastf|50 mcg/g+0,5 mg/g|D05AX52|01.05.2009||R|A||0|0|B|0|LEP|0|0|0|100|DKK|5435|8216|lyfalmen|||00|30|0|0|Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||||5435|8216 154475|D05AX5203 |Xamiol|hlaup|0||60|g|1|plastf|50 mcg/g+0,5 mg/g|D05AX52|01.05.2009||R|A||0|0|B|0|LEP|0|0|0|100|DKK|10407|14963|lyfalmen|||00|60|0|0|Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||||10407|14963 154484|G04CA0102|Xatral Uno|forðatfl|10|mg|30|stk|1|þpakki||G04CA01|01.01.2003||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|6721|9961|lyfalmen|||00|30|0|40|Vistor hf|Sanofi-aventis Norge AS|Alfúzósín||6721||6721|9961 154591|M01AB5501|Arthrotec|töflur|50,2|mg|20|stk|1|pakki|þp (0,2+50 mg)|M01AB55|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|1557|2953|lyfalmen|||10|20|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Díklófenaknatríum í blöndum||1557||1557|2953 154708|M01AB5501|Arthrotec|töflur|50,2|mg|100|stk|1|pakki|þp (0,2+50 mg)|M01AB55|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|5643|8498|lyfalmen|V2130|8497|10|100|0|50|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Díklófenaknatríum í blöndum||5643||5643|8498 154728|N06AX1608|Venlafaxin Actavis|forðahlk|75|mg|28|stk|1|þpakki|hart|N06AX16|01.08.2009||R|A||0|0|B|0|AGP|0|0|0|100|XEU|2297|3958|lyfalmen|V0954|3958|00|28|0|21|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||||2297|3958 154732|G04CA0102|Xatral Uno|forðatfl|10|mg|90|stk|1|þpakki||G04CA01|01.01.2003||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|7749|11356|lyfalmen|V0438|9667|00|90|0|120|Vistor hf|Sanofi-aventis Norge AS|Alfúzósín||7749||7749|11356 154739|N06AX1608|Venlafaxin Actavis|forðahlk|75|mg|98|stk|1|þpakki|hart|N06AX16|01.08.2009||R|A||0|0|B|0|AGP|0|0|0|100|XEU|9316|12850|lyfalmen|V0955|12850|00|98|0|74|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||8850||8850|12850 154750|N06AX1608|Venlafaxin Actavis|forðahlk|150|mg|28|stk|1|þpakki|hart|N06AX16|01.08.2009||R|A||0|0|B|0|AGP|0|0|0|100|XEU|3974|6233|lyfalmen|V0957|6233|00|28|0|42|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||||3974|6233 154761|N06AX1608|Venlafaxin Actavis|forðahlk|150|mg|98|stk|1|þpakki|hart|N06AX16|01.08.2009||R|A||0|0|B|0|AGP|0|0|0|100|XEU|15414|20469|lyfalmen|V0956|20469|00|98|0|147|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||14686||14686|20469 155085|L01AA0201|Leukeran|töflur|2|mg|25|stk|1|glas||L01AA02|01.06.2001||R|K|3|0|0|*|0|GSK|0|0|0|100|GBP|1345|2666|lyfalmen|||00|25|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Chlorambucíl||1345||1345|2666 155390|N05AF0301|Truxal|töflur|50|mg|100|stk|1|glas||N05AF03|01.12.1972||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|1944|3478|lyfalmen|||00|100|0|17|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||1944||1944|3478 155432|N05AF0301|Truxal|töflur|15|mg|100|stk|1|glas||N05AF03|01.12.1972||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|602|1657|lyfalmen|||00|100|0|5|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||602||602|1657 155648|J02AC0201|Sporanox|hylki|100|mg|28|stk|1|þpakki||J02AC02|01.04.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|12099|17248|lyfalmen|||00|28|0|14|Vistor hf|Janssen-Cilag AB|Ítracónazól||12099||12099|17248 156505|A08AB0101|Xenical|hylki|120|mg|42|stk|1|þpakki||A08AB01|01.07.1999||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|7311|10762|lyfalmen|||00|42|0|14|Icepharma hf|Roche|Orlístat||7311||7311|10762 156596|A08AB0101|Xenical|hylki|120|mg|84|stk|1|þpakki||A08AB01|01.07.1999||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|9740|14058|lyfalmen|||00|84|0|28|Icepharma hf|Roche|Orlístat||9740||9740|14058 156661|P02CA0101|Vermox|töflur|100|mg|6|stk|1|þpakki||P02CA01|01.12.1982||R|A|3|0|0|0|0|JAS|0|0|0|100|SEK|947|2126|lyfalmen|||00|6|0|3|Vistor hf|Janssen-Cilag AB|Mebendazól||947||947|2126 156964|N07BA0137 |Nicorette (D.A.C.)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2009||L|A|2.5|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|210|0|14|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 156986|N07BA0138 |Nicorette Freshmint (D.A.C.)|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|105|0|14|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 156997|N07BA0138 |Nicorette Freshmint (D.A.C.)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|210|0|28|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157020|N07BA0138 |Nicorette Freshmint (D.A.C.)|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|105|0|7|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157031|N07BA0138 |Nicorette Freshmint (D.A.C.)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|210|0|14|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157053|N07BA0139 |Nicorette Fruitmint (D.A.C.)|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|105|0|14|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157064|N07BA0139 |Nicorette Fruitmint (D.A.C.)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|210|0|28|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157086|N07BA0139 |Nicorette Fruitmint (D.A.C.)|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|105|0|7|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157097|N07BA0139 |Nicorette Fruitmint (D.A.C.)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|210|0|14|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157206|QP52AF0201|Banminth, vet.|pasta|11,4|g/skdæla|26|g|10|spr|.|QP52AF02|01.04.1992||R|A|1|0|0|0|0|PAL|0|0|0|100|DKK|8430|14589|vetorma|||16|260|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health|||8430||8430|14589 157419|N07BA0134 |Nicotinell Mint (D.A.C.)|munnstfl|1|mg|204|stk|1|pakki||N07BA01|01.05.2009||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|204|0|7|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157430|N07BA0140 |Nicorette Peppermynte (D.A.C.)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2009||L|A|2.5|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|210|0|14|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157463|N07BA0134 |Nicotinell Mint (D.A.C.)|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.05.2009||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|96|0|6|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157598|N07BA0134|Nicotinell Mint (D.A.C.)|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|96|0|13|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157609|N07BA0134|Nicotinell Mint (D.A.C.)|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|204|0|27|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157642|N07BA0134|Nicotinell Mint (D.A.C.)|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|204|0|14|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157768|S01AA3001|Terramycin Polymyxin B|augnsm|0| |3,5|g|1|túpa||S01AA30|01.01.2000||R|S|5|0|0|E|0|PCO|0|0|1|100|DKK|574|1619|lyfalmen|||07|4|1|0|Distica|Distica - óskráð lyf|||574||574|1619 158287|N03AF0104|Tegretol|töflur|200|mg|50|stk|1|þpakki||N03AF01|01.12.1972||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|1164|2420|lyfalmen|||00|50|0|10|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1164||1164|2420 158431|B02BD0801 |NovoSeven|sts|1|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|A|2|0|1|0|1|NON|0|0|0|100|DKK|119599|150768|lyfsjukr|||00|1|0|0|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||||119599|150768 158442|B02BD0801 |NovoSeven|sts|2|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|A|2|0|1|0|1|NON|0|0|0|100|DKK|239199|299670|lyfsjukr|||00|1|0|0|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||||239199|299670 158453|B02BD0801 |NovoSeven|sts|5|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|A|2|0|1|0|1|NON|0|0|0|100|DKK|678243|846280|lyfsjukr|||00|1|0|0|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||||678243|846280 158608|J02AX0501|Mycamine|irs|50|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|A|3|0|1|0|1|APG|0|0|0|100|XEU|61099|77936|lyfsjukr|||0|1|0|0|Vistor hf|Astellas Pharma GmbH|||||61099|77936 158619|J02AX0501|Mycamine|irs|100|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|A|3|0|1|0|1|APG|0|0|0|100|XEU|96230|121674|lyfsjukr|||0|1|0|1|Vistor hf|Astellas Pharma GmbH|||||96230|121674 158683|H01BB0201|Syntocinon|nefúði|6,7|mcg/sk|5|ml|1|stauk||H01BB02|01.07.1988||R|K|4|0|0|E|0|NOH|0|0|0|100|DKK|1295|2598|lyfalmen|||23|5|0|13|Vistor hf|Novartis Healthcare A/S-|Oxýtócín||1295||1295|2598 158725|M01AB0515|Diklofenak Merck NM|sþ-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.12.2008||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|1029|2237|lyfalmen|V0608|2237|10|100|0|50|Actavis Group PTC ehf|Mylan AB|Díklófenak||||1029|2237 158729|C07AB0208|Selo-ZOC (D.A.C.)|forðatfl|47,5|mg|98|stk|1|þpakki||C07AB02|01.11.2008||R|A|3|0|0|B|0|DAC|0|0|0|100|SEK|2427|3628|lyfalmen|V2003|3253|00|98|0|31|D.A.C. ehf|D.A.C. ehf|Metóprólól||2054||2054|3628 159107|N02AB0303|Fentanyl Actavis|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|4059|6349|lyfalmen|V1050|6349|00|5|0|21|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||||4059|6349 159118|N02AB0303|Fentanyl Actavis|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|7816|11447|lyfalmen|V1051|11447|00|5|0|42|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||||7816|11447 159130|N02AB0303|Fentanyl Actavis|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|10938|15684|lyfalmen|V1052|15684|00|5|0|62|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||||10938|15684 159141|N02AB0303|Fentanyl Actavis|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|13148|18554|lyfalmen|V1053|18554|00|5|0|83|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||||13148|18554 159517|N06AB0401|Cipramil|töflur|20|mg|56|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|7512|5072|lyfalmen|V0925|3253|00|56|0|56|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3118||3118|5072 159533|L02BG0601|Aromasin|töflur|25|mg|30|stk|1|þpakki||L02BG06|01.06.2001||R|A|3|0|0|*|0|PFI|0|0|0|100|DKK|29744|39216|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Exemestan||29744||29744|39216 159541|N06AB0401|Cipramil|töflur|40|mg|56|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|15377|13891|lyfalmen|V0929|7881|00|56|0|112|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||9617||9617|13891 159558|N06AB0401|Cipramil|töflur|10|mg|28|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|2174|2748|lyfalmen|V0921|1893|00|28|0|14|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||1406||1406|2748 159632|N06AB0401|Cipramil|töflur|20|mg|28|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|3764|3963|lyfalmen|V0923|2097|00|28|0|28|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2301||2301|3963 159640|N06AB0401|Cipramil|töflur|40|mg|28|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|7757|5354|lyfalmen|V0927|3332|00|28|0|56|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3326||3326|5354 159772|B01AD0701|Rapilysin|sts|10|ae/hgl|2|hgl|1|pakki|+ leysir|B01AD07|01.02.2002||R|A|3|0|0|0|1|ACA|0|0|0|100|DKK|196501|246511|lyfsjukr|||00|2|0|1|Actavis Group PTC ehf|Actavis Group PTC ehf|Reteplasi||196501||196501|246511 160325|N05BA0105|Stesolid|stl|5|mg/ml|2|ml|25|lykjur||N05BA01|01.04.1974||R|A|3|0|0|0|1|AGT|0|0|0|100|DKK|2629|3764|lyfsjukr|||02|50|0|25|Actavis Group hf|Actavis Group hf|Díazepam||2629||2629|3764 160408|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|45479|58489|lyfsjukr|||00|100|0|0|Icepharma hf|GE Healthcare AS|Gadódíamíð||45479||45479|58489 160457|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|68218|86799|lyfsjukr|||00|150|0|0|Icepharma hf|GE Healthcare AS|Gadódíamíð||68218||68218|86799 160523|N05AB0401|Stemetil|töflur|5|mg|100|stk|1|þpakki||N05AB04|01.06.1981||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|1048|2263|lyfalmen|||00|100|0|5|Vistor hf|Sanofi-aventis Norge AS|Próklórperazín||1048||1048|2263 160531|C10AC0101|Questran|skammtar|4|g|50|skammtar|1|pakki||C10AC01|01.04.1988||R|A|5|0|0|0|0|BRS|0|0|0|100|DKK|2738|4556|lyfalmen|||42|50|0|14|Vistor hf|Bristol-Myers Squibb|Kólestýramín||2738||2738|4556 160622|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|90958|115110|lyfsjukr|||00|200|0|0|Icepharma hf|GE Healthcare AS|Gadódíamíð||90958||90958|115110 160739|M01AB0515|Diklofenak Merck NM|sþ-tfl|50|mg|30|stk|1|þpakki||M01AB05|01.12.2008||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|389|1368|lyfalmen|||10|30|0|15|Actavis Group PTC ehf|Mylan AB|Díklófenak||||389|1368 160852|R01AX0301|Atrovent|nefúði|21|mcg/sk|15|ml|1|glas|180 sk, lausn|R01AX03|01.09.2009||R|A||0|0|E|0|BOI|0|0|1|100|DKK|1635|3059|lyfalmen|||24|15|0|16|Vistor hf|Boehringer Ingelheim|Ípratrópínbrómíð||1635||1635|3059 160945|N02AA5901|Panocod|freyðit|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.01.1992||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|408|1394|lyfalmen|||14|20|0|7|Vistor hf|Sanofi-aventis Norge AS|Kódein í blöndum nema með geðlyfjum||408||408|1394 161065|J05AG0401|Intelence|töflur|100|mg|120|stk|1|glas||J05AG04|01.02.2009||R|A|2|0|1|0|1|JCI|0|0|0|100|SEK|90836|114958|lyfsjukr|||0|120|0|30|Vistor hf|Janssen-Cilag International N.V.|||||90836|114958 161075|H02AB0403|Solu-Medrol|sts|40|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.08.1980||R|A|2|0|0|B|0|PFI|0|0|1|100|DKK|886|2043|lyfalmen|||03|1|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metýlprednisólón||886||886|2043 161091|H02AB0901|Solu-Cortef|sts|250|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|2074|2969|lyfsjukr|||03|1|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Hýdrókortisón||2074||2074|2969 161117|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|5|hgl|Act-O-Vial |H02AB09|01.08.1998||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|3186|4562|lyfsjukr|||03|5|0|17|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Hýdrókortisón||3186||3186|4562 161125|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|813|1944|lyfalmen|||03|1|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Hýdrókortisón||813||813|1944 161133|G03CA0306|Evorel|forðapl|75|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|5872|8809|lyfalmen|||23|26|0|136|Vistor hf|Janssen-Cilag AB|Estradíól||5872||5872|8809 161547|L02BG0601|Aromasin|töflur|25|mg|100|stk|1|þpakki||L02BG06|01.06.2001||R|A|3|0|0|*|0|PFI|0|0|0|100|DKK|69817|89107|lyfalmen|||00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Exemestan||69817||69817|89107 161802|V03AF0401|Isovorin|stl|10|mg/ml|2,5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|WAB|0|0|0|100|USD|3547|5078|lyfsjukr|||00|2|0|1|Icepharma hf|Wyeth AB|Kalsíumlevófólínat||3547||3547|5078 161901|D11AC0301|Selsun|hársápa|25|mg/ml|120|ml|1|glas||D11AC03|01.12.1972||L|A|3|0|0|0|0|CHT|0|0|0|100|IKR|||lyflausa|||01|120|0|120|Vitaflo Scandinavia AB|Chattem Clobal Consumer Products|Selensambönd||||| 162016|V03AF0401|Isovorin|stl|10|mg/ml|5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|WAB|0|0|0|100|USD|6967|9975|lyfsjukr|||00|5|0|2|Icepharma hf|Wyeth AB|Kalsíumlevófólínat||6967||6967|9975 162305|V03AF0401|Isovorin|stl|10|mg/ml|17,5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|WAB|0|0|0|100|USD|22002|29260|lyfsjukr|||00|18|0|6|Icepharma hf|Wyeth AB|Kalsíumlevófólínat||22002||22002|29260 162354|A07EC0101|Salazopyrin|töflur|500|mg|100|stk|1|glas||A07EC01|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|0|100|DKK|2740|4559|lyfalmen|||00|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Súlfasalazín||2740||2740|4559 162929|G04CA0205 |Ranomax|forðahlk|0,4|mg|100|stk|1|þpakki||G04CA02|01.04.2009||R|A|4|0|0|E|0|RAN|0|0|0|100|XEU|5501|7438|lyfalmen|V0437|7438|00|100|0|100|Gróco ehf|Ranbaxy (UK) Ltd|Tamsúlósín||4862||4862|7438 162933|R03BA0501|Flixotide|innúðal|50|mcg/sk|120|sk|1|stauk||R03BA05|01.07.1994||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|2357|4039|lyfalmen|||24|120|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2357||2357|4039 163089|N06BA0401|Ritalin|töflur|10|mg|30|stk|1|þpakki||N06BA04|01.12.1972||R|A|2|1|0|0|0|NOH|0|0|0|100|DKK|1326|2640|lyfalmen|||00|30|0|10|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||1326||1326|2640 163246|P01AB0102|Flagyl|töflur|400|mg|30|stk|1|þpakki||P01AB01|01.10.1995||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|2021|3583|lyfalmen|||41|30|0|6|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||2021||2021|3583 163274|C03AA0304|Dehydratin Neo|töflur|25|mg|20|stk|1|pakki||C03AA03|01.02.2009||R|A|3|0|0|E|0|AEA|0|0|0|100|XEU|235|1159|lyfalmen|||0|20|0|20|Actavis hf|Actavis EAD|||||235|1159 163493|R03BA0501|Flixotide|innúðal|125|mcg/sk|120|sk|1|stauk||R03BA05|01.07.1994||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|3141|5103|lyfalmen|||24|120|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||3141||3141|5103 163709|V03AE0101|Resonium|duft|0| |454|g|1|stauk||V03AE01|01.01.2000||R|A||0|0|0|0|PCO|0|0|0|100|IKR|8140|11887|lyfalmen|||00|454|1|0|Distica|Distica - óskráð lyf|||8140||8140|11887 164251|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.06.2001||R|A|5|0|0|*|0|GSK|0|0|0|100|GBP|2965|4864|lyfalmen|||00|25|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Merkaptópúrín||2965||2965|4864 164807|N04BD0105|Selegilin Mylan|töflur|5|mg|100|stk|1|glas||N04BD01|01.10.1995||R|A|1.5|0|0|E|0|MNA|0|0|0|100|SEK|3003|4916|lyfalmen|||00|100|0|100|Actavis Group PTC ehf|Merck NM AB|Selegilín||||3003|4916 164840|N06AA0406|Klomipramin Mylan|töflur|25|mg|100|stk|1|glas||N06AA04|01.10.1992||R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|956|2138|lyfalmen|||00|100|0|25|Actavis Group PTC ehf|Merck NM AB|Klómípramín||||956|2138 164871|A07EC0204|Asacol|eþ-stil|500|mg|60|stk|1|pakki||A07EC02|01.01.2000||R|A|3|0|0|B|0|TIL|0|0|0|100|SEK|7335|10794|lyfalmen|V0299|10794|98|60|0|20|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||7335||7335|10794 165001|C05AA0102|Proctosedyl|eþ-stil|0| |12|stk|1|pakki||C05AA01|01.12.1972||L|K|1,5|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||04|12|0|0|Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón||||| 165019|C05AA0102|Proctosedyl|eþ-smyr|0| |30|g|1|túpa||C05AA01|01.03.1981||L|A|3|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||00|30|0|0|Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón||||| 165431|C08CA0202|Plendil|forðatfl|2,5|mg|98|stk|1|þpakki||C08CA02|01.01.1992||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|5820|8738|lyfalmen|||43|98|0|49|Vistor hf|AstraZeneca A/S DK|Felódipín||5820||5820|8738 165449|C08CA0202|Plendil|forðatfl|10|mg|98|stk|1|þpakki||C08CA02|01.10.1995||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|5081|7736|lyfalmen|V0324|3906|43|98|0|196|Vistor hf|AstraZeneca A/S DK|Felódipín||5081||5081|7736 165548|C08CA0202|Plendil|forðatfl|5|mg|98|stk|1|þpakki||C08CA02|01.10.1995||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3279|5290|lyfalmen|V0316|2769|43|98|0|98|Vistor hf|AstraZeneca A/S DK|Felódipín||3279||3279|5290 165639|H01CA0201|Synarela|nefúði|200|mcg/sk|4|ml|1|stauk|30 sk|H01CA02|01.04.1992||R|A|2|0|1|E|0|PFI|0|0|0|100|DKK|16714|22994|lyfalmen|||23|4|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Nafarelín||16714||16714|22994 165761|R06AE0501|Postafen|töflur|25|mg|100|stk|1|þpakki||R06AE05|01.12.1972||R|A|5|0|0|E|0|UCN|0|0|1|100|SEK|1034|2244|lyfalmen|||00|100|0|50|Vistor hf|UCB Nordic A/S|Meklózín||1034||1034|2244 165779|R06AE0501|Postafen|töflur|25|mg|25|stk|1|þpakki||R06AE05|01.12.1972||R|A|5|0|0|E|0|UCN|0|0|1|100|SEK|367|1338|lyfalmen|||00|25|0|12|Vistor hf|UCB Nordic A/S|Meklózín||367||367|1338 165787|R06AE0501|Postafen|töflur|25|mg|10|stk|1|þpakki||R06AE05|01.12.1972||L|A|5|0|0|0|0|UCN|0|0|1|100|IKR|||lyflausa|||00|10|0|5|Vistor hf|UCB Nordic A/S|Meklózín||||| 165894|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|227395|284974|lyfsjukr|||00|500|0|0|Icepharma hf|GE Healthcare AS|Gadódíamíð||227395||227395|284974 166033|R06AB0201|Polaramin|forðatfl|6|mg|100|stk|1|þpakki||R06AB02|01.06.1980||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|2869|4734|lyfalmen|||10|100|0|100|Vistor hf|Schering-Plough|Dexklórfeníramín||2869||2869|4734 166090|N05AA0401|Plegicil|töflur|10|mg|10|stk|1|glas||N05AA04|01.03.2007||R|A|5|0|0|0|0|PSW|0|0|0|100|SEK|1073|2296|lyfalmen|||00|10|0|1|Vistor hf|Pharmaxim Sweden AB|Aceprómazín||1073||1073|2296 166157|P01BA0201|Plaquenil|töflur|200|mg|100|stk|1|þpakki||P01BA02|01.12.1972||R|A|3|0|0|B|0|SNO|0|0|0|100|NOK|2780|4613|lyfalmen|||00|100|0|39|Vistor hf|Sanofi-aventis Norge AS|Hydroxýklórókín||2780||2780|4613 166165|H01CA0201|Synarela|nefúði|200|mcg/sk|8|ml|1|stauk|60 sk|H01CA02|01.04.1992||R|A|2|0|1|E|0|PFI|0|0|0|100|DKK|17619|24121|lyfalmen|||23|8|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Nafarelín||17619||17619|24121 166362|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|100|stk|1|glas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|4212|6556|lyfalmen|||10|100|0|100|Actavis Group PTC ehf|Merck NM AB|Naproxen||4212||4212|6556 166709|G04CA0103|Alfuzosin Ranbaxy|forðatfl|10|mg|90|stk|1|þpakki||G04CA01|01.07.2009||R|A||0|0|E|0|RAN|0|0|0|100|XEU|11449|9667|lyfalmen|V0438|9667|00|90|0|120|Gróco ehf|Ranbaxy (UK) Ltd|Alfúzósín||6504||6504|9667 166918|J02AA0102|Amphocil|irs|50|mg/hgl|1|hgl|1|pakki||J02AA01|01.04.1996||R|A|2|0|0|0|1|TRP|0|0|0|100|SEK|30302|39593|lyfsjukr|||00|1|0|1|Vitaflo Scandinavia AB|Three Rivers Pharmaceuticals Limited|Amfóterícín||30302||30302|39593 167007|J02AA0102|Amphocil|irs|100|mg/hgl|1|hgl|1|pakki||J02AA01|01.04.1996||R|A|2|0|0|0|1|TRP|0|0|0|100|SEK|60603|77318|lyfsjukr|||00|1|0|3|Vitaflo Scandinavia AB|Three Rivers Pharmaceuticals Limited|Amfóterícín||60603||60603|77318 167319|N06AX1608|Venlafaxin Actavis|forðahlk|37,5|mg|7|stk|1|þpakki|hart|N06AX16|01.08.2009||R|A||0|0|B|0|AGP|0|0|0|100|XEU|575|1621|lyfalmen|V0953|1621|00|7|0|3|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||||575|1621 168275|M04AA0104|Allopurinol|töflur|100|mg|100|stk|1|þpakki||M04AA01|01.06.2009||R|A|3|0|0|E|0|AUK|0|0|0|100|GBP|656|1731|lyfalmen|||00|100|0|25|Actavis Group hf|Actavis UK Ltd.|Allópúrinol||||656|1731 168309|A02BC0306|Lanser|sþ-hylki|30|mg|98|stk|1|þpakki||A02BC03|01.08.2009||R|A||0|0|E|0|AGP|0|0|0|100|XEU|5729|7126|lyfalmen|||00|98|0|98|Actavis|Actavis Group PTC ehf|Lansóprazól||4632||4632|7126 168716|N03AF0105|Tegretol Retard|forðatfl|200|mg|50|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|1328|2643|lyfalmen|||10|50|0|10|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1328||1328|2643 168740|N03AF0105|Tegretol Retard|forðatfl|200|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|3539|5643|lyfalmen|V0789|5642|10|200|0|40|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||3539||3539|5643 168750|C07AB0209|Metoprolol Actavis|forðatfl|47,5|mg|98|stk|1|þpakki||C07AB02|01.09.2009||R|A||0|0|B|0|AGP|0|0|0|100|XEU|1976|3253|lyfalmen|V2003|3253|00|98|0|31|Actavis Group hf|Actavis Group PTC ehf|Metóprólól||1778||1778|3253 168761|C07AB0209|Metoprolol Actavis|forðatfl|95|mg|98|stk|1|þpakki||C07AB02|01.09.2009||R|A||0|0|B|0|AGP|0|0|0|100|XEU|3102|4670|lyfalmen|V2004|4670|00|98|0|62|Actavis Group hf|Actavis Group PTC ehf|Metóprólól||2822||2822|4670 168815|N03AF0105|Tegretol Retard|forðatfl|400|mg|30|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|1390|2727|lyfalmen|||10|30|0|12|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1390||1390|2727 168971|N03AF0105|Tegretol Retard|forðatfl|400|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|6532|9705|lyfalmen|V0713|9703|10|200|0|80|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||6532||6532|9705 168997|L01CA0401|Navelbine|irþ|10|mg/ml|1|ml|10|hgl||L01CA04|01.03.1998||R|K|3|0|1|0|1|PFP|0|0|0|100|SEK|54591|69833|lyfsjukr|||00|10|0|0|Vistor hf|Pierre Fabre Pharma|Vínorelbín||54591||54591|69833 169433|L01CA0401|Navelbine|irþ|10|mg/ml|5|ml|10|hgl||L01CA04|01.03.1998||R|K|3|0|1|0|1|PFP|0|0|0|100|SEK|247943|310557|lyfsjukr|||00|50|0|0|Vistor hf|Pierre Fabre Pharma|Vínorelbín||247943||247943|310557 169540|P01BB0101|Paludrin|töflur|100|mg|100|stk|1|glas||P01BB01|01.01.1998||R|A||0|0|0|0|PCO|0|0|0|100|IKR|1500|2876|lyfalmen|||00|100|1|50|Distica|Distica - óskráð lyf|||1500||1500|2876 169557|J05AB0601|Cymevene|irs|500|mg|5|hgl|1|pakki|+innr.sía|J05AB06|01.10.1995||R|A|3|0|0|0|1|ROA|0|0|0|100|DKK|28130|36889|lyfsjukr|||00|5|0|5|Icepharma hf|Roche A.S.|Gancíklóvír||28130||28130|36889 169664|J07BK0101|Varilrix|bóluefni|0| |0,5|ml|1|hgl|þurrefni + 0.5 ml leysir|J07BK01|01.10.1995||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|5870|8806|lyfalmen|||02|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Hlaupabóla, veikluð veira||5870||5870|8806 169729|D10BA0105|Isotretinoin Portfarma|hylki|10|mg|30|stk|1|þpakki||D10BA01|01.10.2009||R|A||0|1|C|0|POF|0|0|0|30|IKR|1407|2750|lyfalmen|V0409|2750|67|30|0|10|Portfarma ehf|Portfarma|Ísótretínóín||1407||1407|2750 169740|D10BA0105|Isotretinoin Portfarma|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.10.2009||R|A||0|1|C|0|POF|0|0|0|30|IKR|2450|4165|lyfalmen|V0410|4165|67|30|0|20|Portfarma ehf|Portfarma|Ísótretínóín||2450||2450|4165 169751|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|20|stk|1|þpakki||J01MA02|01.06.2009||R|A|3|0|0|0|0|POF|0|0|1|100|IKR|1168|2425|lyfalmen|V0526|2425|00|20|0|10|Portfarma ehf|Portfarma|Cíprófloxacín||1168||1168|2425 169762|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|10|stk|1|þpakki||J01MA02|01.06.2009||R|A|3|0|0|0|0|POF|0|0|1|100|IKR|647|1718|lyfalmen|V0522|1718|00|10|0|5|Portfarma ehf|Portfarma|Cíprófloxacín||647||647|1718 169773|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|20|stk|1|þpakki||J01MA02|01.06.2009||R|A|3|0|0|0|0|POF|0|0|1|100|IKR|638|1706|lyfalmen|V0518|1706|00|20|0|5|Portfarma ehf|Portfarma|Cíprófloxacín||638||638|1706 169784|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|10|stk|1|þpakki||J01MA02|01.06.2009||R|A|3|0|0|0|0|POF|0|0|1|100|IKR|393|1374|lyfalmen|V0514|1374|00|10|0|2|Portfarma ehf|Portfarma|Cíprófloxacín||393||393|1374 169912|N01BB0102|Marcain|stl|2,5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3477|5559|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|Búpívakaín||3477||3477|5559 169920|N01BB0102|Marcain|stl|5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3737|5912|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|Búpívakaín||3737||3737|5912 170062|L04AC0701|RoActemra|irþ|20|mg/ml|4|ml|1|hgl||L04AC07|01.07.2009||R|A||0|1|0|1|RRL|0|0|0|100|DKK|28168|36937|lyfsjukr|||00|4|0|0|Icepharma hf|Roche Registration Limited|||||28168|36937 170085|L04AC0701|RoActemra|irþ|20|mg/ml|10|ml|1|hgl||L04AC07|01.07.2009||R|A||0|1|0|1|RRL|0|0|0|100|DKK|69910|88905|lyfsjukr|||00|10|0|0|Icepharma hf|Roche Registration Limited|||||69910|88905 170092|J07BC2001|Twinrix Adult|bóluefni|0| |1|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|5376|8136|lyfalmen|||00|1|0|0|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|blöndur||5376||5376|8136 170107|L04AC0701|RoActemra|irþ|20|mg/ml|20|ml|1|hgl||L04AC07|01.07.2009||R|A||0|1|0|1|RRL|0|0|0|100|DKK|139101|175048|lyfsjukr|||00|20|0|0|Icepharma hf|Roche Registration Limited|||||139101|175048 170225|R01AA0702|Otrivin|nefdr|1|mg/ml|10|ml|1|glas||R01AA07|01.12.1972||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|12|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín||||| 170233|R01AA0702|Otrivin|nefdr|0,5|mg/ml|10|ml|1|glas||R01AA07|01.12.1972||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|6|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín||||| 170514|C01BC0301|Rytmonorm|töflur|150|mg|100|stk|1|þpakki||C01BC03|01.04.1996||R|A|5|0|1|B|0|ABS|0|0|0|100|XEU|5661|8523|lyfalmen|||59|100|0|50|Vistor hf|Abbott Scandinavia AB|Própafenón||5661||5661|8523 170548|C01BC0301|Rytmonorm|töflur|300|mg|100|stk|1|þpakki||C01BC03|01.04.1996||R|A|5|0|1|B|0|ABS|0|0|0|100|XEU|10398|14951|lyfalmen|||59|100|0|100|Vistor hf|Abbott Scandinavia AB|Própafenón||10398||10398|14951 170555|N01BB5301|Carbocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|10 mg+5 míkróg/ml|N01BB53|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|2505|4240|lyfalmen|||17|100|0|0|Vistor hf|AstraZeneca A/S DK|||2505||2505|4240 170697|M05BA0406 |Alendronat Actavis|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.06.2009||R|A|2|0|0|E|0|AGP|0|0|0|100|XEU|5489|7528|lyfalmen|V0718|7528|00|12|0|84|Actavis Group hf|Actavis Group PTC ehf|Alendrónsýra||4928||4928|7528 170712|A07AA0901|Vancocin|hylki|125|mg|30|stk|1|þpakki|hart hylki|A07AA09|01.10.1988||R|A|2|0|0|E|0|NMA|0|0|1|100|IKR|10000|14411|lyfalmen|||10|30|0|2|Icepharma hf|NordMedica A/S|Vankómýcín||10000||10000|14411 170997|L01BC0701|Vidaza|irþ|25|mg/ml|100|mg|1|hgl||L01BC07|01.09.2009||R|A||0|1|0|1|CEE|0|0|0|100|XEU|76181|96713|lyfsjukr|||00|100|0|0|Celgene Europe ltd|Celgene Europe ltd|||||76181|96713 171603|N01BB5101|Marcain adrenalin|stl|2,5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|3669|5819|lyfalmen|||17|100|0|0|Vistor hf|AstraZeneca A/S DK|||3669||3669|5819 171611|N01BB5101|Marcain adrenalin|stl|5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|3953|6205|lyfalmen|||17|100|0|0|Vistor hf|AstraZeneca A/S DK|||3953||3953|6205 171777|H03BB0101|Neo-Mercazole|töflur|5|mg|100|stk|1|glas||H03BB01|01.08.2005||R|A||0|0|B|0|LDR|0|0|0|100|NOK|1639|3065|lyfalmen|||00|100|1|33|Parlogis hf|Parlogis - óskráð lyf|||1639||1639|3065 171793|N03AX1101|Topimax|töflur|25|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|4479|6919|lyfalmen|V0709|6916|00|60|0|5|Vistor hf|Janssen-Cilag AB|Tópíramat||4479||4479|6919 171876|N03AX1101|Topimax|töflur|50|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|7372|10845|lyfalmen|V0710|10843|00|60|0|10|Vistor hf|Janssen-Cilag AB|Tópíramat||7372||7372|10845 171991|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|54786|70076|lyfsjukr|||02|75|0|0|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||54786||54786|70076 172049|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|47063|60461|lyfsjukr|||02|50|0|0|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||47063||47063|60461 172353|N03AX1101|Topimax|töflur|100|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|13314|18761|lyfalmen|V0711|18760|00|60|0|20|Vistor hf|Janssen-Cilag AB|Tópíramat||13314||13314|18761 172395|N03AX1101|Topimax|töflur|200|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|27305|36180|lyfalmen|||00|60|0|40|Vistor hf|Janssen-Cilag AB|Tópíramat||27305||27305|36180 172411|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|81796|103704|lyfsjukr|||02|100|0|0|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||81796||81796|103704 172619|L01AB0101|Myleran|töflur|2|mg|100|stk|1|glas||L01AB01|01.06.2001||R|A|3|0|0|*|0|GSK|0|0|0|100|GBP|2994|4903|lyfalmen|||00|100|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Búsúlfan||2994||2994|4903 172627|C07FB0202|Logimax forte|forðatfl|105|mg|98|stk|1|pakki|þp 10 + 95 mg|C07FB02|01.07.1999||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|14909|20747|lyfalmen|||00|98|0|0|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóðþrýst­ings­­lækkandi lyf||14909||14909|20747 172684|N02AA0303|Palladon|forðahlk|4|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|7705|11296|lyfalmen|||10|56|0|11|Icepharma hf|Norpharma |Hýdrómorphón||7705||7705|11296 172692|N02AA0303|Palladon|forðahlk|8|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|14704|20491|lyfalmen|||10|56|0|22|Icepharma hf|Norpharma |Hýdrómorphón||14704||14704|20491 172759|N02AA0303|Palladon|forðahlk|16|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|24456|32633|lyfalmen|||10|56|0|45|Icepharma hf|Norpharma |Hýdrómorphón||24456||24456|32633 172767|J07AJ5204|DiTeKik|bóluefni|0| |0,5|ml|1|hgl||J07AJ52|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|2659|4449|lyfalmen|||51|0|0|0|Icepharma hf|Statens Serum Institut|Kíghósti, í blöndum með öðrum toxóíðum||2659||2659|4449 172775|J07AJ5204|DiTeKik|bóluefni|0| |0,5|ml|1|spr|einnota sprauta|J07AJ52|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|2659|4449|lyfalmen|||51|0|0|0|Icepharma hf|Statens Serum Institut|Kíghósti, í blöndum með öðrum toxóíðum||2659||2659|4449 172825|J07CA0203|DiTeKiPol|bóluefni|0| |0,5|ml|1|spr|einnota sprauta|J07CA02|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|3787|5980|lyfalmen|||51|0|0|0|Icepharma hf|Statens Serum Institut|barnaveiki, kíghósti, mænusótt, stífkrampi||3787||3787|5980 172916|N02AA0303|Palladon|forðahlk|24|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|28076|37140|lyfalmen|||10|56|0|67|Icepharma hf|Norpharma |Hýdrómorphón||28076||28076|37140 173088|N05CD0202|Mogadon|töflur|5|mg|50|stk|1|þpakki||N05CD02|01.12.1972||R|A|5|0|0|0|0|MAB|0|0|1|100|DKK|908|2073|lyfalmen|V0901|2050|00|50|0|50|Vistor hf|Meda AB|Nítrazepam||908||908|2073 173310|N05BE0107|Buspiron Merck NM|töflur|5|mg|100|stk|1|þpakki||N05BE01|01.04.1995||R|A|5|0|0|E|0|MEK|0|0|1|100|SEK|2889|4761|lyfalmen|||00|100|0|17|Actavis Group PTC ehf|Merck NM AB (A)|||2889||2889|4761 173344|A06AG1101|Microlax|innhl|0| |5|ml|12|túpa||A06AG11|01.12.1972||L|A|5|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||56|60|0|12|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||3826 173518|N05BE0107|Buspiron Merck NM|töflur|10|mg|100|stk|1|þpakki||N05BE01|01.04.1995||R|A|5|0|0|E|0|MEK|0|0|1|100|SEK|6167|9209|lyfalmen|||00|100|0|33|Actavis Group PTC ehf|Merck NM AB (A)|||6167||6167|9209 173641|M01AC0202|Tilcotil|töflur|20|mg|10|stk|1|þpakki||M01AC02|01.04.1988||R|A|5|0|0|E|0|MAS|0|0|1|100|SEK|1108|2344|lyfalmen|||00|10|0|10|Vistor hf|Meda AS|Tenoxíkam||1108||1108|2344 173856|N05CF0104|Zopiklon Merck NM|töflur|5|mg|30|stk|1|þpakki||N05CF01|01.10.2001||R|A|2|0|0|0|0|MNA|0|0|1|100|SEK|354|1321|lyfalmen|||00|30|0|20|Actavis Group PTC ehf|Merck NM AB|Zópíklón||354||354|1321 173898|N07AA0201|Mestinon|töflur|10|mg|250|stk|1|glas||N07AA02|01.05.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|2087|3673|lyfalmen|||00|250|1|14|Distica|Distica - óskráð lyf|||2087||2087|3673 173948|N07AA0201|Mestinon|töflur|60|mg|150|stk|1|glas||N07AA02|01.05.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|9140|13244|lyfalmen|||00|150|1|50|Distica|Distica - óskráð lyf|||9140||9140|13244 173955|N05BA0106|Stesolid Novum|stl|5|mg/ml|2|ml|10|lykjur||N05BA01|01.07.1985||R|A|2|0|0|0|1|AGT|0|0|0|100|DKK|1596|2285|lyfsjukr|||02|20|0|10|Actavis Group hf|Actavis Group hf|Díazepam||1596||1596|2285 174300|J01CE0204|Kaavepenin|töflur|800|mg|14|stk|1|þpakki||J01CE02|01.01.1989||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|676|1758|lyfalmen|||00|14|0|6|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||676||676|1758 174359|J01CE0204|Kaavepenin|töflur|1|g|14|stk|1|þpakki||J01CE02|01.01.1989||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|692|1779|lyfalmen|||00|14|0|7|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||692||692|1779 174433|S01EA0501 |Alphagan|augndr|2|mg/ml|5|ml|1|glas||S01EA05|01.04.2009||R|A|4|0|0|*|0|ALL|0|0|0|100|SEK|2067|3645|lyfalmen|||00|5|0|25|Vistor hf|Allergan|||||2067|3645 174615|N05CF0104|Zopiklon Merck NM|töflur|7,5|mg|30|stk|1|þpakki||N05CF01|01.09.1999||R|A|2|0|0|0|0|MNA|0|0|0|100|SEK|261|1195|lyfalmen|V0886|1195|00|30|0|30|Actavis Group PTC ehf|Merck NM AB|Zópíklón||||261|1195 174664|S01EA0501 |Alphagan|augndr|2|mg/ml|5|ml|3|glös||S01EA05|01.04.2009||R|A|4|0|0|*|0|ALL|0|0|0|100|SEK|6062|9067|lyfalmen|||00|15|0|150|Vistor hf|Allergan|||||6062|9067 175612|J05AB1101|Valtrex|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.10.1996||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|2671|3941|lyfalmen|V0507|3941|00|10|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||2285||2285|3941 176214|N05AH0301|Zyprexa|húðuðtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.01.1999||R|A|2|0|0|*|0|ELD|0|1|0|100|XEU|7682|5415|lyfalmen|V0809|4652|00|28|0|7|Icepharma hf|Eli Lilly Nederland -|Olanzapín||3371||3371|5415 177022|J01MA0101|Tarivid|töflur|200|mg|20|stk|1|þpakki||J01MA01|01.10.1988||R|A|3|0|0|0|0|SNO|0|0|1|100|NOK|4928|7528|lyfalmen|||00|20|0|10|Vistor hf|Sanofi-aventis Norge AS|Ófloxacín||4928||4928|7528 177253|N03AG0101|Depakine|sh-tfl|200|mg|40|stk|1|glas||N03AG01|01.04.1986||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|861|2009|lyfalmen|||43|40|0|5|Vistor hf|Sanofi-aventis Norge AS|Valpróínsýra||861||861|2009 177295|M02AA1501|Voltaren Emulgel|hlaup|11,6|mg/g|50|g|1|túpa||M02AA15|01.10.2004||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|50|0|0|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak||||| 177311|QJ51RC2202|Nafpenzal vet.|spenalyf|0| |3|g|4|spr||QJ51RC22|01.04.1985||R|A|2|0|0|0|0|INI|0|0|0|100|XEU|733|1446|vetalmen|||16|12|0|0|Icepharma hf|Intervet International B.V.|||733||733|1446 177360|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|1|hgl|5 + 2 mg/ml|H02AB01|01.09.2004||R|A|2|0|0|B|0|SPL|0|0|1|100|DKK|849|1993|lyfalmen|||03|1|0|5|Vistor hf|Schering-Plough Europe|Betametasón||849||849|1993 178004|H02AB0801|Kenalog|stl|40|mg/ml|1|ml|1|hgl||H02AB08|01.02.2002||R|A|3|0|0|E|0|PCO|0|0|1|100|IKR|632|1698|lyfalmen|||03|1|1|5|Distica|Distica - óskráð lyf|Tríamcínólón||632||632|1698 179267|M03AC0901|Esmeron|stl|10|mg/ml|5|ml|12|hgl||M03AC09|01.01.1997||R|K|3|0|0|0|1|ORG|0|0|0|100|DKK|11701|16435|lyfsjukr|||00|60|0|0|Vistor hf|N.V. Organon|Rókúrón, brómíð||11701||11701|16435 179333|R02AA0304|Strepsils Menthol|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.12.2005||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||| 180166|A07EC0301|Dipentum|hylki|250|mg|100|stk|1|glas||A07EC03|01.01.1990||R|A|5|0|0|B|0|UCB|0|0|0|100|DKK|6675|9899|lyfalmen|||10|100|0|25|Vistor hf|U.C.B|Olsalazín||6675||6675|9899 180539|R01AA0705|Otrivin Menthol ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.05.2001||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|12|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín||||| 180646|C10AA0302|Pravachol|töflur|20|mg|98|stk|1|þpakki||C10AA03|01.08.2008||R|A|2|0|0|0|0|BRS|0|0|0|100|DKK|17792|24336|lyfalmen|||00|98|0|65|Vistor hf|Bristol-Myers Squibb|Pravastatín||17792||17792|24336 180729|S03CA0401|Hydrocortison m.Terram.|aug.eydr|0| |5|ml|1|túpa|+ Polymyxin B|S03CA04|01.11.1981||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|925|2096|lyfalmen|||30|5|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Hýdrókortisón og sýkingalyf||925||925|2096 181131|J01EE0103|Primazol|mixtúra|48|mg/ml|100|ml|1|glas|8+40 mg/ml|J01EE01|01.04.1989||R|A|2|0|0|0|0|ACA|0|0|1|100|XEU|855|2001|lyfalmen|||01|100|0|2|Actavis Group hf|Actavis hf|Súlfametoxazól og trímetóprím||855||855|2001 181255|G01AF0201|Canesten|sk-krem|10|mg/g|50|g|1|sett|+stjaka|G01AF02|01.12.1982||L|A|3|0|0|0|0|BAS|0|0|0|100|IKR|||lyflausa|||23|50|0|5|Vistor hf|Bayer A/S|Klótrímazól||||| 181552|QJ51DA3201|Pathozone, vet.|spenalyf|250|mg/dælu|10|ml|10|dælur|dæla + rýja|QJ51DA32|01.10.1995||R|A|1,5|0|0|0|0|PFV|0|0|0|100|DKK|8642|16633|vetalmen|||16|100|0|0|Icepharma hf|Pfizer vet.|||8642||8642|16633 181750|L01BA0105|Methotrexate Wyeth Lederle|irþ|100|mg/ml|10|ml|1|hgl||L01BA01|01.04.1991||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|11346|15993|lyfsjukr|||00|10|0|0|Icepharma hf|Wyeth AB|Metótrexat||11346||11346|15993 181990|L01BA0105|Methotrexate Wyeth Lederle|irþ|100|mg/ml|50|ml|1|hgl||L01BA01|01.04.1991||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|42829|55190|lyfsjukr|||00|50|0|0|Icepharma hf|Wyeth AB|Metótrexat||42829||42829|55190 182170|QM01AG9001|Finadyne, vet.|kyrni|25|mg/g|10|g|10|skammt||QM01AG90|01.01.1991||R|A|2|0|0|0|0|IBV|0|0|0|100|DKK|5661|10955|vetalmen|||16|100|0|0|Vistor hf|Intervet International BV|||5661||5661|10955 183327|QM01AG9001|Finadyne, vet.|stl|50|mg/ml|50|ml|1|hgl||QM01AG90|01.07.1992||R|A|2|0|0|0|0|IBV|1|0|0|100|DKK|6257|12090|vetalmen|||27|50|0|0|Vistor hf|Intervet International BV|||6257||6257|12090 183871|H02AA0201|Florinef|töflur|0,1|mg|100|stk|1|glas||H02AA02|01.12.1972||R|K|2|0|0|B|0|BRS|0|0|0|100|DKK|1379|2712|lyfalmen|||00|100|0|100|Vistor hf|Bristol-Myers Squibb|Flúdrókortisón||1379||1379|2712 183947|P01AB0102|Flagyl|töflur|200|mg|21|stk|1|þpakki||P01AB01|01.10.1995||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|1008|2208|lyfalmen|||41|21|0|2|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1008||1008|2208 184143|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|2|stk|1|þpakki||N02CC03|01.05.2001|31.08.2009|R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|1692|3137|lyfalmen|||00|2|0|2|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||1692||1692|3137 184176|J01CR0201|Amoksiklav|mixtúrud|31,25|mg/ml|100|ml|1|glas|25+6.25 mg/ml|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|437|1433|lyfalmen|||08|100|0|2|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||437||437|1433 184192|J01CR0201|Amoksiklav|mixtúrud|62,5|mg/ml|100|ml|1|glas|50+12.5 mg/ml|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|795|1919|lyfalmen|||08|100|0|5|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||795||795|1919 184200|J01CR0201|Amoksiklav|töflur|375|mg|15|stk|1|glas|250+125 mg|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|555|1594|lyfalmen|||00|15|0|4|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||555||555|1594 184234|A07EC0204|Asacol|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.02.2000||R|A|3|0|0|B|0|TIL|0|0|0|100|SEK|5088|7745|lyfalmen|||98|700|0|5|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||5088||5088|7745 184259|L02BG0401|Femar|töflur|2,5|mg|30|stk|1|þpakki||L02BG04|01.03.1998||R|A|5|0|0|*|0|NOH|0|0|0|100|DKK|27054|35867|lyfalmen|||00|30|0|30|Vistor hf|Novartis Healthcare A/S-|Letrózól||27054||27054|35867 184275|L02BG0401|Femar|töflur|2,5|mg|100|stk|1|þpakki||L02BG04|01.03.1998||R|A|5|0|0|*|0|NOH|0|0|0|100|DKK|64085|81971|lyfalmen|V0563|81970|00|100|0|100|Vistor hf|Novartis Healthcare A/S-|Letrózól||64085||64085|81971 184341|J01CR0201|Amoksiklav|töflur|625|mg|16|stk|1|glas|500+125 mg|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1104|2339|lyfalmen|||00|16|0|8|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1104||1104|2339 184432|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|6|stk|1|þpakki||N02CC03|01.05.2001||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|5580|8413|lyfalmen|||00|6|0|6|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||5580||5580|8413 184671|N06AX0306|Mianserin Merck NM|filmhtfl|10|mg|90|stk|1|þpakki||N06AX03|01.06.2008||R|A|3|0|0|B|0|MNA|0|1|0|100|SEK|1198|2466|lyfalmen|V1140|2466|00|90|0|15|Actavis Group PTC ehf|Merck NM AB|Míanserín||1198||1198|2466 187203|B01AA0101|Dicumarol|töflur|20|mg|100|stk|1|glas||B01AA01|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|5152|7832|lyfalmen|||00|100|1|20|Distica|Distica - óskráð lyf|||5152||5152|7832 188631|N03AG0102|Orfiril|mixtúra|60|mg/ml|250|ml|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|3397|5450|lyfalmen|||00|250|0|10|Vistor hf|Desitin Artzneimittel|Valpróínsýra||3397||3397|5450 188987|S01EC0101|Diamox|töflur|250|mg|100|stk|1|glas||S01EC01|01.12.1972||R|A|4|0|0|*|0|GPL|0|0|0|100|XEU|2359|4042|lyfalmen|||00|100|0|33|Icepharma hf|Goldshield Pharmaceuticals Ltd|Acetazólamíð||2359||2359|4042 189175|V03AC0101|Desferal|irs|500|mg|10|hgl|1|pakki|lausn|V03AC01|01.04.2007||R|A|4|0|0|0|1|NOV|0|0|0|100|DKK|12080|16907|lyfsjukr|||00|10|0|0|Icepharma hf|Novartis Healthcare A/S|Deferoxamín||12080||12080|16907 189506|H02AB0401|Depo-Medrol|stl|40|mg/ml|5|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|3525|5624|lyfalmen|||03|5|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metýlprednisólón||3525||3525|5624 189514|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|1192|2458|lyfalmen|||03|2|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metýlprednisólón||1192||1192|2458 189522|H02AB0401|Depo-Medrol|stl|40|mg/ml|1|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|577|1623|lyfalmen|||03|1|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metýlprednisólón||577||577|1623 190702|M01AB0101|Confortid|eþ-stil|100|mg|10|stk|1|pakki||M01AB01|01.12.1972||R|A|3|0|0|E|0|AGT|0|0|1|100|DKK|936|2111|lyfalmen|||04|10|0|10|Actavis Group hf|Actavis Group hf|Indómetacín||936||936|2111 190728|M01AB0101|Confortid|eþ-stil|50|mg|10|stk|1|pakki||M01AB01|01.12.1972||R|A|3|0|0|E|0|AGT|0|0|1|100|DKK|507|1528|lyfalmen|||04|10|0|5|Actavis Group hf|Actavis Group hf|Indómetacín||507||507|1528 190751|M01AB0101|Confortid|hylki|25|mg|100|stk|1|glas||M01AB01|01.12.1972||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|2057|3632|lyfalmen|||10|100|0|25|Actavis Group hf|Actavis Group hf|Indómetacín||2057||2057|3632 191064|B05XC03|Vitalipid Infant|irþ|0| |10|ml|10|lykjur||B05XC|01.10.1985||R|K|2|0|0|0|1|FRP|0|0|0|100|DKK|5188|7428|lyfsjukr|||00|100|0|0|Icepharma hf|Fresenius Kabi|||5188||5188|7428 191247|B05XC02|Vitalipid Adult|irþ|0| |10|ml|10|lykjur||B05XC|01.10.1985||R|K|2|0|0|0|1|FRP|0|0|0|100|DKK|5291|7575|lyfsjukr|||00|100|0|0|Icepharma hf|Fresenius Kabi|||5291||5291|7575 191254|B05XC01|Soluvit|irs|0| |10|ml|10|hgl||B05XC|01.10.1985||R|K||0|0|0|1|FRP|0|0|0|100|DKK|6832|9782|lyfsjukr|||00|100|0|0|Icepharma hf|Fresenius Kabi|||6832||6832|9782 191403|R01AA0503|Nezeril|nefúði|0,25|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|A|3|0|0|0|0|GCO|0|0|1|100|IKR|||lyflausa|||23|8|0|5|Vistor hf|GlaxoSmithKline CH AB|Oxýmetazólín||||| 191916|S01AA0101|Chloromycetin|augnsm|10|mg/g|4|g|1|túpa||S01AA01|01.12.1972|31.10.2009|R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|571|1615|lyfalmen|||07|4|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klóramfeníkól||571||571|1615 192617|C03AB0101|Centyl med kaliumklorid|sh-tfl|0| |100|stk|1|glas||C03AB01|01.12.1972||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|1865|3371|lyfalmen|||10|100|0|100|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíð og kalíum||1865||1865|3371 192625|C03AB0101|Centyl med kaliumklorid|sh-tfl|0| |25|stk|1|glas||C03AB01|01.12.1972||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|520|1546|lyfalmen|||10|25|0|25|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíð og kalíum||520||520|1546 193573|R06AB0201|Polaramin|forðatfl|6|mg|25|stk|1|þpakki||R06AB02|01.10.1991||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|782|1902|lyfalmen|||10|25|0|25|Vistor hf|Schering-Plough|Dexklórfeníramín||782||782|1902 193821|A12AA0601|Calcium-Sandoz|freyðit|500|mg|20|stk|1|glas||A12AA06|01.12.1972||L|A|3|0|0|0|0|SAN|0|0|0|100|IKR|||lyfalmen|||14|20|0|22|Vistor hf|Sandoz A/S|Kalsíumlaktóglúkónat|||||2085 193862|A12AA0201|Calcium Sandoz|stl|100|mg/ml|10|ml|5|lykjur||A12AA02|01.12.1972||R|A|5|0|0|0|0|SAN|0|0|0|100|DKK|1306|2613|lyfalmen|||02|50|0|3|Vistor hf|Sandoz A/S|Kalsíumglúbíónat||1306||1306|2613 194076|N02CA5201|Cafergot|töflur|0| |20|stk|1|þpakki||N02CA52|01.03.1999||R|A|3|0|0|E|0|LDR|0|0|0|100|IKR|2645|4430|lyfalmen|||00|20|1|5|Parlogis hf|Parlogis - óskráð lyf|||2645||2645|4430 194209|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|2|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|1235|1768|lyfsjukr|||02|2|0|0|Icepharma hf|Wyeth AB|Metótrexat||1235||1235|1768 194258|A03BB0101|Buscopan|töflur|10|mg|100|stk|1|glas||A03BB01|01.12.1972||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|2386|4078|lyfalmen|||00|100|0|17|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||2386||2386|4078 194266|A03BB0101|Buscopan|töflur|10|mg|20|stk|1|glas||A03BB01|01.12.1972||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|574|1619|lyfalmen|||00|20|0|3|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||574||574|1619 194720|N03AX0901|Lamictal|dreifit.|5|mg|28|stk|1|þpakki||N03AX09|01.01.1996|31.08.2009|R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|639|1708|lyfalmen|||00|28|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||639||639|1708 194977|J01MA0202|Ciproxin|töflur|250|mg|10|stk|1|þpakki||J01MA02|01.10.1988||R|A|5|0|0|0|0|BAV|0|0|1|100|SEK|2134|3736|lyfalmen|V0514|1374|00|10|0|2|Vistor hf|Bayer Schering Pharma AG (V)|Cíprófloxacín||2134||2134|3736 194985|J01MA0202|Ciproxin|töflur|250|mg|20|stk|1|þpakki||J01MA02|01.10.1988||R|A|5|0|0|0|0|BAV|0|0|1|100|SEK|4629|7122|lyfalmen|V0518|1706|00|20|0|5|Vistor hf|Bayer Schering Pharma AG (V)|Cíprófloxacín||4629||4629|7122 195032|J01MA0202|Ciproxin|töflur|500|mg|10|stk|1|þpakki||J01MA02|01.01.1991||R|A|5|0|0|0|0|BAV|0|0|1|100|SEK|4533|6992|lyfalmen|V0522|1718|00|10|0|5|Vistor hf|Bayer Schering Pharma AG (V)|Cíprófloxacín||4533||4533|6992 195040|C07AB0311|Atenolol Mylan|töflur|25|mg|250|stk|1|glas||C07AB03|01.07.2009||R|A||0|0|B|0|MYL|0|0|0|100|SEK|1428|2778|lyfalmen|||00|250|0|83|Actavis Group PTC ehf|Mylan AB|Atenólól||||1428|2778 195065|J01MA0202|Ciproxin|töflur|500|mg|20|stk|1|þpakki||J01MA02|01.01.1991||R|A|5|0|0|0|0|BAV|0|0|1|100|SEK|8793|12773|lyfalmen|V0526|2425|00|20|0|10|Vistor hf|Bayer Schering Pharma AG (V)|Cíprófloxacín||8793||8793|12773 195149|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|5|lykjur||B03BA02|01.11.1981||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|2234|3872|lyfalmen|||03|5|0|250|Actavis Group hf|Actavis Group hf|Cýanókóbalamíntannín-komplex||2234||2234|3872 195156|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|1|lykja||B03BA02|01.12.1972||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|913|2079|lyfalmen|||03|1|0|50|Actavis Group hf|Actavis Group hf|Cýanókóbalamíntannín-komplex||913||913|2079 195354|A07DA0301|Imodium|töflur|2|mg|40|stk|1|þpakki||A07DA03|01.10.1991||R|A|5|0|0|E|0|JAS|0|0|0|100|SEK|1043|2256|lyfalmen|||10|40|0|8|Vistor hf|Janssen-Cilag AB|Lóperamíð||1043||1043|2256 195610|G03AC0801|Implanon|vefjalyf|68|mg|1|stk|1|pakki||G03AC08|01.02.2001||R|A|5|0|0|0|0|ORG|0|0|0|100|DKK|25175|33528|lyfalmen|||00|1|0|1015|Vistor hf|N.V. Organon|Etónógestrel||25175||25175|33528 195669|D01AC2002|Pevisone|krem|0| |15|g|1|túpa||D01AC20|01.10.1988||R|A|4|0|0|0|0|JAS|0|0|1|100|SEK|805|1933|lyfalmen|||20|15|0|15|Vistor hf|Janssen-Cilag AB|Blöndur||805||805|1933 195768|R01BA0101|Rinexin|forðatfl|50|mg|30|stk|1|þpakki||R01BA01|01.03.1981||R|A|5|0|0|E|0|REP|0|0|1|100|SEK|388|1367|lyfalmen|||10|30|0|15|Vistor hf|Recip AB|Fenýlprópanólamín||388||388|1367 195776|R01BA0101|Rinexin|forðatfl|50|mg|100|stk|1|glas||R01BA01|01.03.1981||R|A|5|0|0|E|0|REP|0|0|1|100|SEK|919|2088|lyfalmen|||10|100|0|50|Vistor hf|Recip AB|Fenýlprópanólamín||919||919|2088 196022|C07AB0311|Atenolol Mylan|töflur|50|mg|250|stk|1|glas||C07AB03|01.07.2009||R|A||0|0|B|0|MYL|0|0|0|100|SEK|1662|3096|lyfalmen|||00|250|0|167|Actavis Group PTC ehf|Mylan AB|Atenólól||||1662|3096 196121|G03AB0302|Triquilar|töflur|80|mcg|63|stk|1|pakki|þp, 50+30 míkróg etc.|G03AB03|01.01.1985||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|1464|2827|lyfalmen|||23|63|0|84|Icepharma hf|Bayer Schering Pharma AG|Levónorgestrel og östrógen||1464||1464|2827 197103|QH01CA9001|Receptal, vet.|stl|4|mcg/ml|10|ml|1|hgl||QH01CA90|01.07.1998||R|A|5|0|0|0|0|INI|1|0|0|100|DKK|2966|5821|vetalmen|||27|10|0|0|Icepharma hf|Intervet International B.V.|||2966||2966|5821 197111|QH01CA9001|Receptal, vet.|stl|4|mcg/ml|10|ml|5|hgl||QH01CA90|01.07.1986||R|A|5|0|0|0|0|INI|1|0|0|100|DKK|14124|27075|vetalmen|||27|50|0|0|Icepharma hf|Intervet International B.V.|||14124||14124|27075 197343|D11AX0101|Regaine|húðlausn|20|mg/ml|60|ml|1|glas||D11AX01|01.10.1988||L|A|4|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||00|60|0|60|Vistor hf|McNeil Denmark ApS|Mínoxidíl|||||6701 197400|S01GA5101|Antistina-Privin|augndr|5,25|mg/ml|10|ml|1|glas|5+0,25 mg|S01GA51|01.03.1981||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|883|2039|lyfalmen|||06|10|0|0|Vistor hf|Novartis Healthcare A/S-|Nafazólín í blöndum með öðrum efnum||883||883|2039 197533|N03AX0901|Lamictal|dreifit.|100|mg|56|stk|1|þpakki||N03AX09|01.01.1996|31.08.2009|R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|3690|5347|lyfalmen|||00|56|0|19|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||3321||3321|5347 197657|N05BA1203|Tafil|töflur|1|mg|20|stk|1|þpakki||N05BA12|01.10.1990||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|988|2181|lyfalmen|V0857|1720|00|20|0|20|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||988||988|2181 197673|N05BA1203|Tafil|töflur|1|mg|100|stk|1|þpakki||N05BA12|01.10.1990||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|4679|7190|lyfalmen|||00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||4679||4679|7190 197848|N01BB0203|Xylocain|hlaup|20|mg/ml|10|g|10|plspr||N01BB02|01.10.2003||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|2329|4001|lyfalmen|||00|100|0|0|Vistor hf|AstraZeneca A/S DK|Lídókaín||2329||2329|4001 198580|L01AA0301|Alkeran|töflur|2|mg|25|stk|1|glas||L01AA03|01.06.2001||R|K|2|0|1|*|0|GSK|0|0|0|100|GBP|1809|3295|lyfalmen|||00|25|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Melphalan||1809||1809|3295 198648|L01BC0203|Flurablastin|stl|50|mg/ml|20|ml|10|hgl||L01BC02|01.04.1991||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|11780|16534|lyfsjukr|||02|200|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúóróúracíl||11780||11780|16534 198861|N04AA0201|Akineton|stl|5|mg/ml|1|ml|5|lykjur||N04AA02|01.12.1975||R|A|5|0|0|0|1|LFS|0|1|0|100|DKK|482|690|lyfsjukr|||02|5|0|2|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||482||482|690 199091|L01XX1101|Estracyt|hylki|140|mg|100|stk|1|glas||L01XX11|01.12.1978||R|A|5|0|0|*|0|PFI|0|0|0|100|DKK|42998|55717|lyfalmen|||00|100|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Estramústín||42998||42998|55717 199307|L01CB0101|Vepesid|stl|20|mg/ml|5|ml|10|hgl||L01CB01|01.01.1998|30.09.2009|R|A||0|1|0|1|PCO|0|0|0|100|IKR|29063|38051|lyfsjukr|||00|50|1|0|Distica|Distica - óskráð lyf|||29063||29063|38051 199539|N05CD0503|Halcion|töflur|0,25|mg|30|stk|1|þpakki||N05CD05|01.11.1981||R|A|4|0|0|0|0|PFI|0|0|1|100|DKK|729|1830|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Tríazólam||729||729|1830 199737|G02CB0301|Dostinex|töflur|0,5|mg|8|stk|1|glas||G02CB03|01.07.1993||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|7261|10694|lyfalmen|||44|8|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Kabególín||7261||7261|10694 199836|B01AC1301|ReoPro|stl|2|mg/ml|5|ml|1|hgl||B01AC13|01.09.1997||R|K|3|0|0|0|1|CET|0|0|0|100|XEU|65278|83139|lyfsjukr|||00|5|0|0|Icepharma hf|Centocor -|Abciximab||65278||65278|83139 300373|A05AA0201|Destolit|töflur|150|mg|60|stk|1|glas||A05AA02|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|GBP|5636|8311|lyfalmen|||00|60|1|12|Distica|Distica - óskráð lyf|||5505||5505|8311 327817|A03AA0701|Dicykloverinklorid|mixtúra|1|mg/ml|100|ml|1|glas|sykursaft|A03AA07|01.01.2000||R|A||0|1|E|0|LDR|0|0|0|100|IKR|4615|7103|lyfalmen|||00|100|1|1|Parlogis hf|Parlogis - óskráð lyf|||4615||4615|7103 335968|A04AD0102|Skopolamin|stl|0,3|mg/ml|1|ml|10|lykjur||A04AD01|01.01.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|6034|9029|lyfalmen|||00|10|1|0|Parlogis hf|Parlogis - óskráð lyf|Skópólamín||6034||6034|9029 336792|A03AA0701|Dicykloverinklorid|mixtúra|1|mg/ml|100|ml|1|glas|sykurlaus|A03AA07|01.01.1998||R|A||0|1|E|0|LDR|0|0|0|100|IKR|2125|3724|lyfalmen|||00|100|1|1|Parlogis hf|Parlogis - óskráð lyf|||2125||2125|3724 338236|C01CA0301|Noradrenalin|stl|1|mg/ml|2|ml|10|lykjur||C01CA03|01.01.2000||R|A||0|0|0|1|LDR|0|0|0|100|IKR|3940|5641|lyfsjukr|||00|20|1|3|Parlogis hf|Parlogis - óskráð lyf|||3940||3940|5641 370007|B02BA0102|Konakion Novum|stl|10|mg/ml|0,2|ml|5|lykjur||B02BA01|01.10.1995||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|662|948|lyfsjukr|||02|1|0|0|Icepharma hf|Roche|Fýtómenadíón||662||662|948 370353|V08AB0501|Ultravist|stl/irl|300|mg J/ml|20|ml|10|hgl||V08AB05|01.04.1989||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|21170|28224|lyfsjukr|||02|200|0|0|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||21170||21170|28224 370940|J01DB0401|Kefzol|sts|1|g|1|stk|1|hgl||J01DB04|01.07.1995||R|A|2|0|0|0|1|NOM|0|0|0|100|DKK|676|968|lyfsjukr|||03|1|0|0|Icepharma hf|NordMedica ApS|Cefazólín||676||676|968 371583|A06AG1001|Klyx|innhl|0| |240|ml|1|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||23|240|0|1|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum||||| 371609|A06AG1001|Klyx|innhl|0| |120|ml|1|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||23|120|0|1|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum||||| 371617|A06AG1001|Klyx|innhl|0| |120|ml|10|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|SEK|||lyfalmen|||23|1200|0|10|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||9747 371658|A02BA0201|Asyran|töflur|150|mg|10|stk|1|þpakki||A02BA02|01.10.1995||L|A|3|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||00|10|0|5|Actavis Group hf|Actavis hf|Ranitidín||||| 372037|N05AL0501|Solian|töflur|50|mg|30|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|3376|5422|lyfalmen|||00|30|0|4|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||3376||3376|5422 372045|N05AL0501|Solian|töflur|50|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|7887|11543|lyfalmen|||00|90|0|11|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||7887||7887|11543 372151|N04BA0209|Madopar Quick "125"|lausnart|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.11.2000||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|4771|7315|lyfalmen|||00|100|0|17|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||4771||4771|7315 372177|N07BA0103|Nicorette|innsogsl|10|mg|42|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|42|0|7|Vistor hf|McNeil Denmark ApS|Nikótín||||| 372185|N07BA0103|Nicorette|innsogsl|10|mg|18|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|18|0|3|Vistor hf|McNeil Denmark ApS|Nikótín||||| 372714|N05AL0501|Solian|töflur|200|mg|30|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|11284|16153|lyfalmen|||00|30|0|15|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||11284||11284|16153 372722|B02BD0801|NovoSeven|sts|1,2|mg|1|hgl|1|pakki|+leysir|B02BD08|01.10.2006||R|K|2|0|0|0|1|NON|0|0|0|100|DKK|120786|152246|lyfsjukr|||00|1|0|0|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||120786||120786|152246 372730|B02BD0801|NovoSeven|sts|2,4|mg|1|hgl|1|pakki|+leysir|B02BD08|01.10.2006||R|K|2|0|0|0|1|NON|0|0|0|100|DKK|240905|301794|lyfsjukr|||00|1|0|0|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||240905||240905|301794 372748|B02BD0801|NovoSeven|sts|4,8|mg|1|hgl|1|pakki|+leysir|B02BD08|01.10.2006||R|K|2|0|0|0|1|NON|0|0|0|100|DKK|637310|795318|lyfsjukr|||00|1|0|0|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||637310||637310|795318 373001|G03AB0501|Gracial|töflur|0| |66|stk|1|pakki|þp 3 x (15+7 stk)|G03AB05|01.07.1998||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|2893|4766|lyfalmen|||23|66|0|88|Vistor hf|N.V. Organon|Desógestrel og östrógen||2893||2893|4766 373241|N05AL0501|Solian|töflur|200|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|21874|29418|lyfalmen|||00|90|0|45|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||21874||21874|29418 373324|R03AK0602|Seretide Diskus|innúðadu|150|mcg/sk|60|sk|1|pakki|50+100 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|B|0|GSK|0|0|0|100|GBP|4585|7062|lyfalmen|||23|60|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||4585||4585|7062 373340|R03AK0602|Seretide Diskus|innúðadu|300|mcg/sk|60|sk|1|pakki|50+250 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|B|0|GSK|0|0|0|100|GBP|7161|10558|lyfalmen|||23|60|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||||7161|10558 373365|R03AK0602|Seretide Diskus|innúðadu|550|mcg/sk|60|sk|1|pakki|50+500 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|B|0|GSK|0|0|0|100|GBP|9372|13559|lyfalmen|||23|60|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||||9372|13559 373951|G02CB0301|Dostinex|töflur|0,5|mg|2|stk|1|glas||G02CB03|01.04.1998||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|3375|5420|lyfalmen|||44|2|0|1|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Kabególín||3375||3375|5420 374231|A10BA0201|Glucophage|töflur|500|mg|100|stk|1|þpakki||A10BA02|01.01.1987||R|A|5|0|0|*|0|MCK|0|0|0|100|XEU|729|1830|lyfalmen|||00|100|0|25|Icepharma hf|Merck Santé s.a.s.|Metformín||729||729|1830 374348|G04CA0201|Omnic|forðahlk|0,4|mg|30|stk|1|þpakki||G04CA02|01.08.1998||R|A|4|0|0|E|0|YAM|0|0|0|100|XEU|5303|8037|lyfalmen|||00|30|0|30|Vistor hf|Yamanouchi Europe|Tamsúlósín||5303||5303|8037 374397|J05AB1101|Valtrex|töflur|250|mg|60|stk|1|þpakki||J05AB11|01.01.2003||R|A|2|0|0|E|0|GSK|0|0|1|100|GBP|12042|17177|lyfalmen|||00|60|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||12042||12042|17177 374504|G01AF0502|Pevaryl Depot|krem/sti|0| |15|g|1|sett|kr.+1sk-stíll m.forðaverkun|G01AF05|01.01.1997||L|A|3|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||00|15|0|2|Vistor hf|Janssen-Cilag AB|Ekónazól||||| 374520|L02BB0301|Casodex|töflur|50|mg|30|stk|1|þpakki||L02BB03|01.04.1997||R|A|5|0|0|*|0|ASZ|0|0|0|100|SEK|13724|19271|lyfalmen|V0560|19271|00|30|0|30|Vistor hf|AstraZeneca UK Ltd|Bíkalútamíð||13724||13724|19271 374579|R01AC0101|Lomudal Nasal|nefúði|5,2|mg/sk|15|ml|1|glas||R01AC01|01.10.1992||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|3045|4973|lyfalmen|||23|15|0|15|Vistor hf|Sanofi-aventis Norge AS|Krómóglíkatsýra||3045||3045|4973 374587|B01AB0501|Klexane|stl|100|mg/ml|0,6|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|8749|12713|lyfalmen|||00|6|0|30|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||8749||8749|12713 374595|B01AB0501|Klexane|stl|100|mg/ml|0,8|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|9729|14043|lyfalmen|||00|8|0|40|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||9729||9729|14043 374603|B01AB0501|Klexane|stl|100|mg/ml|1|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|13262|18696|lyfalmen|||00|10|0|50|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||13262||13262|18696 377242|J01FA0901|Klacid|töflur|500|mg|14|stk|1|þpakki||J01FA09|01.04.1992||R|A|5|0|0|0|0|ABS|0|0|1|100|DKK|5182|7873|lyfalmen|||63|14|0|14|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||5182||5182|7873 377259|J01FA0901|Klacid|töflur|500|mg|100|stk|1|glas||J01FA09|01.04.1992||R|A|2|0|0|0|0|ABS|0|0|1|100|DKK|42391|54962|lyfalmen|||63|100|0|100|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||42391||42391|54962 377333|J05AB1101|Valtrex|töflur|500|mg|42|stk|1|þpakki||J05AB11|01.10.1996||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|11662|14361|lyfalmen|V0508|14361|00|42|0|7|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||9963||9963|14361 379669|H01CB0202|Sandostatin Lar|sts|10|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|181947|228392|lyfsjukr|||00|2|0|14|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||181947||181947|228392 379677|H01CB0202|Sandostatin Lar|sts|20|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|189513|237811|lyfsjukr|||00|2|0|29|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||189513||189513|237811 379685|H01CB0202|Sandostatin Lar|sts|30|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|237615|297698|lyfsjukr|||00|2|0|43|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||237615||237615|297698 379875|N05BA0105|Stesolid|innhl|5|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|1741|3203|lyfalmen|||00|12|0|2|Actavis Group hf|Actavis Group hf|Díazepam||1741||1741|3203 379883|N05BA0105|Stesolid|innhl|10|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|2152|3761|lyfalmen|||00|12|0|5|Actavis Group hf|Actavis Group hf|Díazepam||2152||2152|3761 379925|L01CD0201|Taxotere|irs|40|mg/ml|0,5|ml|1|hgl|+ leysir|L01CD02|01.10.1996||R|K|1,5|0|1|0|1|AVS|0|0|0|100|NOK|31876|41553|lyfsjukr|||00|0|0|0|Vistor hf|Aventis Pharma SA|Docetaxel||31876||31876|41553 379933|L01CD0201|Taxotere|irs|40|mg/ml|2|ml|1|hgl|+ leysir|L01CD02|01.10.1996||R|K|2|0|1|0|1|AVS|0|0|0|100|NOK|127989|161214|lyfsjukr|||00|2|0|0|Vistor hf|Aventis Pharma SA|Docetaxel||127989||127989|161214 380642|A10AD0402|Humalog Mix50 100 E/ml Pen|stl|100|ae/ml|3|ml|5|pennar||A10AD04|01.12.2001||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|6919|10230|lyfalmen|||17|15|0|38|Icepharma hf|Eli Lilly Nederland -|Insulín lispro||6919||6919|10230 381194|A10AD0401|Humalog Mix25 100 E/ml Pen|stl|100|ae/ml|3|ml|5|pennar||A10AD04|01.09.1999||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|6455|9600|lyfalmen|||00|15|0|38|Icepharma hf|Eli Lilly Nederland -|Insulín lispro||6455||6455|9600 382531|C10AA0101|Zocor|töflur|40|mg|98|stk|1|þpakki||C10AA01|01.07.1995|31.10.2009|R|A|2|0|0|0|0|MSD|0|0|0|100|XEU|17363|3514|lyfalmen|||00|98|0|131|Icepharma hf|M.S.D.|Simvastatín||1970||1970|3514 383000|R03CC1201|Bambec|töflur|10|mg|100|stk|1|glas||R03CC12|01.10.1991||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|7008|10351|lyfalmen|||00|100|0|50|Vistor hf|AstraZeneca A/S DK|Bambúteról||7008||7008|10351 383075|N02AA5904|Ibukod sterkar|töflur|0| |20|stk|1|glas|30+200 mg|N02AA59|01.02.1999||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|460|1465|lyfalmen|||00|20|0|7|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||460||460|1465 383117|QP52AA5103|Drontal Vet.|töflur|250|mg|2|stk|1|pakki|230+20 mg|QP52AA51|01.06.2000||L|A|5|0|0|0|0|BAN|0|0|0|100|DKK|||vetorma|||00|2|0|0|Vistor hf|Bayer Animal Health GmbH||||||1976 383133|QP52AA5103|Drontal Vet.|töflur|250|mg|20|stk|1|pakki|230+20 mg|QP52AA51|01.06.2000||R|A|5|0|0|0|0|BAN|0|0|0|100|DKK|8939|15469|vetorma|||00|20|0|0|Vistor hf|Bayer Animal Health GmbH|||8939||8939|15469 383257|D01AC0802|Dermatin|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1998||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||23|60|0|60|Actavis Group hf|Actavis hf|Ketókónazól||||| 383265|D01AC0802|Dermatin|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.07.1998||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||23|120|0|120|Actavis Group hf|Actavis hf|Ketókónazól||||| 383737|R06AX1301|Clarityn|freyðit|10|mg|10|stk|1|þpakki||R06AX13|01.10.1995||L|A|2|0|0|0|0|SCP|0|0|1|100|IKR|||lyflausa|||00|10|0|10|Vistor hf|Schering-Plough|Lóratadín||||| 386953|L02BG0301|Arimidex|töflur|1|mg|98|stk|1|þpakki||L02BG03|01.03.1998||R|A|5|0|0|*|0|ASZ|0|0|0|100|SEK|63157|80815|lyfalmen|||00|98|0|98|Vistor hf|AstraZeneca UK Ltd|Anastrózól||63157||63157|80815 387662|QA12CC0202|Magnesiumsulfat Icepharma vet.|stl|200|mg/ml|100|ml|1|plhgl||QA12CC02|01.07.1996||R|A|3|0|0|0|0|ICE|0|0|0|100|XEU|844|1665|vetalmen|||00|100|0|0|Icepharma hf|Icepharma hf|||844||844|1665 387746|J02AA0101|Abelcet|irþ|5|mg/ml|20|ml|10|hgl|+ síunálar|J02AA01|01.04.1996||R|K|2|0|0|0|1|ZPL|0|0|0|100|DKK|259034|324365|lyfsjukr|||00|200|0|29|Zeneus Pharma Limited|Zeneus Pharma Limited|Amfóterícín||259034||259034|324365 388256|N01BB2001|Emla|krem|0| |5|g|5|túpa|+12 umbúð.|N01BB20|01.01.1987||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3714|5880|lyfalmen|V2002|5780|00|25|0|5|Vistor hf|AstraZeneca A/S DK|Blöndur||3714||3714|5880 388264|N01BB2001|Emla|krem|0| |30|g|1|túpa||N01BB20|01.01.1987||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|4190|6526|lyfalmen|||00|30|0|30|Vistor hf|AstraZeneca A/S DK|Blöndur||4190||4190|6526 388272|N01BB2001|Emla|plástur|0| |2|stk|1|pakki||N01BB20|01.04.1994||L|A|2|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||23|2|0|0|Vistor hf|AstraZeneca A/S DK|Blöndur||||| 388280|N01BB2001|Emla|plástur|0| |20|stk|1|pakki||N01BB20|01.04.1994||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|8148|11898|lyfalmen|||23|20|0|0|Vistor hf|AstraZeneca A/S DK|Blöndur||8148||8148|11898 388660|C09BA0201|Darazið|töflur|22,5|mg|100|stk|1|glas|10+12.5 mg|C09BA02|01.04.1998||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|2966|4865|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|Enalapríl og þvagræsilyf||2966||2966|4865 389106|G03FA0103|Femanor|töflur|0| |84|stk|1|pakki|þp 2+1 mg |G03FA01|01.08.1998||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|2746|4567|lyfalmen|V0388|4567|23|84|0|84|Vistor hf|BioPhausia AB|Noretísterón og östrógen||2746||2746|4567 389122|G03FB0503|Femasekvens|töflur|0| |84|stk|1|pakki|þp samsett pk. |G03FB05|01.08.1998||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|2509|4245|lyfalmen|||23|84|0|84|Vistor hf|BioPhausia AB|Noretísterón og östrógen||2509||2509|4245 389155|G03CA0312|Femanest|töflur|2|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|796|1921|lyfalmen|V0408|1921|00|84|0|84|Vistor hf|BioPhausia AB|Estradíól||796||796|1921 389171|G03CA0312|Femanest|töflur|1|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|736|1839|lyfalmen|||00|84|0|42|Vistor hf|BioPhausia AB|Estradíól||736||736|1839 389361|V08AB0501|Ultravist|stl/irl|300|mg J/ml|500|ml|8|fl||V08AB05|01.04.1989||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|370867|463597|lyfsjukr|||02|4000|0|0|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||370867||370867|463597 389395|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|10|sk-hyl|einnota hylki|S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|1122|2363|lyfalmen|||00|3|0|0|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1122||1122|2363 389577|A04AA0201|Kytril|töflur|2|mg|5|stk|1|þpakki||A04AA02|01.10.1994||R|A|3|0|0|E|0|ROA|0|0|0|100|DKK|13813|19382|lyfalmen|||00|5|0|5|Icepharma hf|Roche A.S.|Granisetrón||13813||13813|19382 390757|A07AA0201|Mycostatin|mixtúra|100000|ae/ml|100|ml|1|glas||A07AA02|01.04.1974||R|K|1|0|0|E|0|BRS|0|0|1|100|DKK|3383|5431|lyfalmen|||01|100|0|7|Vistor hf|Bristol-Myers Squibb|Nýstatín||3383||3383|5431 390971|M01AH0101|Celebra|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|8106|11841|lyfalmen|||00|100|0|50|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Celekoxíb||8106||8106|11841 390997|M01AH0101|Celebra|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.07.2002||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|3202|5186|lyfalmen|||00|20|0|20|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Celekoxíb||3202||3202|5186 391268|M01AH0101|Celebra|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|15622|21634|lyfalmen|V2140|21633|00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Celekoxíb||15622||15622|21634 391730|N01BB0203|Xylocain|úðalyf|100|mg/ml|50|ml|1|glas|+ sk-úðari|N01BB02|01.10.1990||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3384|5433|lyfalmen|||00|50|0|0|Vistor hf|AstraZeneca A/S DK|Lídókaín||3384||3384|5433 392563|A04AA0103|Zofran|mixtúra|0,8|mg/ml|50|ml|1|flaska||A04AA01|01.08.2009||R|A||0|0|E|0|PCO|0|0|0|100|IKR|12000|17125|lyfalmen|||00|50|1||Distica|Distica - óskráð lyf|Ondansetrón||||12000|17125 393918|QJ51CF0204|Orbenin vet.|spenalyf|500|mg/dælu|1|stk|24|spr||QJ51CF02|01.09.1983||R|S|4|0|0|0|0|PAL|0|0|0|100|XEU|5803|11225|vetalmen|||16|24|0|0|Icepharma hf|Pfizer Oy Animal Health|||5803||5803|11225 393934|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|14|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 393942|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 393959|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|14|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 394262|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 395954|V08CA0101|Magnevist|stl|469|mg/ml|30|ml|10|hgl|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|214884|269398|lyfsjukr|||02|300|0|0|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||214884||214884|269398 397745|L01BC0601|Xeloda|töflur|150|mg|60|stk|1|þpakki||L01BC06|01.01.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|12435|17349|lyfsjukr|||00|60|0|0|Icepharma hf|Roche|Capecitabín||12435||12435|17349 397752|L01BC0601|Xeloda|töflur|500|mg|120|stk|1|þpakki||L01BC06|01.01.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|66047|84096|lyfsjukr|||00|120|0|0|Icepharma hf|Roche|Capecitabín||66047||66047|84096 399519|N03AX0901|Lamictal|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.03.1999||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|2049|3343|lyfalmen|V0703|3343|00|56|0|9|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||1844||1844|3343 399527|N03AX0901|Lamictal|dreifit.|200|mg|56|stk|1|þpakki||N03AX09|01.03.1999|31.08.2009|R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|6434|8873|lyfalmen|||00|56|0|37|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||5919||5919|8873 399733|B01AB0401|Fragmin|stl|25000|ae/ml|0,3|ml|10|spr|einnotadæla|B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|10452|15024|lyfalmen|||02|3|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||10452||10452|15024 399782|D06BB0601|Vectavir|krem|10|mg/g|2|g|1|túpa||D06BB06|01.04.1997||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|2|0|2|Artasan ehf|Novartis Healthcare A/S-A|Pencíklóvír||||| 400044|S03CA0102|Sofradex|aug.eydr|0| |8|ml|1|glas||S03CA01|01.03.1980||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|1878|3389|lyfalmen|||06|8|0|0|Vistor hf|Sanofi-aventis Norge AS|Dexametasón og sýkingalyf||1878||1878|3389 400101|R05DB2002|Pektolin|mixtúra|0| |150|ml|1|glas||R05DB20|01.06.1981||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|150|0|0|Actavis Group hf|Actavis hf|Blöndur||||| 400143|C10AB0401|Lopid|hylki|300|mg|100|stk|1|þpakki||C10AB04|01.04.1988||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|6450|9593|lyfalmen|||10|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gemfíbrózíl||6450||6450|9593 400267|N05BA0402|Sobril|töflur|25|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|420|1410|lyfalmen|||00|25|0|12|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Oxazepam||420||420|1410 400424|N05BA0402|Sobril|töflur|15|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|500|1519|lyfalmen|||00|100|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Oxazepam||500||500|1519 400432|N05BA0402|Sobril|töflur|15|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|298|1245|lyfalmen|||00|25|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Oxazepam||298||298|1245 400804|N07BA0103|Nicorette|forðapl|15|mg/16kls|7|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|7|0|8|Vistor hf|McNeil Denmark ApS|Nikótín||||| 401828|N06AA1001|Noritren|töflur|10|mg|100|stk|1|glas||N06AA10|01.01.1985||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|878|2032|lyfalmen|||00|100|0|13|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||878||878|2032 401851|N06AA1001|Noritren|töflur|25|mg|100|stk|1|glas||N06AA10|01.01.1985||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|1406|2748|lyfalmen|||00|100|0|33|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||1406||1406|2748 401877|C09AA0103|Katopril|töflur|25|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|1246|2531|lyfalmen|||00|100|0|50|Actavis Group hf|Actavis hf|Kaptópríl||1246||1246|2531 401901|C09AA0103|Katopril|töflur|50|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|2000|3554|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|Kaptópríl||2000||2000|3554 402651|J07BB0205|Influvac|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07BB02|01.12.1998||R|K|1|0|0|0|0|SOB|0|0|0|100|XEU|755|1865|lyfalmen|||51|0|0|0|Icepharma hf|Solvay Biologicals B.V.|Inflúensa, hreinsaðir mótefnavakar||755||755|1865 402743|QJ01RA0102|Streptocillin, vet.|stl|0| |100|ml|1|hgl||QJ01RA01|01.11.1979||R|K|2|0|0|0|0|BID|0|0|0|100|DKK|1843|3637|vetalmen|||58|100|0|0|Vistor hf|Boehringer Ingelheim Danmark|||1843||1843|3637 403444|QG02AD9001|Estrumat, vet.|stl|0,25|mg/ml|20|ml|1|hgl||QG02AD90|01.01.1991||R|A|2|0|0|0|0|IBV|1|0|0|100|DKK|5952|11509|vetalmen|||27|20|0|0|Vistor hf|Intervet International BV|||5952||5952|11509 403550|C08CA0302|Lomir Retard|forðahlk|2,5|mg|100|stk|1|þpakki||C08CA03|01.10.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|8109|11845|lyfalmen|||10|100|0|50|Vistor hf|Novartis Healthcare A/S-|Ísradipín||8109||8109|11845 403915|S01GX0101|Lomudal|augndr|20|mg/ml|13,5|ml|1|glas||S01GX01|01.07.1992||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1501|2877|lyfalmen|||06|14|0|0|Vistor hf|Sanofi-aventis Norge AS|Krómóglíkatsýra||1501||1501|2877 404426|S01XA2019|Oftagel|augngel|2,5|mg/g|10|g|1|túpa||S01XA20|01.04.2004||L|A|2,5|0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen|||00|10|0|0|Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar sam­setningar|||||1849 404533|B01AD0201|Actilyse|sts/irs|50|mg|1|stk|1|hgl|+ leysir|B01AD02|01.07.1989||R|A|3|0|0|0|1|BOI|0|0|0|100|DKK|107918|136225|lyfsjukr|||02|1|0|0|Vistor hf|Boehringer Ingelheim|Alteplasi||107918||107918|136225 404939|B02BA0102|Konakion Novum|stl|10|mg/ml|1|ml|5|lykjur||B02BA01|01.04.1991||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|726|1039|lyfsjukr|||02|5|0|2|Icepharma hf|Roche|Fýtómenadíón||726||726|1039 405589|J07BD5203|Priorix|bóluefni|0| |0,5|ml|1|hgl|+ einnota dæla|J07BD52|01.03.1999||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|1875|3385|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||1875||1875|3385 405597|J07BD5203|Priorix|bóluefni|0| |0,5|ml|10|hgl||J07BD52|01.11.2001||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|23132|30984|lyfalmen|||00|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||23132||23132|30984 405985|N05AE0301|Serdolect|filmhtfl|12|mg|28|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|23885|31922|lyfalmen|||00|28|0|21|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||23885||23885|31922 406025|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|20662|27592|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||20662||20662|27592 406033|N05AE0301|Serdolect|filmhtfl|16|mg|28|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|23885|31922|lyfalmen|||00|28|0|28|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||23885||23885|31922 406165|N05AE0301|Serdolect|filmhtfl|20|mg|28|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|23885|31922|lyfalmen|||00|28|0|35|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||23885||23885|31922 406322|N05AE0301|Serdolect|filmhtfl|4|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|24123|32218|lyfalmen|||00|100|0|25|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||24123||24123|32218 406355|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|23122|30654|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||23122||23122|30654 406371|N05AE0301|Serdolect|filmhtfl|12|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|72726|92729|lyfalmen|||00|100|0|75|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||72726||72726|92729 406389|N05AE0301|Serdolect|filmhtfl|16|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|78880|100391|lyfalmen|||00|100|0|100|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||78880||78880|100391 406397|N05AE0301|Serdolect|filmhtfl|20|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|85033|108051|lyfalmen|||00|100|0|125|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||85033||85033|108051 406462|N05AE0301|Serdolect|filmhtfl|4|mg|30|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|8060|11778|lyfalmen|||00|30|0|8|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||8060||8060|11778 406751|M01AB0101|Confortid|hylki|25|mg|30|stk|1|þpakki||M01AB01|01.05.1974||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|663|1740|lyfalmen|||10|30|0|8|Actavis Group hf|Actavis Group hf|Indómetacín||663||663|1740 407395|N02CA7201|Anervan|töflur|160,5|mg|100|stk|1|pakki|þp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|2285|3941|lyfalmen|||00|100|0|50|Vistor hf|Recip AB|Ergotamínlyf í blöndum með geðlyfjum (psycoleptica)||2285||2285|3941 407981|N05BA0402|Sobril|töflur|10|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|A|1,5|0|0|0|0|PFI|0|0|1|100|DKK|282|1223|lyfalmen|||00|25|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Oxazepam||282||282|1223 407999|N05BA0402|Sobril|töflur|10|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|A|1,5|0|0|0|0|PFI|0|0|0|100|DKK|438|1435|lyfalmen|||00|100|0|20|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Oxazepam||438||438|1435 408724|D07AC0104|Diproderm|smyrsli|0,5|mg/g|20|g|1|túpa||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1230|2510|lyfalmen|||20|20|0|20|Vistor hf|Schering-Plough|Betametasón||1230||1230|2510 408740|D07AC0104|Diproderm|smyrsli|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|5642|8497|lyfalmen|||20|100|0|100|Vistor hf|Schering-Plough|Betametasón||5642||5642|8497 408757|D07AC0104|Diproderm|áburður|0,5|mg/ml|20|ml|1|glas||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1230|2510|lyfalmen|||20|20|0|20|Vistor hf|Schering-Plough|Betametasón||1230||1230|2510 408773|D07AC0104|Diproderm|áburður|0,5|mg/ml|100|ml|1|glas||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|3359|5399|lyfalmen|||20|100|0|100|Vistor hf|Schering-Plough|Betametasón||3359||3359|5399 409078|J02AC0101|Diflucan|mixtúrud|10|mg/ml|35|ml|1|glas||J02AC01|01.07.1992||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|6040|9037|lyfalmen|||08|35|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||6040||6040|9037 409417|C09CA0701|Micardis|töflur|80|mg|28|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|0|0|BII|0|0|0|100|DKK|4461|6894|lyfalmen|||00|28|0|56|Vistor hf|Boehringer Ingelheim International |Telmisartan||4461||4461|6894 409425|R01AD0502|Rhinocort Turbuhaler|nefúðad|100|mcg/sk|200|sk|1|stauk||R01AD05|01.01.1992||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|4451|6881|lyfalmen|||23|200|0|100|Vistor hf|AstraZeneca A/S DK|Búdesóníð||4451||4451|6881 409474|C09CA0701|Micardis|töflur|80|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|0|0|BII|0|0|0|100|DKK|14411|20127|lyfalmen|||00|98|0|196|Vistor hf|Boehringer Ingelheim International |Telmisartan||14411||14411|20127 409516|C09CA0701|Micardis|töflur|40|mg|28|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|0|0|BII|0|0|0|100|DKK|3515|5610|lyfalmen|||00|28|0|28|Vistor hf|Boehringer Ingelheim International |Telmisartan||3515||3515|5610 409532|QN05AA0402|Plegicil vet.|stl|10|mg/ml|20|ml|6|hgl||QN05AA04|01.11.2007||R|A|3|0|0|0|0|PSW|1|0|0|100|DKK|12264|23532|vetalmen|||27|120|0|0|Vistor hf|Pharmaxim Sweden AB|||12264||12264|23532 409631|C07AB0309|Atenolol Actavis|töflur|25|mg|100|stk|1|glas||C07AB03|01.04.1987||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|575|1621|lyfalmen|V0290|1621|00|100|0|33|Actavis Group hf|Actavis hf|Atenólól||||575|1621 409763|C09CA0701|Micardis|töflur|40|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|0|0|BII|0|0|0|100|DKK|11677|16687|lyfalmen|||00|98|0|98|Vistor hf|Boehringer Ingelheim International |Telmisartan||11677||11677|16687 410639|P01BA0102|Klorokinfosfat Recip|filmhtfl|250|mg|20|stk|1|þpakki||P01BA01|01.08.2005||R|A|5|0|0|0|0|REP|0|0|0|100|SEK|1328|2643|lyfalmen|||00|20|0|10|Vistor hf|Recip AB|Klórókín||1328||1328|2643 410712|D10AD0102|Aberela|krem|0,05|%|30|g|1|túpa||D10AD01|01.10.2007||R|A|2|0|0|0|0|JAS|0|0|0|100|SEK|777|1895|lyfalmen|||23|30|0|30|Vistor hf|Janssen-Cilag AB|Tretínóín||777||777|1895 411033|M03BX0104|Baklofen Merck NM|töflur|10|mg|50|stk|1|þpakki||M03BX01|01.01.1990||R|A|3|0|0|E|0|MNA|0|0|1|100|SEK|680|1763|lyfalmen|||00|50|0|10|Actavis Group PTC ehf|Merck NM AB|Baklófen||680||680|1763 411389|N05CD0801|Dormicum|stl|5|mg/ml|10|ml|5|lykjur||N05CD08|01.10.1990||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|7437|10648|lyfsjukr|||02|50|0|17|Icepharma hf|Roche|Mídazólam||7437||7437|10648 411827|J05AF0501|Epivir|töflur|150|mg|60|stk|1|glas||J05AF05|01.03.1999||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|26561|34936|lyfsjukr|||00|60|0|30|GlaxoSmithKline ehf|Glaxo Group Limited|Lamívúdín||26561||26561|34936 411868|M01AB0505|Voltaren|sh-tfl|25|mg|100|stk|1|þpakki||M01AB05|01.11.1981||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|2155|3765|lyfalmen|||67|100|0|25|Vistor hf|Novartis Healthcare A/S-|Díklófenak||2155||2155|3765 411918|N02CC0101|Imigran|nefúði|20|mg/sk|6|sk|1|pakki||N02CC01|01.07.2000||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|8086|11813|lyfalmen|||98|6|0|6|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||8086||8086|11813 412049|L02AE0301|Zoladex|vefjatfl|3,6|mg|1|stk|1|glas|+ dæla|L02AE03|01.01.1990||R|A|3|0|1|*|0|ASZ|0|0|0|100|SEK|26122|34707|lyfalmen|||00|1|0|28|Vistor hf|AstraZeneca UK Ltd|Góserelín||26122||26122|34707 412361|B01AB0501|Klexane|stl|100|mg/ml|3|ml|1|hgl|með rotv.|B01AB05|01.02.1999||R|A|2|0|0|0|1|SNO|0|0|0|100|NOK|3889|5568|lyfsjukr|||00|3|0|15|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3889||3889|5568 412395|QM01AE0301|Romefen, vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.1995||R|A|3|0|0|0|0|MER|1|0|0|100|DKK|11594|22256|vetalmen|||02|100|0|0|Vistor hf|Merial|||11594||11594|22256 412825|L02BA0106|Tamoxifen NM Pharma|töflur|10|mg|100|stk|1|glas||L02BA01|01.01.1990||R|A|5|0|0|*|0|MNA|0|0|0|100|SEK|2255|3901|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck NM AB|Tamoxífen||2255||2255|3901 412833|L02BA0106|Tamoxifen NM Pharma|töflur|20|mg|30|stk|1|glas||L02BA01|01.01.1990||R|A|5|0|0|*|0|MNA|0|0|0|100|SEK|1441|2796|lyfalmen|||00|30|0|30|Actavis Group PTC ehf|Merck NM AB|Tamoxífen||1441||1441|2796 413245|J06BA0205|Sandoglobulin|irs|12|g/fl|12|g|1|sett|leys+áhöld|J06BA02|01.04.1993||R|A|3|0|0|0|1|CSL|0|0|0|100|SEK|126687|159593|lyfsjukr|||00|12|0|0|Icepharma hf|CSL Denmark ApS|Immúnóglóbúlín, normal, manna, gefin í æð||126687||126687|159593 414458|V04CF0102|Tuberkulin|stl|2|TU/0,1ml|1,5|ml|1|hgl||V04CF01|01.01.1998||R|K||0|0|0|0|LDR|0|0|0|100|DKK|2481|4207|lyfalmen|||00|2|1|0|Parlogis hf|Parlogis - óskráð lyf|||2481||2481|4207 414680|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|90|stk|1|þpakki||C03BA11|01.03.1999||R|A|2|0|0|E|0|SEV|0|0|0|100|DKK|5260|7978|lyfalmen|||00|90|0|54|Icepharma hf|Servier|Indapamíð||5260||5260|7978 414789|N03AF0104|Tegretol|mixtúra|20|mg/ml|300|ml|1|glas||N03AF01|01.09.2007||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|1680|3120|lyfalmen|||00|300|0|6|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1680||1680|3120 415679|G03CA0310|Vagifem|sk-tfl|25|mcg|15|stk|1|pakki||G03CA03|01.01.1995||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|2198|3823|lyfalmen|||5|15|0|15|Vistor hf|Novo-Nordisk|Estradíól||2198||2198|3823 416222|C09DA0101|Cozaar Comp|töflur|62,5|mg|28|stk|1|þpakki|50+12,5 mg|C09DA01|01.09.1997||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|4143|6463|lyfalmen|||00|28|0|28|Icepharma hf|M.S.D.|Lósartan og þvagræsilyf||4143||4143|6463 416446|C09DA0101|Cozaar Comp|töflur|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.09.1997||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|10975|10665|lyfalmen|||00|98|0|98|Icepharma hf|M.S.D.|Lósartan og þvagræsilyf||7240||7240|10665 416818|A02BA0205|Zantac|mixtúra|15|mg/ml|300|ml|1|glas||A02BA02|01.07.2000||R|A||0|0|E|0|LDR|0|0|0|100|IKR|3849|6064|lyfalmen|||00|300|1|15|Distica|Distica - óskráð lyf|Ranitidín||3849||3849|6064 416859|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|10|ml|1|túpa||A01AA01|01.10.1995||R|A|5|0|0|E|0|GOG|0|0|1|100|XEU|3346|5381|lyfalmen|||23|10|0|0|Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||3346||3346|5381 416867|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|30|ml|5|túpa||A01AA01|01.10.1988||R|A|5|0|0|E|0|GOG|0|0|1|100|XEU|28137|37216|lyfalmen|||23|150|0|0|Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||28137||28137|37216 416883|D10AX0301|Skinoren|krem|200|mg/g|30|g|1|túpa||D10AX03|01.07.1991||R|A|5|0|0|0|0|IGB|0|0|0|100|SEK|1232|2512|lyfalmen|||00|30|0|30|Icepharma hf|Intendis GmbH Berlin|Azelainsýra||1232||1232|2512 417238|QM01AE0301|Romefen, vet.|töflur|10|mg|10|stk|1|þpakki||QM01AE03|01.10.1995||R|A|3|0|0|0|0|MER|0|0|0|100|XEU|612|1208|vetalmen|||00|10|0|0|Vistor hf|Merial|||612||612|1208 417832|J05AF0601|Ziagen|filmhtfl|300|mg|60|stk|1|þpakki||J05AF06|01.07.2005||R|A|3|0|1|0|1|GGL|0|0|0|100|GBP|43475|55994|lyfsjukr|||00|60|0|30|GlaxoSmithKline ehf|Glaxo Group Limited|Abacavír||43475||43475|55994 418483|A07EC0201|Mesasal|sh-tfl|250|mg|100|stk|1|þpakki||A07EC02|01.10.1991||R|A|3|0|0|B|0|SNO|0|0|0|100|NOK|5102|7764|lyfalmen|||10|100|0|17|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||5102||5102|7764 418665|D07XC0101|Diprosalic|smyrsli|0| |50|g|1|túpa||D07XC01|01.11.1979||R|A|5|0|0|B|0|SCP|0|0|1|100|DKK|2016|3576|lyfalmen|||20|50|0|50|Vistor hf|Schering-Plough|Betametasón||2016||2016|3576 418731|A07EC0201|Mesasal|eþ-stil|500|mg|60|stk|1|pakki||A07EC02|01.10.1991||R|A|4|0|0|B|0|SNO|0|0|0|100|NOK|10376|14921|lyfalmen|V0299|10794|00|60|0|20|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||10376||10376|14921 418988|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|glas||QA07AA01|01.03.1981||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|2256|4452|vetalmen|||13|200|0|0|Vistor hf|Boehringer Ingelheim Danmark|||2256||2256|4452 418996|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|sett|+ dæla|QA07AA01|01.03.1981||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|2929|5750|vetalmen|||13|200|0|0|Vistor hf|Boehringer Ingelheim Danmark|||2929||2929|5750 419242|A11CC0301|Etalpha|hylki|0,25|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|4729|7258|lyfalmen|||10|100|0|25|Vistor hf|LEO Pharma A/S|Alfakalsídól||4729||4729|7258 419309|A11CC0301|Etalpha|hylki|1|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|8239|12021|lyfalmen|||10|100|0|100|Vistor hf|LEO Pharma A/S|Alfakalsídól||8239||8239|12021 419440|L01DB0103|Caelyx|irþ|2|mg/ml|10|ml|1|hgl||L01DB01|01.05.1999||R|K|1,6|0|1|0|1|SCP|0|0|0|100|DKK|72805|92510|lyfsjukr|||00|10|0|0|Vistor hf|Schering-Plough|Doxórúbicín||72805||72805|92510 419820|J05AE0201|Crixivan|hylki|400|mg|180|stk|1|glas||J05AE02|01.04.1997||R|A|3|0|1|0|1|MSD|0|0|0|100|XEU|64128|81707|lyfsjukr|||00|180|0|30|Icepharma hf|M.S.D.|Indínavír||64128||64128|81707 419838|A16AA0401|Cystagon|hylki|150|mg|100|stk|1|glas||A16AA04|01.02.2008||R|A|2|0|1|0|1|ORP|0|0|0|100|DKK|54234|69389|lyfsjukr|||00|100|0|8|Swedish Orphan International AB|Orphan Europe (S)|Mecaptamín||54234||54234|69389 419945|D07AD0101|Dermovat|áburður|0,5|mg/ml|25|ml|1|glas|í hársvörð|D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|878|2032|lyfalmen|||20|25|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||878||878|2032 420117|B01AB0401|Fragmin|stl|10000|ae/ml|1|ml|10|lykjur||B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|13966|19573|lyfalmen|||02|10|0|40|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||13966||13966|19573 420356|B01AB0401|Fragmin|stl|2500|ae/ml|4|ml|10|hgl||B01AB04|01.04.1993||R|A|3|0|0|0|1|PFI|0|0|0|100|DKK|13991|19286|lyfsjukr|||00|40|0|40|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||13991||13991|19286 420471|B01AB0401|Fragmin|stl|12500|ae/ml|0,2|ml|10|spr|einnotadæla|B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|4171|6501|lyfalmen|||02|2|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||4171||4171|6501 420497|B01AB0401|Fragmin|stl|25000|ae/ml|0,2|ml|10|spr|einnotadæla|B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|7118|10500|lyfalmen|||02|2|0|20|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||7118||7118|10500 421180|C01BD0101|Cordarone|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.07.1989||R|A|5|0|0|B|0|SNO|0|0|0|100|NOK|1998|3552|lyfalmen|V0144|3550|70|30|0|15|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1998||1998|3552 422121|C07AB0205 |Seloken|töflur|50|mg|100|stk|1|þpakki||C07AB02|01.05.2009||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|1700|3147|lyfalmen|||00|28|0|33|Vistor hf|AstraZeneca A/S DK|Metóprólól||||1700|3147 422246|C07AB0206|Seloken ZOC|forðatfl|95|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3736|5216|lyfalmen|V2004|4670|43|98|0|62|Vistor hf|AstraZeneca A/S DK|Metóprólól||3224||3224|5216 422337|C07AB0206|Seloken ZOC|forðatfl|190|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|7358|10826|lyfalmen|||43|98|0|124|Vistor hf|AstraZeneca A/S DK|Metóprólól||7358||7358|10826 422659|G02CB0102|Parlodel|töflur|2,5|mg|100|stk|1|glas||G02CB01|01.11.1979||R|A|3|0|0|E|0|MAS|0|0|0|100|SEK|9561|13815|lyfalmen|||49|100|0|50|Vistor hf|Meda AS|Brómókriptín||9561||9561|13815 424846|M04AA0103|Hexanurat|töflur|100|mg|100|stk|1|glas||M04AA01|01.02.2006|31.10.2009|R|A||0|0|E|0|PCO|0|0|0|100|IKR|391|1371|lyfalmen|||00|100|1|25|Distica|Distica - óskráð lyf|||391||391|1371 424960|QP52AC1302|Panacur, vet.|pasta|187,5|mg/g|24|g|1|sk-dæl||QP52AC13|01.05.1999||L|A|3|0|0|0|0|INI|0|0|0|100|DKK|||vetorma|||16|24|0|0|Icepharma hf|Intervet International B.V.||||||2347 425181|N05CD0305|Flunitrazepam Merck NM|töflur|1|mg|100|stk|1|glas||N05CD03|01.10.1992||R|A|5|1|0|0|0|MNA|0|0|0|100|SEK|1068|2290|lyfalmen|||00|100|0|100|Actavis Group PTC ehf|Merck NM AB|Flúnítrazepam||1068||1068|2290 425538|N04BC0102|Parlodel|hylki|10|mg|100|stk|1|þpakki||N04BC01|01.11.1979||R|A|4|0|0|E|0|MAS|0|0|0|100|SEK|33179|43493|lyfalmen|||52|100|0|25|Vistor hf|Meda AS|Brómókriptín||33179||33179|43493 426122|R01AA0503|Nezeril|nefdr|0,1|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|2|0|0|0|0|GCO|0|0|1|100|IKR|||lyflausa|||23|2|0|0|Vistor hf|GlaxoSmithKline CH AB|Oxýmetazólín||||| 426312|J02AC0101|Diflucan|hylki|150|mg|2|stk|1|þpakki||J02AC01|01.04.1993||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|3962|6217|lyfalmen|V0555|2796|10|2|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||3962||3962|6217 426593|J01CE0204|Kaavepenin|töflur|500|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|676|1758|lyfalmen|||00|20|0|5|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||676||676|1758 426601|J01CE0204|Kaavepenin|töflur|500|mg|30|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|883|2039|lyfalmen|||00|30|0|8|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||883||883|2039 427351|N07BA0103|Nicorette|forðapl|5|mg/16kls|14|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|14|0|5|Vistor hf|McNeil Denmark ApS|Nikótín||||| 427369|N07BA0103|Nicorette|forðapl|10|mg/16kls|14|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|14|0|10|Vistor hf|McNeil Denmark ApS|Nikótín||||| 427377|N07BA0103|Nicorette|forðapl|15|mg/16kls|14|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|14|0|15|Vistor hf|McNeil Denmark ApS|Nikótín||||| 427765|A06AB0801|Laxoberal|dropar|7,5|mg/ml|30|ml|1|plglas||A06AB08|01.09.2008||L|A|3|0|0|0|0|BII|0|0|0|100|IKR|||lyfalmen|||00|30|0|45|Vistor hf|Boehringer Ingelheim International |Natríum pícós|||||2541 428441|D07AC1301|Elocon|krem|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|1152|2404|lyfalmen|||20|30|0|30|Vistor hf|Schering-Plough|Mómetasón||1152||1152|2404 428524|D07AC1301|Elocon|smyrsli|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1143|2391|lyfalmen|||20|30|0|30|Vistor hf|Schering-Plough|Mómetasón||1143||1143|2391 428565|J01MA0202|Ciproxin|irl|2|mg/ml|100|ml|10|pokar||J01MA02|01.01.1990||R|A|3|0|0|0|1|BAV|0|0|0|100|SEK|34868|45278|lyfsjukr|||00|1000|0|4|Vistor hf|Bayer Schering Pharma AG (V)|Cíprófloxacín||34868||34868|45278 428656|J01MA0202|Ciproxin|irl|2|mg/ml|200|ml|10|pokar||J01MA02|01.01.1990||R|A|3|0|0|0|1|BAV|0|0|0|100|SEK|54606|69852|lyfsjukr|||00|2000|0|8|Vistor hf|Bayer Schering Pharma AG (V)|Cíprófloxacín||54606||54606|69852 428672|J01CA0406|Flemoxin Solutab|lausnart|125|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|581|1629|lyfalmen|||23|14|0|2|Vistor hf|Astellas Pharma A/S|Amoxicillín||581||581|1629 428680|J01CA0406|Flemoxin Solutab|lausnart|250|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|958|2140|lyfalmen|||23|14|0|4|Vistor hf|Astellas Pharma A/S|Amoxicillín||958||958|2140 428813|C07AB0309|Atenolol Actavis|töflur|25|mg|30|stk|1|glas||C07AB03|01.01.1992||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|180|1085|lyfalmen|||00|30|0|10|Actavis Group hf|Actavis hf|Atenólól||180||180|1085 429167|J07CA0602|Pentavac|bóluefni|0| |0,5|ml|1|hgl|+ dreifa í dælu|J07CA06|01.10.1999||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|6430|9566|lyfalmen|||AC|0|0|0|Icepharma hf|Sanofi Pasteur MSD|barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||6430||6430|9566 429225|J07CA0602|Pentavac|bóluefni|0| |0,5|ml|10|hgl||J07CA06|01.12.1999||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|48100|62069|lyfalmen|||AC|5|0|0|Icepharma hf|Sanofi Pasteur MSD|barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||48100||48100|62069 429837|C03DA0101|Aldactone|töflur|100|mg|100|stk|1|þpakki||C03DA01|01.11.1981||R|A|5|0|0|E|0|PFI|0|0|0|100|DKK|6641|9853|lyfalmen|||00|100|0|133|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Spírónólaktón||6641||6641|9853 430009|N01AH0102|Leptanal|stl|50|mcg/ml|10|ml|5|lykjur||N01AH01|01.10.1989||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|1976|2829|lyfsjukr|||02|50|0|0|Vistor hf|Janssen-Cilag AB|Fentanýl||1976||1976|2829 430074|N05CD0801|Dormicum|stl|1|mg/ml|5|ml|10|lykjur||N05CD08|01.07.1990||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|2259|3234|lyfsjukr|||02|50|0|3|Icepharma hf|Roche|Mídazólam||2259||2259|3234 430157|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|100|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.10.1990||R|A|3|0|0|0|0|IBV|0|0|0|100|DKK|4433|8615|vetalmen|||27|100|0|0|Vistor hf|Intervet International BV|||4433||4433|8615 430710|J07AP0301|Typhim Vi|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07AP03|01.07.1994||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|2940|4830|lyfalmen|||02|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsaðir mótefna­vakar||2940||2940|4830 430967|N07BA0105|Nicorette Mint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.01.1993||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2|Vistor hf|McNeil Denmark ApS|Nikótín||||| 431023|D06AX0101|Fucidin|smyrsli|20|mg/g|15|g|1|túpa||D06AX01|01.04.1989||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|882|2037|lyfalmen|||20|15|0|15|Vistor hf|LEO Pharma A/S|Fúsidínsýra||882||882|2037 431049|C01DA0801|Sorbangil|töflur|10|mg|100|stk|1|þpakki||C01DA08|01.07.1989||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|1367|2695|lyfalmen|||00|100|0|17|Vistor hf|Recip AB|Ísósorbíð dínítrat||1367||1367|2695 431106|N07BA0105|Nicorette Mint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.10.1995||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14|Vistor hf|McNeil Denmark ApS|Nikótín||||| 431122|N07BA0105|Nicorette Mint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.01.1993||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|4|Vistor hf|McNeil Denmark ApS|Nikótín||||| 431171|N07BA0105|Nicorette Mint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.10.1995||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28|Vistor hf|McNeil Denmark ApS|Nikótín||||| 431205|C08DB0107|Korzem|töflur|30|mg|100|stk|1|þpakki||C08DB01|01.01.1989||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|785|1906|lyfalmen|||00|100|0|12|Actavis Group hf|Actavis hf|Diltíazem||785||785|1906 431759|M01AB5503|Arthrotec Forte|töflur|75,02|mg|20|stk|1|þpakki|75+0,2 mg|M01AB55|01.09.2009||R|A||0|0|E|0|PFI|0|0|1|100|DKK|1637|3062|lyfalmen|||00|20|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Díklófenaknatríum í blöndum||||1637|3062 431783|M01AB5503|Arthrotec Forte|töflur|75,02|mg|100|stk|1|þpakki|75+0,2 mg|M01AB55|01.09.2009||R|A||0|0|E|0|PFI|0|0|1|100|DKK|7432|10926|lyfalmen|||00|100|0|75|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Díklófenaknatríum í blöndum||||7432|10926 432880|N02BE0107|Paratabs|töflur|500|mg|300|stk|1|glas|öryggislok|N02BE01|01.11.1981||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|952|2132|lyfalmen|||00|300|0|50|Actavis Group hf|Actavis hf|Paracetamól||952||952|2132 433250|N04BX0201|Comtess|töflur|200|mg|100|stk|1|glas||N04BX02|01.07.1999||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|12808|18131|lyfalmen|V0729|18130|0|100|0|20|Vistor hf|Orion Corporation|Entakapón||12808||12808|18131 433292|N02AA0106|Contalgin Uno|forðahlk|30|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|2872|4738|lyfalmen|||00|28|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||2872||2872|4738 433300|N02AA0106|Contalgin Uno|forðahlk|60|mg|28|stk|1|þpakki||N02AA01|01.05.1998|30.09.2009|R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|5187|7879|lyfalmen|||00|28|0|17|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||5187||5187|7879 433318|N02AA0106|Contalgin Uno|forðahlk|90|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|7046|10402|lyfalmen|||00|28|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||7046||7046|10402 433326|N02AA0106|Contalgin Uno|forðahlk|120|mg|28|stk|1|þpakki||N02AA01|01.05.1998|31.10.2009|R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|8746|12709|lyfalmen|||00|28|0|34|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||8746||8746|12709 433342|N02AA0106|Contalgin Uno|forðahlk|150|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|10164|14633|lyfalmen|||00|28|0|42|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||10164||10164|14633 434639|QP52AC1302|Panacur, vet.|töflur|250|mg|10|stk|1|þpakki||QP52AC13|01.04.1992||L|A|5|0|0|0|0|INI|0|0|0|100|DKK|||vetorma|||99|10|0|0|Icepharma hf|Intervet International B.V.||||||1493 434670|D01AC2001|Daktacort|krem|0| |50|g|1|túpa||D01AC20|01.10.1988||R|K|3|0|0|0|0|JAS|0|0|1|100|SEK|1659|3092|lyfalmen|||20|50|0|50|Vistor hf|Janssen-Cilag AB|Blöndur||1659||1659|3092 434829|C01CA2404|EpiPen|stl|0,3|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|A|1,7|0|0|B|0|ALK|0|0|1|100|DKK|6718|9957|lyfalmen|||00|1|0|1|Vistor hf|ALK-Abello A/S|Epínefrín (adrenalín)||6718||6718|9957 434837|C01CA2405|EpiPen Junior|stl|0,15|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|A|1,75|0|0|B|0|ALK|0|0|1|100|DKK|6718|9957|lyfalmen|||00|1|0|0|Vistor hf|ALK-Abello A/S|Epínefrín (adrenalín)||6718||6718|9957 434852|N06AB0302|Fontex|lausnart|20|mg|100|stk|1|pakki|þp (10x10 stk)|N06AB03|01.06.1998||R|A|2|0|0|B|0|ELI|0|1|0|100|XEU|11893|16980|lyfalmen|||00|100|0|100|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||11893||11893|16980 435537|N02CC0301|Zomig|töflur|5|mg|6|stk|1|þpakki||N02CC03|01.06.1999||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|6727|9969|lyfalmen|||00|6|0|12|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||6727||6727|9969 435594|N02CC0301|Zomig|töflur|2,5|mg|6|stk|1|þpakki||N02CC03|01.11.1998||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|5254|7970|lyfalmen|||00|6|0|6|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||5254||5254|7970 435651|N05AH0401|Seroquel|töflur|25|mg|100|stk|1|þpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|8301|10669|lyfalmen|V0725|9257|00|100|0|6|Vistor hf|AstraZeneca UK Ltd|Quetíapín||7243||7243|10669 435974|C01DA0801|Sorbangil|töflur|10|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|3182|5159|lyfalmen|||00|250|0|42|Vistor hf|Recip AB|Ísósorbíð dínítrat||3182||3182|5159 436022|C09DA0308|Diovan Comp 80 mg/12,5 mg|töflur|92,5|mg|28|stk|1|pakki||C09DA03|01.10.1999||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|4311|6691|lyfalmen|||00|28|0|28|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||4311||4311|6691 436030|C09DA0308|Diovan Comp 80 mg/12,5 mg|töflur|92,5|mg|98|stk|1|pakki||C09DA03|01.10.1999||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|11367|16266|lyfalmen|||00|98|0|98|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||11367||11367|16266 436071|N04BC0401|Requip|töflur|0,25|mg|210|stk|1|þpakki||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|6366|9479|lyfalmen|||00|210|0|9|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||6366||6366|9479 436139|N04BC0401|Requip|töflur|0,5|mg|21|stk|1|þpakki||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|1071|2294|lyfalmen|||00|21|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||1071||1071|2294 436147|M01AE0216|Naproxen-E Merck NM|sh-tfl|250|mg|20|stk|1|þpakki||M01AE02|01.07.1993||L|A|5|0|0|0|0|MNA|0|0|1|100|IKR|||lyflausa|||10|20|0|10|Actavis Group PTC ehf|Merck NM AB|Naproxen||||| 436238|N04BC0401|Requip|töflur|1|mg|84|stk|1|plglas||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|7005|10347|lyfalmen|||00|84|0|14|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||7005||7005|10347 436279|N04BC0401|Requip|töflur|2|mg|84|stk|1|plglas||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|12701|17998|lyfalmen|||00|84|0|28|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||12701||12701|17998 436295|N04BC0401|Requip|töflur|5|mg|84|stk|1|plglas||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|26999|35799|lyfalmen|||00|84|0|70|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||26999||26999|35799 436410|D06AX0101|Fucidin|krem|20|mg/g|15|g|1|túpa||D06AX01|01.01.1989||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|858|2005|lyfalmen|||20|15|0|15|Vistor hf|LEO Pharma A/S|Fúsidínsýra||858||858|2005 436527|M01AE0216|Naproxen-E Merck NM|sh-tfl|250|mg|100|stk|1|glas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|2225|3860|lyfalmen|||10|100|0|50|Actavis Group PTC ehf|Merck NM AB|Naproxen||2225||2225|3860 436550|M01AE0211|Naproxen-E NM Pharma|sh-tfl|375|mg|20|stk|1|þpakki||M01AE02|01.01.1995||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|892|2051|lyfalmen|||10|20|0|15|Actavis Group PTC ehf|Merck NM AB|Naproxen||892||892|2051 436626|M01AE0216|Naproxen-E Merck NM|sh-tfl|375|mg|100|stk|1|glas||M01AE02|01.01.1995||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|3683|5838|lyfalmen|||10|100|0|75|Actavis Group PTC ehf|Merck NM AB|Naproxen||3683||3683|5838 436915|N05AD0101|Haldol|töflur|1|mg|100|stk|1|þpakki||N05AD01|01.12.1972||R|A|5|0|0|*|0|JAS|0|1|0|100|SEK|1037|2248|lyfalmen|||00|100|0|12|Vistor hf|Janssen-Cilag AB|Halóperídól||1037||1037|2248 436931|N05AD0101|Haldol|töflur|4|mg|100|stk|1|þpakki||N05AD01|01.12.1972||R|A|5|0|0|*|0|JAS|0|1|0|100|SEK|3635|5773|lyfalmen|||00|100|0|50|Vistor hf|Janssen-Cilag AB|Halóperídól||3635||3635|5773 438218|N06AX1602|Efexor Depot|forðahlk|75|mg|100|stk|1|glas||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|13276|18714|lyfalmen|V0955|13112|00|100|0|75|Icepharma hf|Wyeth AB|Venlafaxín||13276||13276|18714 438333|N06AX1602|Efexor Depot|forðahlk|150|mg|28|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|7139|10528|lyfalmen|V0957|6233|00|28|0|42|Icepharma hf|Wyeth AB|Venlafaxín||7139||7139|10528 438374|N07BC0201|Metadon|töflur|5|mg|20|stk|1|glas||N07BC02|01.01.1998||R|A||1|0|0|0|LDR|0|0|0|100|IKR|594|1646|lyfalmen|||00|20|1|4|Parlogis hf|Parlogis - óskráð lyf|||594||594|1646 438416|S02CA0301|Ciproxin-Hydrocortison|eyrnadr|0| |10|ml|1|túpa|2 mg + 10 mg/ml|S02CA03|01.09.2002||R|A|2|0|0|E|0|ALC|0|0|1|100|USD|1259|2549|lyfalmen|||00|10|0|0|K.Pétursson hf|Alcon|Hýdrókortisón og sýkingalyf||1259||1259|2549 438424|N06AX1602|Efexor Depot|forðahlk|75|mg|28|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|3740|5916|lyfalmen|V0954|3958|00|28|0|21|Icepharma hf|Wyeth AB|Venlafaxín||3740||3740|5916 438432|N06AX1602|Efexor Depot|forðahlk|75|mg|98|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|12860|18196|lyfalmen|V0955|12850|00|98|0|74|Icepharma hf|Wyeth AB|Venlafaxín||12860||12860|18196 438457|N06AX1602|Efexor Depot|forðahlk|150|mg|98|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|24416|32583|lyfalmen|V0956|20469|00|98|0|147|Icepharma hf|Wyeth AB|Venlafaxín||24416||24416|32583 438465|N06AX1602|Efexor Depot|forðahlk|150|mg|100|stk|1|glas||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|22508|30207|lyfalmen|V0956|20887|00|100|0|150|Icepharma hf|Wyeth AB|Venlafaxín||22508||22508|30207 438762|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.07.1989||L|A|4|0|0|0|0|SCP|0|0|1|100|IKR|||lyflausa|||00|10|0|10|Vistor hf|Schering-Plough|Lóratadín||||| 438770|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.07.1989||R|A|4|0|0|E|0|SCP|0|0|1|100|DKK|2272|3924|lyfalmen|||00|30|0|30|Vistor hf|Schering-Plough|Lóratadín||2272||2272|3924 438788|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.07.1989||R|A|4|0|0|E|0|SCP|0|0|1|100|DKK|6859|10148|lyfalmen|V0984|3119|00|100|0|100|Vistor hf|Schering-Plough|Lóratadín||6859||6859|10148 439208|J01DC0203|Zinnat|töflur|250|mg|14|stk|1|þpakki||J01DC02|01.10.1990||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|2414|4116|lyfalmen|||66|14|0|7|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2414||2414|4116 439489|C07FB0201|Logimax|forðatfl|55|mg|98|stk|1|pakki|þp 5+50 mg|C07FB02|01.04.1997||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|9702|14006|lyfalmen|||00|98|0|98|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóðþrýst­ings­­lækkandi lyf||9702||9702|14006 439794|R01AA0704|Otrivin ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.05.2001||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|12|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín||||| 440099|J01CR0202|Augmentin|mixtduft|91,4|mg/ml|70|ml|1|glas|80+11,4 mg/ml|J01CR02|01.08.1998||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|1066|2287|lyfalmen|||00|70|0|6|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1066||1066|2287 440677|J01CE0106|Penicillin Actavis|sts|600|mg/hgl|10|hgl|1|pakki|1 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|1715|2455|lyfsjukr|||00|10|0|2|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||1715||1715|2455 440693|J01CE0106|Penicillin Actavis|sts|1,2|g/hgl|10|hgl|1|pakki|2 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|2707|3876|lyfsjukr|||00|10|0|3|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||2707||2707|3876 440933|M01AB0507|Vostar|eþ-stil|50|mg|10|stk|1|pakki||M01AB05|01.01.1990||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|548|1584|lyfalmen|||04|10|0|5|Actavis Group hf|Actavis hf|Díklófenak||548||548|1584 441006|C03DA0101|Aldactone|töflur|25|mg|100|stk|1|þpakki||C03DA01|01.12.1972||R|A|5|0|0|E|0|PFI|0|0|0|100|DKK|1676|3115|lyfalmen|V0221|2982|00|100|0|33|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Spírónólaktón||1676||1676|3115 441279|D01AC2002|Pevisone|krem|0| |30|g|1|túpa||D01AC20|01.10.1988||R|A|4|0|0|0|0|JAS|0|0|1|100|SEK|1437|2790|lyfalmen|||20|30|0|30|Vistor hf|Janssen-Cilag AB|Blöndur||1437||1437|2790 441634|P03AC0401|Nix|hársápa|10|mg/ml|59|ml|1|pakki||P03AC04|01.01.1996||L|A|2|0|0|0|0|ACH|0|0|0|100|IKR|||lyflausa|||00|59|0|0|Aco Hud Nordic AB|ACO Hud AB|Permetrín||||| 441949|G03DC0202|Primolut N|töflur|5|mg|30|stk|1|glas||G03DC02|01.12.1972||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|1000|2197|lyfalmen|||00|30|0|30|Icepharma hf|Bayer Schering Pharma AG|Noretísterón||1000||1000|2197 442152|J05AF0101|Retrovir|hylki|250|mg|40|stk|1|þpakki||J05AF01|01.07.1995||R|A|5|0|1|0|1|GSK|0|0|0|100|GBP|31961|41659|lyfsjukr|||61|40|0|17|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Zídóvúdín||31961||31961|41659 443135|H04AA0102|GlucaGen Hypokit|sts|1|mg|1|stk|1|hgl|dæla|H04AA01|01.01.1989||R|K|3|0|0|*|0|NON|0|0|1|100|DKK|4246|6602|lyfalmen|||02|1|0|1|Vistor hf|Novo-Nordisk|Glúkagon||4246||4246|6602 443358|N02AA0101|Contalgin|forðatfl|200|mg|90|stk|1|þpakki||N02AA01|01.04.1993||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|31259|41102|lyfalmen|||10|90|0|180|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||31259||31259|41102 444240|J05AF0401|Zerit|hylki|30|mg|56|stk|1|þpakki||J05AF04|01.11.1998||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|52263|66935|lyfsjukr|||00|56|0|21|Vistor hf|Bristol-Myers Squibb|Stavúdín||52263||52263|66935 444299|J05AF0401|Zerit|hylki|40|mg|56|stk|1|þpakki||J05AF04|01.11.1998||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|53010|67865|lyfsjukr|||00|56|0|28|Vistor hf|Bristol-Myers Squibb|Stavúdín||53010||53010|67865 444315|N06AB0302|Fontex|lausnart|20|mg|30|stk|1|pakki|þp (2 x 15 stk)|N06AB03|01.06.1998||R|A|2|0|0|B|0|ELI|0|1|0|100|XEU|3620|5753|lyfalmen|V0914|2128|00|30|0|30|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||3620||3620|5753 444430|N04BA0208|Madopar Quick "62,5"|lausnart|62,5|mg|100|stk|1|glas|50+12,5 mg|N04BA02|01.11.2000||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|2528|4271|lyfalmen|||00|100|0|8|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2528||2528|4271 444927|M05BA0601|Bondronat|irþ|1|mg/ml|2|ml|1|hgl||M05BA06|01.04.2006||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|21025|28044|lyfsjukr|||00|2|0|0|Icepharma hf|Roche|||21025||21025|28044 445155|D07CA0102|Fucidin-Hydrocortison|krem|30|mg/g|30|g|1|túpa|20 + 10 mg|D07CA01|01.02.1998||R|A|3|0|0|B|0|LEO|0|0|1|100|DKK|1950|3487|lyfalmen|||00|30|0|30|Vistor hf|LEO A/S|Hýdrókortisón og sýklalyf||1950||1950|3487 445759|G04CB0101|Proscar|töflur|5|mg|98|stk|1|þpakki||G04CB01|01.04.1993||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|14178|6457|lyfalmen|V0411|6060|10|98|0|98|Icepharma hf|M.S.D.|Fínasteríð||4139||4139|6457 446187|QA12CX9001|Tonophosphan, vet.|stl|200|mg/ml|50|ml|1|hgl||QA12CX90|01.12.1972||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|1674|3303|vetalmen|||27|50|0|0|Icepharma hf|Intervet International B.V.|||1674||1674|3303 446807|J02AC0101|Diflucan|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|4681|7193|lyfalmen|V0551|3202|10|7|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||4681||4681|7193 446930|J02AC0101|Diflucan|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|1994|3546|lyfalmen|V0554|1864|10|1|0|1|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||1994||1994|3546 447052|B01AB0401|Fragmin|stl|25000|ae/ml|0,72|ml|5|áf.spr|anti Xa|B01AB04|01.04.2008||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|13047|18428|lyfalmen|||00|4|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||13047||13047|18428 447110|B01AB0401|Fragmin|stl|25000|ae/ml|0,4|ml|5|áf.spr|anti Xa|B01AB04|01.04.2008||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|7443|10941|lyfalmen|||00|2|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||7443||7443|10941 447136|B01AB0401|Fragmin|stl|25000|ae/ml|0,5|ml|5|áf.spr|anti Xa|B01AB04|01.04.2008||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|9117|13213|lyfalmen|||00|2|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||9117||9117|13213 447151|B01AB0401|Fragmin|stl|25000|ae/ml|0,6|ml|5|áf.spr|anti Xa|B01AB04|01.04.2008||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|10947|15696|lyfalmen|||00|3|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||10947||10947|15696 447912|C08DB0107|Korzem|töflur|60|mg|100|stk|1|þpakki||C08DB01|01.01.1989|31.10.2009|R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|706|1798|lyfalmen|||00|100|0|25|Actavis Group hf|Actavis hf|Diltíazem||706||706|1798 448217|C05AA0801|Doloproct|eþ-stil|0| |10|stk|1|pakki||C05AA08|01.01.1991||R|A|4|0|0|E|0|IGB|0|0|0|100|SEK|633|1699|lyfalmen|||04|10|0|0|Icepharma hf|Intendis GmbH Berlin|Flúókortólón||633||633|1699 448233|C05AA0801|Doloproct|eþ-krem|0| |30|g|1|túpa||C05AA08|01.01.1991||R|A|3|0|0|E|0|IGB|0|0|0|100|SEK|1237|2519|lyfalmen|||00|30|0|0|Icepharma hf|Intendis GmbH Berlin|Flúókortólón||1237||1237|2519 448498|R03DA0503|Aminophylline|stl|30|mg/ml|10|ml|10|lykjur||R03DA05|01.07.2000||R|A||0|0|E|0|LDR|0|0|0|100|IKR|6496|9656|lyfalmen|||02|100|1|5|Parlogis hf|Parlogis - óskráð lyf|||6496||6496|9656 448688|M03BX0103|Lioresal|töflur|25|mg|50|stk|1|þpakki||M03BX01|01.12.1972||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|2730|4545|lyfalmen|V0712|2865|00|50|0|25|Vistor hf|Novartis Healthcare A/S-|Baklófen||2730||2730|4545 449595|C07AB0310|Atenolol Merck NM|töflur|50|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|651|1724|lyfalmen|||00|98|0|65|Actavis Group PTC ehf|Merck NM AB|Atenólól||651||651|1724 449611|C07AB0310|Atenolol Merck NM|töflur|100|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|1398|2738|lyfalmen|||00|98|0|131|Actavis Group PTC ehf|Merck NM AB|Atenólól||1398||1398|2738 449819|J01CE0106|Penicillin Actavis|sts|3|g/hgl|10|hgl|1|pakki|5 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|6420|9192|lyfsjukr|||00|10|0|8|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||6420||6420|9192 450155|J01CR0202|Augmentin|töflur|1|g|12|stk|1|pakki|þp 875+125 mg|J01CR02|01.01.1997||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|1115|2233|lyfalmen|V0466|2218|00|12|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1026||1026|2233 450734|N05CF0201|Stilnoct|töflur|10|mg|20|stk|1|þpakki||N05CF02|01.10.1992||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|1174|1876|lyfalmen|V0902|1709|00|20|0|20|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||763||763|1876 450775|N05CF0201|Stilnoct|töflur|10|mg|100|stk|1|þpakki||N05CF02|01.10.1992||R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|4132|5619|lyfalmen|V0903|4916|00|100|0|100|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||3521||3521|5619 451153|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|IKR|45479|58806|lyfalmen|||00|100|0|0|Icepharma hf|GE Healthcare AS|Gadódíamíð||45479||45479|58806 451419|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|IKR|68218|87116|lyfalmen|||00|150|0|0|Icepharma hf|GE Healthcare AS|Gadódíamíð||68218||68218|87116 451476|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|IKR|90958|115428|lyfalmen|||00|200|0|0|Icepharma hf|GE Healthcare AS|Gadódíamíð||90958||90958|115428 451989|N06AB0401|Cipramil|töflur|30|mg|28|stk|1|þpakki||N06AB04|01.11.1999||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|6628|8935|lyfalmen|||00|28|0|42|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||5965||5965|8935 451997|N06AB0401|Cipramil|töflur|30|mg|100|stk|1|glas||N06AB04|01.11.1999||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|17505|23979|lyfalmen|||00|100|0|150|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||17505||17505|23979 452268|J02AC0101|Diflucan|hylki|50|mg|30|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|19212|26104|lyfalmen|V0552|8757|10|30|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||19212||19212|26104 452284|M01AB1501|Toradol|stl|30|mg/ml|1|ml|5|lykjur||M01AB15|01.04.1992||R|A|3|0|0|E|0|ROA|0|0|1|100|DKK|1345|2666|lyfalmen|||00|5|0|5|Icepharma hf|Roche A.S.|Ketórólak||1345||1345|2666 452300|J02AC0101|Diflucan|hylki|50|mg|100|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|64341|82290|lyfalmen|||10|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||64341||64341|82290 452482|V07AB09|Sterilt Vann B. Braun|leysir|0||100|ml|10|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|1000|0|0|Actavis Group hf|Braun|||||| 452862|D06BB1001|Aldara|krem|50|mg/g|250|mg|12|stk|einnota pokar|D06BB10|01.03.2000||R|A|2|0|0|0|0|LAB|0|0|1|100|SEK|15490|21470|lyfalmen|||00|3000|0|3|Vistor hf|Laboratories 3M Santé|Imikvímóð||15490||15490|21470 452896|A06AD1701|Phosphoral|mixtúra|0| |45|ml|2|fl||A06AD17|01.03.1999||R|A|3|0|0|0|0|LCF|0|0|0|100|DKK|3500|5590|lyfalmen|||00|90|0|0|Vistor hf|Laboratorios Casen-Fleet S.L.U.|Natríumfosföt||3500||3500|5590 452904|N02AA0501|Oxycontin|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|2960|4857|lyfalmen|||10|28|0|4|Icepharma hf|Norpharma |Oxýcódon||2960||2960|4857 452920|N02AA0501|Oxycontin|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|8611|12526|lyfalmen|||10|98|0|13|Icepharma hf|Norpharma |Oxýcódon||8611||8611|12526 452953|L04AX0102|Imurel|töflur|50|mg|100|stk|1|þpakki||L04AX01|01.10.1995||R|A|5|0|0|*|0|GSK|0|0|0|100|GBP|2706|4513|lyfalmen|||10|100|0|33|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Azatíóprín||2706||2706|4513 452995|N02AA0501|Oxycontin|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|5590|8426|lyfalmen|||10|28|0|7|Icepharma hf|Norpharma |Oxýcódon||5590||5590|8426 453126|QP54AA0101|Eqvalan, vet.|pasta|18,7|mg/g|6,4|g|1|sk-dæl||QP54AA01|01.01.1991||L|A|3|0|0|0|0|MEF|0|0|0|100|XEU|||vetorma|||16|6|0|0|Vistor hf|Merial (MSD)||||||2952 453175|N02AA0501|Oxycontin|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|16701|22978|lyfalmen|||10|98|0|26|Icepharma hf|Norpharma |Oxýcódon||16701||16701|22978 453498|N02AA0501|Oxycontin|forðatfl|40|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|11261|16122|lyfalmen|||10|28|0|15|Icepharma hf|Norpharma |Oxýcódon||11261||11261|16122 453571|N02AA0501|Oxycontin|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|28550|37730|lyfalmen|||10|98|0|52|Icepharma hf|Norpharma|Oxýcódon||28550||28550|37730 453753|N05AE0401|Zeldox|sts|20|mg/hgl|1|hgl|1|pakki|+leysir|N05AE04|01.03.2002||R|A|3|0|0|0|1|PFI|0|1|0|100|DKK|4182|5988|lyfsjukr|||02|1|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ziprasidon||4182||4182|5988 453795|J07AL0102|Pneumo 23|bóluefni|0| |0,5|ml|1|dæla||J07AL01|01.09.2003||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|2661|4451|lyfalmen|||00|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Hreinsuð pneumococca poly­sakkaríð mótefnavakar||2661||2661|4451 454199|C10AA0101|Zocor|töflur|20|mg|98|stk|1|þpakki||C10AA01|01.01.1991|31.10.2009|R|A|2|0|0|0|0|MSD|0|0|0|100|XEU|11659|9188|lyfalmen|||00|98|0|65|Icepharma hf|M.S.D.|Simvastatín||6151||6151|9188 454439|N06DA0201|Aricept|töflur|5|mg|28|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|17803|24350|lyfalmen|||00|28|0|19|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dónepezíl||17803||17803|24350 454454|N06DA0201|Aricept|töflur|5|mg|98|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|50406|64940|lyfalmen|V0375|44058|00|98|0|65|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dónepezíl||50406||50406|64940 454678|N06DA0201|Aricept|töflur|10|mg|28|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|20085|27191|lyfalmen|||00|28|0|37|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dónepezíl||20085||20085|27191 454686|N06DA0201|Aricept|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|55535|71326|lyfalmen|V0376|49182|00|98|0|131|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dónepezíl||55535||55535|71326 454850|L01XX1701|Hycamtin|irs|4|mg/hgl|1|hgl|1|pakki||L01XX17|01.02.1999||R|A|3|0|1|0|1|GSK|0|0|0|100|GBP|56017|71609|lyfsjukr|||00|1|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Tópótecan||56017||56017|71609 454918|QJ01CE0902|Penovet, vet.|stl|300000|ae/ml|100|ml|1|hgl||QJ01CE09|01.10.1997||R|K|2|0|0|0|0|BID|0|0|0|100|DKK|1267|2500|vetalmen|||16|100|0|0|Vistor hf|Boehringer Ingelheim Danmark|||1267||1267|2500 455329|A10BF0101|Glucobay|töflur|50|mg|30|stk|1|þpakki||A10BF01|01.12.1997||R|A|3|0|0|*|0|BAV|0|0|0|100|SEK|1020|2225|lyfalmen|||00|30|0|5|Vistor hf|Bayer Schering Pharma AG (V)|Acarbósa||1020||1020|2225 455337|A10BF0101|Glucobay|töflur|50|mg|120|stk|1|þpakki||A10BF01|01.12.1997||R|A|3|0|0|*|0|BAV|0|0|0|100|SEK|3665|5814|lyfalmen|||00|120|0|20|Vistor hf|Bayer Schering Pharma AG (V)|Acarbósa||3665||3665|5814 455584|J05AB0901|Famvir|töflur|500|mg|21|stk|1|þpakki||J05AB09|01.10.1995||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|25401|33809|lyfalmen|||00|21|0|14|Vistor hf|Novartis Healthcare A/S-|Famcíclóvír||25401||25401|33809 455717|C05AD0102|Sulgan|eþ-smyr|0| |30|g|1|túpa||C05AD01|01.12.1972||L|A|5|0|0|0|0|DOE|0|0|0|100|IKR|||lyflausa|||00|30|0|0|Icepharma hf|Doetsch Grether|Lídókaín||||| 455725|C05AD0102|Sulgan|eþ-stil|0| |10|stk|1|pakki||C05AD01|01.12.1972||L|A|5|0|0|0|0|DOE|0|0|0|100|IKR|||lyflausa|||00|10|0|0|Icepharma hf|Doetsch Grether|Lídókaín||||| 455949|J01AA0207|Doxylin|töflur|100|mg|10|stk|1|þpakki|0|J01AA02|01.10.2008||R|A|4|0|0|0|0|ACA|0|0|1|100|XEU|1155|2408|lyfalmen|||00|10|0|10|Actavis Group hf|Actavis Group hf|Doxýcýklín||1155||1155|2408 455956|J01AA0207|Doxylin|töflur|100|mg|15|stk|1|þpakki||J01AA02|01.01.2009||R|A|4|0|0|0|0|ACA|0|0|1|100|XEU|1259|2549|lyfalmen|||0|15|0|15|Actavis Group hf|Actavis Group hf|Doxýcýklín||1259||1259|2549 455972|J01AA0207|Doxylin|töflur|100|mg|30|stk|1|þpakki|0|J01AA02|01.10.2008||R|A|4|0|0|0|0|ACA|0|0|1|100|XEU|2759|4584|lyfalmen|||00|30|0|30|Actavis Group hf|Actavis Group hf|Doxýcýklín||2759||2759|4584 456079|B05DA0001|Dianeal PD1 Glucose|kvið.sk|13,6|mg/ml|6000|ml|2|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|4901|7017|lyfsjukr|||00|12000|0|12|Icepharma hf|Baxter|||4901||4901|7017 456202|B05DB0001|Dianeal PD1 Glucose|kvið.sk|22,7|mg/ml|6000|ml|2|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|4901|7017|lyfsjukr|||00|12000|0|12|Icepharma hf|Baxter|||4901||4901|7017 456277|B05DA0001|Dianeal PD1 Glucose|kvið.sk|13,6|mg/ml|5000|ml|2|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|5351|7661|lyfsjukr|||00|10000|0|0|Icepharma hf|Baxter|||5351||5351|7661 456392|B05DB0001|Dianeal PD1 Glucose|kvið.sk|22,7|mg/ml|5000|ml|2|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|5351|7661|lyfsjukr|||00|10000|0|0|Icepharma hf|Baxter|||5351||5351|7661 457002|B05DA0001|Dianeal PD1 Glucose|kvið.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|8011|11470|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||8011||8011|11470 457036|B05DB0001|Dianeal PD1 Glucose|kvið.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|8011|11470|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||8011||8011|11470 457069|B05DB0001|Dianeal PD1 Glucose|kvið.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|8011|11470|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||8011||8011|11470 457119|B05DA0002|Dianeal PD1 Glucose Duo|kvið.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|10028|14352|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||10028||10028|14352 457242|B05DB0002|Dianeal PD1 Glucose Duo|kvið.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|9776|13997|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||9776||9776|13997 457291|B05DB0002|Dianeal PD1 Glucose Duo|kvið.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|12996|18048|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||12996||12996|18048 458067|N05CM0201|Heminevrin|hylki|300|mg|25|stk|1|glas||N05CM02|01.12.1998||R|A|2|0|0|0|0|ARA|0|0|1|100|SEK|1177|2438|lyfalmen|||00|25|0|5|Vistor hf|Astra|Clómetíazól||1177||1177|2438 458349|J01CA0801|Selexid|töflur|200|mg|20|stk|1|þpakki||J01CA08|01.12.1980||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|1670|3107|lyfalmen|||43|20|0|7|Vistor hf|LEO Pharma A/S|Pívmecillínam||1670||1670|3107 458356|J01CA0801|Selexid|töflur|200|mg|30|stk|1|þpakki||J01CA08|01.12.1980||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|2428|4135|lyfalmen|||43|30|0|10|Vistor hf|LEO Pharma A/S|Pívmecillínam||2428||2428|4135 458422|J01CA0801|Selexid|töflur|200|mg|100|stk|1|þpakki||J01CA08|01.12.2007||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|10120|14574|lyfalmen|V0456|14574|00|100|0|33|Vistor hf|LEO Pharma A/S|Pívmecillínam||10120||10120|14574 458737|B05DA0003|Dianeal PD4 Glucose Duo|kvið.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|13099|18176|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||13099||13099|18176 458778|B05DB0003|Dianeal PD4 Glucose Duo|kvið.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|13099|18176|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||13099||13099|18176 458794|B05DB0003|Dianeal PD4 Glucose Duo|kvið.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|13099|18176|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||13099||13099|18176 459214|B05DB0004|Nutrineal PD4 1,1% Amino Acids Clear|kvið.sk|0| |2000|ml|5|pokar||B05DB00|01.06.2004|31.10.2009|R|S|2|0|0|0|1|BAM|0|0|0|100|SEK|15527|21199|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|||15527||15527|21199 459354|J01FF0101|Dalacin|stl|150|mg/ml|2|ml|1|lykja||J01FF01|01.11.1979||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|1648|2360|lyfsjukr|||02|2|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||1648||1648|2360 459412|M05BA0601|Bondronat|irþ|1|mg/ml|2|ml|5|lykjur||M05BA06|01.02.2002||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|98940|125048|lyfsjukr|||00|10|0|2|Icepharma hf|Roche|||98940||98940|125048 459420|J01FF0101|Dalacin|stl|150|mg/ml|4|ml|1|lykja||J01FF01|01.11.1979||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|2021|2894|lyfsjukr|||02|4|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||2021||2021|2894 459727|S01ED0105|Optimol|augndr|2,5|mg/ml|5|ml|3|glös||S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|2339|4015|lyfalmen|||06|15|0|75|Icepharma hf|Santen Oy|Tímólól||2339||2339|4015 459743|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|3|glös||S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|2564|4320|lyfalmen|||06|15|0|75|Icepharma hf|Santen Oy|Tímólól||2564||2564|4320 459859|B02AA0201|Cyklokapron|töflur|500|mg|30|stk|1|þpakki||B02AA02|01.04.1989||R|A|3|0|0|E|0|MAS|0|0|1|100|SEK|2674|4469|lyfalmen|||00|30|0|8|Vistor hf|Meda AS|Tranexamsýra||2674||2674|4469 459867|B02AA0201|Cyklokapron|töflur|500|mg|60|stk|1|þpakki||B02AA02|01.04.1989||R|A|3|0|0|E|0|MAS|0|0|1|100|SEK|4812|7370|lyfalmen|||00|60|0|15|Vistor hf|Meda AS|Tranexamsýra||4812||4812|7370 460071|J01CA0406|Flemoxin Solutab|lausnart|250|mg|20|stk|1|þpakki||J01CA04|01.07.1989||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|1165|2421|lyfalmen|||23|20|0|5|Vistor hf|Astellas Pharma A/S|Amoxicillín||1165||1165|2421 460170|J07BC0202|Avaxim|bóluefni|0| |0,5|ml|1|dæla|einnota dæla|J07BC02|01.04.1998||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|4914|7509|lyfalmen|||51|0|0|0|Icepharma hf|Aventis Pasteur MSD A/S|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||4914||4914|7509 460196|J01CA0406|Flemoxin Solutab|lausnart|500|mg|20|stk|1|þpakki||J01CA04|01.07.1989||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|1277|2573|lyfalmen|||23|20|0|10|Vistor hf|Astellas Pharma A/S|Amoxicillín||1277||1277|2573 460303|J01CA0406|Flemoxin Solutab|lausnart|750|mg|20|stk|1|þpakki||J01CA04|01.07.1989||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|2671|4465|lyfalmen|||23|20|0|15|Vistor hf|Astellas Pharma A/S|Amoxicillín||2671||2671|4465 460618|L01AX0301|Temodal|hylki|5|mg|20|stk|1|glas| |L01AX03|01.05.2001||R|A|3|0|1|0|1|SCP|0|0|0|100|DKK|20976|27983|lyfsjukr|||00|20|0|0|Vistor hf|Schering-Plough|Temozolomid||20976||20976|27983 460782|D01AC0801|Fungoral|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.10.1992||L|A|3|0|0|0|0|JAS|0|0|1|100|SEK|||lyflausa|||23|120|0|120|Vistor hf|Janssen-Cilag AB|Ketókónazól||||| 460972|J07BB0205|Influvac|bóluefni|0| |0,5|ml|10|spr|einnotaspr|J07BB02|01.12.1998||R|K|1|0|0|0|0|SOB|0|0|0|100|XEU|7030|10380|lyfalmen|||51|5|0|0|Icepharma hf|Solvay Biologicals B.V.|Inflúensa, hreinsaðir mótefnavakar||7030||7030|10380 461178|L01AX0301|Temodal|hylki|20|mg|20|stk|1|glas| |L01AX03|01.05.2001||R|A|3|0|1|0|1|SCP|0|0|0|100|DKK|83899|106322|lyfsjukr|||00|20|0|0|Vistor hf|Schering-Plough|Temozolomid||83899||83899|106322 461335|L01AX0301|Temodal|hylki|100|mg|5|stk|1|glas| |L01AX03|01.05.2001||R|A|3|0|1|0|1|SCP|0|0|0|100|DKK|82861|105029|lyfsjukr|||00|5|0|0|Vistor hf|Schering-Plough|Temozolomid||82861||82861|105029 461467|L01AX0301|Temodal|hylki|250|mg|5|stk|1|glas| |L01AX03|01.05.2001||R|A|3|0|1|0|1|SCP|0|0|0|100|DKK|205745|258020|lyfsjukr|||00|5|0|0|Vistor hf|Schering-Plough|Temozolomid||205745||205745|258020 461731|N02BE5102|Parkodin|töflur|510|mg|10|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1989||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|193|1102|lyfalmen|||00|10|0|2|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||193||193|1102 462028|D07AD0101|Dermovat|krem|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|702|1793|lyfalmen|||20|25|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||702||702|1793 462044|D07AD0101|Dermovat|smyrsli|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|702|1793|lyfalmen|||20|25|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||702||702|1793 462358|A07EA0601|Entocort|innhl|20|mcg/ml|7|stk|1|pakki|samsett pk|A07EA06|01.04.1993||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|8606|12519|lyfalmen|||56|7|0|7|Vistor hf|AstraZeneca A/S DK|Búdesóníð||8606||8606|12519 462986|QM01AE9101|Rimadyl vet.|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2000||R|K|3|0|0|0|0|PAL|1|0|0|100|DKK|7767|14966|vetalmen|||02|20|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health|||7767||7767|14966 463612|QM01AE9101|Rimadyl vet.|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.06.2000||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|6196|11974|vetalmen|||00|100|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health|||6196||6196|11974 464164|N02BE0101|Panodil|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.04.1992||L|A|5|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|30|0|5|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||||| 464370|N05AD0301|Buronil|töflur|25|mg|100|stk|1|glas||N05AD03|01.12.1972||R|A|5|0|0|*|0|LPI|0|1|0|100|DKK|2050|3622|lyfalmen|||00|100|0|8|Swedish Orphan International AB|Lundbeck Pharmaceuticals Ireland Ltd.|Melperón||2050||2050|3622 465203|QJ01RA0103|Depomycine, vet.|stl|0| |100|ml|1|hgl||QJ01RA01|01.12.1982||R|K|2|0|0|0|0|INI|0|0|0|100|DKK|1376|2715|vetalmen|||58|100|0|0|Icepharma hf|Intervet International B.V.|||1376||1376|2715 465237|QJ01CR5001|Duplocillin L.A., vet.|stl|0| |100|ml|1|hgl||QJ01CR50|01.05.1983||R|S|3|0|0|0|0|INI|1|0|0|100|DKK|1300|2565|vetalmen|||58|100|0|0|Icepharma hf|Intervet International B.V.|||1300||1300|2565 465260|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.12.1982||R|A|3|0|0|0|0|INI|0|0|0|100|DKK|1393|2749|vetalmen|||27|100|0|0|Icepharma hf|Intervet International B.V.|||1393||1393|2749 465278|QJ51RC2301|Nafpenzal DC, vet.|spenalyf|0| |3|g|4|spr||QJ51RC23|01.04.1985||R|A|3|0|0|0|0|INI|0|0|0|100|XEU|733|1446|vetalmen|||16|12|0|0|Icepharma hf|Intervet International B.V.|||733||733|1446 466086|N02AA0101|Contalgin|forðatfl|10|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|869|2020|lyfalmen|||10|25|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||869||869|2020 466094|N02AA0101|Contalgin|forðatfl|10|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|2392|4086|lyfalmen|||10|100|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||2392||2392|4086 466169|N02AA0101|Contalgin|forðatfl|30|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|1849|3350|lyfalmen|||10|25|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||1849||1849|3350 466219|N02AA0101|Contalgin|forðatfl|30|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|7077|10444|lyfalmen|||10|100|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||7077||7077|10444 466466|N02AA0101|Contalgin|forðatfl|60|mg|25|stk|1|þpakki||N02AA01|01.10.1995||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|3556|5666|lyfalmen|||10|25|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||3556||3556|5666 466482|L04AD0102|Sandimmun Neoral|hylki|25|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|9171|13286|lyfalmen|||10|50|0|5|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||9171||9171|13286 466680|N02AA0101|Contalgin|forðatfl|100|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|5692|8565|lyfalmen|||10|25|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||5692||5692|8565 466813|N06AG0201|Aurorix|töflur|150|mg|100|stk|1|þpakki||N06AG02|01.10.1990||R|A|5|0|0|B|0|MAS|0|1|0|100|SEK|5783|8688|lyfalmen|||64|100|0|50|Vistor hf|Meda AS|Móklóbemíð||5783||5783|8688 467191|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|18382|24753|lyfsjukr|||00|0|0|1|Vistor hf|Amgen Europe B.V.|Fílgrastím||18382||18382|24753 467258|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|28809|37735|lyfsjukr|||00|0|0|1|Vistor hf|Amgen Europe B.V.|Fílgrastím||28809||28809|37735 467480|L03AB0502|IntronA|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|31193|40703|lyfsjukr|||00|1|0|9|Vistor hf|Schering-Plough|Interferón alfa-2b||31193||31193|40703 467498|L03AB0502|IntronA|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|50809|65125|lyfsjukr|||00|1|0|15|Vistor hf|Schering-Plough|Interferón alfa-2b||50809||50809|65125 467514|L04AA1001|Rapamune|mixtúra|1|mg/ml|60|ml|1|fl||L04AA10|01.04.2004||R|A|2|0|1|*|0|WTE|0|0|0|100|USD|39244|51044|lyfalmen|||00|60|0|20|Icepharma hf|Wyeth Europe|Sirolimus||39244||39244|51044 467563|L04AD0102|Sandimmun Neoral|hylki|50|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|17892|24461|lyfalmen|||10|50|0|10|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||17892||17892|24461 467621|L03AB0502|IntronA|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|104005|131354|lyfsjukr|||00|1|0|30|Vistor hf|Schering-Plough|Interferón alfa-2b||104005||104005|131354 467720|L04AD0102|Sandimmun Neoral|hylki|100|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|34067|44598|lyfalmen|||10|50|0|20|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||34067||34067|44598 467993|N05AD0101|Haldol|stl|5|mg/ml|1|ml|5|lykjur||N05AD01|01.08.2000||R|A|5|0|0|0|1|JAS|0|1|0|100|SEK|837|1198|lyfsjukr|||00|5|0|3|Vistor hf|Janssen-Cilag AB|Halóperídól||837||837|1198 468082|N06AB0401|Cipramil|töflur|10|mg|100|stk|1|plglas||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|7425|7370|lyfalmen|V0922|4508|00|100|0|50|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||4812||4812|7370 468116|N01AH0102|Leptanal|stl|50|mcg/ml|2|ml|5|lykjur||N01AH01|01.11.2001||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|488|699|lyfsjukr|||02|10|0|0|Vistor hf|Janssen-Cilag AB|Fentanýl||488||488|699 468124|N06AB0401|Cipramil|töflur|20|mg|100|stk|1|glas||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|10810|7010|lyfalmen|V0926|4309|00|100|0|100|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||4546||4546|7010 468165|N06AB0401|Cipramil|töflur|40|mg|100|stk|1|glas||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|27315|14400|lyfalmen|V0930|8459|00|100|0|200|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||9992||9992|14400 469346|C10AB0401|Lopid|töflur|600|mg|98|stk|1|þpakki||C10AB04|01.07.1991||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|11775|16820|lyfalmen|||00|98|0|49|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gemfíbrózíl||11775||11775|16820 469742|N02AX0206|Nobligan Retard|forðatfl|200|mg|20|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|3362|5403|lyfalmen|||00|20|0|13|Icepharma hf|Grunenthal|Tramadól||3362||3362|5403 469817|N02AX0206|Nobligan Retard|forðatfl|200|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|13705|19248|lyfalmen|V0738|14179|00|100|0|67|Icepharma hf|Grunenthal|Tramadól||13705||13705|19248 469866|N02AX0206|Nobligan Retard|forðatfl|150|mg|20|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|2629|4408|lyfalmen|||00|20|0|10|Icepharma hf|Grunenthal|Tramadól||2629||2629|4408 469874|N02AX0206|Nobligan Retard|forðatfl|150|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|10407|14963|lyfalmen|V0736|9650|00|100|0|50|Icepharma hf|Grunenthal|Tramadól||10407||10407|14963 469890|N02AX0206|Nobligan Retard|forðatfl|100|mg|20|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1787|3265|lyfalmen|V0733|2674|00|20|0|7|Icepharma hf|Grunenthal|Tramadól||1787||1787|3265 469932|N02AX0206|Nobligan Retard|forðatfl|100|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|7109|10488|lyfalmen|V0734|6581|00|100|0|33|Icepharma hf|Grunenthal|Tramadól||7109||7109|10488 470385|R03BA0501|Flixotide|innúðal|250|mcg/sk|120|sk|1|stauk||R03BA05|01.04.1995||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|5666|8529|lyfalmen|||24|120|0|50|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||5666||5666|8529 470989|V08AB0201|Omnipaque|stl|180|mg J/ml|15|ml|10|plastf||V08AB02|01.01.2005||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|12452|17370|lyfsjukr|||02|150|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||12452||12452|17370 471144|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|10063|14396|lyfsjukr|||02|200|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||10063||10063|14396 471151|V08AB0201|Omnipaque|stl|300|mg J/ml|10|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|6396|9157|lyfsjukr|||02|100|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||6396||6396|9157 471169|V08AB0201|Omnipaque|stl|300|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|16799|22782|lyfsjukr|||02|200|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||16799||16799|22782 471177|V08AB0201|Omnipaque|stl|350|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|14438|19843|lyfsjukr|||02|200|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||14438||14438|19843 471425|A10BB0701|Mindiab|töflur|5|mg|100|stk|1|þpakki||A10BB07|01.07.1990||R|A|5|0|0|*|0|PFI|0|0|0|100|DKK|2306|3970|lyfalmen|||68|100|0|50|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Glípízíð||2306||2306|3970 471821|QP52AC1302|Panacur, vet.|töflur|250|mg|20|stk|1|þpakki||QP52AC13|01.04.1992||L|A|5|0|0|0|0|INI|0|0|0|100|DKK|||vetorma|||99|20|0|0|Icepharma hf|Intervet International B.V.||||||2708 471938|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|þpakki||L01AA01|01.01.1988||R|A|3|0|0|*|0|BAM|0|0|0|100|SEK|2574|4333|lyfalmen|||00|100|0|0|Icepharma hf|Baxter Medical AB|Cýklófosfamíð||2574||2574|4333 471953|QV03AB9001|Antisedan, vet.|stl|5|mg/ml|10|ml|1|hgl||QV03AB90|01.08.2006||R|A|3|0|0|0|0|ORC|1|0|0|100|DKK|5516|10678|vetalmen|||27|10|0|0|Vistor hf|Orion Corporation|||5516||5516|10678 472092|C07AB0206|Seloken ZOC|forðatfl|47,5|mg|98|stk|1|þpakki||C07AB02|01.07.1989||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2476|3629|lyfalmen|V2003|3253|43|98|0|31|Vistor hf|AstraZeneca A/S DK|Metóprólól||2055||2055|3629 472332|J07BC0201|Havrix|bóluefni|1440|ein/ml|0,5|ml|1|dæla|einnota dæla|J07BC02|01.10.1995||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|2624|4401|lyfalmen|||02|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||2624||2624|4401 474007|B05AA0507|Promiten|stl|150|mg/ml|20|ml|20|lykjur|plastlykjur|B05AA05|01.03.1999||R|A|3|0|0|0|1|MAB|0|0|0|100|SEK|15534|21207|lyfsjukr|||00|400|0|0|Vistor hf|Meda AB|Dextran||15534||15534|21207 474106|M02AA1301|Deep Relief|hlaup|5|%|50|g|1|túpa||M02AA13|01.06.2000||L|A|3|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||00|50|0|0|Icepharma hf|Mentholatum Company Ltd.|Íbúprófen||||| 474114|N02CA7201|Anervan|töflur|160,5|mg|30|stk|1|pakki|þp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|1114|2352|lyfalmen|||00|30|0|15|Vistor hf|Recip AB|Ergotamínlyf í blöndum með geðlyfjum (psycoleptica)||1114||1114|2352 474197|M02AA1301|Deep Relief|hlaup|5|%|15|g|1|túpa||M02AA13|01.06.2000||L|A|3|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||00|15|0|0|Icepharma hf|Mentholatum Company Ltd.|Íbúprófen||||| 474395|J05AG0101|Viramune|töflur|200|mg|60|stk|1|þpakki||J05AG01|01.03.2007||R|A|3|0|1|0|1|BII|0|0|0|100|DKK|48270|61964|lyfsjukr|||00|60|0|30|Vistor hf|Boehringer Ingelheim International |Nevírapín||48270||48270|61964 474551|R01AD0901|Nasonex|nefúði|50|mcg/sk|140|skammtar|1|úðagl|18 g í pakkn.|R01AD09|01.05.1998||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|2144|3750|lyfalmen|||00|140|0|35|Vistor hf|Schering-Plough|Mómetasón||2144||2144|3750 475327|N02BE0113|Pinex Junior|eþ-stil|250|mg|10|stk|1|pakki||N02BE01|01.07.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||04|10|0|1|Actavis Group hf|Actavis Group hf|Paracetamól||||| 475434|B01AA0301|Kovar|töflur|2|mg|100|stk|1|glas||B01AA03|01.10.1995||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|720|1817|lyfalmen|||00|100|0|27|Actavis Group hf|Actavis hf|Warfarín||720||720|1817 475467|G03CA0306|Evorel|forðapl|50|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|4533|6992|lyfalmen|||23|26|0|91|Vistor hf|Janssen-Cilag AB|Estradíól||4533||4533|6992 475491|N02AA5902|Parkodin forte|töflur|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|A|2|0|0|0|0|ACA|0|0|1|100|NOK|251|1181|lyfalmen|V0775|1181|00|20|0|7|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||251||251|1181 475533|N02AA5902|Parkodin forte|töflur|530|mg|30|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|A|2|0|0|0|0|ACA|0|0|1|100|NOK|348|1313|lyfalmen|||00|30|0|10|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||348||348|1313 475715|N02AA5902|Parkodin forte|töflur|530|mg|100|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|A|2|1|0|0|0|ACA|0|0|1|100|NOK|975|2163|lyfalmen|V0780|2163|00|100|0|33|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||975||975|2163 475756|C09AA0801|Inhibace|töflur|2,5|mg|98|stk|1|þpakki||C09AA08|01.07.1991||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|7226|10646|lyfalmen|||00|98|0|98|Icepharma hf|Roche|Cílazapríl||7226||7226|10646 475798|R03AC1302|Oxis Turbuhaler|innúðadu|4,5|mcg/sk|60|sk|1|stauk||R03AC13|01.10.1997||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|3706|5870|lyfalmen|||00|60|0|11|Vistor hf|AstraZeneca A/S DK|Formóteról||3706||3706|5870 475822|R03AC1302|Oxis Turbuhaler|innúðadu|9|mcg/sk|60|sk|1|stauk||R03AC13|01.10.1997||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|4957|7567|lyfalmen|||00|60|0|22|Vistor hf|AstraZeneca A/S DK|Formóteról||4957||4957|7567 475889|C09AA0801|Inhibace|töflur|5|mg|98|stk|1|þpakki||C09AA08|01.07.1991|31.08.2009|R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|8375|12206|lyfalmen|||00|98|0|196|Icepharma hf|Roche|Cílazapríl||8375||8375|12206 475921|A10AB0404|Humalog Pen|stl|100|ae/ml|3|ml|5|pennar|einnota pennar|A10AB04|01.11.1999||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|6457|9603|lyfalmen|||00|15|0|38|Icepharma hf|Eli Lilly Nederland -|Insúlín lispró||6457||6457|9603 476093|A10AC0106|Humulin NPH Pen|stl|100|ae/ml|3|ml|5|pennar|Einnota pennar|A10AC01|01.06.1999||R|K|2|0|0|*|0|ELI|0|0|0|100|XEU|5483|8281|lyfalmen|||51|15|0|38|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||5483||5483|8281 476580|R03AC0206|Ventoline|lausn|2|mg/ml|2,5|ml|20|lykjur|f. vél|R03AC02|01.04.1992||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|1211|2484|lyfalmen|||00|50|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||1211||1211|2484 476648|N05AH0401|Seroquel|töflur|100|mg|30|stk|1|þpakki|stakskammtar|N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|7560|11100|lyfalmen|||00|30|0|8|Vistor hf|AstraZeneca UK Ltd|Quetíapín||7560||7560|11100 476655|N05AH0401|Seroquel|töflur|200|mg|30|stk|1|þpakki|stakskammtar|N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|11489|16432|lyfalmen|||00|30|0|15|Vistor hf|AstraZeneca UK Ltd|Quetíapín||11489||11489|16432 477059|P01BB5101|Malarone|filmhtfl|350|mg|12|stk|1|glas|250 + 100 mg|P01BB51|01.02.2006||R|A|5|0|0|0|0|GSK|0|0|0|100|GBP|4753|7290|lyfalmen|||00|12|0|3|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Prógúaníl í blöndum||4753||4753|7290 477547|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|0| |20|ml|10|hgl|fyrir stungulyf|V07AB00|01.02.2007||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|200|0|0|Icepharma hf|Fresenius Kabi|||||| 477554|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|0| |50|ml|10|hgl|fyrir stungulyf|V07AB00|01.02.2007||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|500|0|0|Icepharma hf|Fresenius Kabi|||||| 477752|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|200|0|0|Icepharma hf|Fresenius Kabi|||||| 477760|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|50|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|500|0|0|Icepharma hf|Fresenius Kabi|||||| 477786|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|100|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|1000|0|0|Icepharma hf|Fresenius Kabi|||||| 479691|C09AA0701|Cibacen|töflur|10|mg|98|stk|1|þpakki||C09AA07|01.07.1991||R|A|3|0|0|0|0|MAS|0|0|0|100|SEK|11093|15894|lyfalmen|||00|98|0|131|Vistor hf|Meda AS|Benazepríl||11093||11093|15894 479717|C09AA0701|Cibacen|töflur|20|mg|98|stk|1|þpakki||C09AA07|01.07.1991||R|A|3|0|0|0|0|MAS|0|0|0|100|SEK|23798|31813|lyfalmen|||00|98|0|261|Vistor hf|Meda AS|Benazepríl||23798||23798|31813 480863|G03XC0101|Evista|töflur|60|mg|28|stk|1|þpakki||G03XC01|01.02.1999||R|A|3|0|0|E|0|DSG|0|0|0|100|SEK|5132|7805|lyfalmen|||00|28|0|28|Icepharma hf|Daiichi Sankyo Europe GmbH|Raloxífen||5132||5132|7805 480897|G03XC0101|Evista|töflur|60|mg|84|stk|1|þpakki||G03XC01|01.02.1999||R|A|3|0|0|E|0|DSG|0|0|0|100|SEK|13288|18729|lyfalmen|||00|84|0|84|Icepharma hf|Daiichi Sankyo Europe GmbH|Raloxífen||13288||13288|18729 481176|N06AX1201|Zyban|forðatfl|150|mg|100|stk|1|þpakki||N06AX12|01.09.2000||R|A|2|0|0|0|0|GSK|0|1|1|100|GBP|12285|17480|lyfalmen|||00|100|0|50|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Buprofienum||12285||12285|17480 481598|M03AX0102|Dysport|sts|500|ein|1|hgl|1|pakki||M03AX01|01.05.2003||R|K|2|0|1|0|1|INP|0|0|0|100|XEU|39592|51160|lyfsjukr|||02|1|0|0|Icepharma hf|Institut Produits Synthése (IPSEN) AB|Clostridium botulinum toxín-A||39592||39592|51160 483552|J02AC0101|Diflucan|hylki|200|mg|28|stk|1|þpakki||J02AC01|01.08.2000||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|71913|91717|lyfalmen|V0557|27676|10|28|0|28|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||71913||71913|91717 483602|J02AC0101|Diflucan|irl|2|mg/ml|50|ml|1|fl||J02AC01|01.04.1990||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|4169|5969|lyfsjukr|||00|50|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||4169||4169|5969 483636|N07BA0103|Nicorette|tungur.t|2|mg|30|stk|1|þpakki||N07BA01|01.02.1999||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2|Vistor hf|McNeil Denmark ApS|Nikótín||||| 483644|N07BA0103|Nicorette|tungur.t|2|mg|105|stk|1|þpakki||N07BA01|01.02.1999||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|7|Vistor hf|McNeil Denmark ApS|Nikótín||||| 483685|J02AC0101|Diflucan|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.03.2001||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|5772|8264|lyfsjukr|||00|100|0|1|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||5772||5772|8264 484022|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|3|spr|+ leysir|L02AE04|01.01.1995||R|K|3|0|1|0|1|FER|0|0|0|100|DKK|95339|120565|lyfsjukr|||00|3|0|84|Vistor hf|Ferring|Triptórelín||95339||95339|120565 484238|D11AX1001|Propecia|töflur|1|mg|28|stk|1|þpakki||D11AX10|01.08.1999||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|6871|10165|lyfalmen|||00|28|0|28|Icepharma hf|M.S.D.|Fínasteríð||6871||6871|10165 484618|A01AD0201|Andolex|lausn|1,5|mg/ml|300|ml|1|glas|lausn til munnskolunar|A01AD02|01.01.1996||R|A|3|0|0|E|0|MEB|0|0|1|100|SEK|1463|2826|lyfalmen|||00|300|0|0|Vistor hf|Meda AB (V)|Benzýdamín||1463||1463|2826 486779|M01AE0215|Naproxen Merck NM|töflur|250|mg|20|stk|1|þpakki||M01AE02|01.04.1995||L|A|4|0|0|0|0|MNA|0|0|1|100|IKR|||lyflausa|||00|20|0|10|Actavis Group PTC ehf|Merck NM AB|Naproxen||||| 486860|S01BA0101|Maxidex|augndr|1|mg/ml|5|ml|1|glas||S01BA01|01.01.1977||R|A|3|0|0|E|0|ALC|0|0|1|100|USD|481|1493|lyfalmen|||29|5|0|0|K.Pétursson hf|Alcon|Dexametasón||481||481|1493 486886|S01CA0101|Maxitrol|augndr|0| |5|ml|1|glas||S01CA01|01.07.1990||R|A|2|0|0|E|0|ALC|0|0|1|100|USD|686|1771|lyfalmen|||29|5|0|0|K.Pétursson hf|Alcon|Dexametasón||686||686|1771 487264|C09AA0401|Coversyl|töflur|2|mg|30|stk|1|þpakki||C09AA04|01.01.1992||R|A|2|0|0|0|0|SEV|0|0|0|100|DKK|2883|4753|lyfalmen|||00|30|0|15|Icepharma hf|Servier|Perindópríl||2883||2883|4753 487280|C09AA0401|Coversyl|töflur|4|mg|30|stk|1|þpakki||C09AA04|01.01.1992||R|A|2|0|0|0|0|SEV|0|0|0|100|DKK|4208|6551|lyfalmen|||00|30|0|30|Icepharma hf|Servier|Perindópríl||4208||4208|6551 487900|J01XE0101|Furadantin|töflur|50|mg|25|stk|1|þpakki||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|887|2044|lyfalmen|||00|25|0|6|Vistor hf|Recip AB|Nítrófúrantóín||887||887|2044 487959|N02BE0113|Pinex Junior|eþ-stil|125|mg|10|stk|1|pakki||N02BE01|01.07.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||04|10|0|0|Actavis Group hf|Actavis Group hf|Paracetamól||||| 488049|M01AX0101|Relifex|töflur|500|mg|20|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|954|2135|lyfalmen|||00|20|0|10|Vistor hf|Meda AB|Nabúmeton||954||954|2135 488056|M01AX0101|Relifex|töflur|500|mg|60|stk|1|plglas||M01AX01|01.07.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|2842|4697|lyfalmen|||00|60|0|30|Vistor hf|Meda AB|Nabúmeton||2842||2842|4697 488114|N02BE0114|Pinex|eþ-stil|500|mg|10|stk|1|pakki||N02BE01|01.07.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||04|10|0|2|Actavis Group hf|Actavis Group hf|Paracetamól||||| 488767|D05BB0201|Neotigason|hylki|10|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|A|3|0|1|B|0|ACA|0|0|0|100|DKK|7277|10716|lyfalmen|||67|50|0|14|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||7277||7277|10716 488791|D05BB0201|Neotigason|hylki|25|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|A|3|0|1|B|0|ACA|0|0|0|100|DKK|20360|27533|lyfalmen|||67|50|0|36|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||20360||20360|27533 489591|M01AB0506|Voltaren Rapid|töflur|50|mg|10|stk|1|þpakki||M01AB05|01.01.1996||R|A|3|0|0|0|0|NOH|0|0|1|100|IKR|338|1101|lyfalmen|||67|10|0|5|Vistor hf|Novartis Healthcare A/S-|Díklófenak||192||192|1101 489609|M01AB0506|Voltaren Rapid|töflur|50|mg|30|stk|1|þpakki||M01AB05|01.01.1996||R|A|3|0|0|0|0|NOH|0|0|1|100|IKR|882|1474|lyfalmen|V0609|1424|67|30|0|15|Vistor hf|Novartis Healthcare A/S-|Díklófenak||467||467|1474 490417|G03FB0504|Evorel Sequi|forðapl|0| |8|stk|1|pakki||G03FB05|01.08.1999||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|2670|4464|lyfalmen|||23|8|0|28|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2670||2670|4464 490425|G03FA0104|Evorel Conti|forðapl|0| |8|stk|1|pakki||G03FA01|01.08.1999||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|2976|4879|lyfalmen|||23|8|0|28|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2976||2976|4879 490557|A04AA0201|Kytril|stl|1|mg/ml|1|ml|5|lykjur||A04AA02|01.10.1999||R|A|3|0|0|E|0|ROA|0|0|0|100|DKK|9937|14325|lyfalmen|||00|5|0|2|Icepharma hf|Roche A.S.|Granisetrón||9937||9937|14325 490797|C10AA0501|Zarator|töflur|10|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|5467|8259|lyfalmen|||00|30|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||5467||5467|8259 490805|C10AA0501|Zarator|töflur|10|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|12541|11876|lyfalmen|||00|100|0|50|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||8132||8132|11876 490813|C10AA0501|Zarator|töflur|20|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|8485|12355|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||8485||8485|12355 490821|C10AA0501|Zarator|töflur|20|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|17798|16201|lyfalmen|||00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||11319||11319|16201 490839|C10AA0501|Zarator|töflur|40|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|13170|18582|lyfalmen|||00|30|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||13170||13170|18582 490854|C10AA0501|Zarator|töflur|40|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|22636|19962|lyfalmen|V0339|5868|00|100|0|200|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||14279||14279|19962 491639|N06DA0301|Exelon|mixtúra|2|mg/ml|120|ml|1|fl||N06DA03|01.05.2003|31.10.2009|R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|25317|33705|lyfalmen|||00|120|0|27|Vistor hf|Novartis Europharm Ltd|Rívastigmín||25317||25317|33705 491860|L03AX0301|Oncotice|duft|500|millj ae|3|hgl|1|pakki|Fyrir ídreypivökva.|L03AX03|01.03.1999||R|K|1|0|1|0|1|ORG|0|0|0|100|DKK|52540|67280|lyfsjukr|||00|3|0|21|Vistor hf|N.V. Organon|BCG bóluefni||52540||52540|67280 492405|N04BA0202|Madopar Depot|forðahlk|125|mg|100|stk|1|hylki|100+25 mg|N04BA02|01.01.1991||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|3839|6050|lyfalmen|||10|100|0|17|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3839||3839|6050 492512|A02BC0102 |Losec|sh-tfl|10|mg|14|stk|1|þpakki||A02BC01|01.09.2009||L|A||0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||00|14|0|7|Vistor hf|AstraZeneca A/S DK|Ómeprazól||||| 492520|A02BC0105|Losec MUPS|sh-tfl|10|mg|100|stk|1|glas||A02BC01|01.01.1999||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|12615|17891|lyfalmen|||00|100|0|50|Vistor hf|AstraZeneca A/S DK|Ómeprazól||12615||12615|17891 492546|A02BC0102 |Losec|sh-tfl|20|mg|14|stk|1|þpakki||A02BC01|01.05.2009||L|A|3|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||00|14|0|7|Vistor hf|AstraZeneca A/S DK|Ómeprazól||||| 492587|N06AX0303|Mianserin NM Pharma|töflur|10|mg|100|stk|1|glas||N06AX03|01.01.1994||R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|1571|2972|lyfalmen|V1140|2740|00|100|0|17|Actavis Group PTC ehf|Merck NM AB|Míanserín||1571||1571|2972 493148|C10AA0302|Pravachol|töflur|20|mg|28|stk|1|þpakki||C10AA03|01.07.1989||R|A|2|0|0|0|0|BRS|0|0|0|100|DKK|4962|7574|lyfalmen|||00|28|0|19|Vistor hf|Bristol-Myers Squibb|Pravastatín||4962||4962|7574 494013|N06AA0601|Surmontil|töflur|25|mg|100|stk|1|glas||N06AA06|01.10.1995||R|A|5|0|0|B|0|SNO|0|1|0|100|NOK|1785|3263|lyfalmen|||00|100|0|17|Vistor hf|Sanofi-aventis Norge AS|Trímípramín||1785||1785|3263 494138|N02CX0101|Sandomigrin|töflur|0,5|mg|100|stk|1|þpakki||N02CX01|01.04.1974||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|4550|7015|lyfalmen|||00|100|0|33|Vistor hf|Novartis Healthcare A/S-|Pízótífen||4550||4550|7015 494237|L01XC0201|MabThera|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.11.2003||R|A|2,5|0|1|0|1|RRL|0|0|0|100|DKK|98356|124321|lyfsjukr|||00|20|0|0|Icepharma hf|Roche Registration Limited|Rítúxímab||98356||98356|124321 494286|L01XC0201|MabThera|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.11.2003||R|A|2,5|0|1|0|1|RRL|0|0|0|100|DKK|245890|308001|lyfsjukr|||00|50|0|0|Icepharma hf|Roche Registration Limited|Rítúxímab||245890||245890|308001 494559|D10AF0101|Dalacin|fleyti|10|mg/ml|60|ml|1|glas|Áburður, fleyti|D10AF01|01.10.1995||R|A|2|0|0|0|0|PFI|0|0|0|100|DKK|2628|4407|lyfalmen|||00|60|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||2628||2628|4407 494682|G03CA0320|Estrofem 2 mg|töflur|2|mg|84|stk|1|skífup||G03CA03|01.12.1980||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|2997|4907|lyfalmen|V0408|1921|23|84|0|84|Vistor hf|Novo-Nordisk|Estradíól||2997||2997|4907 494724|G03FA0102|Kliogest|töflur|0| |84|stk|1|skífup||G03FA01|01.10.1986||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|3802|6000|lyfalmen|V0388|4567|23|84|0|84|Vistor hf|Novo-Nordisk|Noretísterón og östrógen||3802||3802|6000 494831|B01AC0702|Persantin retard|forðahlk|200|mg|60|stk|1|glas|hart hylki|B01AC07|01.04.2006||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|2545|4294|lyfalmen|||00|60|0|30|Vistor hf|Boehringer Ingelheim International |Dípýrídamól||2545||2545|4294 495259|A02BA0205|Zantac|freyðit|150|mg|15|stk|2|stauk|2 x 15 stk.|A02BA02|01.04.1990||L|A|2|0|0|0|0|GSK|0|0|0|100|IKR|||lyfalmen|||14|30|0|15|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín|||||4097 495283|A04AA0101|Zofran|töflur|8|mg|15|stk|1|þpakki||A04AA01|01.01.1991||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|19507|26471|lyfalmen|||00|15|0|8|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||19507||19507|26471 495382|A04AA0101|Zofran|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.01.1991||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|7587|11136|lyfalmen|V1088|9079|02|10|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||7587||7587|11136 495390|A04AA0101|Zofran|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.01.1991||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|10840|15551|lyfalmen|V1089|14054|02|20|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||10840||10840|15551 495820|J05AH0101|Relenza|innúðadu|5|mg/úðask|20|sk|1|stauk|+diskhaler|J05AH01|01.02.2000||R|A|5|0|0|0|0|GSK|0|0|0|100|GBP|2977|4880|lyfalmen|||00|20|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Zanamivír||2977||2977|4880 496174|QJ01M0001|Baytril vet.|töflur|150|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|4894|9494|vetalmen|||0|10|0|0|Vistor hf|Bayer Animal Health GmbH|||||4894|9494 496547|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.01.1985||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|4299|6674|lyfalmen|||02|100|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Labetalól||4299||4299|6674 496554|C07AG0101|Trandate|töflur|100|mg|50|stk|1|glas||C07AG01|01.02.1982||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|1086|2314|lyfalmen|||00|50|0|8|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Labetalól||1086||1086|2314 496752|C07AG0101|Trandate|töflur|200|mg|100|stk|1|glas||C07AG01|01.01.1986||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|3406|5462|lyfalmen|||00|100|0|33|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Labetalól||3406||3406|5462 496935|N02AG0201|Ketogan|eþ-stil|0| |10|stk|1|pakki||N02AG02|01.07.1994||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|646|1717|lyfalmen|||04|10|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||646||646|1717 496950|N02AG0201|Ketogan|töflur|0| |20|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|A|5|1|0|E|0|PFI|0|0|0|100|DKK|981|2172|lyfalmen|||00|20|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||981||981|2172 497099|N02AG0201|Ketogan|töflur|0| |100|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|A|5|1|0|E|0|PFI|0|0|0|100|DKK|3738|5913|lyfalmen|||00|100|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||3738||3738|5913 497263|N06BA0103|Amfetamin Actavis|töflur|5|mg|30|stk|1|glas||N06BA01|01.07.1991||R|A|3|1|0|0|0|ACA|0|0|0|100|IKR|1036|2246|lyfalmen|||00|30|0|10|Actavis Group hf|Actavis hf|Amfetamín||1036||1036|2246 497289|C09AA0201|Daren|töflur|5|mg|30|stk|1|glas||C09AA02|01.07.1990||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|419|1409|lyfalmen|||00|30|0|15|Actavis Group hf|Actavis hf|Enalapríl||419||419|1409 497297|C09AA0201|Daren|töflur|5|mg|100|stk|1|glas||C09AA02|01.07.1990||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|527|1556|lyfalmen|V0167|1556|00|100|0|50|Actavis Group hf|Actavis hf|Enalapríl||527||527|1556 497313|C09AA0201|Daren|töflur|20|mg|100|stk|1|glas||C09AA02|01.07.1990||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1094|2325|lyfalmen|V0169|2325|00|100|0|200|Actavis Group hf|Actavis hf|Enalapríl||1094||1094|2325 497511|D08AC0202|Hibitane|sk-krem|10|mg/ml|250|ml|1|glas||D08AC02|01.12.1983||L|A|3|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||00|250|0|250|Icepharma hf|Bioglan AB|Klórhexidín||||| 497818|D07AC0401|Synalar|smyrsli|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|A|3|0|0|B|0|BIG|0|0|1|100|SEK|883|2039|lyfalmen|||20|30|0|30|Icepharma hf|Bioglan AB|Flúócínólón||883||883|2039 498048|H02AB0103|Diprospan|stl|7|mg/ml|2|ml|1|hgl|5 + 2 mg/ml|H02AB01|01.09.2004||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|1576|2979|lyfalmen|||03|2|0|35|Vistor hf|Schering-Plough|Betametasón||1576||1576|2979 498964|N05AE0401|Zeldox|hylki|20|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|19639|26636|lyfalmen|||00|56|0|14|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ziprasidon||19639||19639|26636 498980|N05AE0401|Zeldox|hylki|40|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|20949|28266|lyfalmen|||00|56|0|28|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ziprasidon||20949||20949|28266 499004|N05AE0401|Zeldox|hylki|60|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|30940|40705|lyfalmen|||00|56|0|42|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ziprasidon||30940||30940|40705 499020|N05AE0401|Zeldox|hylki|80|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|31526|41435|lyfalmen|||00|56|0|56|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ziprasidon||31526||31526|41435 500314|D07AC0401|Synalar|krem|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|A|3,5|0|0|B|0|BIG|0|0|1|100|SEK|883|2039|lyfalmen|||20|30|0|30|Icepharma hf|Bioglan AB|Flúócínólón||883||883|2039 501734|M01AB0508|Vostar-R|forðatfl|75|mg|100|stk|1|glas||M01AB05|01.03.2000||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|3199|5182|lyfalmen|||67|100|0|75|Actavis Group hf|Actavis hf|Díklófenak||3199||3199|5182 502047|N04BA0201|Madopar|hylki|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.12.1983||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|3390|5441|lyfalmen|||10|100|0|17|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3390||3390|5441 502187|D07AB0201|Locoid|lausn|1|mg/ml|100|ml|1|glas||D07AB02|01.03.1977|31.08.2009|R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|2385|4077|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||2385||2385|4077 502633|N06AA2101|Ludiomil|töflur|25|mg|100|stk|1|þpakki||N06AA21|01.06.1977||R|A|5|0|0|B|0|AMD|0|1|0|100|DKK|3456|5530|lyfalmen|||00|100|0|25|Vistor hf|Amdipharm Ltd|Maprótilín||3456||3456|5530 503151|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|1|spr|+ leysir|L02AE04|01.01.1995||R|K|3|0|1|0|1|FER|0|0|0|100|DKK|35769|46400|lyfsjukr|||00|1|0|28|Vistor hf|Ferring|Triptórelín||35769||35769|46400 503961|D07AC0301|Ibaril|krem|2,5|mg/g|50|g|1|túpa||D07AC03|01.10.1976||R|A|5|0|0|B|0|SNO|0|0|1|100|NOK|2488|4217|lyfalmen|||20|50|0|50|Vistor hf|Sanofi-aventis Norge AS|Desoxímetasón||2488||2488|4217 504266|G03CA0401|Ovestin|töflur|1|mg|90|stk|1|þpakki||G03CA04|01.01.1988||R|A|5|0|0|E|0|ORG|0|0|0|100|DKK|2573|4332|lyfalmen|||00|90|0|45|Vistor hf|N.V. Organon|Estríól||2573||2573|4332 504878|N05BA0801|Lexotan|töflur|3|mg|100|stk|1|glas||N05BA08|01.01.1987||R|A|5|0|0|0|0|ROC|0|0|1|100|DKK|1344|2664|lyfalmen|||00|100|0|30|Icepharma hf|Roche|Brómazepam||1344||1344|2664 505743|N06AA2101|Ludiomil|töflur|75|mg|100|stk|1|þpakki||N06AA21|01.05.1978||R|A|5|0|0|B|0|AMD|0|1|0|100|DKK|9508|13743|lyfalmen|||00|100|0|75|Vistor hf|Amdipharm Ltd|Maprótilín||9508||9508|13743 505834|L01DB0101|Adriamycin|stl|2|mg/ml|5|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PFI|0|0|0|100|DKK|3827|5479|lyfsjukr|||02|5|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Doxórúbicín||3827||3827|5479 505875|L01DB0101|Adriamycin|stl|2|mg/ml|10|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PFI|0|0|0|100|DKK|7450|10667|lyfsjukr|||02|10|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Doxórúbicín||7450||7450|10667 505883|L01DB0101|Adriamycin|stl|2|mg/ml|25|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PFI|0|0|0|100|DKK|11488|16170|lyfsjukr|||02|25|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Doxórúbicín||11488||11488|16170 506774|J01GB0301|Garamycin|stl|10|mg/ml|2|ml|10|lykjur||J01GB03|01.11.1977||R|A|5|0|0|0|1|SCP|0|0|0|100|DKK|3618|5180|lyfsjukr|||02|20|0|1|Vistor hf|Schering-Plough|Gentamícín||3618||3618|5180 506949|N01AB0601|Forene|innönd.l|0| |250|ml|1|stauk||N01AB06|01.10.1993||R|A|5|0|0|0|1|ABS|0|0|0|100|DKK|33548|43635|lyfsjukr|||00|250|0|0|Vistor hf|Abbott Scandinavia AB|Ísóflúran||33548||33548|43635 506972|N06AA1201|Sinquan|hylki|50|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|2837|4690|lyfalmen|||10|100|0|50|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Doxepín||2837||2837|4690 506998|A06AB0202|Toilax|sh-tfl|5|mg|25|stk|1|þpakki||A06AB02|01.12.1975||L|A|3|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||10|25|0|12|Vistor hf|Orion Pharma|Bisakódýl||||| 507004|A06AB0202|Toilax|sh-tfl|5|mg|100|stk|1|þpakki||A06AB02|01.12.1975||R|A|3|0|0|0|0|ERC|0|0|0|100|DKK|463|1469|lyfalmen|||10|100|0|50|Vistor hf|Orion Pharma|Bisakódýl||463||463|1469 507103|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|1|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|24|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||1320 507111|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|5|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|120|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||5614 507343|QP52AC1302|Panacur, vet.|mixtúra|100|mg/ml|1000|ml|1|fl||QP52AC13|01.12.1978||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|10527|18217|vetorma|||13|1000|0|0|Icepharma hf|Intervet International B.V.|||10527||10527|18217 507582|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|50|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.06.1999||R|A|3|0|0|0|0|IBV|0|0|0|100|DKK|2911|5716|vetalmen|||27|50|0|0|Vistor hf|Intervet International BV|||2911||2911|5716 508622|C08DA0103|Isoptin retard|forðatfl|240|mg|98|stk|1|þpakki||C08DA01|01.10.1993||R|A|3|0|0|B|0|ABS|0|0|0|100|DKK|2961|4859|lyfalmen|||10|98|0|98|Vistor hf|Abbott Scandinavia AB|Verapamíl||2961||2961|4859 508671|QJ01M0001|Baytril vet.|mixtúra|25|mg/ml|100|ml|1|plastf||QJ01MA90|01.03.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|5918|11444|vetalmen|||0|100|0|0|Vistor hf|Bayer Animal Health GmbH|||||5918|11444 508689|QJ01M0001|Baytril vet.|stl|50|mg/ml|50|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|4746|9212|vetalmen|||0|50|0|0|Vistor hf|Bayer Animal Health GmbH|||4746||4746|9212 508705|QJ01M0001|Baytril vet.|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|14683|28140|vetalmen|||0|100|0|0|Vistor hf|Bayer Animal Health GmbH|||14683||14683|28140 509042|N05AF0502|Cisordinol Depot|stl|200|mg/ml|1|ml|10|lykjur||N05AF05|01.03.1984||R|A|3|0|0|*|0|LBK|0|1|0|100|DKK|11559|16527|lyfalmen|||02|10|0|133|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||11559||11559|16527 509273|G03CA0401|Ovestin|sk-krem|1|mg/g|15|g|1|túpa|+stjaka|G03CA04|01.01.1988||L|A|3|0|0|E|0|ORG|0|0|0|100|DKK|||lyfalmen|||00|15|0|75|Vistor hf|N.V. Organon|Estríól|||||2956 509448|D10AE0102|Panoxyl|hlaup|50|mg/g|40|g|1|túpa||D10AE01|01.12.1982|31.10.2009|R|A|5|0|0|0|0|STI|0|0|0|100|XEU|471|1480|lyfalmen|||23|40|0|40|Smerud Medical Research Norway AS|Stiefel Laboratories (UK) Limited (S)|Benzóýl peroxíð||471||471|1480 509455|D10AE0102|Panoxyl|hlaup|100|mg/g|40|g|1|túpa||D10AE01|01.12.1982|31.10.2009|R|A|5|0|0|0|0|STI|0|0|0|100|XEU|531|1561|lyfalmen|||23|40|0|40|Smerud Medical Research Norway AS|Stiefel Laboratories (UK) Limited (S)|Benzóýl peroxíð||531||531|1561 509463|D10AE0102|Panoxyl|áburður|50|mg/ml|30|ml|1|fl||D10AE01|01.12.1982|31.10.2009|R|A|3|0|0|0|0|STI|0|0|0|100|XEU|389|1368|lyfalmen|||23|30|0|30|Smerud Medical Research Norway AS|Stiefel Laboratories (UK) Limited (S)|Benzóýl peroxíð||389||389|1368 509471|D10AE0102|Panoxyl|krem|50|mg/g|40|g|1|túpa||D10AE01|01.12.1982|31.10.2009|R|A|5|0|0|0|0|STI|0|0|0|100|XEU|471|1480|lyfalmen|||23|40|0|40|Smerud Medical Research Norway AS|Stiefel Laboratories (UK) Limited (S)|Benzóýl peroxíð||471||471|1480 509653|J05AR0101|Combivir|filmhtfl|450|mg|60|stk|1|þpakki|150+300 mg|J05AR01|01.05.2004||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|50454|64683|lyfsjukr|||00|60|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|Zídóvúdín og lamívúdín||50454||50454|64683 510248|B03XA0103|NeoRecormon|stl|1000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|15219|20815|lyfsjukr|||00|2|0|6|Icepharma hf|Roche|Epóetín||15219||15219|20815 510255|B03XA0103|NeoRecormon|stl|2000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|27687|36338|lyfsjukr|||00|2|0|12|Icepharma hf|Roche|Epóetín||27687||27687|36338 510263|B03XA0103|NeoRecormon|stl|3000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|35533|46106|lyfsjukr|||00|2|0|18|Icepharma hf|Roche|Epóetín||35533||35533|46106 510271|B03XA0103|NeoRecormon|stl|5000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|58295|74445|lyfsjukr|||00|2|0|30|Icepharma hf|Roche|Epóetín||58295||58295|74445 510305|B03XA0103|NeoRecormon|stl|10000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|112955|142496|lyfsjukr|||00|4|0|60|Icepharma hf|Roche|Epóetín||112955||112955|142496 510321|B03XA0103|NeoRecormon|stl|20000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|284641|356246|lyfsjukr|||00|4|0|120|Icepharma hf|Roche|Epóetín||284641||284641|356246 510974|G04CB0102|Finol|töflur|5|mg|98|stk|1|glas||G04CB01|01.01.1998||R|A|3|0|0|E|0|ACA|0|0|0|100|XEU|4823|6060|lyfalmen|V0411|6060|00|98|0|98|Actavis Group hf|Actavis hf|Fínasteríð||3846||3846|6060 511071|C09CA0701|Micardis|töflur|20|mg|28|stk|1|þpakki||C09CA07|01.03.2008||R|A|3|0|0|0|0|BII|0|0|0|100|DKK|3302|5321|lyfalmen|||00|28|0|14|Vistor hf|Boehringer Ingelheim International |Telmisartan||3302||3302|5321 511303|G03FB0501|Trisekvens|töflur|0| |84|stk|1|skífup||G03FB05|01.12.1980||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|3117|5070|lyfalmen|V0385|4967|23|84|0|84|Vistor hf|Novo-Nordisk|Noretísterón og östrógen||3117||3117|5070 511493|B05AA0509|Rheomacrodex med NaCl|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991||R|A|2|0|0|0|1|MAB|0|0|0|100|SEK|23368|30961|lyfsjukr|||00|6000|0|6|Vistor hf|Meda AB|Dextran||23368||23368|30961 511501|B05AA0502|Macrodex 60 mg/ml med NaCl|irl|0| |500|ml|12|pokar||B05AA05|01.07.1991||R|A|3|0|0|0|1|MAB|0|0|0|100|SEK|14618|20067|lyfsjukr|||00|6000|0|6|Vistor hf|Meda AB|Dextran||14618||14618|20067 512608|B05XA3101|Peditrace|irþ|0| |10|ml|10|hgl||B05XA31|01.07.1993||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|11012|15577|lyfsjukr|||00|100|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með öðrum efnum||11012||11012|15577 513309|D04AB0101|Xylocain|smyrsli|5|%|35|g|1|pakki||D04AB01|01.09.2003||L|A|5|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||00|35|0|0|Vistor hf|AstraZeneca A/S DK|Lídókaín||||| 514265|R03AC0302|Bricanyl Turbuhaler|innúðadu|0,25|mg/sk|200|sk|1|stauk||R03AC03|01.07.1993||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|2194|3818|lyfalmen|||23|200|0|25|Vistor hf|AstraZeneca A/S DK|Terbútalín||2194||2194|3818 515031|N06AX1801|Edronax|töflur|4|mg|20|stk|1|þpakki||N06AX18|01.06.2000||R|A|3|0|0|B|0|PFI|0|1|0|100|DKK|2431|4139|lyfalmen|||00|20|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2431||2431|4139 515049|N06AX1801|Edronax|töflur|4|mg|60|stk|1|þpakki||N06AX18|01.06.2000||R|A|3|0|0|B|0|PFI|0|1|0|100|DKK|5116|7783|lyfalmen|||00|60|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5116||5116|7783 516476|A02BC0105|Losec MUPS|sh-tfl|10|mg|14|stk|1|glas||A02BC01|01.01.1999||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|2018|3579|lyfalmen|||00|14|0|7|Vistor hf|AstraZeneca A/S DK|Ómeprazól||2018||2018|3579 517714|A10BX0201|Novonorm|töflur|0,5|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|4565|7035|lyfalmen|||00|90|0|11|Vistor hf|Novo-Nordisk|Repaglíníð||4565||4565|7035 517755|A10BX0201|Novonorm|töflur|1|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|5358|8111|lyfalmen|||00|90|0|22|Vistor hf|Novo-Nordisk|Repaglíníð||5358||5358|8111 517813|A10BX0201|Novonorm|töflur|2|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|6591|9785|lyfalmen|||00|90|0|45|Vistor hf|Novo-Nordisk|Repaglíníð||6591||6591|9785 518241|M01AB0509|Modifenac|forðahlk|75|mg|20|stk|1|þpakki||M01AB05|01.11.2000||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|1063|2283|lyfalmen|||00|20|0|15|Actavis Group hf|Actavis Group hf|Díklófenak||1063||1063|2283 518258|M01AB0509|Modifenac|forðahlk|75|mg|100|stk|1|þpakki||M01AB05|01.11.2000||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|3915|6153|lyfalmen|||00|100|0|75|Actavis Group hf|Actavis Group hf|Díklófenak||3915||3915|6153 518332|G03AC0901|Cerazette|töflur|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.01.2001||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|2414|4116|lyfalmen|||23|84|0|84|Vistor hf|N.V. Organon|Desógestrel||2414||2414|4116 518944|J01CE0205|Kaavepenin Frukt|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CE02|01.10.1985||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|1107|2343|lyfalmen|||08|125|0|3|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1107||1107|2343 519819|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|1|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|9582|13844|lyfalmen|||02|2|0|6|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||9582||9582|13844 520239|G04BE0301|Viagra|filmhtfl|25|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|5574|8405|lyfalmen|||00|4|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Síldenafíl||5574||5574|8405 520288|G04BE0301|Viagra|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|6295|9383|lyfalmen|||00|4|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Síldenafíl||6295||6295|9383 520338|G04BE0301|Viagra|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|17736|24266|lyfalmen|||00|12|0|12|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Síldenafíl||17736||17736|24266 520346|G04BE0301|Viagra|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|6751|10002|lyfalmen|||00|4|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Síldenafíl||6751||6751|10002 520379|G04BE0301|Viagra|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|18679|25440|lyfalmen|||00|12|0|24|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Síldenafíl||18679||18679|25440 520502|C08CA0102|Amlo|töflur|5|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1355|2679|lyfalmen|V0308|2679|00|100|0|100|Actavis Group hf|Actavis hf|Amlódipín||1355||1355|2679 520577|C08CA0102|Amlo|töflur|10|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|2163|3776|lyfalmen|V0310|3776|00|100|0|200|Actavis Group hf|Actavis hf|Amlódipín||2163||2163|3776 520759|M03BC5101|Norgesic|töflur|0| |30|stk|1|þpakki||M03BC51|01.03.1981||R|A|5|0|0|E|0|MEB|0|0|1|100|SEK|446|1446|lyfalmen|||00|30|0|9|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||446||446|1446 521203|N04BC0502|Sifrol|töflur|0,7|mg|100|stk|1|þpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|37127|48408|lyfalmen|||00|100|0|28|Vistor hf|Boehringer Ingelheim International|Pramipexól||37127||37127|48408 521757|L01XX0501|Hydrea|hylki|500|mg|100|stk|1|glas||L01XX05|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|8676|12422|lyfsjukr|||00|100|1|0|Distica|Distica - óskráð lyf|||8676||8676|12422 522003|QJ51RC2302|Streptocillin, vet.|spenalyf|0| |8|g|40|spr||QJ51RC23|01.12.1982||R|A|3|0|0|0|0|BID|0|0|0|100|DKK|9251|17793|vetalmen|||16|320|0|0|Vistor hf|Boehringer Ingelheim Danmark|||9251||9251|17793 522599|J07CA0202|Tetravac|bóluefni|0| |0,5|ml|1|spr|einnota dæla|J07CA02|01.10.1999||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|3846|6060|lyfalmen|||AC|0|0|0|Icepharma hf|Sanofi Pasteur MSD|barnaveiki, kíghósti, mænusótt, stífkrampi||3846||3846|6060 522706|L04AC0201|Simulect|sts|20|mg|1|hgl|1|pakki|+leysir|L04AC02|01.06.2004||R|K|1,5|0|1|0|1|NOE|0|0|0|100|DKK|307613|384846|lyfsjukr|||00|1|0|0|Vistor hf|Novartis Europharm Ltd|Basiliximab||307613||307613|384846 522730|N02AX0204|Tradolan|töflur|50|mg|20|stk|1|þpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|SEK|488|1503|lyfalmen|||00|20|0|3|Vistor hf|Lannacher Heimittel Gmbh|Tramadól||488||488|1503 522771|N02AX0204|Tradolan|töflur|50|mg|100|stk|1|þpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|SEK|848|1991|lyfalmen|||00|100|0|17|Vistor hf|Lannacher Heimittel Gmbh|Tramadól||848||848|1991 522797|N02AX0204|Tradolan|töflur|50|mg|250|stk|1|þpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|DKK|11275|16141|lyfalmen|||00|250|0|208|Vistor hf|Lannacher Heimittel Gmbh|Tramadól||11275||11275|16141 522813|N02AX0204|Tradolan|stl|50|mg/ml|2|ml|5|lykjur||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|DKK|997|2193|lyfalmen|V0732|2193|02|10|0|2|Vistor hf|Lannacher Heimittel Gmbh|Tramadól||997||997|2193 522839|D05AX0201|Daivonex|lausn|50|mcg/ml|120|ml|1|glas|í hársvörð|D05AX02|01.12.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|10292|14807|lyfalmen|||00|120|0|0|Vistor hf|LEO Pharma A/S|Kalcípótríól||10292||10292|14807 523043|N02AA5902|Parkodin forte|töflur|530|mg|40|stk|1|pakki|þp 30+500 mg|N02AA59|01.11.1998||R|A|2|0|0|0|0|ACA|0|0|1|100|NOK|446|1446|lyfalmen|||00|40|0|13|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||446||446|1446 523274|S01XA2008|Artelac|augndr|0| |10|ml|1|glas|plastglas|S01XA20|01.05.1998||L|A|3|0|0|E|0|GEM|0|0|0|100|IKR|||lyfalmen|||00|10|0|0|Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar sam­setningar|||||1253 523779|R06AD0201|Phenergan|töflur|25|mg|100|stk|1|þpakki||R06AD02|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|1328|2643|lyfalmen|||00|100|0|100|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||1328||1328|2643 523886|L02BB0101|Eulexin|töflur|250|mg|84|stk|1|þpakki||L02BB01|01.01.1993||R|A|5|0|0|*|0|SCP|0|0|0|100|DKK|27632|36587|lyfalmen|||00|84|0|28|Vistor hf|Schering-Plough|Flútamíð||27632||27632|36587 524215|C01DA1401|Imdur|forðatfl|30|mg|28|stk|1|þpakki||C01DA14|01.07.1993||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|1123|2364|lyfalmen|||43|28|0|21|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||1123||1123|2364 524223|C01DA1401|Imdur|forðatfl|30|mg|98|stk|1|þpakki||C01DA14|01.07.1993||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2853|4712|lyfalmen|||43|98|0|74|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||2853||2853|4712 524694|C01DA0204|Nitromex|tungur.t|0,25|mg|30|stk|1|glas||C01DA02|01.12.1983||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|30|0|3|Actavis Group hf|Actavis Group hf|Glýcerýltrínítrat|||||1170 524710|C01DA0204|Nitromex|tungur.t|0,5|mg|30|stk|1|glas||C01DA02|01.11.1981||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|30|0|6|Actavis Group hf|Actavis Group hf|Glýcerýltrínítrat|||||1148 525014|M03BC5101|Norgesic|töflur|0| |100|stk|1|þpakki||M03BC51|01.06.1981||R|A|5|0|0|E|0|MEB|0|0|1|100|SEK|1225|2503|lyfalmen|||00|100|0|29|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||1225||1225|2503 525030|M01AB0505|Voltaren|stl|25|mg/ml|3|ml|5|lykjur|lausn|M01AB05|01.05.2007||R|A|2|0|0|0|0|NOH|0|0|0|100|DKK|1170|2428|lyfalmen|||00|15|0|0|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1170||1170|2428 525147|M01AB0504|Klofen-L|forðahlk|100|mg|30|stk|1|hylki||M01AB05|01.01.1993||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|1532|2919|lyfalmen|||10|30|0|30|Actavis Group hf|Actavis hf|Díklófenak||1532||1532|2919 525170|M01AB0504|Klofen-L|forðahlk|100|mg|100|stk|1|hylki||M01AB05|01.01.1993||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|5105|7768|lyfalmen|||10|100|0|100|Actavis Group hf|Actavis hf|Díklófenak||5105||5105|7768 525188|N06BA0701|Modiodal|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.03.2002||R|A|5|0|0|0|0|CPA|0|0|0|100|DKK|11714|16737|lyfalmen|||00|30|0|10|Vistor hf|Cephalon France (V)|Modafinil||11714||11714|16737 525998|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|50|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|1000|0|0|Actavis Group hf|Braun|||||| 526004|V07AB09|Sterilt Vann B. Braun|leysir|0||50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|1000|0|0|Actavis Group hf|Braun|||||| 526368|N04BA0201|Madopar|töflur|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.11.1981||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|8444|12299|lyfalmen|||00|100|0|33|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||8444||8444|12299 526376|N03AG0103|Orfiril Retard|forðatfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|4803|7358|lyfalmen|||10|100|0|20|Vistor hf|Desitin Artzneimittel|Valpróínsýra||4803||4803|7358 526384|QJ01EW1001|Tribrissen, vet.|pasta|400|mg/g|37,5|g|5|spr|til inntöku|QJ01EW10|01.03.2007||R|A|5|0|0|0|0|IBV|0|0|0|100|DKK|7716|14869|vetalmen|||16|188|0|0|Vistor hf|Intervet International BV|||7716||7716|14869 526798|N03AG0102|Orfiril|sh-tfl|600|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|4108|6415|lyfalmen|||10|100|0|40|Vistor hf|Desitin Artzneimittel|Valpróínsýra||4108||4108|6415 527143|J01XD0102|Flagyl|irl|5|g/1000ml|100|ml|20|pokar||J01XD01|01.12.1983||R|A|3|0|0|0|1|SNO|0|0|0|100|NOK|16321|22187|lyfsjukr|||00|2000|0|7|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||16321||16321|22187 527523|S01GX0601|Emadine|augndr|0,5|mg/ml|5|ml|1|glas||S01GX06|01.05.2003||R|A|2,5|0|0|E|0|ALC|0|0|0|100|USD|1271|2565|lyfalmen|||00|5|0|0|K.Pétursson hf|Alcon|Emedastín||1271||1271|2565 529263|N07BC0101|Subutex|tungur.t|2|mg|7|stk|1|þpakki||N07BC01|01.11.1999||R|A|1|1|0|0|1|SCP|0|0|0|100|DKK|2220|3178|lyfsjukr|||00|7|0|2|Vistor hf|Schering-Plough|Búprenorfín||2220||2220|3178 529289|R02AA0301|Strepsils|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.09.1982||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||| 529438|QJ51RC2002|Ampiclox vet.|spenalyf|0| |3|g|24|spr|spenadælur|QJ51RC20|01.06.1998||R|A|1.5|0|0|0|0|PAL|0|0|0|100|DKK|4951|9602|vetalmen|||16|72|0|0|Icepharma hf|Pfizer Oy Animal Health|||4951||4951|9602 529446|QJ01CA0401|Clamoxyl, vet.|töflur|40|mg|100|stk|1|þpakki||QJ01CA04|01.10.1987||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|4264|8293|vetalmen|||16|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||4264||4264|8293 529586|N07BC0101|Subutex|tungur.t|8|mg|7|stk|1|þpakki||N07BC01|01.11.1999||R|A|1|1|0|0|1|SCP|0|0|0|100|DKK|5678|8129|lyfsjukr|||00|7|0|7|Vistor hf|Schering-Plough|Búprenorfín||5678||5678|8129 529735|N03AB0501|Pro-Epanutin|irþ|50|mg/ml|10|ml|10|hgl||N03AB05|01.12.2001||R|K|2|0|0|0|1|PFI|0|0|0|100|DKK|83523|105854|lyfsjukr|||00|100|0|11|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Fosfenýtóín||83523||83523|105854 530030|J06BA0205|Sandoglobulin|irs|1|g/fl|1|g|1|sett|leys+áhöld|J06BA02|01.06.1984||R|A|3|0|0|0|1|CSL|0|0|0|100|SEK|11680|16409|lyfsjukr|||00|1|0|0|Icepharma hf|CSL Denmark ApS|Immúnóglóbúlín, normal, manna, gefin í æð||11680||11680|16409 530048|J06BA0205|Sandoglobulin|irs|3|g/fl|3|g|1|sett|leys+áhöld|J06BA02|01.06.1984|31.10.2009|R|A|3|0|0|0|1|CSL|0|0|0|100|SEK|31556|41155|lyfsjukr|||00|3|0|0|Icepharma hf|CSL Denmark ApS|Immúnóglóbúlín, normal, manna, gefin í æð||31556||31556|41155 530055|J06BA0205|Sandoglobulin|irs|6|g/fl|6|g|1|sett|leys+áhöld|J06BA02|01.06.1984||R|A|3|0|0|0|1|CSL|0|0|0|100|SEK|63343|80730|lyfsjukr|||00|6|0|0|Icepharma hf|CSL Denmark ApS|Immúnóglóbúlín, normal, manna, gefin í æð||63343||63343|80730 530741|G03FA0105|Activelle|töflur|0| |84|stk|1|pakki|þp 1+0,5 mg|G03FA01|01.03.2000||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|3589|5711|lyfalmen|||23|84|0|84|Vistor hf|Novo-Nordisk|Noretísterón og östrógen||3589||3589|5711 531459|R03CC0303|Bricanyl Retard|forðatfl|7,5|mg|100|stk|1|glas||R03CC03|01.01.1985||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2987|4894|lyfalmen|||43|100|0|50|Vistor hf|AstraZeneca A/S DK|Terbútalín||2987||2987|4894 531913|J05AG0101|Viramune|mixtúra|10|mg/ml|240|ml|1|fl||J05AG01|01.03.2007||R|A|0,5|0|1|0|1|BII|0|0|0|100|DKK|10488|14925|lyfsjukr|||00|240|0|6|Vistor hf|Boehringer Ingelheim International |Nevírapín||10488||10488|14925 532374|P02CA0101|Vermox|mixtúra|20|mg/ml|30|ml|1|glas||P02CA01|01.12.1982||R|A|5|0|0|0|0|JAS|0|0|0|100|SEK|893|2052|lyfalmen|||01|30|0|3|Vistor hf|Janssen-Cilag AB|Mebendazól||893||893|2052 533737|R03CC0303|Bricanyl Retard|forðatfl|5|mg|100|stk|1|glas||R03CC03|01.04.1986||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2017|3578|lyfalmen|||43|100|0|33|Vistor hf|AstraZeneca A/S DK|Terbútalín||2017||2017|3578 535773|P03AA5401|Tenutex|áburður|245|mg/g|100|g|1|túpa|(20 mg + 225 mg)/g|P03AA54|01.12.1997||L|K|3|0|0|0|0|BPA|0|0|0|100|IKR|||lyflausa|||00|100|0|0|Icepharma hf|Bioglan Pharma AB|Dísúlfíram í blöndum||||| 535898|G04BD0401|Ditropan|töflur|5|mg|84|stk|1|þpakki||G04BD04|01.06.1998||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|6874|10169|lyfalmen|||00|84|0|28|Vistor hf|Sanofi-aventis Norge AS|Oxýbútýnín||6874||6874|10169 536037|S01EB0105|Isopto Carpine|augndr|20|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|A|4|0|0|*|0|ALC|0|0|0|100|USD|448|1448|lyfalmen|||06|10|0|25|K.Pétursson hf|Alcon|Pílókarpín||448||448|1448 536052|S01EB0105|Isopto Carpine|augndr|40|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|A|4|0|0|*|0|ALC|0|0|0|100|USD|571|1615|lyfalmen|||06|10|0|25|K.Pétursson hf|Alcon|Pílókarpín||571||571|1615 536938|N04BC0102|Parlodel|hylki|5|mg|100|stk|1|þpakki||N04BC01|01.05.1983||R|A|4|0|0|E|0|MAS|0|0|0|100|SEK|17206|23606|lyfalmen|||52|100|0|12|Vistor hf|Meda AS|Brómókriptín||17206||17206|23606 537373|QP52AF0201|Banminth, vet.|pasta|115,3|mg/g|2|g|1|spr||QP52AF02|01.07.1995||L|A|3|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|2|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||727 537811|G03CA0401|Ovestin|sk-stil|0,5|mg|15|stk|1|pakki||G03CA04|01.01.1988||L|A|3|0|0|E|0|ORG|0|0|0|100|DKK|||lyfalmen|||05|15|0|38|Vistor hf|N.V. Organon|Estríól|||||2484 538181|A02AD0106|Rennie|sog/tugg|0| |24|stk|1|þpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||00|24|0|2|Icepharma hf|Bayer AB|Blöndur saltsambanda||||| 538199|A02AD0106|Rennie|sog/tugg|0| |48|stk|1|þpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||00|48|0|5|Icepharma hf|Bayer AB|Blöndur saltsambanda||||| 538207|A02AD0106|Rennie|sog/tugg|0| |96|stk|1|þpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||00|96|0|10|Icepharma hf|Bayer AB|Blöndur saltsambanda||||| 538496|L03AB0702|Rebif|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.05.1999||R|K|2|0|1|0|1|SEN|0|0|0|100|SEK|150549|189301|lyfsjukr|||00|6|0|61|Gróco ehf|Serono Nordic|Interferón beta-1a||150549||150549|189301 539031|N03AG0401|Sabrilex|töflur|500|mg|100|stk|1|þpakki||N03AG04|01.10.1992||R|A|5|0|1|E|0|SNO|0|0|0|100|NOK|11385|16290|lyfalmen|||00|100|0|25|Vistor hf|Sanofi-aventis Norge AS|Vígabatrín||11385||11385|16290 539551|N05BA0105|Stesolid|töflur|2|mg|25|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|203|1116|lyfalmen|||00|25|0|5|Actavis Group hf|Actavis Group hf|Díazepam||203||203|1116 539577|N05BA0105|Stesolid|töflur|2|mg|100|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|0|100|DKK|442|1440|lyfalmen|||00|100|0|20|Actavis Group hf|Actavis Group hf|Díazepam||442||442|1440 539783|D01AC2001|Daktacort|krem|0| |15|g|1|túpa||D01AC20|01.04.1986||L|K|3|0|0|0|0|JAS|0|0|1|100|IKR|||lyflausa|||20|15|0|15|Vistor hf|Janssen-Cilag AB|Blöndur||||| 539973|G01AA1001|Dalacin|sk-krem|20|mg/g|40|g|1|sett|+7 stjökur|G01AA10|01.10.1994||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|2944|4836|lyfalmen|||23|40|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||2944||2944|4836 540070|D06BA0101|Flamazine|krem|10|mg/g|250|g|1|dos||D06BA01|01.10.1988||R|A|3|0|0|0|0|SON|0|0|1|100|DKK|3227|5220|lyfalmen|||00|250|0|250|Icepharma hf|Smith & Nephew|Silfursúlfadíazín||3227||3227|5220 540989|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíð 20 mg|S01ED51|01.07.2000||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|6795|10062|lyfalmen|||06|15|0|0|Icepharma hf|M.S.D.|Tímólól í blöndum||6795||6795|10062 541060|R03AC0302|Bricanyl Turbuhaler|innúðadu|0,5|mg/sk|200|sk|1|stauk||R03AC03|01.01.1989||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|2136|3739|lyfalmen|||23|200|0|50|Vistor hf|AstraZeneca A/S DK|Terbútalín||2136||2136|3739 541128|M01CC0101|Atamir|hylki|150|mg|200|stk|1|glas||M01CC01|01.09.1983||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|11006|15776|lyfalmen|||10|200|0|60|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||11006||11006|15776 541136|M01CC0101|Atamir|hylki|250|mg|200|stk|1|plglas||M01CC01|12.10.2004||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|17828|24381|lyfalmen|||10|200|0|100|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||17828||17828|24381 541169|R02AA0302|Strepsils med honning og citron|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.09.1982||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||| 542803|C08DA0103|Isoptin retard|forðatfl|240|mg|28|stk|1|þpakki||C08DA01|01.10.1993||R|A|3|0|0|B|0|ABS|0|0|0|100|DKK|1732|3191|lyfalmen|||10|28|0|28|Vistor hf|Abbott Scandinavia AB|Verapamíl||1732||1732|3191 542977|J04BA0201|Dapson|töflur|50|mg|100|stk|1|glas||J04BA02|01.05.1998||R|A||0|1|E|0|LDR|0|0|0|100|IKR|1638|3063|lyfalmen|||00|100|1|100|Parlogis hf|Parlogis - óskráð lyf|||1638||1638|3063 543330|C07AA0302|Visken|töflur|10|mg|98|stk|1|þpakki||C07AA03|01.12.1983||R|A|5|0|0|B|0|NOH|0|0|0|100|DKK|5094|7753|lyfalmen|||00|98|0|65|Vistor hf|Novartis Healthcare A/S-|Pindólól||5094||5094|7753 543413|R06AA5201|Koffinatin|töflur|0| |10|stk|1|þpakki||R06AA52|01.12.1982||L|A|4|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|10|0|2|Actavis Group hf|Actavis hf|Dífenhýdramín í blöndum||||| 543710|A06AC0101|Vi-Siblin|kyrni|610|mg/g|250|g|1|stauk||A06AC01|01.06.1999||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||42|250|0|22|Vistor hf|Recip AB|Semen psyllii (ispaghula)||||| 543744|R01AA0503|Nezeril|nefúði|0,5|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|A|3|0|0|0|0|GCO|0|0|1|100|IKR|||lyflausa|||23|8|0|9|Vistor hf|GlaxoSmithKline CH AB|Oxýmetazólín||||| 543926|D11AC0302|Selsun Blue|hársápa|10|mg/ml|120|ml|1|glas||D11AC03|01.08.1984|31.08.2009|L|A|3|0|0|0|0|CHT|0|0|0|100|IKR|||lyflausa|||01|120|0|120|Vitaflo Scandinavia AB|Chattem Clobal Consumer Products|Selensambönd||||| 544502|G03GA0501|Gonal-F|sts|37,5|ae/lykju|10|lyk|1|pakki|+ leysir 1 ml|G03GA05|01.02.2002||R|A|2|0|1|E|0|SEN|0|0|0|100|SEK|27859|36869|lyfalmen|||00|10|0|5|Gróco ehf|Serono Nordic|Follitrópín alfa||27859||27859|36869 545681|D06AX0901|Bactroban|smyrsli|20|mg/g|15|g|1|túpa||D06AX09|01.07.1994||R|A|2|0|0|0|0|GSK|0|0|1|100|GBP|772|1888|lyfalmen|||00|15|0|15|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Múpírócín||772||772|1888 545814|N05AF0501|Cisordinol|töflur|2|mg|100|stk|1|glas||N05AF05|01.06.1984||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|1378|2710|lyfalmen|||00|100|0|7|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||1378||1378|2710 545848|N05AF0501|Cisordinol|töflur|10|mg|100|stk|1|glas||N05AF05|01.06.1984||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|3662|5810|lyfalmen|||00|100|0|33|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||3662||3662|5810 545996|V01AA0507|Alutard SQ, birkifrjo|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA05|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|34983|45739|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|trjáfrjó||34983||34983|45739 546002|V01AA0507|Alutard SQ, birkifrjo|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA05|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|28205|37300|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|trjáfrjó||28205||28205|37300 546044|V01AA0210|Alutard SQ, vallarfoxgras|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA02|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|35189|45995|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|grasfrjó||35189||35189|45995 546051|V01AA0210|Alutard SQ, vallarfoxgras|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA02|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|29895|39404|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|grasfrjó||29895||29895|39404 546143|N02BE0108|Paratabs Retard|forðatfl|500|mg|30|stk|1|þpakki||N02BE01|01.10.1993||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||10|30|0|5|Actavis Group hf|Actavis hf|Paracetamól||||| 546168|N02BE0108|Paratabs Retard|forðatfl|500|mg|100|stk|1|þpakki||N02BE01|01.10.1993||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|521|1547|lyfalmen|||10|100|0|17|Actavis Group hf|Actavis hf|Paracetamól||521||521|1547 546531|N06AF0101|Marplan|töflur|10|mg|56|stk|1|glas||N06AF01|01.10.2001||R|A||0|0|E|0|LDR|0|0|0|100|DKK|9560|13814|lyfalmen|||00|56|1|37|Parlogis hf|Parlogis - óskráð lyf|||9560||9560|13814 547612|A02BX0202|Antepsin|töflur|1|g|60|stk|1|þpakki||A02BX02|01.01.1986||L|A|5|0|0|0|0|ORC|0|0|0|100|IKR|||lyfalmen|||23|60|0|15|Vistor hf|Orion Corporation|Súkralfat|||||4622 547687|B01AC1601|Integrilin|irl|0,75|mg/ml|100|ml|1|fl||B01AC16|01.07.2000||R|K|3|0|1|0|1|GGL|0|0|0|100|GBP|10774|15281|lyfsjukr|||00|100|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíð||10774||10774|15281 547695|B01AC1601|Integrilin|stl|2|mg/ml|10|ml|1|hgl||B01AC16|01.07.2000||R|K|3|0|1|0|1|GGL|0|0|0|100|GBP|3550|5083|lyfsjukr|||00|10|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíð||3550||3550|5083 547729|G03GA0601|Puregon|stl|100|ae/hgl|0,5|ml|1|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|9922|14305|lyfalmen|||63|0|0|1|Vistor hf|N.V. Organon|Follitrópín beta||9922||9922|14305 547869|G03GA0601|Puregon|stl|150|ae/hgl|0,5|ml|5|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|61686|78984|lyfalmen|||63|2|0|5|Vistor hf|N.V. Organon|Follitrópín beta||61686||61686|78984 547893|G03GA0601|Puregon|stl|50|ae/hgl|0,5|ml|1|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|5096|7756|lyfalmen|||63|0|0|0|Vistor hf|N.V. Organon|Follitrópín beta||5096||5096|7756 547901|G03GA0601|Puregon|stl|50|ae/hgl|0,5|ml|5|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|24804|33066|lyfalmen|||63|2|0|2|Vistor hf|N.V. Organon|Follitrópín beta||24804||24804|33066 548297|A08AA1001|Reductil|hylki|10|mg|98|stk|1|þpakki||A08AA10|01.08.2001||R|A|3|0|0|0|0|ABL|0|0|0|100|DKK|18911|25729|lyfalmen|||00|98|0|98|Vistor hf|Abbott Laboratories A/S|Sibutramin||18911||18911|25729 548347|A08AA1001|Reductil|hylki|15|mg|98|stk|1|þpakki||A08AA10|01.08.2001||R|A|3|0|0|0|0|ABL|0|0|0|100|DKK|18911|25729|lyfalmen|||00|98|0|147|Vistor hf|Abbott Laboratories A/S|Sibutramin||18911||18911|25729 548511|J01CF0101|Diclocil|sts/irs|500|mg|1|stk|10|hgl||J01CF01|01.04.1987||R|A|3|0|0|0|1|BRS|0|0|0|100|DKK|2429|3478|lyfsjukr|||03|10|0|2|Vistor hf|Bristol-Myers Squibb|Díkloxacillín||2429||2429|3478 548776|M05BA0701|Optinate|filmhtfl|5|mg|28|stk|1|þpakki||M05BA07|01.03.2001||R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|6432|9569|lyfalmen|||00|28|0|28|Vistor hf|Sanofi-aventis Norge AS|||6432||6432|9569 548784|M05BA0701|Optinate|filmhtfl|5|mg|84|stk|1|þpakki||M05BA07|01.03.2001||R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|17558|24045|lyfalmen|||00|84|0|84|Vistor hf|Sanofi-aventis Norge AS|||17558||17558|24045 548792|M05BA0701|Optinate|filmhtfl|30|mg|28|stk|1|þpakki||M05BA07|01.03.2001||R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|45007|58219|lyfalmen|||00|28|0|168|Vistor hf|Sanofi-aventis Norge AS|||45007||45007|58219 549113|J06BB1601|Synagis|sts|50|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|K|2|0|0|0|1|ABT|0|0|0|100|DKK|120071|151356|lyfsjukr|||17|1|0|0|Vistor hf|Abbott Laboratories Ltd|Palivisumab||120071||120071|151356 549139|N05AD0102|Haldol Depot|stl|100|mg/ml|1|ml|5|lykjur||N05AD01|01.01.1987||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|9505|13739|lyfalmen|||02|5|0|152|Vistor hf|Janssen-Cilag AB|Halóperídól||9505||9505|13739 549170|J06BB1601|Synagis|sts|100|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|K|2|0|0|0|1|ABT|0|0|0|100|DKK|171263|215090|lyfsjukr|||17|1|0|0|Vistor hf|Abbott Laboratories Ltd|Palivisumab||171263||171263|215090 550020|J07AP0302|Typherix|bóluefni|50|mcg/ml|0,5|ml|1|spr|einnota sprauta|J07AP03|01.10.2001||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|2249|3892|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Taugaveiki, hreinsaðir mótefna­vakar||2249||2249|3892 550061|N02BE0102|Panodil Brus|freyðit|500|mg|24|stk|1|þpakki||N02BE01|01.04.1992||L|A|4|0|0|0|0|GCH|0|0|1|100|IKR|||lyfalmen|||00|24|0|4|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól|||||1448 550624|N02BE0103|Panodil Junior|mixtúra|24|mg/ml|60|ml|1|glas||N02BE01|01.11.1981||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|60|0|0|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||||| 550731|N02BE0103|Panodil Junior|eþ-stil|125|mg|10|stk|1|pakki||N02BE01|01.11.1981||L|A|5|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|10|0|0|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||||| 551408|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|12|stk|1|þpakki||N02CC03|01.05.2001||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|10992|15757|lyfalmen|||00|12|0|12|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||10992||10992|15757 551572|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|1|hgl|dreifa|H02AB08|01.11.2003||R|A|3|0|0|B|0|MAB|0|0|1|100|SEK|1832|3326|lyfalmen|||03|1|0|3|Vistor hf|Meda AB|Tríamcínólón||1832||1832|3326 551606|M01AX0101|Relifex|töflur|500|mg|100|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|4177|6509|lyfalmen|||00|100|0|50|Vistor hf|Meda AB|Nabúmeton||4177||4177|6509 551739|N02AA0102|Morfin|töflur|10|mg|20|stk|1|pakki||N02AA01|01.04.1999||R|S||1|0|E|0|LDR|0|0|0|100|IKR|905|2069|lyfalmen|||00|20|1|2|Parlogis hf|Parlogis - óskráð lyf|Morfín||905||905|2069 551846|A02BC0401|Pariet|sh-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|2157|2128|lyfalmen|||00|28|0|14|Vistor hf|Eisai Ltd|Rabeprazól||949||949|2128 551853|A02BC0401|Pariet|sh-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|3931|3975|lyfalmen|||00|56|0|28|Vistor hf|Eisai Ltd|Rabeprazól||2310||2310|3975 551879|A02BC0401|Pariet|sh-tfl|20|mg|14|stk|1|þpakki||A02BC04|01.11.2001||R|A|2|0|0|0|0|EIS|0|0|0|100|SEK|2725|4538|lyfalmen|||00|14|0|14|Vistor hf|Eisai Ltd|Rabeprazól||2725||2725|4538 551929|A02BC0401|Pariet|sh-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|949|2128|lyfalmen|||00|28|0|28|Vistor hf|Eisai Ltd|Rabeprazól||949||949|2128 551937|A02BC0401|Pariet|sh-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|7916|4256|lyfalmen|||00|56|0|56|Vistor hf|Eisai Ltd|Rabeprazól||2517||2517|4256 552224|C08CA0501|Adalat|töflur|20|mg|100|stk|1|þpakki||C08CA05|01.04.1985||R|A|5|0|0|B|0|BAV|0|0|0|100|SEK|4306|6684|lyfalmen|||63|100|0|67|Vistor hf|Bayer Schering Pharma AG (V)|Nífedipín||4306||4306|6684 552703|M01AB0509|Modifenac|forðahlk|75|mg|10|stk|1|þpakki||M01AB05|01.11.2000||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|694|1782|lyfalmen|||00|10|0|8|Actavis Group hf|Actavis Group hf|Díklófenak||694||694|1782 552877|N05CF0104|Zopiklon Merck NM|filmhtfl|7,5|mg|500|stk|1|plglas||N05CF01|01.07.2007||R|A|2|0|0|0|0|MNA|0|0|0|100|SEK|5041|7681|lyfalmen|||00|500|0|500|Actavis Group PTC ehf|Merck NM AB|Zópíklón||5041||5041|7681 552901|N03AF0201|Trileptal|filmhtfl|150|mg|100|stk|1|þpakki||N03AF02|01.10.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|4044|6328|lyfalmen|||00|100|0|15|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||4044||4044|6328 552919|N03AF0201|Trileptal|filmhtfl|300|mg|50|stk|1|glas||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|4015|6289|lyfalmen|||00|50|0|15|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||4015||4015|6289 553206|N02CC0601|Relpax|filmhtfl|40|mg|18|stk|1|þpakki||N02CC06|01.08.2009||R|A||0|0|E|0|PFI|0|0|0|100|DKK|13892|19481|lyfalmen|||00|18|0|18|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Eletriptan||||13892|19481 553313|N02CC0601|Relpax|filmhtfl|40|mg|3|stk|1|þpakki||N02CC06|01.10.2001||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|2757|4582|lyfalmen|||00|3|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Eletriptan||2757||2757|4582 553339|N02CC0601|Relpax|filmhtfl|40|mg|6|stk|1|þpakki||N02CC06|01.10.2001||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|4751|7288|lyfalmen|||00|6|0|6|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Eletriptan||4751||4751|7288 554154|QA12CE9902|Selevitan, vet.|stl|0| |100|ml|5|hgl||QA12CE99|01.05.1983||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|8386|16145|vetalmen|||27|500|0|0|Vistor hf|Boehringer Ingelheim Danmark|||8386||8386|16145 555607|N06AB0601|Zoloft|mixtúruþ|20|mg/ml|60|ml|1|fl||N06AB06|01.03.2001|30.09.2009|R|A|3|0|0|B|0|PFI|0|1|0|100|DKK|5563|8390|lyfalmen|||00|60|0|24|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sertralín||5563||5563|8390 556589|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3654|5232|lyfsjukr|||00|6000|0|6|Icepharma hf|Fresenius Kabi|Elektrólýtar||3654||3654|5232 556654|B05BA0313|Glucos 500 mg/ml Fresenius Kabi|irl|500|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.05.2004||R|A|1|0|0|0|1|FRP|0|0|0|100|DKK|7031|10067|lyfsjukr|||00|6000|0|6|Icepharma hf|Fresenius Kabi|Kolvetni||7031||7031|10067 556662|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|5962|8536|lyfsjukr|||00|6000|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||5962||5962|8536 556738|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|4392|6288|lyfsjukr|||00|6000|0|6|Icepharma hf|Fresenius Kabi|Kolvetni||4392||4392|6288 556753|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|4083|5846|lyfsjukr|||00|6000|0|6|Icepharma hf|Fresenius Kabi|Kolvetni||4083||4083|5846 556936|N03AF0201|Trileptal|filmhtfl|300|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|5643|8498|lyfalmen|V2150|8497|00|100|0|30|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||5643||5643|8498 556944|N03AF0201|Trileptal|filmhtfl|600|mg|50|stk|1|glas||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|7786|11406|lyfalmen|||00|50|0|30|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||7786||7786|11406 556951|N03AF0201|Trileptal|filmhtfl|600|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|11001|15769|lyfalmen|||00|100|0|60|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||11001||11001|15769 557546|D10AF0202|Zineryt|áburður|0| |30|ml|1|glas|+ leysir|D10AF02|01.07.1985||R|A|2|0|0|0|0|ASP|0|0|0|100|XEU|1847|3347|lyfalmen|||38|30|0|30|Vistor hf|Astellas Pharma A/S|Erýtrómýcín||1847||1847|3347 558585|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|10|hgl|röntgenskuggaefni|V08CA01|01.07.1992||R|A|5|0|0|0|1|SAG|0|0|0|100|SEK|182690|229317|lyfsjukr|||02|200|0|0|Icepharma hf|Schering AG|Gadópentetat||182690||182690|229317 559013|C08DA0103|Isoptin retard|forðatfl|120|mg|28|stk|1|þpakki||C08DA01|01.01.1995||R|A|4|0|0|B|0|ABS|0|0|0|100|DKK|1133|2378|lyfalmen|||10|28|0|14|Vistor hf|Abbott Scandinavia AB|Verapamíl||1133||1133|2378 559021|C08DA0103|Isoptin retard|forðatfl|120|mg|98|stk|1|þpakki||C08DA01|01.01.1995||R|A|4|0|0|B|0|ABS|0|0|0|100|DKK|2249|3892|lyfalmen|||10|98|0|49|Vistor hf|Abbott Scandinavia AB|Verapamíl||2249||2249|3892 559062|N02AX0201|Nobligan|hylki|50|mg|100|stk|1|pakki||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1135|2381|lyfalmen|V0731|1524|10|100|0|17|Icepharma hf|Grunenthal|Tramadól||1135||1135|2381 559070|N02AX0201|Nobligan|hylki|50|mg|20|stk|1|pakki||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|679|1762|lyfalmen|V0730|1238|10|20|0|3|Icepharma hf|Grunenthal|Tramadól||679||679|1762 559104|N02AX0201|Nobligan|eþ-stil|100|mg|20|stk|1|pakki||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1894|3411|lyfalmen|||04|20|0|7|Icepharma hf|Grunenthal|Tramadól||1894||1894|3411 559120|N02AX0201|Nobligan|stl|50|mg/ml|2|ml|5|lykjur||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1089|2318|lyfalmen|V0732|2193|02|10|0|2|Icepharma hf|Grunenthal|Tramadól||1089||1089|2318 559286|C05BA0101|Hirudoid|krem|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|A|5|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||00|100|0|100|Icepharma hf|STADA Arzneimittel AG|Heparínóíð||||| 559401|S01ED5104|Fotil|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|2804|4646|lyfalmen|||06|5|0|0|Icepharma hf|Santen Oy|Tímólól í blöndum||2804||2804|4646 559476|C05BA0101|Hirudoid|hlaup|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|A|5|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||00|100|0|0|Icepharma hf|STADA Arzneimittel AG|Heparínóíð||||| 559948|G03CA0303|Estring|sk-hring|7,5|mcg/sólh|1|stk|1|pakki||G03CA03|01.07.1994||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|6625|9831|lyfalmen|||23|1|0|90|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Estradíól||6625||6625|9831 559963|C01DA0201|Discotrine|forðapl|5|mg/sólh|30|stk|1|þpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|SEK|3168|5140|lyfalmen|||23|30|0|30|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||3168||3168|5140 559971|C01DA0201|Discotrine|forðapl|10|mg/sólh|30|stk|1|þpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|SEK|3500|5590|lyfalmen|||23|30|0|60|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||3500||3500|5590 559989|N01AB0701|Suprane|innönd.l|0| |240|ml|1|fl||N01AB07|01.01.1995||R|A|3|0|0|0|1|BAX|0|0|0|100|SEK|16501|22411|lyfsjukr|||00|240|0|0|Icepharma hf|Baxter|Desflúran||16501||16501|22411 560060|S01XA2004|Vidisic|augngel|2|mg/g|10|g|1|túpa||S01XA20|01.04.1993||L|A|3|0|0|E|0|GEM|0|0|0|100|XEU|||lyfalmen|||07|10|0|0|Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar sam­setningar|||||1348 560326|J05AB0102|Zovir|töflur|200|mg|25|stk|1|þpakki||J05AB01|01.07.1989||R|A|5|0|0|E|0|GSK|0|0|1|100|GBP|3210|5197|lyfalmen|||00|25|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||3210||3210|5197 560367|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa||D06BB03|01.07.1994||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||20|2|0|2|Icepharma hf|GlaxoSmithKline CH A/S|Acíklóvír||||| 560375|S01AD0301|Zovir|augnsm|30|mg/g|4,5|g|1|túpa||S01AD03|01.01.1988||R|A|5|0|0|E|0|GSK|0|0|1|100|GBP|1830|3324|lyfalmen|||07|4|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||1830||1830|3324 560383|J05AB0102|Zovir|mixtúra|40|mg/ml|125|ml|1|glas||J05AB01|01.01.1995||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|6118|9143|lyfalmen|||00|125|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||6118||6118|9143 560391|J05AB0102|Zovir|mixtúra|80|mg/ml|100|ml|1|glas||J05AB01|01.01.1995||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|6634|9843|lyfalmen|||00|100|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||6634||6634|9843 560490|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|1|lykja||C01CX08|01.09.2001||R|K|3|0|1|0|1|ORC|0|0|0|100|DKK|116002|146290|lyfsjukr|||00|5|0|1|Vistor hf|Orion Corporation|Levosimendan||116002||116002|146290 560557|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|4|lykjur||C01CX08|01.09.2001||R|K|3|0|1|0|1|ORC|0|0|0|100|DKK|660384|620027|lyfsjukr|||00|20|0|5|Vistor hf|Orion Corporation|Levosimendan||496514||496514|620027 561159|S01ED5105|Fotil forte|augndr|45|mg/ml|5|ml|1|glas|5+40 mg/ml|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|2810|4654|lyfalmen|||06|5|0|0|Icepharma hf|Santen Oy|Tímólól í blöndum||2810||2810|4654 561571|N06AX1101|Remeron|töflur|30|mg|250|stk|1|glas|til notkunar vélskömmtun lyfja|N06AX11|01.11.2002||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|38548|50177|lyfalmen|||00|250|0|250|Vistor hf|N.V. Organon|Mirtazapín||38548||38548|50177 563346|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|3|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|28807|38050|lyfalmen|||02|6|0|17|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||28807||28807|38050 563361|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|5|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|44346|57396|lyfalmen|||02|10|0|29|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||44346||44346|57396 563379|D07AC1701|Cutivat|krem|0,5|mg/g|30|g|1|túpa||D07AC17|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|714|1809|lyfalmen|||20|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||714||714|1809 563387|D07AC1701|Cutivat|krem|0,5|mg/g|100|g|1|túpa||D07AC17|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|2216|3848|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2216||2216|3848 563395|D07AC1701|Cutivat|smyrsli|50|mcg/g|30|g|1|túpa||D07AC17|01.07.1995|31.10.2009|R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|740|1845|lyfalmen|||20|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||740||740|1845 563403|D07AC1701|Cutivat|smyrsli|50|mcg/g|100|g|1|túpa||D07AC17|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|2216|3848|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2216||2216|3848 563502|N02AA0101|Contalgin|forðatfl|5|mg|100|stk|1|þpakki||N02AA01|01.10.1993||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|1875|3385|lyfalmen|||10|100|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||1875||1875|3385 563528|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|30|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|238228|298779|lyfalmen|||02|60|0|172|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||238228||238228|298779 563577|S01ED5104|Fotil|augndr|25|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|5488|8288|lyfalmen|||00|15|0|0|Icepharma hf|Santen Oy|Tímólól í blöndum||5488||5488|8288 563593|S01ED5105|Fotil forte|augndr|45|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|5781|8685|lyfalmen|||00|15|0|0|Icepharma hf|Santen Oy|Tímólól í blöndum||5781||5781|8685 563684|C10AA0401|Lescol|hylki|20|mg|98|stk|1|þpakki||C10AA04|01.10.1997||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|10220|14709|lyfalmen|||00|98|0|33|Vistor hf|Novartis Healthcare A/S-|Flúvastatín||10220||10220|14709 563700|C10AA0401|Lescol|hylki|40|mg|98|stk|1|þpakki||C10AA04|01.10.1997||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|12939|18294|lyfalmen|||00|98|0|65|Vistor hf|Novartis Healthcare A/S-|Flúvastatín||12939||12939|18294 564088|J05AB0401|Rebetol|hylki|200|mg|168|stk|1|þpakki|hart|J05AB04|01.02.2002||R|A|2|0|1|0|1|SCP|0|0|0|100|DKK|175681|220590|lyfsjukr|||00|168|0|34|Vistor hf|Schering-Plough|Ribavirin||175681||175681|220590 565275|C07AG0202|Dimitone|töflur|12,5|mg|100|stk|1|pakki||C07AG02|01.07.2001||R|A||0|0|B|0|LDR|0|0|0|100|IKR|6003|8987|lyfalmen|||00|100|1|33|Parlogis hf|Parlogis - óskráð lyf|||6003||6003|8987 565325|C07AG0202|Dimitone|töflur|25|mg|100|stk|1|pakki||C07AG02|01.07.2001||R|A||0|0|B|0|LDR|0|0|0|100|IKR|9009|13066|lyfalmen|||00|100|1|67|Parlogis hf|Parlogis - óskráð lyf|||9009||9009|13066 565374|C07AG0202|Dimitone|töflur|6,25|mg|28|stk|1|pakki||C07AG02|01.07.2001||R|A||0|0|B|0|LDR|0|0|0|100|IKR|1593|3002|lyfalmen|||00|28|1|5|Parlogis hf|Parlogis - óskráð lyf|||1593||1593|3002 565457|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.10.1994||R|A|4|0|0|B|0|UCB|0|0|0|100|DKK|13367|18827|lyfalmen|||00|100|0|50|Vistor hf|U.C.B|Olsalazín||13367||13367|18827 566018|D01BA0201|Lamisil|töflur|125|mg|14|stk|1|þpakki||D01BA02|01.07.1995||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|3141|2835|lyfalmen|||00|14|0|7|Vistor hf|Novartis Healthcare A/S-|Terbínafín||1470||1470|2835 566182|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.01.2001||R|A|2|0|0|*|0|ALC|0|0|0|100|USD|1419|2766|lyfalmen|||06|5|0|25|K.Pétursson hf|Alcon|Brinzólamíð||1419||1419|2766 566661|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.11.2000||R|K|3|0|1|0|1|WTE|0|0|0|100|USD|85427|108224|lyfsjukr|||00|100|0|14|Icepharma hf|Wyeth Europe|Etanercept||85427||85427|108224 566992|J02AC0101|Diflucan|hylki|150|mg|4|stk|1|þpakki||J02AC01|01.10.1993||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|6690|9919|lyfalmen|V0556|4233|10|4|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||6690||6690|9919 567016|R06AD0201|Phenergan|mixtúra|1|mg/ml|100|ml|1|glas||R06AD02|01.10.1995||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|1773|3246|lyfalmen|||00|100|0|4|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||1773||1773|3246 567073|A10BG0201|Avandia|töflur|4|mg|56|stk|1|þpakki|filmuhúðaðar töflur|A10BG02|01.12.2000||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|8383|12217|lyfalmen|||00|56|0|37|GlaxoSmithKline ehf|SmithKline Beecham PLC|Rósíglítazón||||8383|12217 567149|A10BG0201|Avandia|töflur|8|mg|28|stk|1|þpakki|filmuhúðaðar töflur|A10BG02|01.12.2000||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|6638|9848|lyfalmen|||00|28|0|37|GlaxoSmithKline ehf|SmithKline Beecham PLC|Rósíglítazón||6638||6638|9848 567503|N05AX0801|Risperdal|töflur|1|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|6509|9673|lyfalmen|V0791|4040|00|60|0|12|Vistor hf|Janssen-Cilag AB|Risperídón||6509||6509|9673 567511|N05AX0801|Risperdal|töflur|2|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|15015|20879|lyfalmen|V0793|7206|00|60|0|24|Vistor hf|Janssen-Cilag AB|Risperídón||15015||15015|20879 567529|N05AX0801|Risperdal|töflur|3|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|24956|33255|lyfalmen|V0794|11709|00|60|0|36|Vistor hf|Janssen-Cilag AB|Risperídón||24956||24956|33255 567537|N05AX0801|Risperdal|töflur|4|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|33067|43353|lyfalmen|V0795|18331|00|60|0|48|Vistor hf|Janssen-Cilag AB|Risperídón||33067||33067|43353 567545|R01AC0201|Livostin|nefúði|0,5|mg/úðask|15|ml|1|glas||R01AC02|01.06.1998||L|A|3|0|0|0|0|JAS|0|0|1|100|IKR|||lyflausa|||24|15|0|12|Vistor hf|Janssen-Cilag AB|Levókabastín||||| 567636|N05BA1205|Alprazolam Mylan|töflur|1|mg|20|stk|1|þpakki||N05BA12|01.07.2009||R|A||0|0|0|0|RAN|0|0|1|100|SEK|648|1720|lyfalmen|V0857|1720|00|20|0|20|Actavis Group PTC ehf|Mylan AB|Alprazólam||||648|1720 568238|A02BC0401|Pariet|sh-tfl|20|mg|120|stk|1|þpakki||A02BC04|01.05.2002||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|16169|9120|lyfalmen|||00|120|0|120|Vistor hf|Eisai Ltd|Rabeprazól||6101||6101|9120 568709|R01AX0601|Bactroban Nasal|nefsm|20|mg/g|3|g|1|túpa||R01AX06|01.07.1994||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|1148|2398|lyfalmen|||00|3|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Mupirocin||1148||1148|2398 568790|N02AA5902|Parkodin forte|eþ-stil|530|mg|10|stk|1|pakki|30+500 mg|N02AA59|01.07.1993||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|489|1504|lyfalmen|||04|10|0|3|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||489||489|1504 568840|C08CA0201|Feldil|forðatfl|5|mg|100|stk|1|glas||C08CA02|01.04.2003||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|1463|2826|lyfalmen|V0316|2826|10|100|0|100|Actavis Group hf|Actavis hf|Felódipín||1463||1463|2826 568865|C08CA0201|Feldil|forðatfl|10|mg|100|stk|1|glas||C08CA02|01.04.2003||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|2318|3986|lyfalmen|V0324|3986|10|100|0|200|Actavis Group hf|Actavis hf|Felódipín||2318||2318|3986 569467|M03BX0103|Lioresal|stl|2|mg/ml|5|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|20582|27492|lyfsjukr|||02|5|0|18|Vistor hf|Novartis Healthcare A/S-|Baklófen||20582||20582|27492 569483|M03BX0103|Lioresal|stl|0,5|mg/ml|20|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|A|5|0|0|0|1|NOH|0|0|0|100|DKK|20582|27492|lyfsjukr|||02|20|0|18|Vistor hf|Novartis Healthcare A/S-|Baklófen||20582||20582|27492 569897|J07AJ5204|DiTeKik|bóluefni|0| |0,5|ml|1|spr|án nálar|J07AJ52|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|2659|4449|lyfalmen|||51|0|0|0|Icepharma hf|Statens Serum Institut|Kíghósti, í blöndum með öðrum toxóíðum||2659||2659|4449 569913|J07CA0203|DiTeKiPol|bóluefni|0| |0,5|ml|1|spr|án nálar|J07CA02|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|3787|5980|lyfalmen|||51|0|0|0|Icepharma hf|Statens Serum Institut|barnaveiki, kíghósti, mænusótt, stífkrampi||3787||3787|5980 572768|B02BC1001|Tisseel Duo Quick|vefjalím|0| |0,5|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|149175|187590|lyfsjukr|||00|5|0|0|Icepharma hf|Baxter|Fíbrínógen manna||149175||149175|187590 572776|B02BC1001|Tisseel Duo Quick|vefjalím|0| |1|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|195261|244967|lyfsjukr|||00|10|0|0|Icepharma hf|Baxter|Fíbrínógen manna||195261||195261|244967 572784|B02BC1001|Tisseel Duo Quick|vefjalím|0| |2|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|367335|459200|lyfsjukr|||00|20|0|0|Icepharma hf|Baxter|Fíbrínógen manna||367335||367335|459200 573287|G03CA0306|Evorel|forðapl|25|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|4057|6346|lyfalmen|||23|26|0|46|Vistor hf|Janssen-Cilag AB|Estradíól||4057||4057|6346 573477|L01XC0301|Herceptin|sts|150|mg/hgl|1|hgl|1|pakki||L01XC03|01.01.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|112624|142084|lyfsjukr|||00|1|0|0|Icepharma hf|Roche|Trastuzumab||112624||112624|142084 573634|J01DH0201|Meronem|sts/irs|500|mg/hgl|500|mg|10|hgl||J01DH02|01.10.1995||R|A|4|0|0|0|1|ASZ|0|0|0|100|SEK|31619|41233|lyfsjukr|||00|5000|0|2|Vistor hf|AstraZeneca UK Ltd|Meropenem||31619||31619|41233 573642|J01DH0201|Meronem|sts/irs|1|g/hgl|1|g|10|hgl||J01DH02|01.10.1995||R|A|4|0|0|0|1|ASZ|0|0|0|100|SEK|61884|78913|lyfsjukr|||00|10|0|5|Vistor hf|AstraZeneca UK Ltd|Meropenem||61884||61884|78913 573790|M01AB0506|Voltaren Rapid|töflur|50|mg|100|stk|1|þpakki||M01AB05|01.01.1996||R|A|3|0|0|0|0|NOH|0|0|1|100|IKR|2756|2507|lyfalmen|V0610|2451|67|100|0|50|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1228||1228|2507 575324|N06AB0601|Zoloft|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.10.1995||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|3433|3803|lyfalmen|V0931|2220|00|28|0|28|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sertralín||2183||2183|3803 575340|N06AB0601|Zoloft|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.10.1995||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|8919|10511|lyfalmen|V0933|4933|00|98|0|98|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sertralín||7126||7126|10511 575357|N06AB0601|Zoloft|töflur|100|mg|28|stk|1|þpakki||N06AB06|01.03.2001||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|7138|5806|lyfalmen|V0935|3246|00|28|0|56|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sertralín||3659||3659|5806 575365|N06AB0601|Zoloft|töflur|100|mg|98|stk|1|þpakki||N06AB06|01.03.2001||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|15890|17181|lyfalmen|V0937|7759|00|98|0|196|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sertralín||12045||12045|17181 575472|P03AX0301|Prioderm|hársápa|10|mg/ml|40|g|1|túpa||P03AX03|01.04.1994||L|K|2|0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa|||23|40|0|0|Icepharma hf|Norpharma |Malatíón||||| 575506|C01EB1001|Adenocor|stl|3|mg/ml|2|ml|6|hgl||C01EB10|01.11.2007||R|A|3|0|0|0|1|SAA|0|0|0|100|NOK|6860|9822|lyfsjukr|||00|12|0|0|Vistor hf|Sanofi - Aventis|Adenósín||6860||6860|9822 575787|L04AB0201|Remicade|irs|100|mg|1|hgl|1|pakki||L04AB02|01.12.2000||R|K|3|0|1|0|1|CEO|0|0|0|100|DKK|103744|131029|lyfsjukr|||00|1|0|27|Vistor hf|Centocor B.V.|Infliximab||103744||103744|131029 577668|C07FB0201|Logimax|forðatfl|55|mg|28|stk|1|pakki|þp 5+50 mg|C07FB02|01.04.1997||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3371|5415|lyfalmen|||00|28|0|28|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóðþrýst­ings­­lækkandi lyf||3371||3371|5415 579110|R03CC0301|Bricanyl|stl|0,5|mg/ml|1|ml|10|lykjur||R03CC03|01.12.1972||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|1312|2621|lyfalmen|||02|10|0|0|Vistor hf|AstraZeneca A/S DK|Terbútalín||1312||1312|2621 579854|L04AX0301|Methotrexate Wyeth Lederle|töflur|2,5|mg|30|stk|1|glas||L04AX03|01.01.1994||R|A|3|0|0|*|0|WAB|0|0|0|100|USD|817|1949|lyfalmen|||00|30|0|30|Icepharma hf|Wyeth AB|Metótrexat||817||817|1949 582080|H01AC0107|Humatrope 6 mg|sts|6|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|XEU|35499|46064|lyfsjukr|||02|1|0|9|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||35499||35499|46064 582114|H01AC0108|Humatrope 12 mg|sts|12|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|XEU|70678|89862|lyfsjukr|||02|1|0|18|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||70678||70678|89862 582130|H01AC0109|Humatrope 24 mg|sts|24|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|XEU|135453|170506|lyfsjukr|||02|1|0|36|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||135453||135453|170506 582213|R01AA0503|Nezeril|nefúði|0,1|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|A|3|0|0|0|0|GCO|0|0|1|100|IKR|||lyflausa|||23|8|0|2|Vistor hf|GlaxoSmithKline CH AB|Oxýmetazólín||||| 582247|QP54AA0301|Dectomax vet.|stl|10|mg/ml|50|ml|1|hgl||QP54AA03|01.02.1999||R|A|2|0|0|0|0|PAL|1|0|0|100|DKK|5748|9947|vetorma|||16|50|0|0|Icepharma hf|Pfizer Oy Animal Health|||5748||5748|9947 582262|QP54AA0301|Dectomax vet.|stl|10|mg/ml|200|ml|1|hgl||QP54AA03|01.02.1999||R|A|2|0|0|0|0|PAL|1|0|0|100|DKK|21660|37484|vetorma|||16|200|0|0|Icepharma hf|Pfizer Oy Animal Health|||21660||21660|37484 582452|V08AB0201|Omnipaque|stl|300|mg J/ml|100|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|61502|78437|lyfsjukr|||02|1000|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||61502||61502|78437 582635|V08AB0201|Omnipaque|stl|300|mg J/ml|500|ml|6|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|156656|196904|lyfsjukr|||02|3000|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||156656||156656|196904 582783|C07AB0205|Seloken|töflur|100|mg|28|stk|1|þpakki||C07AB02|01.12.2001||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|817|1949|lyfalmen|||00|28|0|19|Vistor hf|AstraZeneca A/S DK|Metóprólól||817||817|1949 582882|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|66699|84908|lyfsjukr|||02|1000|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||66699||66699|84908 583401|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|123665|155830|lyfsjukr|||02|2000|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||123665||123665|155830 583443|C07AA0705|Sotalol Mylan|töflur|80|mg|100|stk|1|þpakki||C07AA07|01.01.1994||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|1190|2455|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck NM AB|Sótalól||1190||1190|2455 583450|V08AB0901|Visipaque|stl|270|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|184611|231708|lyfsjukr|||02|3000|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||184611||184611|231708 583518|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|75497|95861|lyfsjukr|||02|1000|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||75497||75497|95861 583609|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|148254|186444|lyfsjukr|||02|2000|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||148254||148254|186444 583708|V08AB0901|Visipaque|stl|320|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|200325|251272|lyfsjukr|||02|3000|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||200325||200325|251272 583849|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4400|6300|lyfsjukr|||00|5000|0|5|Icepharma hf|Fresenius Kabi|Elektrólýtar||4400||4400|6300 583856|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2291|3280|lyfsjukr|||00|9000|0|9|Icepharma hf|Fresenius Kabi|Elektrólýtar||2291||2291|3280 583914|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|50|ml|30|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|8461|12114|lyfsjukr|||00|1500|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar||8461||8461|12114 583922|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|20|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|6941|9938|lyfsjukr|||00|5000|0|5|Icepharma hf|Fresenius Kabi|Kolvetni||6941||6941|9938 583930|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3372|4828|lyfsjukr|||00|9000|0|9|Icepharma hf|Fresenius Kabi|Kolvetni||3372||3372|4828 584011|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|30|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|9638|13799|lyfsjukr|||00|3000|0|3|Icepharma hf|Fresenius Kabi|Kolvetni||9638||9638|13799 584029|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3813|5459|lyfsjukr|||00|9000|0|9|Icepharma hf|Fresenius Kabi|Kolvetni||3813||3813|5459 584102|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|4545|6507|lyfsjukr|||00|9000|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||4545||4545|6507 584276|B05BB0115|Ringer-acetat Fresenius Kabi|irl|0| |1000|ml|9|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2570|3680|lyfsjukr|||00|9000|0|9|Icepharma hf|Fresenius Kabi|Elektrólýtar||2570||2570|3680 584284|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|0| |100|ml|30|pokar|excel umbúðir|V07AB00|01.02.2007||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|3000|0|0|Icepharma hf|Fresenius Kabi|||||| 584292|N06AG0201|Aurorix|töflur|300|mg|30|stk|1|þpakki||N06AG02|01.07.1995||R|A|5|0|0|B|0|MAS|0|1|0|100|SEK|4096|6399|lyfalmen|||64|30|0|30|Vistor hf|Meda AS|Móklóbemíð||4096||4096|6399 585646|B01AB0101|Heparin Leo|stl|25000|ae/ml|2|ml|10|hgl||B01AB01|01.11.1981||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|11505|16191|lyfsjukr|||02|20|0|50|Vistor hf|LEO Pharma A/S|Heparín||11505||11505|16191 585679|B01AB0101|Heparin Leo|stl|5000|ae/ml|5|ml|5|hgl||B01AB01|01.12.1972||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|4191|6000|lyfsjukr|||02|25|0|12|Vistor hf|LEO Pharma A/S|Heparín||4191||4191|6000 585844|J01DH5101|Tienam|irs|500|mg|12|hgl|1|pakki|monovial|J01DH51|01.04.1988||R|A|2|0|0|0|1|MSD|0|0|0|100|XEU|41154|53104|lyfsjukr|||00|12|0|3|Icepharma hf|M.S.D.|Imipenem og ensímhemill||41154||41154|53104 585869|J07BC0201|Havrix|bóluefni|1440|ein/ml|1|ml|1|dæla|einnota dæla|J07BC02|01.07.1994||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|3809|6009|lyfalmen|||02|1|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3809||3809|6009 586107|L04AD0102|Sandimmun Neoral|mixtúra|100|mg/ml|50|ml|1|glas||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|39904|51865|lyfalmen|||00|50|0|20|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||39904||39904|51865 586206|D07AB0201|Locoid|smyrsli|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|A|5|0|0|B|0|ASP|0|0|1|100|XEU|3033|4956|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||3033||3033|4956 587667|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|0| |1000|ml|9|plpok|Excel umbúðir|B05BB02|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3571|5113|lyfsjukr|||00|9000|0|9|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||3571||3571|5113 588152|S01GX0401|Tilavist|augndr|20|mg/ml|5|ml|1|glas||S01GX04|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1650|3080|lyfalmen|||06|5|0|0|Vistor hf|Sanofi-aventis Norge AS|Nedókrómíl||1650||1650|3080 588574|J01FF0101|Dalacin|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.10.1995||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|2531|4275|lyfalmen|V0426|4203|43|20|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||2531||2531|4275 588608|B01AC0501|Ticlid|töflur|250|mg|100|stk|1|þpakki||B01AC05|01.04.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|14557|20308|lyfalmen|||00|100|0|50|Vistor hf|Sanofi-aventis Norge AS|Tíklópídín||14557||14557|20308 588772|H05BA0103|Miacalcic Nasal|nefúði|200|ae/sk|2|ml|1|úðagl|14 skammt|H05BA01|01.03.2002||R|K|3|0|0|E|0|NOH|0|0|0|100|DKK|10128|14585|lyfalmen|||23|2|0|14|Vistor hf|Novartis Healthcare A/S-|Samtengt laxakalsítónín||10128||10128|14585 589358|QP54AA0501|Stronghold vet.|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|7019|12147|vetorma|||16|3|0|0|Icepharma hf|Pfizer Animal Health|||7019||7019|12147 589366|QP54AA0501|Stronghold vet.|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|2720|4707|vetorma|||16|1|0|0|Icepharma hf|Pfizer Animal Health|||2720||2720|4707 589374|QP54AA0501|Stronghold vet.|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|6772|11719|vetorma|||16|6|0|0|Icepharma hf|Pfizer Animal Health|||6772||6772|11719 589382|QP54AA0501|Stronghold vet.|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|3658|6330|vetorma|||16|1|0|0|Icepharma hf|Pfizer Animal Health|||3658||3658|6330 589390|QP54AA0501|Stronghold vet.|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|3799|6574|vetorma|||16|2|0|0|Icepharma hf|Pfizer Animal Health|||3799||3799|6574 589408|QP54AA0501|Stronghold vet.|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|2943|5093|vetorma|||16|2|0|0|Icepharma hf|Pfizer Animal Health|||2943||2943|5093 589497|D11AF0102|Canthacur|lausn|0,7|%|7,5|ml|1|glas||D11AF01|01.01.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|2566|4323|lyfalmen|||00|8|1|8|Parlogis hf|Parlogis - óskráð lyf|||2566||2566|4323 589500|D11AF0103|Canthacur-PS|lausn|36|%|7,5|ml|1|glas|1%+30%+5%|D11AF01|01.01.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|5480|8277|lyfalmen|||00|8|1|8|Parlogis hf|Parlogis - óskráð lyf|||5480||5480|8277 589911|L01BB0501|Fludara|sts|50|mg/hgl|50|mg|5|hgl||L01BB05|01.01.1996||R|A|3|0|1|0|1|BAP|0|0|0|100|SEK|164733|206960|lyfsjukr|||00|250|0|0|Icepharma hf|Bayer Schering Pharma AG|Flúdarabín||164733||164733|206960 590315|J05AE0301|Norvir|hylki|100|mg|84|stk|4|glös|mjúk hylki|J05AE03|01.08.2003||R|K|2|0|1|0|1|ABL|0|0|0|100|DKK|99024|125152|lyfsjukr|||00|336|0|28|Vistor hf|Abbott Laboratories A/S|Ritonavír||99024||99024|125152 590497|D01AC0101|Canesten|krem|10|mg/g|20|g|1|túpa||D01AC01|01.12.1982||L|A|3|0|0|0|0|BAS|0|0|1|100|IKR|||lyflausa|||00|20|0|20|Vistor hf|Bayer A/S|Klótrímazól||||| 590539|A01AD1101|Bonjela|hlaup|0| |15|g|1|túpa|hlaup í munn|A01AD11|01.01.1996||L|A|3|0|0|0|0|REB|0|0|1|100|IKR|||lyflausa|||00|15|0|0|Icepharma hf|Reckitt Benckiser Healthcare Ltd.|Ýmis lyf||||| 590562|C01DA1403|Ismo|forðatfl|60|mg|98|stk|1|þpakki||C01DA14|01.10.1999||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|1404|2746|lyfalmen|V0139|2746|10|98|0|147|Actavis Group hf|Actavis hf|Ísósorbíð mónónítrat||1404||1404|2746 590752|N05AF0102|Fluanxol Depot|stl|100|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1979||R|A|4|0|0|*|0|LBK|0|1|0|100|DKK|30581|40258|lyfalmen|||02|10|0|250|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||30581||30581|40258 590919|B01AD1101|Metalyse|sts/irs|10000|ein|1|stk|1|hgl|+ leysir áfyllt sprauta|B01AD11|01.07.2001||R|A|2|0|0|0|1|BOI|0|0|0|100|DKK|225522|282642|lyfsjukr|||00|1|0|1|Vistor hf|Boehringer Ingelheim|Tenekteplasi||225522||225522|282642 592097|N01AF0301|Pentothal Natrium|sts|500|mg|1|stk|12|hgl||N01AF03|01.07.1990||R|A|4|0|0|0|1|HOS|0|0|0|100|DKK|3752|5372|lyfsjukr|||02|12|0|0|Vistor hf|Hospira Enterprises B.V.|Tíópentalnatríum||3752||3752|5372 592147|D05AX0301|Silkis|smyrsli|3|mcg/g|100|g|1|túpa||D05AX03|01.06.2001||R|A|3|0|0|B|0|GAN|0|0|0|100|XEU|7229|10650|lyfalmen|||00|100|0|0|Icepharma hf|Galderma Nordic AB|Kalcítríól||7229||7229|10650 592378|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|500|ml|1|glas||D08AC02|01.10.1976||L|A|3|0|0|0|0|REM|0|0|0|100|IKR|||lyflausa|||00|500|0|500|Vistor hf|Regent Medical Overseas Limited|Klórhexidín||||| 592469|N02BE0107|Paratabs|lausnart|160|mg|30|stk|1|þpakki||N02BE01|01.01.1995||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||09|30|0|2|Actavis Group hf|Actavis hf|Paracetamól||||| 593384|N03AE0101|Rivotril|töflur|0,5|mg|50|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|597|1651|lyfalmen|||00|50|0|3|Icepharma hf|Roche|Klónazepam||597||597|1651 593392|N03AE0101|Rivotril|töflur|0,5|mg|150|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|1035|2245|lyfalmen|||00|150|0|9|Icepharma hf|Roche|Klónazepam||1035||1035|2245 593434|N03AE0101|Rivotril|töflur|2|mg|100|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|1542|2933|lyfalmen|||00|100|0|25|Icepharma hf|Roche|Klónazepam||1542||1542|2933 594325|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|12|hgl|dreifa|H02AB08|01.12.2003||R|A|3|0|0|B|0|MAB|0|0|1|100|SEK|21471|28916|lyfalmen|||03|12|0|32|Vistor hf|Meda AB|Tríamcínólón||21471||21471|28916 594713|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|1|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|10|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||675 594721|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|10|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|100|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||5614 594903|B05BB0209|Glucos 100 mg/ml med Na40 + K20 Fres|irl|0| |1000|ml|9|plpok|Exel umbúðir|B05BB02|01.04.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3292|4713|lyfsjukr|||02|9000|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||3292||3292|4713 594945|QA12CE9903|Selenevit, vet.|stl|26|mg/ml|100|ml|1|hgl|1+25 mg/ml|QA12CE99|01.09.1982||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|1181|2330|vetalmen|||27|100|0|0|Icepharma hf|Intervet International B.V.|||1181||1181|2330 595066|H05BA0102|Miacalcic|stl|100|ae/ml|1|ml|5|lykjur||H05BA01|01.03.1979||R|K|5|0|0|0|1|NOH|0|0|0|100|DKK|10048|14377|lyfsjukr|||02|5|0|5|Vistor hf|Novartis Healthcare A/S-|Samtengt laxakalsítónín||10048||10048|14377 595991|J07BB0201|Fluarix|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07BB02|01.10.1994||R|K|1|0|0|0|0|GSK|0|0|0|100|GBP|649|1721|lyfalmen|||02|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsaðir mótefnavakar||649||649|1721 596023|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|250|ml|1|glas||D08AC02|01.06.1982||L|A|3|0|0|0|0|REM|0|0|0|100|IKR|||lyflausa|||00|250|0|250|Vistor hf|Regent Medical Overseas Limited|Klórhexidín||||| 597401|J01FF0101|Dalacin|hylki|150|mg|24|stk|1|þpakki||J01FF01|01.06.1979||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|4483|6924|lyfalmen|||43|24|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||4483||4483|6924 597567|D01AC0301|Pevaryl|krem|10|mg/g|30|g|1|túpa||D01AC03|01.05.1978||L|A|2|0|0|0|0|JAS|0|0|1|100|IKR|||lyflausa|||00|30|0|30|Vistor hf|Janssen-Cilag AB|Ekónazól||||| 598094|R06AD0101|Vallergan|mixtúra|5|mg/ml|150|ml|1|glas||R06AD01|01.03.2004||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|1098|2330|lyfalmen|||00|150|0|25|Vistor hf|Sanofi-aventis Norge AS|Alímemazín||1098||1098|2330 801120|A11HA0503|Biotin Bayer|töflur|5|mg|20|stk|1|glas||A11HA05|01.12.2005||R|A||0|0|0|0|PCO|0|0|0|100|DKK|1536|2925|lyfalmen|||00|20|1|0|Distica|Distica - óskráð lyf|||1536||1536|2925 908048|J07AM5201|Tetagam P/Tetanogamma P|bóluefni|250|ae|1,2|ml|1|hgl||J07AM52|01.01.1998||R|K||0|0|0|0|LDR|0|0|1|100|IKR|19419|26362|lyfalmen|||00|1|1|0|Parlogis hf|Parlogis - óskráð lyf|||19419||19419|26362 912792|N07CA0301|Sibelium|hylki|5|mg|50|stk|1|glas||N07CA03|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|SEK|4880|7463|lyfalmen|||00|50|1|25|Distica|Distica - óskráð lyf|||4880||4880|7463 916827|A03FA0301|Motilium|töflur|10|mg|100|stk|1|glas||A03FA03|01.05.1998||R|A||0|0|0|0|PCO|0|0|1|100|SEK|2701|4506|lyfalmen|||00|100|1|33|Distica|Distica - óskráð lyf|||2701||2701|4506 922866|N05BA0602|Ativan|stl|4|mg/ml|1|ml|4|lykjur||N05BA06|01.11.2005||R|A||0|0|0|1|LDR|0|0|0|100|USD|3217|4606|lyfsjukr|||00|4|1|0|Parlogis hf|Parlogis - óskráð lyf|||3217||3217|4606 923351|S01XA2006|Lacri - Lube|augnsm|0| |3,5|g|1|túpa||S01XA20|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|480|1492|lyfalmen|||00|4|1|0|Distica|Distica - óskráð lyf|Gervitár og aðrar óvirkar sam­setningar||480||480|1492 923608|C03BA0801|Metenix|töflur|5|mg|100|stk|1|þpakki||C03BA08|01.05.1998||R|A||0|0|0|0|PCO|0|0|0|100|IKR|4460|6893|lyfalmen|||00|100|1|100|Distica|Distica - óskráð lyf|||4460||4460|6893 924698|G03DA0402|Gestone|stl|50|mg/ml|2|ml|10|lykjur||G03DA04|01.11.2005||R|A||0|1|E|0|PCO|0|0|0|100|IKR|8792|12772|lyfalmen|||00|20|1|200|Distica|Distica - óskráð lyf|||8792||8792|12772 927361|A12AA1201|Phos-Ex|töflur|167|mg|180|stk|1|glas||A12AA12|01.01.1998||R|A||0|1|0|0|LDR|0|0|0|100|IKR|1768|3240|lyfalmen|||00|180|1|15|Parlogis hf|Parlogis - óskráð lyf|||1768||1768|3240 937980|C01CA2403|Adrenalin|stl|0,1|mg/ml|10|ml|1|spr||C01CA24|01.05.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|2064|2955|lyfsjukr|||02|10|1|2|Parlogis hf|Parlogis - óskráð lyf|Epínefrín (adrenalín)||2064||2064|2955 938376|N07BC0201|Metadon|hylki|40|mg|100|stk|1|glas||N07BC02|01.07.2000||R|A||1|0|0|0|LDR|0|0|0|100|IKR|11317|16198|lyfalmen|||00|100|1|160|Parlogis hf|Parlogis - óskráð lyf|||11317||11317|16198 938417|N07BC0201|Metadon|stl|10|mg/ml|1,1|ml|10|lykjur||N07BC02|01.07.2000||R|A||1|0|0|0|LDR|0|0|0|100|IKR|2403|4101|lyfalmen|||00|11|1|4|Parlogis hf|Parlogis - óskráð lyf|||2403||2403|4101 938483|M04AC0101|Colchicine|töflur|0,5|mg|100|stk|1|glas||M04AC01|01.01.1998||R|A||0|0|E|0|LDR|0|0|0|100|GBP|4886|7471|lyfalmen|||00|100|1|50|Parlogis hf|Parlogis - óskráð lyf|||4886||4886|7471 938524|G04BE0201|Papaverin|stl|40|mg/ml|1|ml|10|lykjur||G04BE02|01.01.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|3002|4914|lyfalmen|||00|10|1|4|Parlogis hf|Parlogis - óskráð lyf|||3002||3002|4914 938649|C05BA0401|Elmiron|hylki|100|mg|100|stk|1|glas||C05BA04|01.05.1998||R|A||0|0|E|0|LDR|0|0|0|100|IKR|35415|46277|lyfalmen|||00|100|1|0|Parlogis hf|Parlogis - óskráð lyf|||35415||35415|46277 938665|A12CX0001|K-Phos Neutral|töflur|0| |100|stk|1|glas||A12CX00|01.03.2001||R|A||0|0|0|0|LDR|0|0|0|100|IKR|4071|6365|lyfalmen|||00|100|1|0|Parlogis hf|Parlogis - óskráð lyf|||4071||4071|6365 938780|C09AA0104|Captopril|hylki|1|mg|100|stk|1|glas||C09AA01|01.01.2000||R|A||0|0|0|0|LDR|0|0|0|100|GBP|10316|14840|lyfalmen|||00|100|1|2|Parlogis hf|Parlogis - óskráð lyf|Kaptópríl||10316||10316|14840 939366|G03DA0402|Gestone|stl|50|mg/ml|1|ml|10|lykjur||G03DA04|01.11.2005||R|A||0|1|E|0|PCO|0|0|0|100|IKR|11596|16577|lyfalmen|||00|10|1|100|Distica|Distica - óskráð lyf|||11596||11596|16577 940256|G03CA0313|Oestradiol|vefjatfl|25|mg|1|stk|1|pakki||G03CA03|01.04.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|2245|3887|lyfalmen|||00|1|1|83|Distica|Distica - óskráð lyf|Estradíól||2245||2245|3887 940264|G03CA0313|Oestradiol|vefjatfl|50|mg|1|stk|1|pakki||G03CA03|01.04.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|4490|6934|lyfalmen|||00|1|1|167|Distica|Distica - óskráð lyf|Estradíól||4490||4490|6934 940272|G03CA0313|Oestradiol|vefjatfl|100|mg|1|stk|1|pakki||G03CA03|01.04.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|8395|12233|lyfalmen|||00|1|1|333|Distica|Distica - óskráð lyf|Estradíól||8395||8395|12233 940313|G03BA0302|Testosteron|vefjatfl|100|mg|1|stk|1|pakki||G03BA03|01.04.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|1837|3333|lyfalmen|||00|1|1|1|Distica|Distica - óskráð lyf|Testósterón||1837||1837|3333 944505|H02AB1005|Cortisonacetat|töflur|5|mg|100|stk|1|glas||H02AB10|01.12.2002||R|A||0|0|E|0|PCO|0|0|1|100|IKR|4544|7007|lyfalmen|||00|100|1|13|Distica|Distica - óskráð lyf|||4544||4544|7007 944745|G03BA0302|Testosteron|vefjatfl|25|mg|1|stk|1|pakki||G03BA03|01.01.2002||R|A||0|0|E|0|PCO|0|0|0|100|IKR|1061|2280|lyfalmen|||00|1|1|8|Distica|Distica - óskráð lyf|Testósterón||1061||1061|2280 944852|A06AX0102|Glycerol infant|eþ-stil|0| |12|stk|1|pakki||A06AX01|01.10.1998||R|S||0|0|0|0|LDR|0|0|0|100|IKR|342|1304|lyfalmen|||00|12|1|0|Parlogis hf|Parlogis - óskráð lyf|||342||342|1304 944886|H02AB0601|Prednisolon|töflur|1|mg|28|stk|1|pakki||H02AB06|01.10.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|122|1006|lyfalmen|||00|28|1|3|Parlogis hf|Parlogis - óskráð lyf|Prednisólón||122||122|1006 944985|A06AX0103|Glycerol adult|eþ-stil|0| |12|stk|1|pakki||A06AX01|01.10.1998||R|S||0|0|0|0|LDR|0|0|0|100|IKR|342|1304|lyfalmen|||00|12|1|0|Parlogis hf|Parlogis - óskráð lyf|||342||342|1304 944993|V03AB1702|Methylen Blue|stl|10|mg/ml|10|ml|10|lykjur||V03AB17|01.11.1998||R|A||0|0|0|1|LDR|0|0|0|100|GBP|18963|25476|lyfsjukr|||00|100|1|0|Parlogis hf|Parlogis - óskráð lyf|||18963||18963|25476 945602|A11EA08|Vitamin B-komplex|stl|0| |2|ml|10|lykjur||A11EA|01.01.2000||R|A||0|0|0|0|LDR|0|0|0|100|IKR|1533|2921|lyfalmen|||00|20|1|0|Parlogis hf|Parlogis - óskráð lyf|||1533||1533|2921 945850|R06AD0202|Atosil|stl|25|mg/ml|2|ml|5|lykjur||R06AD02|01.03.2001||R|A||0|0|0|0|PCO|0|0|1|100|IKR|2293|3952|lyfalmen|||00|10|1|10|Distica|Distica - óskráð lyf|Prómetazín||2293||2293|3952 947236|N06BC0101|Koffein|töflur|200|mg|50|stk|1|glas||N06BC01|01.01.2000||R|A||0|0|0|0|LDR|0|0|0|100|IKR|1558|2955|lyfalmen|||00|50|1|25|Parlogis hf|Parlogis - óskráð lyf|||1558||1558|2955 947715|H02AB1004|Cortisone Acetat|töflur|25|mg|100|stk|1|glas||H02AB10|01.01.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|3625|5760|lyfalmen|||00|100|1|67|Parlogis hf|Parlogis - óskráð lyf|||3625||3625|5760 947822|H02AB0203|Dexamethason|töflur|4|mg|50|stk|1|glas||H02AB02|01.11.2001||R|A||0|0|E|0|LDR|0|0|1|100|IKR|8756|12723|lyfalmen|||00|50|1|133|Parlogis hf|Parlogis - óskráð lyf|||8756||8756|12723 947913|A11HA0203|Vitamin B6 Heve|stl|12,5|mg/ml|2|ml|10|lykjur||A11HA02|01.06.2000||R|A||0|0|0|0|LDR|0|0|0|100|IKR|582|1630|lyfalmen|||00|20|1|2|Parlogis hf|Parlogis - óskráð lyf|||582||582|1630 948242|H02AB0203|Dexamethason|töflur|0,5|mg|100|stk|1|pakki||H02AB02|01.04.2005||R|A||0|0|E|0|LDR|0|0|1|100|IKR|2071|3651|lyfalmen|||00|100|1|33|Parlogis hf|Parlogis - óskráð lyf|||2071||2071|3651 949620|G03DA0401|Utrogestan|hylki|100|mg|30|stk|1|pakki||G03DA04|01.01.1999||R|A||0|1|E|0|LDR|0|0|0|100|IKR|2001|3556|lyfalmen|||00|30|1|10|Parlogis hf|Parlogis - óskráð lyf|||2001||2001|3556 950742|H02AB0204|Dexa-Ratiopharm|stl|4|mg/ml|1|ml|10|hgl||H02AB02|01.01.2003||R|A||0|0|0|1|LDR|0|0|0|100|IKR|1436|2056|lyfsjukr|||55|10|1|0|Parlogis hf|Parlogis - óskráð lyf|||1436||1436|2056 951005|G03CA0102|Etinylestradiol|töflur|25|mcg|21|stk|1|pakki||G03CA01|01.09.2002||R|A||0|0|E|0|LDR|0|0|0|100|IKR|838|1978|lyfalmen|||00|21|1|21|Parlogis hf|Parlogis - óskráð lyf|||838||838|1978 951287|J01CA0101|Ampicillin|sts|0| |1|g|10|hgl||J01CA01|01.07.2003||R|A||0|0|0|1|LDR|0|0|0|100|IKR|5818|8330|lyfsjukr|||00|10|1|5|Parlogis hf|Parlogis - óskráð lyf|||5818||5818|8330 951592|H02AB0907|Hydrocortison|töflur|1|mg|100|stk|1|glas||H02AB09|01.08.2009||R|A||0|0|E|0|PCO|0|0|1|100|IKR|4851|7423|lyfalmen|||00|100|1||Distica|Distica - óskráð lyf|Hýdrókortisón||||4851|7423 952251|J01CA0101|Ampicillin|sts|500|mg|10|hgl|1|pakki||J01CA01|01.07.2003||R|A||0|0|0|1|LDR|0|0|0|100|IKR|4403|6304|lyfsjukr|||00|5000|1|2|Parlogis hf|Parlogis - óskráð lyf|||4403||4403|6304 952855|N02AA0102|Morfin|eþ-stil|10|mg|12|stk|1|pakki||N02AA01|01.10.2004||R|S||1|0|E|0|LDR|0|0|0|100|IKR|3127|5084|lyfalmen|||00|12|1|4|Parlogis hf|Parlogis - óskráð lyf|Morfín||3127||3127|5084 952929|A03AA0403|Duspatalin|töflur|135|mg|100|stk|1|glas||A03AA04|01.08.2009||R|A||0|0|E|0|LDR|0|0|0|100|IKR|5186|7878|lyfalmen|||00|100|1|45|Parlogis hf|Parlogis - óskráð lyf|Mebeverín||||5186|7878 953374|N05AB0602|Stelazine|töflur|1|mg|112|stk|1|glas||N05AB06|01.06.2007|30.09.2009|R|A||0|0|*|0|LDR|0|0|0|100|IKR|1410|2754|lyfalmen|||00|112|1|6|Parlogis hf|Parlogis - óskráð lyf|||1410||1410|2754 953621|R03DA0504|Theofyllamin EDA Ratiopharm|stl|120|mg/ml|1|ml|5|lykja||R03DA05|01.09.2004||R|A||0|0|0|0|LDR|0|0|0|100|IKR|289|1233|lyfalmen|||00|5|1|1|Parlogis hf|Parlogis - óskráð lyf|||289||289|1233 954421|C03CA0109|Furosemid|mixtúra|10|mg/ml|60|ml|1|glas||C03CA01|01.08.2009||R|A||0|0|E|0|LDR|0|0|0|100|IKR|1870|3378|lyfalmen|||00|60|1||Parlogis hf|Parlogis - óskráð lyf|Fúrósemíð||||1870|3378 954504|C07AA0510|Syprol|mixtúra|2|mg/ml|150|ml|1|fl||C07AA05|01.08.2009||R|A||0|0|0|0|LDR|0|0|0|100|IKR|5690|8562|lyfalmen|||00|150|1||Parlogis hf|Parlogis - óskráð lyf|Própranólól||||5690|8562 954645|N03AB0207|Phenytoin|mixtúra|25|mg/ml|237|ml|1|glas||N03AB02|01.08.2009||R|A||0|0|E|0|LDR|0|0|0|100|IKR|2953|4848|lyfalmen|||00|237|1||Parlogis hf|Parlogis - óskráð lyf|Fenýtóín||||2953|4848 955239|A11GA0108|Vitamin C 500|stl|100|mg/ml|5|ml|5|lykjur||A11GA01|01.01.2006||R|A||0|0|0|0|LDR|0|0|0|100|IKR|551|1588|lyfalmen|||00|25|1|12|Parlogis hf|Parlogis - óskráð lyf|||551||551|1588 955578|A03AA0403|Duspatalin|töflur|135|mg|50|stk|1|glas||A03AA04|01.08.2009||R|A||0|0|E|0|LDR|0|0|0|100|IKR|2593|4359|lyfalmen|||00|50|1|22|Parlogis hf|Parlogis - óskráð lyf|Mebeverín||||2593|4359 956302|N07AA0101|Neostigmin|stl|0,5|mg/ml|1|ml|10|lykjur||N07AA01|01.01.2006||R|A||0|0|0|0|LDR|0|0|0|100|IKR|848|1991|lyfalmen|||00|10|1|2|Parlogis hf|Parlogis - óskráð lyf|||848||848|1991 958613|V03AB1503|Naloxon|stl|0,4|mg/ml|1|ml|10|lykjur||V03AB15|01.01.2009||R|A||0|0|0|1|LDR|0|0|0|100|IKR|12107|16941|lyfsjukr|||00|10|1|0|Parlogis hf|Parlogis - óskráð lyf|||12107||12107|16941 958829|A06AD0002|Miralax|lausnduf|0| |238|g|1|stauk||A06AD00|01.05.2007||R|A||0|0|0|0|LDR|0|0|0|100|IKR|2093|3681|lyfalmen|||00|238|1|0|Parlogis hf|Parlogis - óskráð lyf|||2093||2093|3681 959132|J01XE0103|Nitrofurantoin|mixtúra|5|mg/ml|300|ml|1|glas||J01XE01|01.08.2009||R|A||0|0|0|0|LDR|0|0|0|100|IKR|23718|31714|lyfalmen|||00|300|1||Parlogis hf|Parlogis - óskráð lyf|Nítrófúrantóín||||23718|31714 960999|L02AB0101|Megace|töflur|160|mg|30|stk|1|glas||L02AB01|01.01.2009||R|A||0|1|0|1|PCO|0|0|0|100|IKR|12918|17950|lyfsjukr|||00|30|1|112|Distica|Distica - óskráð lyf|||12918||12918|17950 961202|A03AA0405|Mebeverine|töflur|135|mg|100|stk|1|glas||A03AA04|01.08.2009||R|A||0|0|E|0|PCO|0|0|0|100|GBP|1643|3070|lyfalmen|||00||1||Distica|Distica - óskráð lyf|Mebeverín||||1643|3070 961393|A04AD0501|Vogalene|hylki|15|mg|20|stk|1|glas||A04AD05|01.01.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|2108|3701|lyfalmen|||00|20|1|20|Parlogis hf|Parlogis - óskráð lyf|||||2108|3701 961591|H02AB0906|Hydrocortisone|töflur|10|mg|20|stk|1|glas||H02AB09|01.08.2009||R|A||0|0|E|0|LDR|0|0|1|100|IKR|2150|3758|lyfalmen|||00|20|1||Parlogis hf|Parlogis - óskráð lyf|Hýdrókortisón||||2150|3758 961658|H02AB0905|Hydrocortisone|töflur|20|mg|25|stk|1|glas||H02AB09|01.01.2009||R|A||0|0|E|0|LDR|0|0|1|100|IKR|5051|7695|lyfalmen|||00|25|1|17|Parlogis hf|Parlogis - óskráð lyf|Hýdrókortisón||5051||5051|7695 962466|H02AB0203|Dexamethason|töflur|4|mg|100|stk|1|glas||H02AB02|01.08.2009||R|A||0|0|E|0|LDR|0|0|1|100|IKR|3451|5524|lyfalmen|||00|100|1|267|Parlogis hf|Parlogis - óskráð lyf|||||3451|5524 962523|B05BB0118|Natrium Bicarbonat|irl|50|mg/ml|100|ml|10|fl||B05BB01|01.05.2009||R|A||0|0|0|1|LDR|0|0|0|100|IKR|11181|15788|lyfsjukr|||0|1000|1|0|Parlogis hf|Parlogis - óskráð lyf|Elektrólýtar||11181||11181|15788 962945|R06AB0201|Polaramin|töflur|2|mg|30|stk|1|þpakki||R06AB02|01.11.2009||R|A||0|0|E|0|PCO|0|0|0|100|IKR|2936|4825|lyfalmen|||00|30|1|10|Parlogis hf|Parlogis - óskráð lyf|||2936||2936|4825